Using FDG-PET functional neuroimaging to investigate regional brain responses to food ingestion in normal weight, obesity and after Roux-en-Y gastric bypass (RYGB) and the role of gut peptides after RYGB by Hunt, Katharine Frances
This electronic thesis or dissertation has been 
downloaded from the King’s Research Portal at 
https://kclpure.kcl.ac.uk/portal/  
Take down policy 
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing 
details, and we will remove access to the work immediately and investigate your claim. 
END USER LICENCE AGREEMENT 
Unless another licence is stated on the immediately following page this work is licensed 
under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International 
licence. https://creativecommons.org/licenses/by-nc-nd/4.0/ 
You are free to copy, distribute and transmit the work
Under the following conditions: 
 Attribution: You must attribute the work in the manner specified by the author (but not in any
way that suggests that they endorse you or your use of the work).
 Non Commercial: You may not use this work for commercial purposes.
 No Derivative Works - You may not alter, transform, or build upon this work.
Any of these conditions can be waived if you receive permission from the author. Your fair dealings and 
other rights are in no way affected by the above. 
The copyright of this thesis rests with the author and no quotation from it or information derived from it 
may be published without proper acknowledgement. 
Using FDG-PET functional neuroimaging to investigate regional brain responses to
food ingestion in normal weight, obesity and after Roux-en-Y gastric bypass (RYGB)














Using FDG-PET functional neuroimaging to 
investigate regional brain responses to food ingestion 
in normal weight, obesity and after Roux-en-Y gastric 




Katharine Frances Hunt 
0545705 





KF Hunt: MD (Res) Thesis 
ABSTRACT 
Roux-en-Y gastric bypass (RYGB) causes reduced food intake and sustained weight 
loss. The nature of differences in gut-to-brain communication and the associated 
differences in brain responses to food ingestion after RYGB that translate into reduced 
food intake are not yet elucidated.  One theory is exaggerated postprandial satiety 
hormone responses.  
 
I conducted a cross-sectional study in twelve normal weight (NW, BMI 22.3±1.4kg/m2), 
21 obese (Ob, BMI 34.1±2.6kg/m2) and 9 post-RYGB (RYGB, 18±12 months post-
surgery, BMI 34.0±3.3kg/m2) subjects.  Subjects underwent [18F]-fluorodeoxyglucose 
positron emission tomography (FDG-PET) neuroimaging after overnight fasting: once 
FED (400 kcal mixed meal), once FASTED (water only) in random order. RYGB 
subjects were also studied FED and FASTED with somatostatin (to inhibit pancreatic 
and gut peptide secretion) with basal insulin replacement.  I compared regional brain 
FDG uptake, a neuronal activation marker, using Statistical Parametric Mapping. 
Subjects underwent a post-scan ad libitum meal; fullness, hunger, anticipated 
pleasantness of eating, nausea and relaxedness were assessed using visual analogue 
scales (VAS); and pancreatic and gut peptides were measured. 
 
This thesis presents: 
• Development of a new functional neuroimaging protocol using FDG-PET to image 
the regional brain responses to food ingestion 
• Regional brain responses to food ingestion across all subjects 
• Differences in regional brain responses to food ingestion between normal weight, 
obese and post-RYGB subjects 
• Correlations between food-evoked signal change and ad libitum food consumption 
and appetitive sensations   
• Investigation of the role of exaggerated postprandial gut peptide responses in post-
RYGB subjects.  
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CHAPTER 1: INTRODUCTION 
1.1 OBESITY 
1.1.1. Overview of obesity and the brain 
The World Health Organisation (WHO) defines overweight and obesity as ‘abnormal or 
excessive fat accumulation that may impair health’ [1].  Both are common and 
increasing in prevalence.  The WHO estimates that in 2014 the prevalence of obesity in 
adults was 13% worldwide, more than double the prevalence in 1980, and 28.1 % in the 
United Kingdom. Obesity carries a wide range of medical and psychosocial 
complications [2].  The metabolic complications include type 2 diabetes (T2DM), 
dyslipidaemia, hypertension, cardiovascular disease and certain cancers and it is these 
that are responsible for the increased mortality associated with obesity [3].   
 
To become obese a person must consume more energy than they expend.  The epidemic 
of obesity is thought to be related to changes in the environment with easy access to 
energy-dense food and little requirement for physical exertion (the ‘obesogenic 
environment’) [4-6].   However, not everybody becomes obese and individual 
differences in susceptibility to developing and maintaining obesity are not understood. 
Genetic susceptibility, fetal and developmental programming, environmental factors and 
socio-cultural influences are thought to have causative roles [4, 5, 7].  
  
During the development of obesity energy intake is greater than energy expenditure.  
However, most people who become obese gain weight gradually and the underlying 
mismatches may be very small (e.g. 1 - 3%) [5].  In many cases a plateau is reached 
where energy intake and expenditure are relatively well matched and the person is 
relatively weight stable.  This high weight is defended against (acute) weight gain or 
loss [5].  Whether this is really a reset ‘set-point’, with different pathological processes 
from those active during weight gain [5], or a ‘settling point’ determined by the 
processes promoting energy gain balanced against signals of energy storage [8] is not 
clear.   
 
The brain has a pivotal role in the control of food intake and energy balance (Figure 
1.1).  The brain receives information about the body’s energy stores; nutrient 
availability in the blood and gastrointestinal tract; the appearance, smell and taste of 
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and other internal cues such as mood.  The brain integrates this information and 
generates outputs which determine food intake (including food seeking, meal initiation, 
food choice, and meal termination) and modulation of energy storage and expenditure.  
It is therefore reasonable to consider that the brain may be an important player in the 
pathogenesis or perpetuation of obesity.   Understanding the mechanisms by which the 
brain regulates food intake and body weight, differences in obesity and after successful 
weight loss may help improve methods to prevent and treat obesity.  Therapeutic 
strategies could be developed specifically to modulate activity in relevant brain regions 
for example non-invasive brain stimulation, neurofeedback, medications, dietary 
modification, cognitive behavioural therapy, or cognitive training [4]. It has been 
suggested that brain imaging techniques could be used to test potential interventions or 
identify those at risk of obesity and individualise interventions [4]. 
 
1.1.2 Approaches to studying the role of the brain in obesity 
The brain’s control of food intake may be divided into homeostatic, reward and 
executive control.  A complementary approach is to look at behavioural differences in 
the stages of eating: food seeking meal initiation, food choice and meal termination. 
These aspects have been studied to varying degrees in obesity, but it has been difficult 
to demonstrate differences.  There may be several reasons for this. Very small mismatch 
between energy intake and expenditure can lead to weight gain if sustained over a long 
period [4]. It is likely there are several different routes to obesity, rather than a single 
pathology [7].  Much research focuses on people who are already obese and relatively 
weight stable therefore in neutral energy balance. The advantages of this approach are 
that subjects are easy to define and identify and there is no acute energy imbalance 
which might impact on study results (although of course this is part of the pathogenic 
process). However,  as mentioned above (section 1.1.1), the processes in action in 
weight-stable obesity may be different to those in the development of obesity [5].  
Another approach is to study people during non-deliberate weight gain or those at high 
risk of obesity before weight gain.  However, subject identification may be difficult: for 
the former identifying those who are aware of weight gain, have a well-documented 
weight trajectory but are not trying to lose weight or avoid further weight gain; for the 
latter having a characteristic sufficiently predictive of obesity.  In both cases, subjects 
should ideally be followed up to demonstrate weight gain.  For those gaining weight 
there is the potential impact of short term energy imbalance at the time of the study 
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research relies on observation of behaviour in clinical research settings, which may not 
reflect real-world behaviour, or self-report, which may create bias.  Finally, differences 
found in obesity may be a consequence, rather than a cause, of obesity and/or dietary 
excess. 
   
1.1.3 Homeostatic control of body weight and differences in obesity  
1.1.3.1 Homeostatic control of body weight 
The homeostatic system is directed at monitoring and maintaining body energy stores.  
Hypothalamus plays a central role, receiving and processing signals relating to energy 
stores, circulating nutrient concentrations and food ingestion, both directly and via vagal 
signalling [9] (Figures 1.1 and 1.3). The best characterised signal of fat stores is leptin 
which is produced by adipocytes.  Plasma leptin concentrations are positively correlated 
with BMI and adipose tissue mass [10]. Insulin may also function as a signal of energy 
stored as increased energy storage increases insulin resistance and thus higher insulin 
concentrations [11]. Neurons in the arcuate nucleus of hypothalamus (ARC) express 
leptin and insulin receptors, are sensitive to local levels of nutrients including glucose, 
long chain fatty acids and some amino acids and carry receptors for gut peptides such as 
peptide YY (PYY) and glucagon like peptide 1 (GLP-1), secreted in response to food 
ingestion (section 1.3.3) [9].  The gut peptides convey information about the recent 
meal (postprandial satiety) and may influence the size of the next meal and the inter-
meal interval [12].  The hypothalamus also receives projections from the nucleus of the 
solitary tract in the medulla conveying information about food ingestion signalled by 
gastric distension and local release of gut peptides (sections 1.1.8.1 and 1.4.1) [13, 14].    
 
The ARC contains 2 neuronal populations central to the control of food intake [11].  
Activation of Neuropeptide Y/Agouti–related peptide (NPY/AgRP) neurons causes 
increased food intake and reduced energy expenditure (orexigenic).  Activation of pro-
opiomelanocortin/cocaine and amphetamine-related transcript (POMC/CART) neurons 
causes reduced food intake and increased energy expenditure (anorexigenic).  Leptin 
and insulin inhibit NPY/AgRP neurons and stimulate POMC/CART neurons.   
 
The effector arms of the homeostatic system operate by modulation of food intake and 
energy expenditure.  Food intake is adjusted by modulation of the food reward system 
(sections 1.1.4.1 and 1.4.4) and of brainstem pathways controlling meal termination 
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which may account for the mild negative valence associated with hunger and result in 
food seeking behaviour [14]. 
 
Energy expenditure is composed of basal energy expenditure (which increases with 
body size [6]), postprandial thermogenesis (related to digestion, absorption and storage 
of ingested food and is associated with meal energy content [15]), and physical activity 
thermogenesis which is further divided into volitional exercise and non-exercise activity 
thermogenesis (NEAT) (that attributed to activities of daily living) [15].  Studies using 
indirect calorimetry to measure energy expenditure (metabolic chamber studies) show 
average 24 hour energy expenditure, which in these studies comprises basal, 
postprandial thermogenesis and non-free-living NEAT, increases with overfeeding and 
decreases with fasting (reviewed in [16]).  Other studies in free-living humans (and 
animals) have shown NEAT is increased with overfeeding and decreased with 
undernutrition (reviewed in [6]). Non-exercise activity thermogenesis (NEAT) is 
regulated by the paraventricular nucleus of the hypothalamus [6]. 
 
1.1.3.2 Differences in homeostatic control in obesity 
Single gene defects identified as causing obesity all affect homeostatic signalling [4]. 
However, to date research has not demonstrated consistent causative differences in 
homeostatic systems in non-single gene obesity. The early promise of leptin has not 
resulted in therapeutic benefits for most people with obesity.  Leptin concentrations are 
higher in obesity [10] but do not maintain normal body weight.  This may be ‘leptin 
resistance’; leptin functioning as an indicator of adequate fat stores but less effectively 
as a signal of excess [17]; or leptin signals to reduce food intake may be overridden by 
other signals.   Extensive gut peptide research (section 1.3.3) has not shown consistent 
differences in obesity, except in fasting ghrelin, which is lower (section 1.3.3.5).  
 
Visual analogue scales (VAS) have been used to assess ‘homeostatic’ hunger and 
fullness but have limitations [18].  Most studies have found no difference in fasting 
hunger or other appetitive VAS scores between obese and normal weight subjects [19-
22].  Three studies found no difference in postprandial appetitive VAS scores (including 
fullness, satiety, hunger, desire to eat, malaise and prospective consumption) between 
obese and normal weight subjects for meal sizes up to 600 kcal  [19, 20, 22, 23], 
although one study found postprandial fullness was lower in obese subjects for larger 
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questionnaire [24] were higher in obese versus normal weight subjects in one study [25] 
although another found no difference [26].  This subscale notably includes items 
referring to hunger in response to external cues (which reflects anticipated reward rather 
than ‘homeostatic hunger’) and the timing as well as degree of hunger.  
 
Although excess energy intake is thought to be the more important in the development 
of obesity [5], differences in energy expenditure may also contribute.  Variance in 
energy expenditure measured in steady state in a metabolic chamber explains very little, 
if any, of the variance in future weight change  [16].   However, there is evidence that 
variance in adjusting energy expenditure to food intake may predispose to obesity.  In 
metabolic chamber studies, subjects who showed smaller increases in energy 
expenditure in response to overfeeding also showed larger decreases in response to 
fasting [16]. Smaller increases in energy expenditure with overfeeding (only with low-
protein overfeeding in one study) and larger decreases in energy expenditure with 
fasting predicted greater weight gain after 6 months (free-living) [27] or  smaller weight 
loss after 6 weeks caloric restriction [28].  As reviewed by Levine [6], there is evidence 
that in free-living humans, reduced NEAT is involved in the development and/or 
maintenance of obesity.  For example, in non-obese free-living people who were 
overfed for 8 weeks, those with the smallest increase in NEAT (assessed by measuring 
total daily energy expenditure using doubly labelled water and subtracting basal and 
postprandial energy expenditure using indirect calorimetry) gained the most fat [15].  
The interindividual differences in increase in basal metabolic rate or postprandial 
thermogenesis did not account for differences in fat gain.  Another study found obese 
people walk (the principle component of NEAT) less distance per day than non-obese 
people [29]. 
 
1.1.4 Food reward and differences in obesity 
1.1.4.1 Food reward   
Reward systems make behaviours necessary for survival, such as eating, pleasurable.  
Much of the initial research in reward was undertaken in the context of drug addiction 
(which subverts reward systems) and extended to food reward [30].   Berridge and 
Robinson proposed reward be considered as three component functions: liking; wanting 
and learning [31]. Liking is the experience of pleasure in response to a stimulus (the 
hedonic response).   Wanting, or desire, is the motivational component of reward, 
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wanted object is said to have ‘incentive salience’.  Learning refers to making 
associations between stimulus and reward which guides future behaviour.  Reward can 
also be considered as anticipatory (response to a cue) and consummatory (response to 
the reinforcer), which with food has both pre-ingestive (to food in the mouth) and post-
ingestive phases [4].   
  
The internal state (whether fasted or fed and fuel stores) influences food reward due to  
interaction between the homeostatic and reward systems.  The reward value of food 
decreases in the fed state.  For example, Cameron et al studied 15 non-obese adults after 
24 hour fast and after a 298 kcal breakfast and found that in the fed state wanting and 
‘liking’ scores for food images were lower, palatability scores for food just eaten (true 
liking) were lower and work for preferred snack food (using a computer task) was lower 
[32]. Ad libitum intake was also lower Snoek et al asked subjects to rate the 
pleasantness of taste (true liking) of 8 different foods before and after eating one of 
them to satiety and found pleasantness of taste ratings for all foods decreased [33].  The 
effect was most marked for the eaten compared to the uneaten foods a phenomenon 
known as sensory specific satiety [34].  In animal studies, mice in the fasted state, 
compared to the fed state, will do more work for food [35].   This modulation of the 
reward value of food is thought to be one of the mechanisms by which the homeostatic 
system influences food intake.  
 
1.1.4.2 Differences in reward responses in obesity  
Desire to eat is increased after exposure to food versus non-food cues and to high versus 
low energy density (ED) food cues [36]. There is some evidence that obese versus 
normal weight subjects are more responsive to external food cues (i.e. anticipate greater 
reward). Obese subjects rated high ED food pictures as more pleasant than low ED food 
pictures whereas normal weight subjects gave similar ratings [37] and obese versus non-
obese subjects rated chocolate odour as more pleasant [38]. Overweight versus normal 
weight subjects showed greater increase in desired pizza portion size after versus before 
exposure to real pizza in the fed state [39].  Using the Power of Food questionnaire to 
assess self-reported motivation to consume highly palatable foods, obese versus non-
obese subjects had higher scores on both the ‘food available’ (food readily available but 
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There is also evidence that obese subjects show greater food wanting (food motivation 
or reinforcement): obese subjects will do more work than non-obese subjects to obtain 
palatable foods [42, 43] and subjects with higher food motivation consumed more at an 
ad libitum meal [42]. However other studies have found no difference between obese 
and non-obese [26] or  normal weight subjects [44] the latter study using a slightly 
different protocol. 
  
Liking is defined as the experience of pleasure in response to a stimulus and therefore 
should be assessed when the subject is actually consuming the food.    However, this is 
rarely done.  Snoek et al did assess true liking, showing a correlation between VAS for 
pleasantness of taste of pieces of food and its subsequent  ad libitum consumption, but 
did not report a comparison between obese and normal weight [33].  Most studies 
reporting liking actually assess liking of food(s) in a more abstract sense which is more 
aligned to anticipatory food reward (discussed above).   
 
Two apparently conflicting theories arise from the substance misuse literature. One 
suggests that obese subjects have increased (consummatory) reward responses to food 
resulting in increased food consumption (the reinforcement sensitivity model) [45]. The 
other suggests obese subjects have impaired (consummatory) reward responses to food 
resulting in increased food consumption to obtain the same reward (reward deficiency 
model) [46].  Combining both theories, and evidence from neuroimaging (section 1.7), 
Alonso-Alonso et al recently proposed that subjects prone to obesity have an initial 
exaggerated liking response to eating, learning results in exaggerated anticipated reward 
to food cues (increased wanting) resulting in overeating which causes downregulation 
of the striatal response with less pleasure on actually eating food (decreased liking) and 
further weight gain [4].  This model is given some support from a study in which obese 
and non-obese women consumed 300 kcal of a chosen snack food daily for 2 weeks 
[26]. Wanting the snack food decreased in non-obese, but increased in obese, subjects.   
However liking of the snack food, although assessed before rather than during eating, 
decreased in both groups.  
 
It has been suggested that obese subjects may have delayed or reduced sensory specific 
satiety and are consequently prone to ongoing food intake [47].    However, Snoek et al 
found no difference between obese and normal weight subjects in sensory specific 
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similar attenuation of liking was achieved with greater food consumption, although  
response profiles were not assessed [33].  
  
1.1.5 Executive control and differences in obesity 
Executive control refers to the cognitive processes (conscious or unconscious) that 
select and monitor behaviour towards a goal [4].   Executive control may override 
homeostatic and reward-driven eating.  Individuals with reduced inhibitory control are 
more likely to gain weight [48] and obese versus normal weight or non-obese subjects 
have higher scores on the ‘disinhibition’ subscale of the three-factor eating 
questionnaire [25, 26]. However there is no difference in conscious restraint [25, 26]. 
 
1.1.6 Differences in meal initiation in obesity 
Meal initiation is thought to involve ‘homeostatic’ hunger (influenced by body energy 
stores and size and time since last meal (inter-meal interval)) responsiveness to external 
food cues, and social eating cues balanced by executive inhibition.   Although there is 
no difference in ‘homeostatic’ hunger in obesity (section 1.1.3.2), there is evidence of 
increased responsivity to external food cues (section 1.1.4.2), greater motivation for 
palatable foods (section 1.1.4.2) and greater reported disinhibition (section 1.1.5) all of 
which might translate into greater likelihood of meal initiation.  However, there are few 
data on meal/snack frequency in obesity, which is difficult to assess because of a 
probable effect of being under observation.   
 
1.1.7 Differences in food choice and dietary composition in obesity  
There are some data suggesting differences in dietary composition in obesity.  One 
study reported obese subjects attending for weight loss therapies consumed meat, white 
bread/toast, and diet soft drinks more frequently than non-obese controls [49] and 
another that obese subjects eat more snack food [50].  However, another study reported 
no difference in number of snack food categories or servings (assessed by 24 hour 
dietary recall) between non-obese and obese [26]). 
 
There is evidence that variation in the FTO (fat mass and obesity-associated) gene may 
predispose to obesity by influencing food choice.  Variation in the FTO gene has been 
linked with obesity in genome-wide association studies [51-54]. The presence of the A 
allele for the FTO SNP (single nucleotide polymorphism) rs9939609 is associated with 
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risk (A) allele have higher BMI and in one study ingested more energy-dense food at an 
ad libitum meal (higher energy intake, but no difference in weight of food consumed) 
[56] and in another selected foods higher in fat at a buffet meal (although there was no 
difference in total energy intake) [57].  Children with at least 1 A allele consumed more 
fat and total energy in a dietary report study [58].  This has been interpreted as the 
presence of the FTO A allele conferring preference for high-fat energy-dense foods, 
supported by finding that adults homozygous for the A allele rate pictures of high-
energy density foods as more appealing that do those homozygous for the T allele 
(studied in the fed state) [59]. 
 
1.1.8 Meal size and meal termination and differences in obesity 
1.1.8.1 Meal size and meal termination 
Meal termination (stopping eating thus completing a discrete episode of food intake) is 
the final step in determining meal size.  The primary pathway mediating meal 
termination involves signals generated by interaction between ingested food and the gut 
being transmitted via afferent vagal neurons to centres in the brainstem including the 
nucleus of the solitary tract (NTS) in the medulla [5, 14] (Figure 1.1).  The onward 
pathway(s) by which this results in stopping eating are less clear, but may involve the 
sensation of fullness and/or attenuation of reward responses.  This pathway is 
modulated by information about body fuel stores.   Meal size and meal termination can 
also be influenced by the type and amount of food available, social cues and conscious 
inhibition, discussed further below.  
  
Food ingestion causes gastric distension, which directly activates vagal neurons 
sensitive to stretch, and local release of satiation factors, which activate vagal neurons 
in a paracrine fashion [12, 14].  Possible satiation factors include the gut peptides 
cholecystokinin (CCK, section 1.3.3.4), peptide YY (PYY, section 1.3.3.1) and 
glucagon-like peptide 1 (GLP-1, section 1.3.3.2), which are released by enteroendocrine 
cells in response to food ingestion, and serotonin (5-hydroxytryptamine, 5-HT).  The 
best established satiation factor is CCK which activates CCK1 receptors on vagal 
afferent terminals [12].  Studies in humans have shown intravenous infusion of CCK to 
achieve physiological levels reduces meal size without adverse effects and CCK1 
receptor blockade reduces fullness during a meal, increases meal size and blocks the 
satiating effects of lipid infused into the duodenum [12, 14].  The role of GLP-1 and 
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These signals of ingested food are transmitted via vagal afferent neurons which synapse 
in the NTS in the medulla.  NTS neurons project to parabrachial nucleus in the 
brainstem, which is key in meal termination [5, 14].  The parabrachial nucleus contains 
CGRPPBN (calcitonin gene-related peptide expressing) neurons.  In animal studies, 
activation of CGRPPBN neurons reduces meal size but not meal frequency (although 
greater activation induces rapid onset, marked anorexia) [5, 14, 60].  Inactivation of 
CGRPPBN neurons increases meal size, and also blocks the effects of CCK and GLP-1to 
reduce food intake, supporting these neurons as key mediators of meal termination [5, 
14, 60]. The forward projections of CGRPPBN neurons by which they cause meal 
termination is less clear. However, they do project to amygdala (section 1.4.2) [14, 60].  
These neurons are also implicated in transmission of aversive experiences [5, 14]. 
 
This central pathway is modulated by information about body fuel stores.   Leptin 
administration reduces meal size, and inactivation of CGRPPBN  neurons blocks this 
effect [60].   Hypothalamic neurons (section 1.1.3.1) project to both NTS and 
parabrachial nucleus (NPY/AgRP neurons inhibit CGRPPBN neurons) providing a route 
by which body fuel stores and time/size of last meal can influence meal size [5, 14, 60].  
NTS neurons project to the hypothalamus conveying information about ingested food 
[14].  
 
In a separate pathway, amylin, which is co-released with insulin from pancreatic beta 
cells, increases within minutes of eating and may contribute to meal termination by 
acting on amylin responsive neurons in the area postrema in the medulla which project 
to NTS [61]. 
 
Meal size can also be influenced by the type and amount of food available and 
environmental and social cues (reviewed in [62]).  Greater consumption is associated 
with: greater reported liking of the presented food; greater (perceived or actual) variety 
of food; larger package or serving; larger plate, bowl or glass; and environmental factors 
such as lower lighting, the presence of other people and distractions. 
 
1.1.8.2 Differences in meal size and meal termination in obesity  
Animal studies suggest isolated inhibition of satiation factors and pathways (for 
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due to compensatory decreases in meal frequency [5, 14, 60]. There is no difference in 
the effect of CCK infusion to reduce meal size between obese and normal weight 
humans and no difference in effect of GLP-1 or PYY infusions [12].  However, 
polymorphisms in the CCK1 receptor in humans are associated with increased meal 
size, increased food intake and obesity [12] suggesting differences in satiation 
signalling may contribute to obesity in some people.  
 
As discussed above, obese subjects may have reduced fullness after large meals (section 
1.1.3.2), and greater disinhibition assessed by the three-factor eating questionnaire 
(section 1.1.5), many items of which refer to ongoing eating (versus meal termination) 
in relation to social situations, emotional state, and other factors [24].   
 
Whether such differences translate into differences in meal size in obesity is unclear.  In 
questionnaire studies, overweight versus normal weight subjects reported larger 
everyday portion sizes of 15 typical foods  [39] and obese versus non-obese reported 
larger portion sizes of main meals [63].  In a 7 day food diary study, there was no 
difference in meal size between overweight/obese versus normal weight, although 
overweight/obese had larger meal sizes when eating outside the home [64]. 
 
However, studies comparing ad libitum consumption (assessed in a research 
environment) have given conflicting results. Studies found no difference between obese 
and normal weight subjects in ad libitum consumption of either pasta salad 3 hours after 
a 600 kcal sandwich [22], Swedish hash 4 hours after a 225 kcal breakfast [65], or 
single variety sandwiches or snacks at lunchtime after a normal breakfast [33].  
However, 2 studies found obese subjects consumed more nutrient drink after an 
overnight fast than normal weight [66, 67], although in one of these (a large study of 
509 people) a significant difference was only found for obese with BMI >35 kg/m2 and 
not for overweight or obese BMI 30-35 kg /m2 [67].  Batterham et al showed that 
consumption at a buffet meal after a fast of at least 16 hours was greater in obese than 
normal weight subjects [68].  The discrepancies might be due to the duration of the fast, 
the degree of obesity studied or the nature of the ad libitum meal (single food versus 
buffet meal). As discussed in section 1.1.4.2 it appears that sensory specific satiety is 
not different between obese and normal weight people. However, Snoeck et al reported 
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significantly higher appetite for a meal or snack suggesting that obese subjects might be 
more likely to eat something different after eating a single food to satiation  [33].    
 
1.1.9 Summary of functional and behavioural differences in obesity  
Obese subjects show increased responsivity to external food cues representing high ED 
foods, greater food motivation for palatable foods, perhaps reduced fullness after large 
(but not small) meals and greater reported disinhibition.  Demonstrating behavioural 
differences is more difficult. However, although ad libitum intake of a single food 
appears no different, obese subjects may be more likely to overeat when presented with 
a variety of foods and may have different dietary composition.  
 
 
1.2 MANAGEMENT OF OBESITY 
Management of obesity includes: assessment of obesity including the presence of  
complications/comorbidities; management of comorbidities where present; and 
interventions directed at weight loss including lifestyle modification, pharmacotherapy  
and surgical approaches [69].   
 
1.2.1 Lifestyle interventions in obesity 
Multicomponent lifestyle interventions are central in obesity management and should 
continue alongside any other approaches [69].  This involves support and education to 
change behaviour in order to reduce energy intake and increase physical activity with 
the goal of weight loss, weight maintenance and improved health.  However, the 
average weight loss attained with lifestyle modification is modest: for example in the 
Finnish Diabetes Prevention Study weight reduction was 5.1±5.3% at 1 year and 
4.0±5.8% at 3 years (mean±SD) [70] and there is a tendency to regain weight [7, 71, 
72].   
 
1.2.2 Pharmacological interventions in obesity 
Several drugs, with a variety of mechanisms of action, have been demonstrated to cause 
weight loss in clinical trials (summarised in [73]).  However not all are currently 
available in the UK and several have been withdrawn after their approval due to adverse 
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1.2.3 Bariatric surgery 
Current NICE guidance (2014) supports bariatric surgery as a treatment option for 
people with obesity with BMI≥40 kg/m2 (or 35-40 kg/m2 with obesity-related 
comorbidity), in whom all appropriate non-surgical measures have been unsuccessful, 
who are managed in a tier 3 service, are fit for anaesthesia/surgery and commit to long-
term follow up [69].  
 
There are three main types of bariatric surgery in current use: Roux en Y gastric bypass 
(RYGB), vertical sleeve gastrectomy (VSG), and adjustable gastric banding (AGB) [74] 
(Figure 1.2). In RYGB, the stomach and jejunum are divided and reconnected such that 
food passes into a small (15-30ml) gastric pouch and then directly, through the gastro-
jejunal anastomosis, into the jejunum (the alimentary limb) bypassing the majority of 
the stomach, duodenum and proximal jejunum [75].  The excluded biliopancreatic limb 
is anastomosed to the alimentary limb (the jejuno-jejunal anastomosis).  In VSG the 
lateral part (70-80%) of the stomach is excised [75].  In AGB an adjustable plastic and 
silicone ring is inserted around the proximal stomach just below the gastro-oesophageal 
junction.  The band is adjusted by adding or removing fluid through a subcutaneous port 
[75].   The UK National Bariatric Surgery Register (NBSR) reports that in 2015-2017 
18,528 primary operations were performed in the UK where the type of operation was 
recorded: RYGB 45.4%, sleeve gastrectomy 36%; and gastric banding 10.1% [74].   
The average weight loss at 1 year was 33.1%, 28.5% and 16.3% respectively [74]. 
 
 
1.3 ROUX-EN-Y GASTRIC BYPASS (RYGB)  
RYGB is the most commonly performed bariatric procedure in the UK [74] and 
worldwide [7].  RYGB causes significant sustained weight loss (20-30%), improvement 
in cardiovascular risk, remission of type 2 diabetes (T2DM), and reduction in mortality 
in obesity [76-79].  However, it does have complications [72].  Understanding the 
mechanisms by which RYGB causes sustained  weight loss and metabolic benefits may 
help improve methods to prevent and treat obesity, whether refining surgical 













Figure 1.2:  Schematic diagram showing the anatomy of Roux-en-Y gastric bypass 
(RYGB) (a), adjustable gastric banding (b) and vertical sleeve gastrectomy 





KF Hunt.   Chapter 1: Introduction. 
1.3.1 Mechanisms of action of RYGB 
Weight loss requires reduction in energy intake and/or increased energy expenditure or 
loss.   There is now consensus that reduction in energy intake is the predominant driver 
of weight loss, and prevention of weight regain, in humans after RYGB [7, 71]: energy 
intake is reduced by about 55% at 6 months and 40% at 2-3 years [71].  There is little 
evidence that increased energy expenditure plays an important role in humans [71].   
Although there is evidence of increased faecal energy loss after RYGB, the contribution 
of malabsorption is relatively small [7, 71, 72] accounting for 6-11% of the reduction in 
metabolizable energy intake [71].  Several differences in eating behaviours, and 
potential underlying differences in responses to food, have been demonstrated after 
RYGB which might contribute to reduced food intake and thus weight loss  
 
1.3.1.1 Hunger, fullness and homeostasis after RYGB  
Fasting hunger, assessed by VAS, is reduced after RYGB from as early as 2 days after 
surgery demonstrated in both longitudinal [80-83] and cross-sectional studies [21, 84]. 
Fasting fullness or satiety is either not reported [80, 81] or not significantly different 
[21, 82-84] .  
 
Longitudinal studies have consistently found increased fullness or satiety and/or 
reduced postprandial hunger after fixed mixed meal (300-500 kcal) from 2-3 days after 
RYGB until at least 1 year [80, 81, 83, 85] with similar findings in a cross-sectional 
study compared to obese unoperated [23].  Where shown, peak fullness and nadir 
hunger are at 10-30 min post-meal and remain different from pre-RYGB/obese until at 
least +90 min.  In studies that have assessed prolonged postprandial response, the 
impact of RYGB on hunger and/or fullness appears to be present, or at least be no 
different, until at least 2-4 hours post meal [21, 44, 65, 83, 85, 86].  
 
People who have had RYGB attain a new lower weight which may increase slightly 
over time but generally does not return to pre-operative levels [7, 71, 72].  This is in 
contrast to weight loss due to dieting, which is usually followed by weight regain, 
thought to be driven by reduction in leptin and possibly other signals of relative 
depletion of energy stores [7, 71, 72].  The post-RYGB weight is defended against 
further weight loss and perhaps against acute weight gain and is sometimes described as 




KF Hunt.   Chapter 1: Introduction. 
by the altered post-RYGB hunger, fullness and eating behaviours balanced against 
signals of energy storage is not clear [71]. 
 
1.3.1.2 Reward responses after RYGB  
There is evidence that post-RYGB subjects are less responsive to external food cues, 
particularly high ED food cues. Before RYGB the desire to eat (any food) after 
exposure to high ED food cues (pictures and spoken name) in the fed state was greater 
than after low ED food cues whereas after RYGB there was no difference, with a large 
reduction for high ED and a small non-significant reduction for low ED cues [87].  A 
similar pattern was seen for abstract liking (reflecting anticipated reward), but with an 
increase for low ED food cues [87].  Post-RYGB subjects versus obese [41] and pre-
RYGB [88] show reduced scores on the ‘Power of Food Scale’ questionnaire in all 3 
domains (food available, food present and food tasted).  Domain scores for food 
available and food present were inversely correlated with weight loss in Schultes et al 
[41] but not in Ullrich et al [88].   
 
There is also evidence that food wanting (motivation) is reduced after RYGB.  Miras et 
al found a reduction in the amount of work subjects did for sweets 8 weeks after RYGB 
versus before RYGB, but not for vegetables: weight loss correlated with decrease in 
breakpoint for sweets [44].   
 
No studies have assessed true food liking (i.e. the experience of pleasure when actually 
eating) after RYGB in humans. Animal studies suggest reduction in liking of high ED 
foods after RYGB (reviewed in [71]) and a number of studies suggest RYGB alters 
central (and/or peripheral) taste processing (reviewed in [71, 72]).   
 
Eating after RYGB can be associated with unpleasant post-ingestive sensations such as 
nausea, extreme fullness and dumping syndrome.  It is possible that these might result 
in post-RYGB subjects learning to avoid foods and meal sizes that cause these 
sensations (conditioned food avoidance) [71, 72]. It is important to note that subjects 
may still experience pleasure when the food is in the mouth [72].  
 
1.3.1.3 Executive control after RYGB 
In a longitudinal study, Laurenius et al reported reduced scores on the disinhibited and  
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There was increased conscious restraint at 6 weeks, perhaps reflecting the specific 
dietary advice for the postoperative period, but not at 1 and 2 years. 
 
1.3.1.4 Meal initiation and frequency after RYGB 
The decreased fasting hunger (section 1.3.1.1), reduced responsiveness to external 
eating cues (section 1.3.1.2) and reduced disinhibited and emotional eating (section 
1.3.1.3) would be expected to reduce meal initiation and meal frequency and indeed 
early studies showed reduced meal frequency after RYGB [89, 90].  However, 
Laurenius et al reported increase in meals per day after versus before RYGB [65] and 
frequent food consumption after RYGB has also been reported in questionnaire studies 
[91, 92]. It has been suggested this may reflect the prevailing dietetic advice to eat 
frequently rather than a direct consequence of RYGB.  Studies assessing prolonged 
postprandial response (up to 2-4 hours) show no suggestion of paradoxical late higher 
hunger or lower fullness which might initiate another meal [44, 65, 83, 85]. 
 
1.3.1.5 Food choice and dietary composition after RYGB 
The reduction in abstract liking for high ED food cues (versus an increase for low ED 
food cues) (section 1.3.1.2), reduction in willingness to work for sweets (but not 
vegetables) (section 1.3.1.2) and unpleasant post-ingestive sensations after certain foods 
(section 1.3.1.2) would be expected to alter food choices and dietary composition after 
RYGB.  Laurenius et al found that dietary ED, assessed by questionnaire, decreased at 6 
weeks, 1 and 2 years after RYGB, but there was no correlation with weight loss [93].  
Consistent with a change in dietary composition from high to lower ED foods, post-
RYGB versus obese subjects [49] or versus pre-RYGB [88] showed more frequent 
consumption of poultry, fish, eggs, and cooked vegetables and less frequent 
consumption of chocolate; cake, biscuits and cookies; and fruit juice or soft drinks 
assessed by a food frequency questionnaire.  Animal studies also show a shift from fat 
to lower ED foods (reviewed in [7]).  Notably, although conditioned food avoidance due 
to unpleasant post-ingestive sensations has been proposed as an underlying mechanism, 
one study has shown that people after RYGB appear to make healthier food choices 
even if they do not experience dumping [72] 
 
1.3.1.6 Meal size and meal termination after RYGB 
The consistent finding after RYGB of increased fullness post fixed-meal, peaking at 10-
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reduced disinhibition (section 1.3.1.3), would be expected to result in smaller meal sizes 
after RYGB.  This has been confirmed in a longitudinal study in 43 subjects which 
found reduced ad libitum consumption (of Swedish hash, 4 hours after a fixed 225 kcal 
breakfast) at 6 weeks, 1 and 2 years after RYGB versus before RYGB (42-66% pre-
RYGB)   [65]. They also showed a negative correlation between ad libitum meal size 
and weight loss at 1 year (although not at 2 years) consistent with enhanced meal 
termination contributing to weight loss.  They found no significant difference between 
pre and post-RYGB in VAS satiation at the end of the ad libitum meal suggesting that 
the degree of fullness that causes meal termination is not different after RYGB, rather it 
occurs at smaller meal size [65]. 
 
1.3.1.7 Summary of differences in responses to food and eating behaviours after RYGB 
The most coherent story after RYGB is increased postprandial fullness or satiety and 
reduced ad libitum meal size which correlates with post-RYGB weight loss.  There is 
also reduced responsivity to high ED external food cues, reduced food motivation for 
high ED foods and lower reported disinhibition after RYGB, which appear to be 
normalisation of differences previously shown in obesity, although as very few of the 
RYGB studies include normal weight controls it is difficult to be certain. These changes 
may underlie the reduction in dietary energy density after RYGB, although this has not 
been shown to correlate with weight loss.  The conflicting data on meal frequency after 
RYGB may be driven by dietetic advice. 
 
1.3.2 Mechanisms of altered gut-to-brain communication after RYGB 
The pathways by which the altered gut structure of RYGB signals to the brain to alter 
food responses and eating behaviour are not fully understood. One of the most 
researched potential mechanisms is alteration in gut peptide secretion, discussed below.  
The early suggestion that the small gastric pouch might cause physical restriction is not 
the case as the pouch empties quickly [94].  However, there is evidence that increased 
pressure in the alimentary limb of jejunum immediately after the gastric pouch might be 
important [72]. Other proposed mechanisms include: disruption of vagus nerve 
branches; altered bile flow through the biliopancreatic limb without mixing with food 
until the common limb; altered gut microbiota and altered peripheral taste receptors 
(reviewed in [72]).   It is likely that several mechanisms are involved, and different 
mechanisms may predominate in the weight loss (typically 6-12 months in humans) and 
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1.3.3 Gut peptides, pancreatic peptides, glucose and adipokines in normal weight, 
obesity and after RYGB 
Many studies have demonstrated that gut peptide and insulin responses to eating are 
altered after RYGB, particularly exaggerated PYY and GLP-1 responses.  These 
changes are evident within 2 or 3 days after RYGB and persist in the longer term [7, 
72].  People with greater weight loss after RYGB have greater postprandial GLP-1 
response [7].   Le Roux et al studied 7 subjects 9.5±1.5 months after RYGB and found 
that the somatostatin analogue octreotide, which inhibits gut peptide (and insulin) 
secretion, reduced fullness 15 min into an ad libitum meal and increased ad libitum 
consumption  [81]. These data, alongside the known physiological effects of gut 
peptides, suggest that the exaggerated PYY and GLP-1 responses to eating post-RYGB 
may be important in reducing meal size and contributing to weight loss [7, 72].  Animal 
studies generally support this hypothesis [7].  
 
Studies investigating differences in gut peptides, pancreatic peptides and adipokines 
between normal weight, obese and/or after RYGB are discussed below and summarised 
in Table 1.1.  Discrepancies between studies may relate to variation in: the subjects 
studied, including time since surgery and the precise surgical procedure for RYGB 
subjects, weight stability, and glycaemic status; food intake on days preceding the 
study; duration of fast; composition of meal stimulus; timing of samples in relation to 
meal; sample handling; and the assay used, particularly whether it measures biologically 
active or total hormone [83].  
 
1.3.3.1 PYY 
PYY1-36 is secreted by L cells in the intestinal mucosa (predominantly distal small 
intestine and colon), stimulated by nutrients in the gut lumen, although the initial rise 
occurs before nutrients reach the distal small intestine and may be stimulated by neural 
or hormonal mechanisms [83].  PYY1-36 is cleaved in the circulation by DPP-IV 
(dipeptidyl peptidase-IV) to the biologically active PYY3-36 which promotes satiety, 
reduces gastric emptying and intestinal motility [12, 95]. 
 
Studies comparing fasting PYY in normal weight, obese and post-RYGB have given 
varying results.  Two found lower total PYY in obese versus normal weight [20, 68], 
two overlapping studies found no difference in PYY (total and/or PYY3-36) between 




KF Hunt.   Chapter 1: Introduction. 
RYGB versus obese [84].  Longitudinal studies have shown a post-RYGB increase in 
total PYY [96], a decrease in total PYY  [97],  and no significant difference in PYY3-36 
[83].   
 
In normal weight subjects postprandial PYY (PYY1-36 and PYY3-36) peaks at 90-120 min 
at about 1.5-2x fasting [20, 21, 86, 98] with a peak proportionate to calorie load in a 
fixed meal series [20].  Some studies have shown a small attenuation in postprandial 
PYY response in obese versus normal weight subjects for ad libitum [68] and fixed 
meals [20, 98] although  others have not [21, 86].   Post-RYGB studies consistently 
show an exaggerated (2-8x fasting) and earlier (at 30-60 min) postprandial peak for both 
PYY1-36 and PYY3-36, concentrations remaining higher until at least 90 min, both in 
cross-sectional studies versus obese and normal weight [21, 80, 86, 98]  and in 
longitudinal studies [80, 83, 96, 97].  The exaggerated postprandial PYY response has 
been shown from 2 days post-RYGB [81] to 35±5months (mean±SE) post-RYGB [21]. 
 
1.3.3.2 GLP-1 
GLP-1 is also secreted by L cells in the intestinal mucosa  in response to nutrients in the 
gut lumen: as for PYY the initial rise may be stimulated by neural or hormonal 
mechanisms [83].  GLP-1 promotes glucose-dependent insulin secretion, improves 
insulin sensitivity, promotes satiety and reduces gastric emptying and intestinal motility 
[12, 95].  Active GLP-1 is subject to enzymatic degradation by endogenous DPP-IV 
[99].   
 
Studies have found no significant difference in fasting GLP-1 between normal weight 
and obese subjects [22, 68, 100] or after RYGB versus obese non-operated [98, 101, 
102] and  pre-RYGB (in both normal glucose tolerance (NGT) and T2DM) [80, 83, 85, 
96, 97, 102-104]. 
 
In normal weight subjects postprandial GLP-1 peaks at 60-90 min at 1.5-2.5x fasting   
[22, 100].  Studies comparing obese and normal weight have found a small, not always 
significant, attenuation in obesity [22, 98, 100].  Post-RYGB studies consistently show 
an exaggerated and earlier postprandial GLP-1 (active and total) response (peaking by 
30 min at 3-10x fasting, falling steeply by 60 min but remaining higher than obese until 
at least 90 min) versus obese unoperated [98, 101, 102] and in longitudinal studies (in 
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Table 1.1:  Comparison of gut peptides, pancreatic peptides and adipokines in normal weight, obese and after RYGB 
 Fasting Postprandial 













PYY ↔ ↓ ↔  ↔ ↓ ↑ 
[20, 21, 68, 83, 
84, 86, 96, 97] 
Peak 
90-120 min 
↔ ↓  




[20, 21, 68, 80, 
81, 83, 86, 96-
98] 
GLP-1 ↔ . ↔ 





↔ ↓ . 
↑ 
earlier 
[22, 80, 81, 83, 
85, 96-98, 100-
104] 










Ghrelin ↓ . ↔ (↓) 
[10, 21, 68, 83-
86, 96-98, 106] 
Nadir 
60-90 min 
↔ ↑ . ↔ ↓ 
[21, 83, 85, 86, 
96, 97, 107] 





↔ ↑ . 
↔ 
↑earlier 
[97, 105, 109, 
111-114]. 
Insulin ↑ ↔   ↓ 
[10, 21, 22, 68, 
85, 86, 96-98, 

















- ↔ ↓ 
[85, 101, 103-
105, 116, 117] 
Peak  
? 30 min 
. . ↔ ↑ 
[85, 101-105, 
118] 
Somatostatin . . ↔ [105] . 
Obese peak 
at 45 min 
. ↔ [105] 
Adiponectin ↓ . ↑ 
[10, 115, 119, 
120]      
Leptin ↑ ↔ ↑ ↓  
[10, 21, 85, 86, 
96, 98, 116, 
120] 
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GLP-1 response has been shown from 2 days post-RYGB [81] to 25±2 months 
(mean±SE) [101]. 
 
1.3.3.3 Glucose-dependent insulinotropic polypeptide (GIP) 
GIP is secreted by K cells in the intestinal mucosa (with highest proportions in the 
duodenum and jejunum) in response to luminal nutrients.  GIP promotes insulin and 
glucagon secretion, satiety and, by increasing lipoprotein lipase activity, conversion of 
glucose to fatty acids and storage in adipose tissue [95].   
 
Two studies have reported similar fasting GIP in obese and normal weight subjects [22, 
100].  Most studies have found no significant difference in fasting GIP between post-
RYGB and obese [101, 102] or pre-RYGB [85, 102, 103] although some  have found 
reduced fasting GIP particularly in the first week [85, 103, 104].   
 
In normal weight subjects postprandial GIP responses peak at 30-90 min and are not 
different between obese and normal weight subjects [22, 100].   After RYGB, the 
postprandial GIP response shows an earlier (before 30 min), and possibly higher, peak 
and a sharp fall, being lower than in obese unoperated subjects before +60 min in both 
cross-sectional [101, 102] and  longitudinal studies (in both NGT and T2DM) [85, 102-
105].  In both NGT and T2DM the GIP response changed over the first year post 
surgery with a higher peak at 3 months than 1 year  [103].   
 
1.3.3.4 Cholecystokinin (CCK) 
CCK is secreted by I cells in the duodenum and proximal jejunum. Secretion is 
stimulated most by duodenal lipids, then protein, then carbohydrate [12, 95].  CCK 
decreases meal size, causes gallbladder contraction releasing bile, and slows gastric 
emptying [12, 14, 95].   
 
Fasting CCK is probably little different in obese compared to normal weight subjects 
being lower in 1 study [108] and no different in 2 others [109, 110].  Longitudinal 
studies have shown no difference in fasting CCK after RYGB [97, 105].   
 
Plasma CCK peaks at 60-90 min post mixed meal [12]. Studies comparing obese and 
normal weight have given variable results: one showed no difference in response to 
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showed increased CCK response to a high-fat meal [111].  A third study looking at 
response to intraduodenal fatty acid infusions showed decreased and delayed CCK 
response [110].  Differences after RYGB have not been a research focus because 
nutrients bypass the duodenum and proximal jejunum (which contain the highest 
density of CCK-secreting cells) after RYGB [12, 95].  Three studies have found no 
difference [112-114] and 2 a higher and earlier peak after RYGB versus before RYGB 
[97, 105].  The mechanisms are not clear.  
 
1.3.3.5 Ghrelin 
Ghrelin secretion by A cells in the gastric fundus and proximal small intestine is 
suppressed by food ingestion.  Acyl-ghrelin (the active form) increases food intake and 
gut motility and decreases insulin sensitivity [95]. Higher acyl-ghrelin fraction is 
associated with a less favourable metabolic profile [106].   
 
Fasting ghrelin is lower in obese versus normal weight subjects [21, 68, 86, 98, 106] 
with the proportion of acyl-ghrelin increasing with increasing BMI [106].  Cummings et 
al found very low fasting ghrelin post-RYGB [107] but this has generally not been 
replicated [10, 21, 83-86, 96-98, 106].   
 
In normal weight subjects there is a modest postprandial suppression in total ghrelin (to 
0.7-0.8x fasting) reaching a nadir at 60-90 min [21, 86, 107] with a larger impact on 
acyl-ghrelin (0.55x fasting) [21, 86].  In obese, versus normal weight, subjects the 
impact of food ingestion on total ghrelin is either no different [107] or attenuated [21, 
86] and the impact on acyl-ghrelin appears no different  [21, 86]. Most studies suggest 
no significant difference in postprandial total ghrelin post-RYGB [85, 96, 97] although 
some show greater suppression of total ghrelin [86] or acyl-ghrelin [83, 86].   
 
The discrepancies might be due to assays used, the nature of the control group, or 
variable disruption of the vagus during surgery [121].   Barrazzoni et al concluded post-
RYGB changes in fasting ghrelin profile are unlikely to contribute, and may even limit, 
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1.3.3.6 Insulin 
Insulin is secreted by pancreatic beta cells in response to incretins (e.g. GLP-1 and GIP) 
and glucose.  As well as its recognised metabolic actions, insulin may have a role in 
appetite control [122]. 
 
Obesity is associated with insulin resistance with higher fasting insulin and measures of 
fasting insulin resistance (e.g. HOMA-IR) in obese versus normal weight subjects [22, 
68].  Cross-sectional studies have shown fasting insulin and HOMA-IR highest in obese 
and equally lower in normal weight and post-RYGB subjects [21, 86, 98]. Several 
longitudinal studies have reported reduced fasting insulin and/or HOMA-IR after 
RYGB both in subjects with NGT and T2DM [10, 85, 96, 97, 103, 104, 115, 116].   
 
In normal weight subjects, insulin peaks at 30-45 min after a mixed meal [22].  In obese 
subjects insulin is higher at all time points with a delayed (60-90 min), higher 
postprandial peak and a slower post-peak fall [21, 22, 86].  After RYGB there is an 
earlier (before +30 min) and higher insulin peak versus obese with a rapid post-peak fall 
such that from +60 min (or earlier) insulin is lower post-RYGB versus obese and 
similar to normal weight (where included) [21, 86, 98, 101] with a similar pattern in 
longitudinal studies [85, 96, 97, 103, 104].  Peak insulin is highest early after surgery 
[97, 103].  Similar results have been found in people with T2DM [103, 104] although 
the peak insulin was lower [103].  
 
1.3.3.7 Glucagon 
Glucagon is secreted by pancreatic alpha cells in response to falling glucose levels.  
Several mechanisms are involved including a direct effect of glucose, low insulin 
(insulin inhibits glucagon secretion), the autonomic nervous system and GIP [123].  
Glucagon increases hepatic glucose production and also increases lipolysis and fatty 
acid oxidation and ketogenesis in the liver, decreases food intake and increases energy 
expenditure [123]. The main focus of glucagon research has been in glucose regulation 
and diabetes [123].   
 
There is little data regarding fasting glucagon in obesity per se,   however it appears that 
glucose tolerance/insulin resistance is key.  In subjects with NGT, there was no 
difference in fasting glucagon between obese and non-obese, whereas in those with IGT 
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subjects, fasting glucagon is either higher in subjects with IGT versus NGT [118] or no 
different in those with IGT or T2DM versus NGT [117].   One study in obese subjects 
with NGT has shown decreased fasting glucagon after deliberate non-surgical weight 
loss, but insulin resistance also improved [117].  After RYGB, compared either to obese 
subjects or pre-RYGB, the few studies show either no difference [85, 101, 105] or a 
small reduction in fasting glucagon [103, 116] with both no change [104] and a 
reduction [103] in people with T2DM who underwent RYGB.   
 
There are little recent data on postprandial glucagon responses in normal weight 
subjects.  In one study in non-obese subjects with NGT, there was a small, non-
significant increase at 30 min post mixed meal, not measured at 60 or 90 min and falling 
to below baseline by 120 min [118].  To my knowledge, there are no recent studies 
directly comparing the glucagon response to mixed-meal in normal weight and obese 
subjects.   However, in obese subjects, glucagon  rises to a peak at 30-60 min and then 
falls, sometimes to below baseline [85, 101, 103-105].   Glucagon response depends on 
meal composition [124] and also on glucose tolerance: in non-obese subjects with IGT 
(or T2DM) compared to NGT, glucagon is increased at 30 min falling to similar levels 
to NGT by 120 min [118].  Most studies on postprandial glucagon responses after 
RYGB have shown no significant differences (although there is a suggestion of a 
slightly earlier or higher peak) [85, 101-104]. However, one showed an increase in 
postprandial glucagon in the first 2 weeks after RYGB [105]and others  a greater 
postprandial response in subjects with T2DM [103, 104].  
 
1.3.3.8 Somatostatin 
Somatostatin is produced by delta cells in the pancreas, stomach and duodenum [95].  
Somatostatin inhibits the secretion of multiple hormones including: gut peptides PYY, 
GLP-1, GIP, cholecystokinin (CCK), gastrin and secretin; pancreatic peptides insulin 
and glucagon; and pituitary hormones growth hormone, thyroid stimulating hormone 
and prolactin [95].  In obese subjects somatostatin peaks at 45 min post mixed meal 
with no significant difference in fasting or post-mixed meal response in subjects studied 
within 2 weeks after RYGB [105]. 
 
1.3.3.9 Glucose 
A discussion of impact of obesity and RYGB on glucose profiles is included here, 
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thesis, is influenced by prevailing glucose levels. This is aspect is considered further in 
sections 2.5.3, 2.5.4 and 6.4.3.2. 
 
Three-group cross-sectional studies show fasting glucose is higher in obese than normal 
weight or post-RYGB subjects, with no difference between normal weight and post-
RYGB [21, 86]. This is consistent with 2-group cross-sectional studies comparing obese 
and normal weight subjects [22] or post-RYGB versus obese controls  [101].  A series 
of longitudinal studies have found lower fasting glucose up to one year after RYGB, 
versus before RYGB, in subjects with a range of pre-RYGB glucose tolerances [10, 85, 
96, 97, 104, 115, 116].  
 
The literature on postprandial glucose profiles is varied, likely due to protocol factors. 
In normal weight subjects after a 600 kcal sandwich meal plasma glucose peaks at 
around 30 min and returns to baseline by 60 min [22] whereas after a 320 kcal mixed 
liquid meal with the first sample at 30 min no rise was identified and glucose was below 
baseline at 60 min [21, 86].   In obese subjects the glucose peak after a mixed meal is 
higher and delayed/prolonged with a slow fall such that in obese versus normal weight 
subjects plasma glucose is similar at 15 min [22], similar [22] or higher [21, 86] at 30 
min and much higher at 60 min [21, 22, 86].  In post-RYGB, versus obese [21, 86, 101] 
or pre-RYGB [85, 96, 97, 103, 104], there is a leftward shift of the post mixed meal 
(300-424 kcal) glucose curve: glucose rises more sharply and may peak earlier with a 
rapid fall to a nadir at about 60 min, which is similar to normal weight subjects where 
included [21, 86] and may be hypoglycaemic [101], and then increases but remains 
lower than pre-RYGB.  Whether the peak glucose is higher [85, 97, 103], unchanged 
[104] [21, 86] [101] [104] or lower [96, 103] after RYGB appears to depend on the 
precise sample timing (if the first postprandial sample is taken at 30 min this may be 
when glucose is falling in post-RYGB subjects and still rising in pre-RYGB/obese 
subjects), the composition of the test meal, the time post-surgery (peak glucose falls 
over the first year post surgery [97]) and the subjects’ glucose tolerance.  Jorgensen et al 
found that in subjects with NGT prior to surgery, peak glucose was higher at 3 months 
and 1 year post-RYGB versus pre-RYGB, whereas in subjects with T2DM prior to 
surgery peak glucose was lower and earlier post-RYGB versus pre-RYGB, but still 
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1.3.3.10 Adiponectin and leptin 
Adiponectin and leptin are adipokines, however it is relevant to mention these here.  
Adiponectin has insulin-sensitising actions in liver and skeletal muscle and reduced 
adiponectin is associated with an increased risk of insulin resistance and type 2 diabetes 
[115].  Arita et al found reduced plasma adiponectin in obese versus non-obese subjects 
[119] and three fairly large studies have found increased adiponectin after RYGB, 
versus before RYGB [10, 115, 120], particularly high molecular weight adiponectin 
[115].  It has been postulated that the increased adiponectin after RYGB may contribute 
to the metabolic benefits.  
 
Regarding leptin (section 1.1.3), 3-group cross-sectional studies reported higher leptin 
in obese than normal weight and RYGB, which were either similar [21, 86] or showed 
lower leptin in normal weight versus post-RYGB [98]. Longitudinal studies have found 
reduced fasting leptin 1–15 months after RYGB, versus pre-RYGB [10, 85, 96, 116, 
120].    
 
 
1.4 BRAIN NETWORKS CONTROLLING FOOD INTAKE 
The brain control of food intake may be considered to comprise three interconnected 
networks: homeostatic; reward; and executive control (Figure 1.1).   
 
1.4.1 Homeostatic network 
The homeostatic network for energy balance is centred on hypothalamus (section 
1.1.3.1) and nucleus of the solitary tract (NTS) in the medulla (Figures 1.1 and 1.3).  
Vagal neurons synapse in the NTS and transmit information about food ingestion 
signalled by gastric distension and local release of gut peptides [13, 14].  NTS neurons 
project to hypothalamus and parabrachial nucleus (section 1.1.8.1) and hypothalamic 
neurons (section 1.1.3.1) project to both NTS and parabrachial nucleus. 
 
1.4.2 Reward network 
The three component functions of reward, learning, wanting and liking (section 1.1.4.1, 
[31]) do not segregate simply into 3 anatomically distinct neural circuits, with many 
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Insula, operculum, amygdala, hippocampal formation, orbital cortex (OC) and anterior 
cingulate cortex (ACC) are involved in the generation, storage and recall of 
representations of food experience [30].  Insula and operculum contain the primary 
gustatory (taste) cortex [125] and also respond to food texture and to internal sensations 
such as gastric distension (interoception).  Amygdala is thought to encode the predicted 
biological relevance of a stimulus.  Hippocampus and parahippocampal gyri encode 
memory.  OC may encode the reward value (or salience) of food, particularly when 
choice is involved  [125].  ‘Wanting’ is considered to be mainly mediated by the 
mesolimbic system: dopaminergic projections from ventral tegmental area (VTA) in the 
midbrain to ventral striatum (nucleus accumbens), dorsal striatum (caudate and 
putamen) and other limbic structures.  The network processing ‘liking’ includes 
striatum, globus pallidus, OC and ACC.   
 
1.4.3 Executive control network 
Regions in the prefrontal cortex appear to play a critical role in executive control 
(Figures 1.1 and 1.5). Dorsolateral frontal cortex (DLFC) is associated with inhibitory 
control (‘stop’), medial frontal cortex (MFC) with action selection (‘go’) and ACC with 
error and conflict detection [126].  
 
1.4.4 Interconnections between homeostatic, reward and executive control 
networks 
These 3 networks do not operate in isolation.  There is evidence from both animal and 
human studies [14] that the fed state impacts on food reward [14] (section 1.1.4.1).  
Modulation of food reward is thought to be one of the main mechanisms by which 
changes in internal status impact, via the homeostatic system, on food seeking/meal 
initiation and thus food intake.  There is a pathway from AgRP neurons via the 
paraventricular thalamus and amygdala to the insula which may  mediate this [14].   
Neurons of the parabrachial nucleus in the brainstem (which receive information about 
food ingestion and are involved in meal termination, section 1.1.8.1) also project to 
amygdala [14, 60].   
 
There is also evidence of ‘top-down’ interactions. In humans there is a degree of 
executive control over food intake, at least on a short term basis, and humans are able to 
consciously modify hunger [127].  Higher brain function is obviously different in mice.  









Figure 1.3:  Diagram showing location of homeostatic and selected reward network 
brain regions. 
Homeostatic network regions shown in greens.  Selected reward network regions shown 
in pink-yellow (amygdala, orbital cortex (OC), anterior cingulate cortex (ACC) not 
shown). Verticofrontal, sagittal, and axial sections are shown with cross-hairs at x=-
5mm, y=10mm, z=-8mm (MNI co-ordinates). Diagrams based on the Tziortzi atlas 
[128] (section 2.7.4) (except NTS, parabrachial nucleus, hypothalamus and VTA which 










Figure 1.4:  Diagram showing location of selected reward network brain regions. 
Selected reward network regions are shown (VTA and ventral striatum not shown). 
Verticofrontal, sagittal, and axial sections are shown with cross-hairs at x=-20mm, y=-










Figure 1.5:  Diagram showing location of executive control network brain regions. 
Executive control network regions are shown in blues.  Verticofrontal, sagittal, and 
axial sections are shown with cross-hairs at x=-5mm, y=+37mm, z=+26mm (MNI co-
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external food cue, results in rapid reduction of activity of hypothalamic AgRP neurons 
starting before food ingestion [14] implying communication from brain regions 
involved in learning and recognising the food cue.   There is also evidence that forebrain 
neurons project to the hypothalamus and influence homeostatic function.  A recent 
mouse study has shown cholinergic neurons in the mouse forebrain project to the 
hypothalamus and modulate food intake and body weight: ablation or impaired 
signalling increased food intake and resulted in obesity, and enhanced signalling 
reduced food consumption [129].  
 
There is still much to learn about the connections within and between these 3 networks.  
 
 
1.5 OVERVIEW OF FUNCTIONAL NEUROIMAGING METHODOLOGIES 
1.5.1 Functional neuroimaging modalities 
The aim of functional neuroimaging is to identify neural correlates of responses or 
behaviours by imaging regional brain activity. This is currently not possible directly, 
and surrogates are used: changes in glucose metabolism (FDG-PET), receptor 
availability (labelled receptor ligand PET and SPECT) and perfusion (water PET, 
BOLD-fMRI, ASL-fMRI).   A comparison of functional neuroimaging modalities is 
given in Table 1.2 [130, 131].    
 
1.5.1.1 [18F]-fluoro-deoxyglucose positron emission tomography (FDG-PET) 
[18F]-FDG is a modified glucose molecule labelled with the radionuclide fluorine-18 
[130].  In FDG-PET, FDG is injected intravenously in tracer quantities (too little to 
interfere with physiological processes), is taken up by cells in the same way as native 
glucose and is phosphorylated by hexokinase to FDG 6-phosphate.  FDG 6-phosphate is 
not metabolised further and dephosphorylation, which would allow escape from cells, 
happens slowly (several hours) and therefore FDG 6-phosphate accumulates within 
cells.  FDG 6-phosphate accumulates in tissues initially rapidly and then more slowly 
over 60 min and more: at 30 min the ratio between trapped (FDG 6-phoshate) and free 
FDG is about 4:1.  Brain FDG uptake correlates with brain glucose metabolism, a 
surrogate marker for neuronal activity.  Therefore in a given brain region, FDG provides 
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Fluorine-18 emits positrons (half-life 110 min) with consequent local production of 2 
gamma rays at 180º to each other.  The PET scanner comprises gamma detectors in a 
cylindrical array: coincident detection implies an annihilation event along the line 
between the two activated detectors.  Images are reconstructed using programs based on 
either back projection or iteration.    
 
FDG is by far the most widely used clinical PET tracer.  FDG-PET provides high 
quality images with a resolution of 5-10mm but involves exposure to radiation.  The 
kinetics of FDG make it ideally suited to imaging the response to a slowly-changing 
stimulus such as food ingestion, but has not previously been used for this purpose. 
 
1.5.1.2 Radiolabelled receptor ligands  
Radioligands are used to image receptor occupancy.  The imaging technique required 
depends on the radionuclide used: either single photon emission computed tomography 
(SPECT) or PET.  This technique gives information about the pathways utilising the 
specific receptor.  Interpretation can be difficult: reduced radioligand binding potential 
could result from increased competition due to increased endogenous ligand or reduced 
receptor numbers. 
 
1.5.1.3 Blood-flow PET 
Neuronal activation is thought to cause local reactive hyperaemia, thus changes in 
cerebral perfusion are used as surrogates.  [15O] is a positron emitter (half-life 2 min) 
and both intravenous [15O]-H2O and inhaled [
15O]-CO2 have been used to image 
cerebral blood flow. Practically [15O] is a difficult radionuclide to work with because it 
is not in routine clinical use and therefore has to be produced specifically and it has a 
very short half-life. 
 
1.5.1.4 Functional Magnetic Resonance Imaging (fMRI) 
In Blood Oxygenation Level Dependent fMRI (BOLD-fMRI) the detected signal 
reflects oxy-to-deoxyhaemoglobin ratio and thus cerebral perfusion. Stimulus-related 
changes in BOLD signal are small versus noise and the baseline drifts, and therefore 
specific imaging paradigms and analysis techniques are required (section 1.5.2.1).  
Arterial Spin Labelling (ASL-fMRI) uses magnetism to apply a signal to blood entering 
the brain to measure changes in regional blood flow.  fMRI does not involved exposure 
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Table 1.2: Comparison of neuroimaging modalities 
 [18F]-FDG-PET Radiolabelled receptor 
ligands SPECT or PET 
Blood-flow PET BOLD-fMRI ASL-fMRI 
Surrogate of neuronal activity 
imaged 
Glucose (FDG) uptake Receptor occupancy Perfusion Oxygenation (perfusion) Perfusion 
Can provide information about 




(only pathways utilising 
the specific receptor) 
Yes 
Yes  
 (issues with signal 
dropout due to air/tissue 
interface eg in OC) 
Yes 
Resolution 5-10 mm 5-10 mm 5-10 mm 3-4mm (or less) 3-4 mm (or less) 
Suitable for slowing changing 
stimulus or steady state 
Yes 
Yes (depending on 
ligand and radionuclide) 
Yes, using repeated 
scans 
Generally no (although 
can image effect of ‘slow 
stimulus’ on response to 
‘on-off’stimulus 
Potentially yes 
Suitable for rapidly changing 
stimulus (on-off stimulus) 
No 
No (depending on ligand 
and radionuclide) 
Yes Yes Potentially yes 
Signal to noise ratio High High High Low Low 
Approx. number of subjects per 
group (dependent on signal:noise 
ratio, analysis (ROI v WB) & 
number of comparisons). 
8-12 8-12 8-12 12-25 12-25 
Exposure to ionizing radiation Yes Yes Yes No No 
MRI-related contraindications 
(metal foreign body, pacemaker 
etc) 
No No No Yes Yes 





220kg 180kg 180kg 
Typical scanner gantry bore size 70cm 
70 cm (PET) 
80 cm (SPECT) 
70cm 60cm 60cm 
Availability 
PET scanners less widely 
available (than MRI), 
however, FDG widely 
used in PET scanning 
PET scanners less widely 
available (than MRI). 
Radioligands not in 
routine clinical use. 
PET scanners less widely 
available (than MRI). 
[15O]-H2O/[15O]-CO2 
produced on site. 
MRI scanners fairly 
widely available 
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1.5.2 Functional neuroimaging analysis  
The impact of a stimulus on brain activity, and/or differences between groups, is 
analysed by comparing images using computer programs such as Statistical Parametric 
Mapping (SPM).  Prior to analysis, pre-processing generates images in standard 
anatomical space, meaning that a given voxel (3-dimensional pixel) should correspond 
to the same anatomical location in all images in all subjects, and can be compared 
across conditions and/or between groups using conventional parametric statistical tests.  
However, given a whole brain volume of 1,200,000 mm3 and a voxel size of 2x2x3.3 
mm3 this equates to about 91,000 voxel-wise comparisons – a major multiple testing 
problem with risk of type 1 error. Non-hypothesis driven, whole-brain analyses usually 
set a voxel-level significance threshold and a second cluster-level threshold (either a 
threshold number of significantly-different voxels or a cluster-level threshold p value 
corrected for family-wise error (pfwe-corr)).  An alternative is to use a region of interest 
(ROI) approach, which increases power but is hypothesis driven and therefore cannot 
identify unsuspected regional responses.   ROIs may be anatomical (atlas defined) or 
‘functional’.  Functional ROIs (fROIs) are defined by response to a stimulus (either a 
sphere centred on the voxel showing the peak difference or a cluster outline).  If the 
fROIs are generated from a separate subject group, it assumes a precise localisation of a 
response between subjects.  However, fROIs defined during the same study are 
sensitive to outliers and artefact [132].  ROI analyses either compare the mean activity 
across the ROI, which might miss differences if the activated cluster is small in relation 
to the ROI, or use voxel-wise comparison within the ROI.  
 
1.5.2.1 BOLD-fMRI paradigms and analysis 
Stimulus-related changes in BOLD-fMRI signal are small versus noise and the baseline 
drifts creating challenges in using BOLD-fMRI.  ‘Block-design’ and ‘event-related’ 
paradigms image responses to a stimulus presented in an ‘on-off’ manner.  BOLD 
signal during ‘on’ versus ‘off’ can be analysed using whole-brain or ROI approaches.  
External food cues such as pictures, smell, or taste can be presented in this way.   
 
Several approaches have been made to utilise BOLD-fMRI to image response to 
slowly-changing stimuli such as food ingestion. One approach focusses on the BOLD 
response in a single pre-defined ROI [133].  Such studies must include a control ROI 
and/or control stimulus otherwise they are subject to signal drift artefact. Whole-brain 
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clusters with BOLD signal response over time similar to a ‘seed’ in a defined region; 
temporal clustering analysis (TCA), which identifies post-stimulus time windows when 
a maximum number of voxels across the whole brain show peak BOLD signal and then 
localises clusters of voxels showing peak signal within each time window [134]; and 
pseudo-block analysis, which divides the image series into time blocks, and contrasts 
each post-stimulus block with the pre-stimulus block. 
 
 
1.6 BRAIN RESPONSES TO FOOD IN NORMAL WEIGHT SUBJECTS 
1.6.1 Brain responses to food cues in normal weight subjects  
Studies investigating brain responses to food cues, such as pictures or odours, give 
information about anticipation of food, including both anticipation of reward and  
cephalic phase physiological responses. Responses to aliquots of ‘food’ in the mouth 
give information about pre-ingestive consummatory reward.   
 
1.6.1.1 Brain responses to food pictures in normal weight subjects (Table 1.3) 
Van der Laan et al performed a meta-analysis of fMRI studies using whole-brain voxel-
wise analysis to compare responses to food pictures in normal weight subjects [135]. 
They used the Activation Likelihood Estimation (ALE) meta-analysis technique which 
looks for concurrence in reported coordinates across studies, but is done at the study 
level therefore does not increase the power to detect differences.  For food versus non-
food pictures (246 subjects, 18 studies) they found increased BOLD signal in at least 2 
studies in insula (bilateral), amygdala (L), lateral OC (L) and a number of non-frontal-
cortex cortical regions not conventionally associated with food such as fusiform, 
occipital and parietal gyri. For high versus low ED food pictures (112 subjects, 7 
studies) they found increased BOLD signal in at least 2 studies in hypothalamus, 
nucleus accumbens/ventral striatum and DLFC (middle frontal gyrus (L)), cortical 
regions not conventionally associated with food (middle occipital gyrus, inferior 
temporal gyrus) and  cerebellum. The authors comment on the lack of concordance 
between studies, with many clusters identified in only 2 studies (11%): at best 41% of 
studies were concordant in the food versus non-food comparison.   
 
Several BOLD-fMRI ROI studies have specifically looked for and sometimes, although 
not consistently, found differences in response to food pictures in regions not identified 
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study published later also identified additional regions [137]:  caudate (high>low ED 
[37]); operculum (high ED>non-food [136]); hippocampal formation (food>non-food 
[37]; MFC (food>non-food [37, 137]; high>low ED [137]);  high<low ED [37]); and 
ACC (food>non-food [137], low ED>non-food [37], high>low ED [137]; high<low ED 
[37]).  Consistent with the meta-analysis, almost all differences identified in these 
studies showed increased BOLD signal with food versus non-food and/or high versus 
low ED food pictures.  The only exceptions to this were decreased BOLD signal to high 
versus low ED food pictures in OC, MFC and ACC found by Stoeckel et al [37] 
(discussed below). Stoeckel included ROIs in the midbrain, putamen, and globus 
pallidus and did not find differences with food (high or low ED) versus non-food or 
high versus low ED.  No study included brainstem or ventral subcallosal gyrus ROIs.  
 
Discrepancies between studies might be due to the task used.  For example one study 
used the one-back task (subjects indicate if the picture is the same as the previous 
image) which might lead to subjects considering pictorial, rather than food-related, 
aspects of the images [137]. Others asked subjects to rate the appeal of images or to 
imagine eating (for food) or using (for non-food) the cue.  Other factors include 





KF Hunt.   Chapter 1: Introduction. 
Key for tables 1.3-1.12 summarising functional neuroimaging papers 
BS=brainstem; Hy=hypothalamus; MB=midbrain (SN=substantia nigra); NA/VS=nucleus accumbens/ventral striatum; Ca=caudate; Pu=putamen; 
Op=operculum (fOp=frontal operculum, rOp=rolandic operculum); Ins=insula; Am=amygdala; Hip/PHG=hippocampus/parahippocampal gyrus; 
OC=orbital cortex (mOC=medial OC; lOC=lateral OC; pOC=posterior OC); VCSG=ventral cingulate subcallosal gyrus; DLFC=dorsolateral frontal 
cortex (SFG=superior frontal gyrus, MiFG=middle frontal gyrus, IFG=inferior frontal gyrus); MFC=medial frontal cortex; ACC=anterior cingulate 
cortex.  PCC=posterior cingulate cortex, TG=temporal gyrus, Th=thalamus, Cb=cerebellum.  




NW=normal weight, Ob=obese, MWL=maintained weight loss. 
 
WB=whole brain analysis; AnROI=anatomical region of interest analysis; fROI=functional region of interest analysis; VW=voxelwise. 
Cells shaded grey indicate regions not included as a ROI in ROI analyses.  
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Table 1.3:  Brain responses to picture food cues in normal weight/non-obese subjects. BOLD-fMRI studies 
Paper, Subjects,  
Fed State, Stimulus, 
Instruction, Analysis 
Contrast BS Hy MB NA/
VS 


















of studies contributing 

















    Pos 
Fusiform G 








         L (3) L (3) LatL 
(2) 
     











  Pos 
Cerebellum 
mOccipital G 
i Temp G 
Stoeckel 2008[37] 
12 NW f 
Fasted 8h 
BOLD-fMRI 
Pictures. Task.  
AnROI, voxelwise 
Lenient thresholds 
HiEDF v NF          Pos Pos Pos   Pos   
LoEDF v NF          Pos Pos Pos   Pos Pos  
HiEDF v 
LoEDF 
    Pos       Neg   Neg Neg  
Porubska 2006[136] 











  Pos 
L 
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continued Table 1.3:  Brain responses to picture food cues in normal weight/non-obese subjects BOLD-fMRI studies 
Paper, Subjects, 
Fed State, Stimulus 
Instruction, Analysis 
Contrast BS Hy MB  NA/
VS 













20 NW (10f,10m) 
Fasted o/n & fed 
Pictures 





















s temp G 
SupramargG 
i parietal lob 
Cerebellum 
Premotor 









       Visual cortex 
Ant fusiform 
HiEDF v lo 
EDF  
FASTED 
   Pos 
R&L 






     
HiEDF v 
loEDF FED 
                 
Frank 2010[137] 
12 NW (6f,6m) 
Fast >3h & fed  
Pictures 
‘1-back’ task’. 
WB & ROI 
F v NF  
WB 












F v NF ROI         Pos   Pos      
HiEDF v lo 
EDF 
        Pos 
R&L 











Fed v Fasted 
(f only) 
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1.6.1.2 Brain responses to non-picture food cues in normal weight subjects (Tables 1.4 
and 1.5) 
Response to odours, including food odours, have been studied in two BOLD-fMRI 
studies using whole-brain analysis [34, 139].   Odour versus no odour increased BOLD 
signal in anterior operculum, insula and OC in both and in ACC in one [34] and 
piriform cortex (primary olfactory cortex) and nucleus accumbens/ventral striatum in 
the other [139].  
 
Responses to aliquots of liquid food in the mouth have also been studied.  Aliquots of 
glucose (BOLD-fMRI, ROI analysis [140]), tomato juice or chocolate milk (BOLD-
fMRI, whole-brain analysis [125]), or sweet fruit drink (BOLD-fMRI, whole-brain and 
fROI [141]) versus tasteless no-calorie drink and aliquots of Ensure plus versus water 
([15O]-H2O-PET, whole-brain analysis [142]) consistently increased blood flow in 
anterior insula and/or anterior operculum, evidencing their role as the primary gustatory 
cortex in humans. There was also increased signal in posterior OC [125, 140, 142] 
which might represent an anterior extension of the primary gustatory cortex; amygdala 
[142]; ACC [125]; and piriform cortex (olfactory cortex, [141, 142].  The [15O]-H2O-
PET study only found decreased signal in frontal operculum (R) and several non-frontal 
cortical areas not conventionally associated with food [142].  This study was conducted 
after a prolonged 36 hour fast which might account for some differences.     
 
Several groups have studied responses to multisensory food stimulation. Viewing or 
touching real food, versus non-food objects, in the fasted state increased BOLD signal 
in  caudate, insula, hippocampal formation and ACC and decreased BOLD signal in 
DLFC (whole-brain analysis, conjunction of visual and tactile [143]).  Viewing, and 
listening to descriptions of, real high ED food, versus low ED food and non-food 
objects, in the fasted state, decreased blood flow ([15O]-CO2-PET) in insula (L) and 
inferior temporo-parietal cortex (whole-brain analysis [36]). Viewing, smelling, tasting 
and describing favourite foods versus neutral non-food stimulation, at 2 separate FDG-
PET imaging visits, resulted in a 24% increase in whole brain metabolism (cerebral 
metabolic rate for glucose) and increased signal (relative to whole brain, whole-brain, 
voxel-wise analysis) in insula (L), OC (L) and also superior temporal and posterior 
central gyri [144].  Repeating the study in a second group of subjects the investigators 
confirmed increase in whole brain metabolism with food stimulation but in their voxel-
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increases they found, at least in female subjects, are difficult to interpret [127].  Using 
the same multisensory food stimulation paradigm and imaging using [11C]-raclopride 
(DA D2 receptor ligand)-PET, they found no significant difference in raclopride binding 
in the striatum although the study may have been underpowered [145].  
 
Another group used a ‘restaurant task’ in which subjects were shown written 
individualised menus of high or low incentive value food when satiated and asked either 
to imagine they were presented with the food or to make a choice [146].  Using [15O]-
H2O-PET and a voxel-wise ROI analysis (amygdala and OC) they found increased 
blood flow: with high versus low incentive value menu in amygdala (L) and medial OC 
(L); with choice versus no-choice in medial OC (L) (and in a whole-brain analysis in 
striatum (R)); and an interaction between choice and incentive value in lateral OC (R) 
with a greater impact when selecting between high incentive value items.    
 
1.6.1.3 Summary of brain responses to food cues in normal weight subjects 
Responses to food versus non-food cues, and/or high versus low ED food cues, have 
been found in almost all the regions conventionally associated with food.  Responses to 
more than one food-cue modality have been identified in nucleus accumbens/ventral 
striatum, insula/operculum, amygdala, OC, DLFC and ACC. The most consistently 
identified region is insula/operculum which, as well as responding to aliquots of liquid 
food in the mouth consistent with its established role as the primary gustatory cortex, 
also responds to viewing food (real or pictures), touching food and food odours.  It is 
also notable that hypothalamus was identified in the meta-analysis as responding to 
food pictures, specifically high versus low ED food pictures, challenging the 
conventional view of hypothalamus as primarily integrating internal nutritional signals.  
Regions not identified in the above studies include brainstem, midbrain, putamen, 
globus pallidus and ventral cingulate subcallosal gyrus. This may be because they do 
not respond to food cues.  However, these regions are relatively small and may be 
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Table 1.4:  Brain responses to non-picture external food cues in normal weight/non-obese/unspecified subjects.  BOLD-fMRI studies. 
Paper, Subjects,  
Fed State, Stimulus, 
Instruction, Analysis 
Contrast BS Hy MB NA/
VS 












O’Doherty 2002 [140] 
8 (3f, 5m) 
BOLD-fMRI 
Visual symbol followed 
by sweet, salt, neutral 





  Pos 
R&L 
  Pos 
R 








   Pos 
L 
       Pos 
R 






















       Pos 
fOp 
R 
   Pos 
R 
     
Pelchat 2004 [147] 
20 (10f,10m) 
2 groups: normal diet v 
bland diet  
Fed  
BOLD-fMRI 
Imagine liked food v 
Imagine bland food 
Normal diet 
LF v BF 
                (no 
activations) 
Bland diet 
LF v BF 



















    Pos 
R 
   Pos 
L 
 PosL       
St-Onge 2005 [143] 
12 (6f,6m), NW 
Fast >12h  
BOLD-fMRI-Block 
Real food & non-food, 
See & touch, ‘Pay 
attention’, WB, 





    Pos 
R&L 










s temp G 
 
Neg 
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continued Table 1.4: Brain responses to non-picture external food cues in normal weight/non-obese/unspecified subjects. BOLD fMRI 
Paper, Subjects,  
Fed State, Stimulus, 
Instruction, Analysis 
Contrast BS Hy MB NA/
VS 












Small 2005 [139] 
11, Fast>1h  
BOLD-fMRI-Block  
Odour (only 1 food)  
Retro & orthonasal 
Odour v no 
odour 










    Pos 
Piriform 
Small 2008 [141] 
12 (7f,5m) 
BOLD-fMRI-event 
FO+ (Fruit odour 
followed by taste) 
FO- (fruit odour 
followed by tasteless) 
Trained beforehand 
Mixed WB & fROI 
(centroids) 
  





  Pos 
L 
















  SN 
Pos 
L 

























       Pos 
Piriform 
O’Doherty 2000 [34] 
5 
BOLD-fMRI-Block 
Vanilla & banana odour  
Fed to satiation with 
bananas 






to odour  






  R or 
L 












           R or 
L 
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continued Table 1.4:  Brain responses to non-picture external food cues in normal weight/non-obese/unspecified subjects.  BOLD-fMRI. 
Paper, Subjects,  
Fed State, Stimulus, 
Instruction, Analysis 
Contrast BS Hy MB NA/
VS 












Kringelbach 2003 [125] 
10 NW  
>6h fast 
BOLD-fMRI-Block  
Taste (tomato juice (TJ)-
tasteless-chocolate milk 
(CM)-tasteless) 
Scan, then fed to satiated 
on either TJ or CM, scan. 
WB voxelwise 
Taste  v 
tasteless 
        Pos 
R&L 
  Pos 
R&L 


































    Somatosensor
y (face) (ns) 
Smeets 2006 [148] 
24 (12f, 12m)  NW 
Fast o/n 
BOLD-fMRI-block 
Choc milk v rest 
(nothing) 




Neg response to choc 




Fed v fasted, 
CM v rest 




































     
Women 
Fed v fasted, 
CM v rest 
 Less
pos 
   Mor
e pos 
R 
   Less
pos 
L 
      More pos 
Precentral G 
s temp G 
 Less  
pos 
       Less 
Pos 
L 




 Yes     Yes 
L 
       Yes 
R 
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continued Table 1.4:  Brain responses to non-picture external food cues in normal weight/non-obese/unspecified subjects.  BOLD-fMRI. 
Paper, Subjects,  
Fed State, Stimulus, 
Instruction, Analysis 
Contrast BS Hy MB NA/
VS 












Haase 2009a [149] 
18 (9f, 9m) 
BOLD-fMRI-event 
Taste (Sucrose produced 
most robust effect) 
(Caffeine, Citric acid, 
Guanosine 
monophosphate (GMP),  
Saccharin,  NaCl) 
2 visits 
1 fed (fast 12h, 700 kcal)  
1 fasted (12h) 
WB voxelwise 






water   
WB 
 R SN 
R&L 
 

























s temp G 
Fed Sucrose 






   R   rOp 
L 
<5v 





s temp G <5v 
Angular G 5v 
Sucrose   
Fed v fasted 
WB 
  SN 
R&L 
 
 R    R 
 
R R&L R  IFG 
R 
(7v) 




s temp G (5v) 
Sucrose v 
water, 



























    Thalamus neg 
v pos 
Entrorhinal 
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Table 1.5: Brain responses to external food cues in normal weight/non-obese subjects. Non BOLD-fMRI studies.  
Paper, Subjects, Fed state 
Imaging, Stimulus,  
Instruction, Analysis 













8 f NW, Fast o/n, 
[15O]-CO2-PET  
6 scans (2 of each) 
View items with audio 
description 
‘Assess emotions’  
WB voxel-wise 








        Neg 
L 









12 scans in 1 visit 
‘Restaurant task’  
Menu of high & low 
incentive value food 
Make choice or not 
Imagine in restaurant  & 





High v low 
incentive 
value 









         Pos 
L 
       
Choice v no 
choice 
           Pos
MO
C L 
     
Choice v no 
choice  









           LOC 
R 




           Pos
MO
C L 
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continued Table 1.5: Brain responses to external food cues in normal weight/non-obese subjects. Non BOLD-fMRI studies.  
Paper, Subjects, Fed state 
Imaging, Stimulus,  
Instruction, Analysis 













12 (7f,5m), Non-obese 
Fast 17-19h 
FDG-PET, 2 visits  
1x food stimulation 
(favourite  real foods 
view, smell, taste, 
describe how like to eat) 
1x neutral non-food 
Global metabolism 
(FvNF ↑ whole brain 
metab by 24%) 




Food v NF         Pos 
L 
  Pos 
L 
    Thalamus nil 
Somatosensor
y Pos (R&L) 
s temporal C 
Pos L 
F v NF WB         Pos 
L 
  Pos 
LOC 
L 





ire for food 
& Δsignal 
Food v NF 
           Pos 
R 
    Post central 
gyrus nil 
s Temp nil 
Wang 2009[127] 
23 (13f,10m) non-obese, 
Fast 17-19 h 
FDG-PET, 3 visits 
1x food stim (as above) 
1x food stim with 
conscious inhibition of 
desire for food 
1x no stimulation  







Pos Large cluster (43% of brain) in bilateral cortical (inferior frontal, parietal, temporal, occipital and cerebellar) and subcortical structures (note 
analyses done on absolute metabolic images and whole brain metabolism is increased) 
± inhibition No differences 
Male  
Food v neut 
Pos 2clusters (note smaller sample size): 
(OC) L, Parietal temporal cortex R (posterior central gyrus, insula, superior temporal gyrus) 
Male 
±inhibition 
     neg 
R 






























    Cerebellum 
more neg 
Correlation:
Δ hunger c 
inhibition & 
Δ signal c 
inhibition 
           mO
C 
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continued Table 1.5: Brain responses to external food cues in normal weight/non-obese subjects. Non BOLD-fMRI studies.  
Paper, Subjects, Fed state 
Imaging, Stimulus,  
Instruction, Analysis 













10m (2f, 8m) 
Fast 16-20h 
[11C]-raclopride –PET 
Neutral placebo  
Food stimulation placebo 
(Also with & without 
methylphenidate) 
Hand-drawn ROI 
Food stim v 
neutral 
placebo 








           
Del Parigi 2002c[142] 
44 (22f, 22m) 
Fast 36h 
Water PET 
Aliquots water then  
aliquots liquid meal  
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Generally the response to food versus non-food cues and/or high versus low 
ED/incentive value food cues is an increase in the surrogate of neuronal activation.  
However, decreases have been found, particularly in insula/frontal operculum [36, 142] 
and frontal cortex (OC [37], MFC [37], DLFC [143], ACC [37]) with Stoeckel et al [37] 
using very lenient statistical thresholds to identify changes.  Direction of change of a 
signal purportedly representing the same surrogate may be different between 
neuroimaging modalities and paradigms.  For example BOLD signal increased in insula 
in response to viewing or touching real food, versus non-food objects [143] whereas 
[15O]-CO2-PET signal decreased in insula in response to viewing, and listening to 
description of, real high ED food, versus low ED food and non-food objects [36]. This 
emphasises the difficulty in interpreting direction of change between studies.   
 
1.6.1.4 Brain responses to acutely-conditioned food cues in normal weight subjects 
All the above studies were in response to food, and non-food, stimuli which had been 
‘conditioned’ by individual experiences of the subjects.  Two BOLD-fMRI studies 
looked at responses when subjects were trained in the association between cue and 
aliquots of food versus tasteless no-calorie drink, one using non-representational visual 
symbols and glucose drink [140] and the other fruit odours and sweet fruit drink [141]. 
Both found increased BOLD signal to cues signalling aliquots of food versus cues 
signalling aliquots of tasteless no-calorie drink in ventral striatum/nucleus accumbens 
and OC.  The latter study also identified increased BOLD signal in other regions, 
perhaps related to different cues or larger sample size, including midbrain, thalamus, 
globus pallidus, and amygdala [141].  These data suggest these regions are involved in 
the learning of association between cue and food, or encode reward value or immediate 
anticipation of food versus non-food, as the cue was followed by the food throughout 
the scans (although not invariably) whereas in the studies discussed above the food cue 
was not followed by food.  Both studies also looked at BOLD signal to cue versus 
aliquots of drink finding a positive difference in midbrain, amygdala and OC, with one 
study also finding positive differences in hypothalamus, nucleus accumbens/ventral 
striatum and hippocampal formation and negative in OC [140]  and the other  positive 
difference in thalamus and globus pallidus and negative in the operculum [141].  This 
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1.6.1.5 Effect of fed state on brain responses to food cues in normal weight subjects 
A number of studies, mainly using BOLD-fMRI, have looked at the impact of fed state 
on responses to food cues, seeking a neurological correlate for the finding that the 
reward value of food decreases in the fed state (section 1.1.4.1).  A meta-analysis (57 
subjects, 5 studies) identified reduced BOLD response to food versus non-food pictures 
in the fed versus fasted state in amygdala, hippocampal formation and lateral OC [135].  
Goldstone et al found reduced BOLD response to high versus low ED food pictures in 
the fed versus fasted state in ventral striatum/nucleus accumbens, insula, amygdala, and 
OC [138].  These results should be viewed with caution as the fROIs were generated by 
high versus low ED food cue contrast in the fasted state in the same experiment [132]. 
Using [15O]-H2O PET, Morris et al found a negative correlation between signal when 
viewing food pictures and satiety scores  in posterior OC (R)  but no correlation for 
non-food picture viewing [150].   
 
Similar results have been found for food odours, flavours and tastes.  Haase et al 
compared the response to aliquots of sucrose (and other pure tastes) versus water 
between fasted and post-mixed meal (700 kcal) and, in a ROI analysis, found 
differences in hypothalamus, thalamus, amygdala, hippocampus and OC (all negative in 
fed versus positive in fasted) and in frontal and central operculum and inferior insula 
(less positive in fed versus fasted) [149].  Investigating sensory-specific satiety:  
O’Doherty et al found reduced BOLD signal to banana, versus vanilla, odour in OC, 
when satiated with bananas [34]; and Kringelbach et al found reduced BOLD response 
specifically to aliquots of chocolate milk or tomato juice after satiation with the same 
drink in OC for both drinks and in putamen and insula for chocolate [125].  The only 
study to find increased BOLD responses to a food cue (chocolate milk aliquots versus 
nothing) in the satiated (with chocolate) state, performed an analysis in which clusters 
showing a negative BOLD response to chocolate milk in fasted or fed state were 
masked out [148].    
 
Using [15O]-H2O PET and the ‘restaurant task’ (section 1.6.1.2), Hinton et al found 
reduced signal change to making a choice from a high versus low incentive food menu 
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1.6.1.6 Summary of effect of fed state on brain responses to food cues in normal weight 
subjects 
Differences in responses across several modalities of food cues in the fed versus fasted 
state have been found in insula/operculum, amygdala, hippocampal formation and most 
consistently in OC, almost always an attenuated positive response to food versus non-
food (or high versus low ED food) cue, or a negative rather than a positive response. 
This supports a role for these regions in encoding food reward value or salience.   The 
particular importance of OC in this role is emphasised by the finding that OC activation 
correlates with pleasantness of taste (as modified by sensory specific satiety [125]) and 
of increased OC activity when subjects are asked to choose between foods [146].  The 
finding of altered insula activity provides evidence that insula is not simply a sensory 
cortex, but its activity is modulated by satiety.    
 
1.6.2 Brain responses to food ingestion in normal weight subjects  
Studies investigating the response to food ingestion can potentially give information 
(depending on study design) about pre and post-ingestive consummatory reward, 
satiation and meal termination.  
 
1.6.2.1 Responses to food ingestion using [15O]-H2O-PET (Table 1.6) 
In a series of pioneering studies initiated by Tataranni, subjects (11 normal weight men 
[152] and 10 normal weight women [153])   fasted for 36 h (water allowed) then 
consumed a liquid mixed meal (50% resting energy expenditure) over 25 min, with two 
pre-meal (10 min apart) and two post-meal (10 min apart) scans. Analysis compared 
post-meal to pre-meal scans using a whole-brain voxel-wise approach, without 
correction for multiple comparisons. Small et al conducted a study in which serial [15O]-
H2O-PET scans, each after consuming a square of chocolate, were performed as 
subjects (5 female, 4 male) ate chocolate to beyond satiation after a 4.5 h fast and used 
whole-brain voxel-wise regression analysis to identify clusters where signal was 
correlated with decreasing score in response to ‘How much would you like or not like 
another piece of chocolate?’ [154].  Morris and Dolan performed a study in which 10 (1 
female, 9 male; majority normal weight) subjects underwent 12 [15O]-H2O-PET scans 
(6 with food pictures and 6 with non-food pictures) and were fed to satiety with a mixed 
meal after either 4 or 8 scans and used whole-brain analysis to identify clusters where 
signal was correlated with satiety score [150].  Hinton et al studied 12 normal weight 
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after overnight fasting and once having consumed a non-standardized meal until full 1 
hour before attending [151].   Subjects undertook a ‘restaurant task’ during scans, 
choosing from high or low incentive value menus and fed and fasted scans were 
compared using voxel-wise analysis within anatomical ROI (hypothalamus, insula, 
amygdala, OC). 
 
Increased signal post-meal versus pre-meal, or positive correlation with decreasing 
desire for more chocolate or increasing satiety score, was found in: OC [151-154]; 
DLFC [152, 154]; MFC [153, 154]; several posterior cortical regions not conventionally 
associated with food [152, 153] and, in one study, hippocampal formation, ACC and 
motor areas [154] and posterior insula [150].   Decreased signal was found in: 
hypothalamus [150-152], thalamus [152-154], midbrain [153, 154], caudate [152-154], 
putamen [152, 154], insula/operculum [150-154], hippocampal formation [152-154], 
OC [152, 154], several posterior cortical areas not conventionally associated with food 
[152-154] and, in one study, nucleus accumbens [150], amygdala [151], ACC [152], 
and ventral cingulate subcallosal gyrus (the largest cluster in this study in extent and 
magnitude) [154]. Discrepancies might be due to duration of fast, the nature of the meal, 
ongoing eating to beyond satiety, timing of imaging or the analytic approaches.    
Although the parallel analyses in female [153] and male [152] subjects identified some 
different regions, direct comparison of responses in female and male subjects (including 
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Table 1.6: Brain responses to food ingestion in normal weight/non-obese subjects.  [15O]-H2O PET studies 
Paper, Subjects, Imaging 
Stimulus, Analysis 
Contrast BS Hy MB NA/
VS 









Tataranni 1999 [152]  
11 NW m  
[15O]-H2O PET 
1 week admission 
Fasted 36h   
2xscans . Ensure Plus, 
50% REE. Then 2 scans 
Eyes closed 
WB, Voxelwise p<0.005 





















lobule Pos L 






Cb neg R&L 
Gautier 2001 [153] 
10 NW f 
[15O]-H2O PET 
Protocol as [152] 












  Pos 
(cent
ral) 
 PCC Pos L 
Occip cortex 
Pos R&L 
Th Neg R 
MiTG neg L 
Cb neg L 
Le 2009 [156]  
31 NW (10f, 21m) 
(all prev reported except 
10m)  
[15O]-H2O PET 
Protocol as above [152, 
153] 
AnROI (mean) DLFC 
(sFG, miFG, iFG) 
NW Fed v 
Fasted 
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continued Table 1.6: Brain responses to food ingestion in normal weight/non-obese subjects.  [15O]-H2O PET studies  
Paper, Subjects, Imaging 
Stimulus, Analysis 
Contrast BS Hy MB NA/
VS 









Small 2001[154] 9 (5f, 
4m)  [15O]-H2O PET 
Fasted 4.5h.  
10 scans 
1 sip water-scan 
7 choc-scan (1 sq choc) 
Between scans choc to 
↓VAS (pleasant /more) 
by >2 pts). 
1 sip water-scan 













































G Neg R&L 








scans, in the 
above 
clusters) 
    Neg 
R 












Pos  miTG neg R 
iTG Neg R&L 
Occipitotemp
G Neg R&L 
Precentral G 
Pos R&L 
Morris 2001 [150] 10 
(1f, 9m) (7 NW). Fasted 
16h  
[15O]-H2O PET. 12 scans 
6xF & 6x NF pic scans. 
Eat to satiation 
(sandwich, cake, apple) 


















     
Hinton 2004 [151] 12 m 
NW. Fasted overnight. 
[15O]-H2O PET x6/visit 
2 visits. 1xfasted, 1x fed 
(eat until full 1h before) 
High OR low incentive 
menu.  Make choice. 
Normalised to global 
mean. AnROI voxelwise. 










     
ROI hi v lo 
incentive 









           Neg 
L 
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1.6.2.2 Responses to food ingestion in dopamine pathways (Table 1.7) 
Small et al studied the response to food ingestion in dopamine pathways using [11C]-
raclopride PET [157].  Seven normal weight subjects were studied: after overnight 
fasting and after eating their favourite meal, starting 30 min pre-raclopride injection.  
Using voxel-wise comparison within the striatum and ROI analysis of striatal 
subsections (raclopride binding being minimal outside the striatum), they found reduced 
binding potential (interpreted as increased extracellular dopamine) in dorsal caudate and 
putamen but not in central caudate and putamen or nucleus accumbens. They also found 
negative correlations between meal pleasantness ratings and raclopride binding potential 
in dorsal caudate (R) and dorsal putamen only.  This study was one of the first to 
emphasize a role for dorsal striatum in food-related consummatory reward (liking) in 
humans.  Notably, this study suggests increased dopamine signalling (interpreted as 
increased neuronal activity) in dorsal striatum post meal where [15O]-H2O-PET 
paradigms found reduced signal (interpreted as reduced neuronal activity) post-meal 
[152-154] reflecting the difficulty of interpreting direction of change across different 
neuroimaging techniques.  
 
1.6.2.3 Responses to glucose ingestion in hypothalamus using BOLD-fMRI  
Three groups have reported lower BOLD signal after oral glucose versus water 
ingestion in parts of hypothalamus across normal weight and obese subjects [133] and 
in normal weight subjects [158, 159].  The first 2 fMRI studies found a decrease in 
BOLD signal versus baseline; the overall rise versus baseline found by Flanagan et al 
was attributed to scanner drift as it was also seen using a phantom.  Liu et al also looked 
at the BOLD response to oral glucose, imaging a single 10 mm midsagittal section 
[134]. Using temporal clustering analysis they found 2 peaks: the first at about 2 min 
may be related to drinking; the second at about 10 min showed reduced BOLD signal in 
hypothalamus.   
 
1.6.2.4 Responses to nutrient ingestion using whole-brain BOLD-fMRI (Table 1.8) 
Li et al compared BOLD response to ingestion of isocaloric amounts of glucose, protein 
and fat with water in normal weight subjects using a voxel-wise ANOVA within 
anatomical ROIs, finding significant pre-post differences in thalamus, caudate, insula, 
amygdala, hippocampal formation and OC but not in hypothalamus or putamen [160]. 
In all identified clusters, after an initial early response related to drinking seen for all 4 
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10 min and a sustained effect at 30 min but no change for water.  They did not include a 
control ROI and the finding of similar patterns in all identified clusters raises the 
possibility than this may be a global effect of calorie ingestion.  Noseworthy et al found 
that high fat drink reduced BOLD signal during a motor task [161].   
 
Lassman et al studied BOLD responses to enteral fat in non-obese subjects, delivering 
dodecanoic acid versus saline via oro-gastric tubes [162]. Using a whole-brain voxel-
wise pseudo-block analysis, they found increased BOLD signal to lipid (versus saline) 
in brainstem, hypothalamus, midbrain, thalamus, caudate and other areas with no 
clusters showing decreased signal.  This contrasts to the findings of all the above studies 
which, when they found differences in these regions, found decreased blood flow.  This 
might be due to the pure lipid stimulus (although Li et al [160] also included a pure lipid 
oral stimulus), the gastric delivery of the meal, the fMRI imaging or the analytic 
approach.   
 
1.6.2.5 Summary of brain responses to food ingestion in normal weight subjects  
There are relatively few studies looking at the brain responses to food ingestion in 
normal weight subjects.  However, there is fairly consistent (although not universal) 
evidence of reduced blood flow in hypothalamus after eating, consistent with its 
homeostatic function.  Several studies found post meal changes in regions of the reward 
network (midbrain, caudate, putamen, operculum/insula, hippocampal formation, OC), 
generally a reduction in blood flow after eating.  Only one study [150] identified post-
meal changes in nucleus accumbens/ventral striatum whereas several found differences 
in  dorsal striatum (caudate and putamen) suggesting dorsal striatum may be involved in 
responses to food ingestion perhaps particularly in liking [157], whereas ventral 
striatum may be more involved in food anticipation (section 1.6.1).  Responses in 
operculum/insula are consistent with their role as the primary gustatory cortex and in 
interoception. In OC both increased and decreased blood flow was identified, often 
within the same study [152, 154], suggesting OC responses to food ingestion are 
complex.  Differences in amygdala were only identified in ROI studies [151, 160], 
suggesting that post-meal responses in amygdala are small.  Only 5 studies used 
approaches that could identify differences in frontal cortex: 3 finding differences [153, 
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Table 1.7: Brain responses to food ingestion in normal weight/non-obese subjects.  Radioligand PET study 
Paper, Subjects, Imaging 
Stimulus, Analysis 
Contrast BS Hy MB NA/
VS 









Small 2003[157] 7 NW 
(5f,2m) 
2x [11C]raclopride PET 
1x fasted overnight 
1x fasted overnight then 
favourite meal 30 min 
pre raclopride. 
Voxelwise comparison 
within whole striatum & 
AnROI (dorsal & central 









    Neg 
dors





           
AnROI 
Fed v Fasted 
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Table 1.8: Brain responses to food ingestion in NW/non-obese subjects.  BOLD-fMRI studies (hypothalamus studies not included) 
Paper, Subjects, Imaging 
Stimulus, Analysis 
Contrast BS Hy MB NA/
VS 









Li 2012[160] 14 NWm 




scan. Ingestion at 6 min 
Eyes closed. Post 
ingestion normalised to 
pre. AnROI, voxelwise. 
ANOVA, 
main effect  
& difference 
in response 
to Gl, P, F, 
W.  





















    Th R&L 
Neg (Gl=P=F)  
In all identified clusters there was a positive change between 0-5 min for all 4 drinks (Gl, P, F, W) thought to be artefacts related to drinking.  
From 5-30 min BOLD signal decrease for Gl, P, F nadir at 5-10 min, sustained effect at 30 min but no change for W.   
Lassman 2010 [162] 19 
non-obese (6f, 13m) 
Fasted 12h BOLD-fMRI. 
Study 1, 12 subjects 
2 visits: Lipid OR saline 
(via oro-gastric tube) 
Study 2, 12 subjects (5 in 
both studies). 4 visits: 
2x2 design. Lipid OR 
saline, CCK-1 antagonist 
OR placebo. 40 min 
scan, fed at 10 min.  
WB pseudo-block, 
conjunction analysis 




















Cb Pos R&L 
 
Liu 2000[134]. 21 (10f, 
11m, BMI not specified) 
12 h fast. BOLD-fMRI. 
48 min scan. 75g oral 
glucose at 10 min 
10 mm Midsagittal 
section. TCA. 2 peaks 
Peak 1 (1.1-
2.7 min) 
           Neg    Pos Supplementar
y motor Pos 
Somatosensor










KF Hunt.   Chapter 1: Introduction. 
1.7 DIFFERENCES IN BRAIN RESPONSES IN OBESITY 
1.7.1 Resting state studies in obesity 
1.7.1.1 Resting state ligand studies in obesity 
Using raclopride PET, two studies reported striatal D2 receptor availability was lower in 
obese versus normal weight subjects, interpreted as decreased functioning in reward 
pathways in obesity [164, 165].   
  
1.7.1.2 Resting state functional connectivity analyses in obesity 
The connectivity literature is complex with several analytic approaches. However, 
several studies have shown altered connectivity in the resting state in obese compared to 
normal weight subjects [166-168]. 
 
1.7.1.3 Structural differences in obesity 
Obese, compared to normal weight, subjects have lower prefrontal cortical thickness 
and grey matter volume [169]. 
 
1.7.2 Differences in brain responses to food cues in obesity 
1.7.2.1 Brain responses to food images in obesity (Table 1.9) 
These studies aim to identify neural correlates for the greater responsivity to external 
food cues in obese versus normal weight subjects (1.1.4.2).  Brooks et al performed an 
ALE meta-analysis of fMRI studies that used whole-brain analysis to compare 
responses to food versus non-food (or non-appetising food) images in obese versus 
normal weight subjects [170] identifying 7 studies published by December 2012 with a 
total of 99 obese and 101 normal weight subjects [25, 171-177].  They found a positive 
difference in BOLD signal to food versus non-food (or non-appetising food) images in 
obese versus normal weight subjects in parahippocampal gyrus (R), DLFC (superior 
and inferior frontal gyri) (R), MFC (L), dorsal ACC (R), and precentral gyrus (R) and a 
negative difference in insula (L) and DLFC (middle frontal gyrus) (L).    
 
From five other BOLD-fMRI studies, 2 using a whole-brain voxel-wise analysis [178, 
179] and 3 using ROI analysis [37, 180, 181] differences have been found between 
obese and normal weight subjects in response to food pictures in a least 2 studies in: 
caudate [37, 178, 180]; putamen [37, 178]; operculum/insula [37, 178, 181]; 
hippocampal formation [37, 178]; and DLFC [178, 179].  Both whole-brain analysis 
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the meta-analysis, generally the differences were positive. However, a positive 
difference can mean a greater positive response, a smaller negative response or a 
positive rather than a negative response to the stimulus in obese versus normal weight.  
Where reported, there was generally no response or negative BOLD signal change in 
normal weight and a positive change in the obese [37, 178, 180].  This would be 
consistent with greater responsivity to visual food cues in the obese, although of the 
studies that included a VAS assessment of response to food pictures, only one 
demonstrated greater increase in the obese [37] whereas 2 other studies found no 
differences [178, 181].   The positive difference in DLFC in the meta-analysis [170] and 
other studies [178, 179] is difficult to understand given the reported decreased 
inhibitory control in obesity (section 1.1.5).  It has been suggested this reflects greater 
attempts to control behaviour in the face of increased food motivation [173].  Where 
there was a negative difference, for example in insula (L) and middle frontal gyrus) (L) 
in the meta-analysis [170], the superior frontal gyrus (bilateral) for high ED versus non-
food pictures in McCaffery et al  [179] and for several regions and contrasts found in 
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Table 1.9:  Differences in brain responses to food pictures in obese versus normal weight subjects.  BOLD-fMRI studies. 
Paper, Subjects, Fed state 
Imaging, Stimulus,  
Instruction, Analysis  


















Pictures: 7 studies.  
101 NW, 99 Ob 
 
All cues (pictures, odour, 
taste): 10 studies,  
129 NW, 126 Ob 
Pictures  
F v NF (or 
non-
appetising) 
Ob v NW 
 



















F v NF 
Ob v NW 





















13NW f, 13Ob f 





HiEDF v NF 
Ob v NW 








     Pos  
Parietal lobule  
LoEDF v NF 
Ob v NW 





 IF R 
  Pos  
m occipital G 
s Temp G 
Hi v loEDF, 
Ob v NW 
     Pos 
R&L 
           
Stoeckel 2008[37] 





Lenient stats  (voxelwise 
p<0.01, KE 7 voxels). 
HiEDF v NF 
Ob v NW 























LoEDF v NF 
Ob v NW 




     Neg 
R&L 







Ob v NW 
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continued Table 1.9:  Differences in brain responses to food pictures in obese versus normal weight subjects.  BOLD-fMRI studies. 
Paper, Subjects, Fed state 
Imaging, Stimulus,  
Instruction, Analysis  























Ob v NW 









HiEDF v NF 
MWL v NW 




HiEDF v NF 
MWLvOb 























14 NW f, 12 Ob f  
Fast o/n ,  
BOLD-fMRI-block 
Pictures ‘Watch’ ROI 
HiEDF v NF 
Ob v NW 
   - - -   Pos 
R&L 
  -  - -   
Stice 2010a[177]  
44 f (adolescent) 
Fast 4-6h 
BOLD-fMRI 
Pictures (appetising food, 
unappetising food, water) 
Correlation with BMI 




v water  
WB 










   
Appetising  
F v water  
fROI 
       Pos 
fOp 
R&L 
   Pos 
LOC 
R&L 




F  WB 









   
Appetising F 
v unapp.  F 
fROI 
     Pos 
L 
     Pos 
LOC 
R 
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1.7.2.2 Brain responses to non-picture external food cues in obesity (Table 1.10) 
Neither of 2 studies looking for differences in response to food odours in obesity found 
differences meeting statistical thresholds – they may have been underpowered (5 NW, 5 
obese [172] and 12 NW, 13 overweight [182]). 
 
1.7.2.3 Differences in brain responses to food in the mouth in obesity (Table 1.10) 
These studies aim to identify neural correlates for pre-ingestive consummatory food 
reward (liking), and align with the un-proven hypothesis that this may be reduced in 
obesity (section 1.1.4.2) [4].  Four studies used a BOLD-fMRI ‘milkshake paradigm’ in 
which subjects received aliquots of milkshake or a tasteless solution, preceded by either 
a symbol [176, 183], a picture [180, 183] or odour [182]). Another fMRI study 
compared response to aliquots of sucrose versus water [184] and a [15O]-H2O-PET 
study compared responses to aliquots of liquid meal versus water after 36 hour fasting 
[185].  The most concordant findings were of positive difference between response to 
food versus water/tasteless solution in obese versus normal weight (or positive 
correlation with BMI/waist circumference) in  operculum/insula [176, 180, 182, 185] 
and a negative correlation in caudate [176, 182-184] with differences in other regions 
found in single studies. Given the potential role of dorsal striatum in food liking (section 
1.6.2.2) [157], the relatively consistent (4/6 studies) finding of reduced caudate response 
in the obese would support the hypothesis of reduced pre-ingestive consummatory food 
reward (liking) in obesity.  Stice et al found the negative correlations in caudate were 
stronger in subjects with the A1 dopamine receptor allele, associated with fewer 
dopamine D2 receptors, so genetic differences might explain some discrepancies [183]. 
 
In contrast to these studies, Szalay et al found positive differences between obese versus 
normal weight in BOLD responses to aliquots of vanilla nutrient drink versus water in 
several regions and no negative differences with similar findings for sucrose and 
quinine versus water.  These extensive changes are somewhat unexpected given the 
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Table 1.10:  Differences in brain responses to non-picture external food cues in obese versus normal weight subjects. 
Paper, Subjects, Fed state 
Imaging, Stimulus,  
Instruction, Analysis  












Del Parigi 2005a[185]  
20 NW (10f,10m)  
21 Ob (11f,10m) 
36 h fast,[15O]-H2O-PET 
2 scans aliquots water 
then 2 scans aliquots 
liquid meal WB 
Ob v NW 
Food v water 























17 NW f, 17 Ob f 
Fast 4-6h 
BOLD-fMRI 
Picture &  taste 
(choc milkshake) 
fROI (voxelwise) 
HiEDF v NF 
picture 
Ob v NW 
    Pos 
R 
           Pos  
PCC 
HiEDF v NF 
picture & 
taste 
Ob v NW 







       
Bragulat 2010[172] 
5 NWf, 5 Ob f 
24 hour fast 
BOLD-fMRI 
Food odour – fat 
(savoury) 

































mi&i Occip G 
Precuneus 
PCC 
Ob v NW 
F odour 
(preferred) v 
NF odour  
  Pos 
R 
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continued Table 1.10:  Differences in brain responses to non-picture external food cues in obese versus normal weight subjects. 
Paper, Subjects, Fed state 
Imaging, Stimulus,  
Instruction, Analysis  












Stice 2008a[176]  
33f (adolescents) 
11 NW, 7 Ob 




milkshake or tasteless,  
paired aliquots 50% of 
time & nothing 50% of 
time. Conditioned on day 
AnROI (voxelwise) 
Ob v NW 
MS symbol  
v TL symbol 









v TL symbol 
corr BMI 
       Pos 
(L) 
     Pos 
R&L 
  Fusiform 
Ob v NW 
MS taste v 
TL taste 
       Pos 
R&L 
 
        Fusiform 
MS taste v 
TL taste  
corr BMI 
    Neg 
L 
(4v) 




       Fusiform 
Stice 2008b[183] ǂ  
BOLD-fMRI 
Versions of milkshake 
paradigm 
?WB voxelwise 
correlation with BMI  
MS v TL 
43f (18-22 
yr) 
    Neg  
L 
            
MS v TL 
33 f (from 
[176]) 




           
Green 2011[184] 
20 young (18-29) 
20 old (65-87) 
BOLD-fMRI 
2 sessions 
Fast 12h   
Fed 700 kcal Ensure 









    Neg 
R&L 












    Neg 
R 
       
Fed Suc v 
water Young 
   - -     -        
Fed Suc v 
water older 
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continued Table 1.10:  Differences in brain responses to non-picture external food cues in obese versus normal weight subjects. 
Paper, Subjects, Fed state 
Imaging, Stimulus,  
Instruction, Analysis  













18 NW (16f, 2m)  
14 Ob (14f)  
17MWL (15f, 2m) 
Fast 4h 
BOLD-fMRI,  





60s v 0-20s 
(main effect) 
     L  R&L R&L     IFG 
L 
  Occipital,  
sTG L 





































12 NW (9f, 3m),  
12 Ob (9f,3m) 
3-4 h post 465kcal meal 
BOLD-fMRI-block 
Sucrose, quinine, vanilla 
nutridrink, water 
VAS pleasantness of 
stimulus after each run 
Whole brain 
Ob v NW 
Sucrose v 
water 
   Pos 
L 











   
Ob v NW 
Vanilla v 
water 



















   
Ob v NW 
Quinine 
versus water 



























   Pos 
L 
















       Pos 
R&L 
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continued Table 1.10:  Differences in brain responses to non-picture external food cues in obese versus normal weight subjects. 
Paper, Subjects, Fed state 
Imaging, Stimulus,  
Instruction, Analysis  














12 NW, 13 OW 
Neither hungry or full 
BOLD-fMRI 
Chocolate or strawberry 
milk or tasteless 
Odour followed by 
aliquots  
FO+ odour then MS 
FO- odour  then tasteless 
(learnt on day) 
(some unpaired) 
Mixed WB, lower 
















   Pos 
L 









OW v NW 
MSvTL 












           
MSvTL corr 
c BMI 
    Neg 
R 
  Pos 
R 
         
OW v NW 
odour v no 
odour 
             Neg 
R  
ns 





KF Hunt.   Chapter 1: Introduction. 
1.7.2.4 Effect of fed state on brain responses to food cues in obesity (Table 1.11)  
Neuroimaging studies have investigated the hypothesis that obese subjects may not 
show the attenuated positive response to food versus non-food (or high versus low ED 
food) cues seen in normal weight subjects after eating (sections 1.6.1.5 and 1.6.1.6).  
However, the studies have not reported (and have been underpowered to perform) the 
full 3 way statistical comparison and must be viewed with caution. One study found a 
positive difference in BOLD response to high ED versus non-food pictures in obese 
versus normal weight in the fed state (30 min after eating to satiety) in caudate (R), 
hippocampal formation, OC, DLFC, MFC and ACC [174]. Visualising responses in 
caudate, OC and ACC clusters,  they found in the obese a positive response to high ED 
versus non-food pre-meal which was sustained (or even increased) post-meal whereas in 
the normal weight there was a negative difference, whether no response (pre-meal) to 
negative (post-meal, caudate), positive to no response (OC), or positive to negative 
(ACC).  A similar study also found a positive difference in response to high hedonic 
value food versus non-food pictures in obesity prone versus obesity resistant in the fed 
state in insula/operculum (bilateral), DLFC (bilateral) and MFC (L) [188].  The obesity-
prone showed a negative response pre-meal and positive response post-meal, whereas in 
the obesity-resistant there was a negative difference, whether positive to negative 
(insula/DLFC) or no response to negative (MFC). Three other smaller studies (10-15 
subjects per group) also found positive differences post-meal in obese versus normal 
weight to food versus non-food pictures in caudate [25], hippocampal formation [25], 
OC [189], DLFC [25, 190] and MFC [25].  The responses were not shown in these 
studies although in most cases the parallel analysis in the fasted state did not identify 
clusters in these regions.  The only negative difference was found in OC in one study 
[190]. 
 
These data are consistent with findings that food-cue responses in normal weight  
subjects are attenuated after eating (section 1.6.1.6)  and suggest that in obesity external 
food cues continue to elicit similar (or even increased) responses in regions encoding 
food reward value after as before eating. The fairly consistent findings in DLFC, which 
in one study was visualised as increased activation post-meal in the obese, has been 
suggested to  reflect greater attempts to control behaviour in the face of 
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Table 1.11:  Differences in effect of fed state on response to food pictures in obese versus normal weight subjects.  BOLD-fMRI studies. 
Paper, Subjects, Fed state 
Imaging, Stimulus,  



















10 NW (5f, 5m) 
10 Ob (5f,fm) 
BOLD-fMRI, Pictures 
2 visits  
Pre-meal 4h fast  
Post-meal: 500 kcal meal 
WB & ROI Parallel 
Pre-meal 
Ob v NW 
F v NF 
             Pos MiF L 
IF L 
Pos R&L Pos 
R&
L 





Ob v NW 
F v NF 
    Pos 
R 
     Pos L   Pos R 
SFG 





10 NW (5f, 5m) 
10 Ob (5f, 5m) 
BOLD-fMRI 
Pictures 
2 visits  
Pre-meal =4h fast 
Post-meal=500kcal meal 
Counterbalanced 
‘Remember the images’ 
Mixed WB, but lower 
threshold required in 
ROI regions 
Pre meal 
Ob v NW 
FvNF 
             Pos SF R 
MiF L 
IF  L 
   
Post meal 
Ob v NW  
FvNF 
           Pos 
L 
     
Obese 
post meal v 
pre meal 
F v NF 






             SFG neg Neg L  Neg 
PCC  
Ob v NW 
F v blurred 
Post v pre 
meal 
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continued Table 1.11:  Differences in effect of fed state on response to food pictures in obese versus normal weight subjects.  BOLD-fMRI. 
Paper, Subjects, Fed state 
Imaging, Stimulus,  




















16 NW (10f, 6m) 
22 Ob (11f, 11m) 
Block-BOLD-fMRI 
1 visit 
Pre (>4 h fast) & post 30 
min after meal (eat to 
satiation up to 750 kcal) 
VAS hunger 
Task = pictures same or 
different 
Whole brain and ROI 




Ob v NW 
FvNF 
             Pos R&L 
Neg L 
  Neg 
Precentral G  
PCC 
Pre-meal  
Ob v NW 
HiEDF v NF 
        Neg L     Pos L 








Ob v NW 
Hi v lo EDF 
        Neg L 
 
 Neg L 
 
     Neg  






≠ lo EDF 
        Ob pos/nil 






      
Post-meal 
Ob v NW 
F v NF 
           Pos 
lOC 
R 
 Pos R   Pos 
sTG, PCC, 
Entorhinal Cb  
Post-meal 
Ob v NW 
HiEDF v NF 
    Pos  
R 
 











HiEDF ≠ NF 
















Hi v Lo EDF 
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continued Table 1.11:  Differences in effect of fed state on response to food pictures in obese versus normal weight subjects.  BOLD-fMRI.  
Paper, Subjects, Fed state 
Imaging, Stimulus,  





















28 (14f,14m) BMI 26.2 
kg/m2 
Obesity resistant  




Fast 10h, scan, meal 25% 
daily energy 
requirement,  scan at +30 
min 
‘View the images’ 






HiHVF v NF  
        Pos R&L     Pos   Pos 
Somatosens, 
Parietal, 
Visual cortex  
Ob resistant  
FEDvFAST 
HiHVF v NF 
     Neg 
R&
L 
  Neg R&L     Neg R&L   Neg 
Somatosens 
PCC  
Visual cortex  
Ob prone 
FASTED 
HiHVF v NF 
        Pos R&L   Pos 
L 






HiHVF v NF 
        Pos R     Pos L 
 




HiHVF v NF 




HiHFV v NF 



















fed = pos 
  
Holsen 2012[190] 
15 NW (9f, 6m) 
14 Ob (9f, 5m) 
BOLD-fMRI 1 visit 
>4h fast, scan, 500kcal, 
scan at 15 min 
Pictures ‘Remember 
images’ AnROI (VW) 
Pre-meal 










  Pos R   
Post-meal 
Ob v NW 
F v NF 
 Pos 
R 
         Neg
R 
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1.7.3 Differences in brain responses to food ingestion in obesity (Table 1.12) 
Gautier et al used their [15O]-H2O-PET protocol to compare responses to consumption 
of a liquid meal (50% REE) after a 36 h fast between obese and normal weight subjects 
initially finding differences in several brain areas [153, 191].  On reanalysing using 
more modern whole-brain voxel-wise neuroimaging analysis techniques they found a 
smaller increase in post-meal (versus pre-meal) signal in the obese (versus normal 
weight) in DLFC in men (middle frontal gyrus, L) [192] and women (inferior frontal 
gyrus, L) [193] also finding differences in women in hippocampal formation (L), 
middle frontal gyrus (R) and ACC (R), although the nature of these differences are not 
reported.  Anatomical ROI analysis (mean) of  DLFC across females and males showed 
attenuated increase in post-meal signal in the obese (versus normal weight) in DLFC 
(middle and inferior frontal gyri) [156].  Interestingly the normal response in the 
inferior frontal gyrus was restored in women with sustained (non-surgical) volitional 
weight loss, which might be a consequence of lower weight or a feature of those who 
are able to lose weight.   Two notable features of this study series are duration of the 
fast, which was chosen to maximise the impact of feeding, and that, because the meal 
size was based on REE, meals were larger for obese than normal weight subjects 
(females 885 versus 641 kcal; males 954 versus 725 kcal), so an alternative interpretion 
would be obese subjects require a larger meal to have the same impact in many regions.  
The investigators found differences in OC response to 50% REE versus a 600 kcal fixed 
meal in obese, but not normal weight, subjects (perhaps because the difference in actual 
meal sizes were smaller) [192].   
 
In hypothalamus, Matsuda et al found an attenuated BOLD signal response to glucose 
ingestion with a delayed nadir in obese versus normal weight subjects [133].   
 
In summary, only 2 groups have studied differences in response to nutrient ingestion in 
obesity: one finding attenuated increase in signal in DLFC and the other attenuated 
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Table 1.12: Brain responses to food ingestion in obesity.  [15O]-H2O PET studies 
Paper Subjects Imaging 
Stimulus Analysis 
Contrast BS Hy MB NA/
VS 










11 NW m (reported in 
[152] 
11 Ob m 
[15O]-H2O PET 
1 week admission 
Fasted 36h   
2xscans . Ensure Plus, 
50% REE. (NW 725, 
Ob 954 kcal)   





Fed v Fasted 





























 Occipital C 
posL& negL 









(Ob v NW)  








































PostTemp C  
Occipital C  
Cb 
Smaller Neg 
Th   
Gautier 2001 [153] 
10 NW f, 12 Ob f 
Protocol as [191] 
 
Ob 
Fed v Fasted 



























ule pos L  
Occip C Pos  
Th Neg R 




neg Cb neg 
Interaction 
(Ob v NW) by 
(Fed v Fast) 






























 Greater neg 
miTempG L  
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continued Table 1.12: Brain responses to food ingestion in obesity.  [15O]-H2O PET studies  
Paper Subjects Imaging 
Stimulus Analysis 
Contrast BS Hy MB NA/
VS 








Le et al 2006[192] 
Protocol  as [191] 
Except :  
Meal proportional to 
REE in 11 NW m, 11 
Ob m (subjects 
reported in [152, 191] 
Fixed 600kcal meal in 
9 NW m, 9 Ob m 
WB, newer version of 
SPM, more stringent p 
value 
Interaction 
(Fed v Fasted) 
by  
(Ob v NW) 
(all subjects) 
             Smaller Pos L  
MiFG 
   
50%REE v 
fixed meal 







     
Le 2007 [193]  
Protocol  as [191] 
Reanalysis of data from 
[153, 194] 
Meal 50% REE 
10 NW f (641 kcal) 
9 Ob f (885 kcal) 




NW v Ob v  
SWL 
FedvFast 
             IFG  
NW pos 
Ob less pos  
SWL restored 
  iTempG  
Ob v NW 
(FedvFast) 
          Neg 
L 
  miF Pos  




SWL v Ob 
(FedvFast)  
           Neg OC  IFG Pos    Occip G neg 
SWL v NW 
(FedvFast) 
                sTempG neg  
miTempG 
neg  
Le 2009[156] Protocol 
as [191] 50% REE 
31 NW (10f, 21m) 
18 Ob (8f, 10m) 
(all prev reported 
except 10 NW m) 
Anatomical ROI 
(mean) DLFC (SFG, 
MiFG, IFG) (?L only) 
NW  
Fed v Fasted 
             (SFG Pos ns L) 
MiFG Pos L 
(IFG Pos ns L) 
   
Ob  
Fed V Fasted 
             (SFG Pos ns L) 
(MiFG neg ns L) 
(IFG Neg ns L) 
   
Ob v NW,  
Fed v Fasted 
             (SFG ns) 
MiFG Neg L 
IFG Neg L 
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1.8 DIFFERENCES IN BRAIN RESPONSES AFTER RYGB 
Fourteen papers have been published on functional neuroimaging after bariatric surgery, 
all except 2 [195, 196] included subjects after RYGB.   
 
1.8.1 Differences in ligand PET or SPECT studies after RYGB 
These studies suggest there is no change in D2/D3 receptor availability in the striatum 
in women in the weeks after RYGB: one small study showed an increase in 4/5 women 
[197], a second small study showed a decrease [198] and a larger study (19 women) 
showed no difference [199]. 
   
1.8.2 Differences in brain responses to external food cues after RYGB 
The brain’s response to external food cues after RYGB (mainly pictures) has been 
studied using BOLD-fMRI block design paradigms in 6 cohorts using a variety of 
protocols mainly aiming to find a neurological correlate of the possible reduced 
responsiveness to external food cues after RYGB (section 1.3.1.2). No studies have 
looked at responses to food in the mouth after RYGB.   Ochner et al performed 2 
within-subject longitudinal studies looking at responses to visual (pictures) and auditory 
(spoken name) food cues before and 1 month after RYGB in the fed state [87, 200] and 
in a second cohort in both fed and fasted states [82] using whole-brain analysis. Scholtz 
et al performed a cross-sectional study looking at response to food pictures after 
overnight fasting in post-RYGB, post-band and obese (BMI matched to post-surgical) 
subjects  and used whole-brain analysis to compare post-RYGB and post-band and a 
pre-specified fROI analysis to compare the 3 groups [84].  They also studied a subset of 
post-RYGB and post-band subjects in the fed state, but did not report statistical 
comparisons of responses between fed and fasted states or between post-RYGB and 
post-band in the fed state [201].  Frank et al performed 2 cross-sectional studies looking 
at response to food pictures: one in the fed state in post-RYGB, obese and normal 
weight subjects analysed using whole-brain and pre-specified ROI approaches [23]; the 
second after at least 3 hours fasting  in post-RYGB and obese (all with T2DM) analysed 
using whole-brain approaches [202].   Goldman et al used whole brain analysis to 
compare response to high ED versus non-food pictures after at least 4 hour fasting in 
people with more versus less successful weight loss at least 1-year post RYGB (no 
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1.8.2.1 Brain responses to external food cues after RYGB: whole-brain analyses 
The three studies which identified differences in responses to food cues using whole-
brain analyses all found reduced responses after RYGB versus before RYGB [82, 87, 
200] or versus post-band [84] with no clusters where response was greater after RYGB.  
In most cases significant clusters were identified in comparisons involving high ED 
cues, with very few only identified in low ED food versus non-food, suggesting the 
impact of RYGB is greater on responses to high ED food cues. Two regions, both 
involved in reward, were identified in both study protocols:  nucleus accumbens/ventral 
striatum (high>low ED [200]; food>non-food & high ED food>non-food [84]; and 
putamen/globus pallidus (high ED food>non-food & high>low ED food [200]; 
food>non-food & high ED>non-food [84]). Clusters in other reward-related regions 
were identified in only one study protocol: Scholtz et al found reduced BOLD responses 
post-RYGB, versus post-band, for high ED>non-food in caudate, OC, subcallosal 
cortex, hippocampus, ACC and frontal pole, with the low ED>non-food contrast 
identifying OC and subcallosal cortex only [84] and Ochner et al found reduced BOLD 
responses after RYGB, versus before RYGB, in insula (low ED>non-food, fed state 
[200]; high>low ED food, fasted state [82]).   Ochner et al also demonstrated reduced 
responses post-RYGB in executive control regions: DLFC (high ED versus non-food, 
fed state [200]; high>low ED food, fasted state [82]) and MFG  (high>low ED food, 
fasted state [82]). They also identified reduced responses post-RYGB in 2 separate 
cohorts in regions not conventionally associated with food: precuneus and superior 
and/or middle temporal gyri [82, 200].  None of the studies showed differences in 
hypothalamus after RYGB.  
 
In parallel analyses (five subjects), Ochner et al  found reduced activation to high versus 
low ED food cues in the fasted state but no differences in the fed state [82]. Although 
such parallel analysis should be viewed with caution, they conclude the impact of 
RYGB on response to food cues is greater in the fasted than the fed state.  Interestingly, 
food ingestion pre-RYGB, and RYGB itself, appear to have similar effects on responses 
to high versus low ED food cues in at least some brain areas (DLFC, MFC, precuneus) 
suggesting that the post-RYGB fasted state is similar to the pre-RYGB fed state [82]. 
 
Two studies using whole-brain analysis did not identify any clusters showing difference 
in responses to food versus non-food pictures post-RYGB versus obese and normal 
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find differences in analyses unrelated to food image viewing per se: in a resting state 
connectivity analysis there were between-group differences in OC, DLFC and ACC, 
with stronger connectivity in obese than normal weight and post-RYGB, which were 
similar [23].   
 
Although they did not have a pre-RYGB or other comparator group, Goldman et al 
found that in post-RYGB subjects instructed to resist craving, those with more 
successful weight loss had greater activation in left DLFC versus those with less 
successful weight loss [203].  There were no significant differences when asked to allow 
cravings. 
 
There are a number of potential explanations for discrepancies.  Lack of power may be 
one.  It is likely that both studies from Frank et al were underpowered for the analyses 
presented: interaction between food versus non-food and group for 3 groups [23]; and 
interaction between group (RYGB versus obese), task (liking versus wanting) and food 
cue (high versus low ED food) [202].   The task performed during scanning may also be 
important.  OC, which encodes reward value or salience, was identified using a 
paradigm in which subjects rated the appeal of each picture as it appeared [84] but not 
in the paradigm where subjects rated desire to eat after each block [87, 200].  The lack 
of findings in Frank et al [23] may relate to the within-scan one-back and control tasks 
(section 1.6.1.1).  Longitudinal studies have the potential confounders of scan order and 
weight loss.  This is particularly important when considering analyses without within-
scan cue contrasts (e.g. high ED food cue, after versus before RYGB) [87, 200], which I 
have excluded from the above discussion. Notably, subjects were studied 1 month post-
RYGB when they were still on a liquid diet and therefore presumably would not have 
eaten the foods portrayed in the pictures since the surgery [82, 87, 200].  The 
comparison with post-band suggests the differences seen are not a consequence of 
weight loss [84]. The fed state might be important, with the impact of RYGB on 
response to food cues appearing greater in the fasted state [82]: in the above studies 
subjects were studied fasted [84], fed [23, 87, 200], and >3 hour post-meal [202]. 
Finally it is possible that the food cue used might be important: all used food pictures, 
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1.8.2.2 Brain responses to external food cues after RYGB: ROI analyses 
ROI analyses were presented for two studies [23, 84].  Scholtz et al compared responses 
to food (any food, high ED, low ED) versus non-food cues between post-RYGB, post-
band and obese in pre-specified fROIs (nucleus accumbens, caudate, anterior insula, 
amygdala, OC), finding significant differences in combined 5 fROIs, amygdala and OC.  
In combined fROIs the BOLD response to high ED versus non-food was lower in post-
RYGB versus obese and post-band (only significant for the latter comparison) whereas 
the BOLD response to low ED versus non-food cues appeared similar in post-RYGB 
and obese.  However, as the response pattern in the 5 fROIs appeared different, this is 
difficult to interpret.  In OC the response in post-RYGB was less positive than post-
band and obese for all food, high ED, and low ED versus non-food cues (although not 
all significant).  In amygdala there was a positive BOLD response  in obese and post-
band and negative BOLD response in post-RYGB for all food, high ED and low ED 
versus non-food (although not all significant).  This finding of a post-RYGB difference 
that was not just smaller in magnitude but a reversal was also found by Ochner et al in 
comparison to pre-RYGB in the fasted state in lentiform nucleus, insula, DLFC and 
MFC: high versus low ED food cue comparison was positive pre-RYGB and negative 
post-RYGB [82].   
 
Frank et al compared responses to high versus low ED food cues between post-RYGB, 
obese and normal weight in pre-specified ROIs (hypothalamus, striatum and DLFC) 
showing  differences in hypothalamus only: normal weight and post-RYGB showed 
positive differences whereas obese subjects showed negative difference.  This is the 
only study which showed a significantly higher response to high ED food cues post-
RYGB.  It is also the only study which included a normal weight group, apparently 
demonstrating restoration of normal responses in hypothalamus after RYGB.  However, 
the  hypothalamic response in these obese subjects may not be typical: of the many 
studies looking at response to food cues in obese versus normal weight subjects (section 
1.7.2.1) only one found a difference in hypothalamus (in a ROI analysis), and that found 
a positive difference between food versus non-food pictures in obese versus normal 
weight [190]. 
 
1.8.2.3 Summary of differences in brain responses to external food cues after RYGB 
Reduced responses to external food cues, especially high ED food cues, have been 
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impact in the fasted state.  Given the studies showing increased responses to external 
food cues in obese versus normal weight subjects in similar regions (section 1.7.2.1) it 
is tempting to conclude that RYGB reverses the abnormal responses seen in obesity.  
However, none of the studies which showed attenuated responses after RYGB included 
a normal weight group. Applying the reasoning of Davids et al [173] (section 1.7.2.4), 
the reduced response to external food cues in executive control regions could be 
interpreted as the post-RYGB reduction in food motivation necessitating a lower 
requirement for inhibitory control.  The greater activation in left DLFC when instructed 
to resist food craving in those with successful weight loss has been interpreted as 
greater ability to mobilise inhibitory control when needed [203].  
 
1.8.3 Differences in brain responses to food ingestion after RYGB 
Only one study has looked at brain responses to nutrient (glucose) ingestion after 
RYGB.  Van de Sande-Lee [204] used BOLD-fMRI to investigate the response to 
consuming 50 g glucose after a 12 hour fast before and 34 weeks after RYGB and in 
normal weight subjects.  Using temporal clustering analysis they showed differences in 
responses to glucose ingestion between pre-RYGB, post-RYGB and normal weight in 
hypothalamus, OC, somatosensory cortex, and occipital cortex.  In general the pattern 
was a difference between normal weight and pre-RYGB, with restoration towards 
normal in post-RYGB subjects. This was most evident for hypothalamus.  The pattern 
in OC was different: there were differences between normal weight and pre-RYGB, and 
post-RYGB was different from both pre-RYGB and normal weight. Hypothalamic 
functional connectivity analysis identified similar regions and showed a similar 
response in post-RYGB and normal weight, which was different in pre-RYGB. 
 
 
1.9 BRAIN RESPONSES TO GUT PEPTIDES, INSULIN AND LEPTIN 
As discussed previously, there is evidence that gut and pancreatic peptides signal  the 
presence of food in the gut to the brain (section 1.1.3.1 and 1.1.8.1) and leptin signals 
the state of fat stores (section 1.1.3.1). Neuroimaging studies demonstrate gut peptides, 
insulin and leptin can modulate brain activity in relevant regions. Zanchi et al performed 
a systematic review of functional neuroimaging studies investigating how gut peptides, 
insulin and leptin influence regional brain activity  in humans [205].  They identified 40 
studies, the majority presenting correlations with hormone concentrations (baseline and 
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to confounding.  Only 9 investigated the effect of administering the hormone of interest 
or its receptor agonist [206-214] and these are discussed here, along with others that 
were not included in the systematic review [215-218].  
 
1.9.1 Functional neuroimaging studies investigating brain responses to gut 
peptides, insulin and leptin 
1.9.1.1 Brain responses to PYY and GLP-1 (or receptor agonist) 
Batterham et al investigated brain responses to PYY in normal weight subjects, who 
underwent 2 BOLD-fMRI studies, 1 with PYY infusion and 1 saline, and identified 
brain regions where BOLD signal co-varied with plasma PYY concentrations (whole 
brain analysis) [206].  They found activation in brainstem, midbrain, putamen, globus 
pallidus, insula, OC (greatest effect), ACC and other cortical and cerebellar regions, 
and, in a ROI analysis, hypothalamus, and deactivation  in DLFC and angular gyrus 
[206].   Focussing on hypothalamus and OC, they found greater decrease in 
hypothalamic signal during the scanning period on the saline day was associated with 
lower subsequent ad libitum intake, with no association on the PYY day, whereas 
greater increase in OC signal during the scanning period on the PYY day was associated 
with lower subsequent ad libitum intake, with no association on the saline day.   
 
De Silva et al investigated the impact of PYY and GLP-1 infusions on responses to 
external food cues (pictures) in normal weight subjects and found combined PYY and 
GLP-1, versus saline, infusion attenuated the positive BOLD response to food versus 
non-food pictures in all ROIs (nucleus accumbens/ventral striatum, caudate, putamen, 
insula, amygdala and OC) only significant in insula  [207].  A similar pattern of 
numerically attenuated responses was seen for PYY alone (only significant for insula) 
and GLP-1 alone (none significant) and also, as would be expected (sections 1.6.1.5 and 
1.6.1.6), for fed versus fasted (only significant for insula, non-significant increase in 
amygdala).   
 
Van Bloemendaal at al investigated the impact of GLP-1 agonist exenatide infusion on 
response to external food cues (pictures) in normal weight, obese (NGT), and obese 
with T2DM subjects [208].  In predefined ROIs (striatum, insula, amygdala, OC) they 
found no effect of exenatide in normal weight subjects.   Exenatide attenuated the 
positive BOLD response to food versus non-food pictures in obese (NGT) in insula and 




KF Hunt.   Chapter 1: Introduction. 
to high ED food versus non-food pictures in obese (NGT) in insula and OC and in obese 
(T2DM) in putamen, insula and OC. 
 
1.9.1.2 Brain responses to ghrelin 
Three fMRI studies have investigated the effect of the orexigenic gut peptide ghrelin in 
non-obese subjects in the postprandial state (when endogenous ghrelin is low) [209, 
212, 213]. 
 
Jones et al found the ghrelin bolus, versus saline, decreased BOLD signal in  brainstem, 
hypothalamus, midbrain, insula, amygdala and hippocampus (also cerebellum, thalamus 
and post-central gyrus) and deceased BOLD signal in motor cortex (whole brain 
pseudo-block analysis) [212].   
 
The other 2 studies looked at the impact of ghrelin bolus on response to external food 
cues (pictures). Malik et al compared after versus before ghrelin injection using whole 
brain analysis [213].  Goldstone et al compared ghrelin with saline given at a separate 
visit and ROI analysis (ventral striatum/nucleus accumbens, caudate, insula, amygdala, 
hippocampus, OC) [209]. In both studies, ghrelin increased the positive BOLD response 
to food versus non-food pictures in hippocampus and OC and additionally in Malik et al 
in the midbrain, caudate, insula, amygdala and other areas.  Additionally, Goldstone et 
al showed the impact of ghrelin was similar to fasting. 
 
1.9.1.3 Brain responses to insulin 
Studies on the action of insulin on the brain in humans are limited by the difficulty of 
delivering insulin to the brain without causing hypoglycaemia.  Two approaches have 
been used: euglycaemic insulin clamp studies [219] and intranasal insulin [220].    
 
Initial neuroimaging studies investigated whether whole brain glucose metabolism is 
insulin responsive and failed to find an impact of hyperinsulinaemia [221-223].  
However, the circulating insulin levels were high. Bingham et al examined the effects at  
lower insulin concentrations, using somatostatin infusion to inhibit endogenous insulin 
secretion and comparing low-dose insulin infusion with saline (euglycaemia maintained 
using IV glucose) in non-obese males [224].  Using FDG-PET they demonstrated 15% 
higher global brain glucose metabolism when basal insulin was replaced.   Tschritter et 
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(MEG) and found that insulin, compared to saline, resulted in significant increase in 
cerebrocortical activity in normal weight subjects [225].   
 
Later studies investigated regional brain responses to insulin.  Using their 
somatostatin±IV insulin protocol in non-obese and obese men, Anthony et al showed 
insulin increased brain glucose metabolic rate (corrected for global effect, whole brain 
analysis) in ventral striatum, insula, prefrontal cortex, anterior cingulate cortex and 
temporo-parietal regions, and decreased brain glucose metabolic rate in amygdala, 
hippocampal regions and cerebellum [215].  Partially consistent with this, Schilling et al 
showed, in normal weight males, intranasal insulin, versus placebo, increased regional 
blood flow (fMRI CASL, whole brain analysis) in caudate, putamen, operculum and 
insula with no regions showing decrease [214].  Using a different imaging paradigm, 
Kullmann et al found intranasal insulin, versus placebo, decreased intrinsic BOLD 
activity in hypothalamus and OC (whole brain analysis) [218]. 
 
Investigating the effect of insulin on responses to external food cues, Guthoff et al 
found intranasal insulin, versus placebo, reduces the BOLD response to food pictures in 
several areas, including hippocampus, frontal cortex, temporal cortex and fusiform 
gyrus with no effect on response to non-food pictures [216].   
 
There is also neuroimaging research focused on insulin and cognitive function, but this 
is outside the scope of this thesis [122]. 
 
1.9.1.4 Brain responses to leptin 
Farooqi et al studied BOLD-fMRI responses to external food cues (pictures) in 2 people 
with congenital leptin deficiency before and after 7 days of leptin treatment and found 
(ROI analysis, striatum) the positive response to food versus non-food pictures in 
ventral striatum, caudate, putamen and globus pallidus was attenuated after leptin 
treatment [217].  Rosenbaum et al studied 6 obese subjects after 10% weight loss and, 
comparing fMRI-BOLD response to food versus non-food pictures after 5 weeks of 
leptin versus 5 weeks of placebo (crossover study), showed (whole brain analysis) 
positive differences (which could be greater activation or smaller deactivation) in 
hypothalamus, putamen, DLFC, medial frontal cortex, thalamus and posterior cortical 
regions and negative differences (which could be attenuated  activation or larger 
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cortical regions [211].  These effects were generally opposite to the effects they 
observed after 10% weight loss.  In an expansion of this study they found leptin versus 
placebo altered functional connectivity with hypothalamus when viewing food versus 
non-food pictures: increased with operculum, insula and posterior cortical regions; 
decreased with OC, DLFC ACC,  frontal pole and posterior cortical regions [210]. 
 
1.9.1.5 Summay of brain responses to gut peptides, insulin and leptin 
There is evidence that gut peptides (PYY, GLP-1, ghrelin), insulin and leptin modify 
brain activity in regions involved in homeostasis, reward and executive control.  
 
PYY increases BOLD signal in homeostatic and reward regions (with the greatest effect 
in OC) and decreases signal in DLFC [206].  Insulin has been shown, using 3 different 
neuroimaging techniques, to alter resting brain activity in homeostatic [218], reward 
[214, 215, 218] and executive control [215] regions.  Ghrelin decreases BOLD signal in 
homeostatic and reward regions (although not OC) [212]   
 
As might be expected, the effect of PYY, GLP-1 and insulin on brain responses to food 
cues are consistent with the effect of fed versus fasted state (section 1.6.1.6).  PYY and 
GLP-1 attenuate the positive BOLD response to external food cues in reward regions, 
with GLP-1 receptor agonist having a similar effect in obese subjects only  (homeostatic 
and executive control regions not investigated) [207, 208]. Insulin attenuates the 
response to external food cues in reward and executive control regions [216]. 
Conversely ghrelin, as might be anticipated given its orexigenic effects, increases the 
positive response to exernal food cues in homeostatic and reward regions [209, 213]. 
 
Leptin alters the BOLD response to external food cues in homeostatic [211], reward 
[211, 217] and executive control [211] regions, with data consistent with leptin 
deficiency being responsible for some of the changes in neural responsivity to external 
food cues after weight loss [211]. 
 
1.9.2 Gut peptides as potential mediators of differences in brain responses to food 
after RYGB 
Alteration in gut peptide secretion is one proposed mechanism of altered gut-to-brain 
signalling after RYGB (section 1.3.2) and there is evidence that gut peptides (PYY, 




KF Hunt.   Chapter 1: Introduction. 
neuroimaging studies have considered the role of gut peptides in the altered brain 
responses to food cues after RYGB. 
 
Ochner et al considered post-RYGB differences in response to food cues were not due 
to gut peptides, because the difference between pre and post-RYGB was greater in the 
fasted state, whereas the impact on gut peptides is greater in the fed state [82] (section 
1.8.2).  Furthermore,  Scholtz et al found no evidence for a role for PYY and GLP-1 in 
differences in BOLD responses to food cues in the fasted state after RYGB, finding no 
significant correlations between BOLD activation to any food, high or low ED food 
pictures in combined 5 fROIs, amygdala or OC and fasting or postprandial 
concentrations [84] (section 1.8.2). 
 
Goldstone et al explored the potential role of gut peptides after RYGB (and AGB) in the 
fed state, studying a subset of post-surgical subjects reported in Scholtz et al [84] using 
the same fMRI paradigm in the fed state, once with  octreotide+insulin and once with 
saline [201].  Octreotide+insulin in post-RYGB and post-band (analysed separately) 
suppressed PYY and GLP-1, increased food appeal rating in post-RYGB (driven by 2 
subjects) but not post-band, but interestingly, in contrast to le Roux et al [81], had no 
effect on postprandial hunger or fullness.  In a fROI analysis (nucleus accumbens, 
caudate, anterior insula, amygdala) they found increased response to food versus non-
food pictures with octreotide+insulin versus saline in combined 4 fROIs and in nucleus 
accumbens in RYGB (both from negative to positive).  There was no significant effect 
in the other fROIs in post-RYGB or in post-band, although the response was 
numerically higher with octreotide+insulin in all 4 fROIs in both post-RYGB and post-
band.  Across all subjects, there was a significant correlation between decrease in PYY 
with octreotide plus insulin and increase in BOLD signal in combined fROIs with a 
trend for a similar pattern for GLP-1.  There was no unoperated control group in the fed 
state, so it is unclear whether octreotide+insulin makes the response more or less like 
the unoperated state - although it does appear to make post-RYGB more like post-band 
supporting a possible role for gut peptides in altered postprandial responses to external 
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1.10 THESIS AIMS 
Probably the most consistent finding after RYGB is increased postprandial fullness or 
satiety and reduced ad libitum meal size which is correlated with post-RYGB weight 
loss. Exaggerated postprandial gut peptide responses after RYGB is one of the main 
proposed mechanisms of altered gut-to-brain communication after RYGB. 
Understanding differences in brain function underlying increased fullness and enhanced 
meal termination may improve understanding of successful weight loss and have 
therapeutic implications.  However, functional neuroimaging protocols looking at 
responses to food ingestion are not well established and only one neuroimaging study 
has looked at responses to nutrient ingestion after RYGB.  
  
This thesis presents: 
• Development of a new functional neuroimaging protocol using FDG-PET to image 
the regional brain responses to food ingestion 
• Regional brain responses to food ingestion across all subjects 
• Differences in regional brain responses to food ingestion between normal weight, 
obese and post-RYGB subjects 
• Correlations between food-evoked signal change and ad libitum food consumption 
and appetitive sensations   
• Investigation of the role of exaggerated postprandial gut peptide responses in post-
RYGB subjects: correlations between gut peptides and food-evoked signal change 
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CHAPTER 2: MATERIALS AND METHODS 
 
2.1 OVERVIEW  
I conducted a cross-sectional study using FDG-PET brain imaging state to examine the 
regional brain responses to food ingestion. Three groups were studied: normal weight 
(NW); obese non-operated (Ob) (recruited as two separate groups obese insulin-
sensitive (ObIS) and obese insulin-resistant (ObIR)); and post successful RYGB for 
obesity (RYGB).  In RYGB I also investigated the effect of inhibiting the expected 
exaggerated gut peptide responses to food ingestion using somatostatin. NW and Ob 
underwent 2 PET scanning visits (FASTED and FED) after overnight fasting in random 
order.  RYGB underwent 4 PET scanning visits after overnight fasting in paired random 
order (placebo-FASTED, placebo-FED, somatostatin-FASTED, somatostatin-FED).   
At FED visit participants consumed a 400 kcal fixed meal, at FASTED visit participants 
continued to fast. At somatostatin visits RYGB subjects received intravenous 
somatostatin and insulin (to replace basal insulin).  FDG-PET scanning was performed 
between +15 and +70 min. To provide functional correlates of neuroimaging data, 
appetitive sensations were assessed using visual analogue scales (VAS) and 
consumption at an ad libitum meal after each scan was measured.  Venous blood 
samples were taken for measurement of glucose, pancreatic and gut peptides and 
adipokines.  Before the first scanning visit all participants underwent a ‘dummy’ scan to 
accustom themselves to the scanner and thus diminish the effect of first scan [221]; NW 
and Ob underwent an oral glucose tolerance test (OGTT) to assess glycaemic status; and 
RYGB participants underwent a test meal to determine capacity to consume the study 
meal and the glucose response.  Participants underwent a structural MRI brain scan to 
assist spatial normalisation of the PET images.  Differences in FDG uptake between 
PET scans were analysed using Statistical Parametric Mapping (SPM). 
 
 
2.2 REGULATORY APPROVALS 
I obtained approvals to conduct the research from : The Royal Marsden Research Ethics 
Committee (08/H0801/152); Research and Development committees of KCH 
(KCH619) and Guy’s and St Thomas (RJI 09/0384); and the Administration of 
Radioactive Substances Advisory Committee (261-1945(23765)).  The research was 




KF Hunt.   Chapter 2: Materials and methods. 
2.3 SUBJECTS, RECRUITMENT, INCLUSION AND EXCLUSION CRITERIA 
Normal weight and obese people and people who had lost weight after RYGB were 
recruited.  I considered studying people before and again after RYGB.  However, 
glucose handling is altered by RYGB (section 1.3.3.9) which might affect FDG uptake 
(sections 1.5.1.1 and 6.4.3.2) and impact on within-subject before and after RYGB 
comparisons.  FDG-PET scanning does involve exposure to ionising radiation and this 
limits the number of scans per person (section 2.5.6.3). The capacity of the FDG-PET 
scanner (gantry bore size and scanner table maximum weight capacity, Table 1.2) places 
some limitations on the physical size of people who can be scanned safely and 
reasonably comfortably.  Finally longitudinal studies comparing subjects before and 
after weight loss, while they have the advantage of within-subject comparisons, have 
the impact of the different weight and perhaps higher risk of loss to follow up. 
   
I recruited participants by e-mail advertisement to students and staff of King’s College 
London and from obesity and bariatric surgery clinics at King’s College Hospital. 
   
Inclusion and exclusion criteria are given in Table 2.1.  Obese participants were 
classified as ObIS (HOMA2-IS≤ 0.76) or ObIR (HOMA2≥1.47) after the OGTT visit, 
and those with intermediate values were not studied further.  Exclusion criteria were 
directed at ensuring participants were able to give consent, were in good general health 
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Table 2.1 : Inclusion and exclusion criteria 
Inclusion criteria 
1.  At least 18 years old 
2.  Right handed 
3a.  Normal weight (NW): BMI 20-25kg/m2,  
3b. Obese (Ob): BMI 30-40kg/m2, 
Obese insulin-sensitive (ObIS): HOMA2-IR ≤ 0.76 [226]. 
Obese insulin-resistant (ObIR): HOMA2-IR ≥ 1.47. 
3c.  Post RYGB (RYGB):  
At least three months after RYGB for obesity,  
Lost more than 10% of excess body weight (weight before RYGB) – (weight if 
BMI 25kg/m2). 
Current BMI 25-40kg/m2  
Exclusion criteria 
1. Inability to give formal consent. 
2. Unable to communicate in spoken English (due to the importance of being able to 
communicate while study subjects are in the scanner). 
3. Age less than 18 years. 
4. Pregnancy, planning pregnancy, or breastfeeding. 
5. Currently enrolled in other clinical study.  
6. Left-handedness 
7. Taking any glucose lowering medications  (except metformin).  Subjects taking 
metformin were asked to omit it the day before and the morning of the Test 
Meal/OGTT visit and the PET scanning visits. 
8. Advanced retinopathy. 
9. Any significant brain disorder e.g. epilepsy, cerebrovascular disease.  
10. Use of psychotropic medication eg antidepressants, antipsychotics.  
11. Unstable angina, myocardial infarction in the previous year, uncontrolled congestive 
cardiac failure. 
12. Chronic kidney disease (Stage 3-5). 
13. Liver function tests more than 3 times the upper normal limit. 
14. Coagulopathy (INR>1.5 or platelets less than 50x109/L). 
15. Anaemia (Hb less than 10g/dL). 
16. Recent history of cancer (< 5 years). 
17. Contraindication to MRI. 
Additional exclusion criteria after OGTT/Test meal visit 
18. Obese subjects only: HOMA2-IR 0.77-1.46 
19. Subjects with plasma glucose >15 mmol/l at any time point after the oral glucose 
tolerance test (NW and Ob) or >11 mmol/l at any time point after the test meal 
(RYGB). 
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2.4 SAMPLE SIZE CALCULATION  
Sample size calculations were performed using G*Power 3.1 [227].  Postulated effect 
sizes were based on the work of Anthony et al [215] which used a similar protocol 
employing FDG-PET to examine the brain responses to insulin. In this study the 
insulin-evoked change in cerebral metabolic rate for glucose (CMRglc) showed an 
effect size of about 1 (amygdala) to 2 (ventral striatum) in healthy participants.  
 
The central hypothesis was that regional brain responses to food ingestion would be 
different between three groups (NW, ObIS, RYGB).  The power calculation was based 
on the hypothesis that ventral striatal response to food ingestion would be different 
between the three groups with an effect size of 1.  Considered as a one-way ANOVA 
model, a total group size in excess of 15 (5 per group) would give greater than 80% 
power to detect an effect size of 1 at a significance level of 5% (Figure 2.1a). 
 
A second hypothesis was that, in RYGB participants, the regional brain responses to 
food ingestion would be different between somatostatin+insulin and placebo.  The 
power calculation was based on the hypothesis that ventral striatal response to food 
ingestion would be different with an effect size of 1.  Considered as a paired t-test, a 
sample size in excess of 10 would provide greater than 80% power to detect an effect 
size of 1 at a significance level of 5% (Figure 2.1b). 
 
I aimed to complete the study in 12 participants in each of the four groups (NW, ObIS, 
ObIR, RYGB) to allow for smaller than postulated effect sizes and for non-hypothesis 














Figure 2.1.  Power plots. 
(A) shows a power plot for difference between three groups (eg NW, ObIS, RYGB) 
using one-way ANOVA. 
(B) shows a power plot for difference between paired means (eg difference between 
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2.5 STUDY DESIGN 
NW and Ob participants underwent five visits: screening; 75g OGTT and dummy scan 
visit; two PET scanning visits (FASTED and FED) in random order; and a structural 
MRI brain scan.  RYGB participants underwent seven visits: screening, test meal and 
dummy scan visit; four PET scanning visits in random order (placebo-FASTED, 




The randomisation was run by the Mental Health and Neurosciences Clinical Trials 
Unit.  NW and Ob participants were randomised to have either FED then FASTED or 
vice versa in a block randomisation model with a block size of eight.  RYGB 
participants were randomised to placebo studies followed by somatostatin studies (or 
vice versa) and within each condition to FED then FASTED or vice versa.  This was to 
ensure that if participants dropped out halfway through the data they had provided 
might be might be usable.  
 
2.5.2 Screening visit 
The study was explained to potential participants and written informed consent to 
participate was obtained.  Data were collected on age, ethnicity (as reported by the 
participant), gender, medical history and regular medications.  Specific questions were 
asked about contraindications to MRI scanning.  Women were asked their menopausal 
status, whether they were planning pregnancy and use of contraception.  In RYGB 
participants, date of surgery and pre-operative weight were taken from the medical 
notes.  Weight, height, neck, waist and hip circumference and blood pressure were 
measured and a general physical examination performed. BMI was calculated as 
(weight in kg)/((height in m)2)[5].  For RYGB participants, percentage weight loss was 
calculated as ((pre-operative weight – weight at screening visit) / pre-operative 
weight)x100. 
 
2.5.3 OGTT visit (NW and Ob) 
These visits were conducted at the Clinical Research Facility, St Thomas’ Hospital, 
London.  Participants fasted from midnight.  An arm or hand vein was cannulated.  
Participants consumed 75 g of glucose in 250 ml water over 5 min and remained seated.  
Blood was sampled from the intravenous cannula for glucose and insulin measurement 
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pre ingestion (baseline) and at +10, +30, +60, +90 and +120 min after finishing glucose 
drink. 
 
The OGTT allowed assessment of glucose tolerance and fasting insulin resistance using 
the HOMA2 model (www.dtu.ox.ac.uk/homacalculator [226]).  Participants with 
plasma glucose >15 mmol/l at any time during the OGTT would have been withdrawn 
from the study due to the potential for major increments in blood glucose to alter the 
dynamics of FDG. I chose a relatively high threshold of 15 mmol/l, compared to 
11mmol/l after ice-cream for RYGB participants, because the glucose excursions after 
ice-cream (used for the meal in the FED PET visits) would be expected to be lower.   
 
To familiarise participants with the VAS panel to be used during the PET scanning 
visits (section 2.5.6.5), these were completed at time 0, +10, +30, +60, +90 and +120 
min.  Before or after the OGTT, the participant attended the PET department and lay in 
the scanner for 15 min.  Neither FDG or CT scan was administered. This dummy study 
was to diminish the impact of first study [221].   Participants unable to tolerate the 
dummy PET scan would have been withdrawn. 
 
2.5.4 Test meal visit (RYGB) 
These visits were conducted at the Clinical Research Facility.  Participants fasted from 
midnight.  An arm or hand vein was cannulated. Participants were asked to consume a 
400 kcal mixed meal (vanilla ice-cream).  Blood was sampled for plasma glucose and 
insulin measurement pre-test meal (baseline) and at +10, +30, +60, +90, +120, +150 and 
+180 min after end of test meal. 
   
The purpose of the test meal was to allow identification of participants unable to 
consume the full 400 kcal.  Such participants were given the amount tolerated for the 
meal at the FED PET scanning visits, thus ensuring that participants consumed the same 
amount before the PET scan at both somatostatin-FED and placebo-FED visits 
(participants consuming more at the somatostatin visit would make data interpretation 
difficult).  Participants with a plasma glucose >11mmol/l post meal would have been 
withdrawn from the study.  I chose not to perform an OGTT in these participants 
because it may be unpleasant for participants (causing ‘dumping’), would require an 
additional visit, and the interpretation of OGTT results after RYGB is not established.  
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As for the OGTT visit (section 2.5.3) participants completed the VAS panel at baseline, 
+10, +30, +60, +90, +120, +150 and +180 min and underwent a dummy PET scan 
before or after the test meal as described above.   
 
2.5.5 MRI visit 
A structural MRI brain scan was performed on a separate occasion using a MP RAGE 
[228] protocol on a Philips Achieva 3.0T scanner in the Rayne Institute, St Thomas’ 
Hospital, London. The structural MRI brain scan was used in spatial normalisation of 
the PET images. 
 
2.5.6 PET imaging visits 
FDG-PET imaging visits were conducted at the PET Imaging Centre, St Thomas’ 
Hospital.  Pre-menopausal women were scanned in the first 10 days of their menstrual 
cycle and those on the oral contraceptive pill were scanned at the same time point in the 
cycle [229, 230].  A urine pregnancy test was performed in pre-menopausal women at 
the beginning of each PET scanning visit.  FDG-PET imaging visits were performed 
after an overnight (>9 hour) fast, with water allowed to avoid thirst.   
 
The sequence of events at each PET imaging visit is shown in Figure 2.2.  Timings are 
from the end of the meal.  At FASTED visits, and in the pre-meal phase of FED visits, it 
was assumed participants would take 5 min to consume the meal. 
• At the start of each visit the participants were told whether the visit was 
FASTED or FED.  This was to reduce difference between visits, because NW 
and Ob participants would know this for the second visit after the first visit. 
• IV cannulae were placed in arm veins, using aseptic technique and local 
anaesthetic (1% lignocaine). 
• RYGB participants only received intravenous infusions from -95 min until the 
end of the ad libitum meal: 0.9% saline at placebo visits and 
somatostatin+insulin at somatostatin visits.  
• For FED studies, participants consumed a 400kcal meal starting at -5 min (NW 
and Ob after 20 min rest, RYGB after 90 min infusions).  For FASTED visits no 
calories were consumed prior to scanning.  Participants were allowed to drink 
water to thirst at all visits. 
• 90MBq FDG was injected intravenously by PET radiographers 15 min after the 
subject finished the meal in FED studies and at equivalent time point in 
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FASTED studies. After a 30 min FDG uptake period, the participant was 
positioned on the scanner couch.  Scanning commenced at +55 min for 15 min.   
• Participants undertook an ad libitum meal after each PET scan [81]. 100 kcal 
ice-cream was presented every 5 min and participants were instructed to eat until 
they felt full.  
• Participants completed a VAS panel at -105min (RYGB only), before the start of 
the infusions, -20 min, -7 min, +10 min and +80 min (after completion of FDG-
PET scanning). 
• Venous blood was taken from the IV cannula for glucose every 5-15 min and for 
measurement of insulin, glucagon, PYY, GLP-1, GIP and ghrelin at -100 min 
(RYGB only), -10 min, +30 min, +80 min (after completion of FDG-PET 
scanning). 
• At the end of the ad libitum meal the infusions were stopped (RYGB only), 
intravenous cannulae were removed and the subject left the department. 
 
2.5.6.1 Intravenous somatostatin+insulin or placebo (RYGB only) 
At somatostatin visits the infusions were somatostatin and insulin. Somatostatin 
(Actavis or Eumedica, made up in 0.9% saline, 3mg in 48ml solution) was infused 
intravenously at 0.1 mcg/kg/min.  The somatostatin infusion rate was based on previous 
work within the research group as being enough to suppress insulin secretion without 
causing nausea [215, 224].  If participants developed nausea the infusion rate was 
reduced to 70%.  
 
Soluble human insulin (Actrapid, Novo Nordisk) was made up to 60ml in a 4% solution 
of autologous blood (to prevent loss of insulin by binding to plastics) in 0.9% saline run 
at 5ml/hour.  The aim was to replace basal insulin because previous work within the 
research group had shown regional differences in brain FDG uptake in reward regions 
with somatostatin with or without low dose insulin infusion [215].   In the first subject 
the initial insulin infusion rate was 0.15 mU/kg/min based on previous work [215, 224] 
which was adjusted. For all subsequent studies a lower constant infusion rate calculated 
according to body surface area (3.6mU/m2BSA/min) was used. Body surface area was 
estimated using the Gehan and George formula (BSA (m2) = 0.0235 x height(cm)0.42246 
x weight(kg)0.51456) [231].  At placebo visits the infusions were 0.9% saline made up in 
the same way without somatostatin or insulin.  The study participant was blind to 
infusion content.   
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Figure 2.2.  Schematic of events at FDG PET imaging visits. 
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At all RYGB PET scanning visits, if venous plasma glucose (VPG) fell, or was 
projected to fall, below 3.8 mmol/l 20% glucose was infused intravenously at a variable 
rate to maintain VPG 4-4.5 mmol/l.  The purpose of this was to avoid hypoglycaemia, 
either spontaneous postprandial or somatostatin induced, which might influence brain 
responses.  The volume of IV 20% glucose infused between -95 min to +80 min was 
recorded. 
 
2.5.6.2 Study meal  
For FED studies participants consumed a 400kcal meal (vanilla ice-cream, Haagen 
Dazs, carbohydrate 32g, fat 27g, protein 8g; energy composition carbohydrate 32 E%, 
fat 60 E%, protein 8 E%) starting at -5 min.  I used ice-cream because it contains fat, 
carbohydrate, and protein, is of consistent composition, is suitable for use in a clinical 
environment, and previous studies show 400kcal ice-cream is tolerated by post-RYGB 
participants [81].  Three RYGB participants unable to consume 400 kcal at the test meal 
visit were given the amount tolerated: RYGB03 256 kcal, RYGB07 220 kcal, RYGB11 
234 kcal.   
 
2.5.6.3 FDG-PET scanning 
90MBq FDG was injected intravenously 15 min after the subject finished the meal in 
FED studies and at equivalent time point in FASTED studies.  The time was chosen to 
exclude the immediate effects of tasting, chewing, swallowing etc and to include 
changes associated with meal termination.  After a 30 min FDG uptake period, the 
participant was positioned on the scanner couch.  Scanning commenced at +55 min (40 
min after FDG injection) for 15 min.   A low dose CT brain scan was taken for 
attenuation correction. Studies used a GE Discovery PET scanner (GE Medical System, 
Milwaukee, WI, USA) with a 15.8 cm axial field of view.  
  
For a single conventional FDG-PET body scan, the standard administered activity is 
350MBq.  Lower doses can be used for FDG-PET brain imaging because the brain takes 
up FDG avidly.   My colleague Dr Joel Dunn modelled brain FDG uptake for a range of 
injected activities (based on data acquired in previous studies [215, 224]) in order to 
calculate the minimum dose of FDG for each PET scan that would still produce images 
of the necessary quality.   For this study, 90MBq FDG was injected for each scan. In 
addition to the FDG-PET-CT scans, each subject underwent a single slice CT abdomen 
to assess abdominal fat (not reported here).   
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The radiation risk assessment was undertaken by my supervisor Paul Marsden, 
Professor of PET Physics, using ARSAC (Administration of Radioactive Substances 
Advisory Committee) Notes for Guidance current in 2008 [232], Recommendations of 
the International Commission of Radiological Protection (ICRP) [233] and the ImPACT 
CT Patient Dosimetry Calculator (www.impactscan.org).  There is little, if any, reliable 
human data quantifying risk of cancer after exposure to diagnostic radiation doses (eg 
<100 mSv) [234, 235].  Estimates of risk are extrapolated from evidence related to very 
high-dose exposure assuming that all acute ionizing radiation exposure down to zero is 
harmful in proportion to the dose (the linear no-threshold hypothesis).  The assumptions 
of this model have been challenged [234, 235] and there is ongoing controversy about 
whether risks of cancer associated with the low-dose (eg effective dose <100 mSv 
[234]) exposure to ionizing radiation due to medical imaging are over-estimated [234, 
235].    
 
The total effective dose (including all scans) for NW and Ob participants was 3.86 mSv, 
equivalent to about 1.5 times the average annual natural background radiation dose in 
the UK.   The lifetime risk of fatal cancer is between 1 in 3 [233] and 1 in 4 [236].  The 
estimated lifetime additional risk of fatal cancer associated with this exposure is  1 in 
5,000.  This increases the estimated risk of fatal cancer by 0.06-0.08 % of the existing 
risk.  The total effective dose for RYGB participants (including all scans) was 7.59 
mSv, equivalent to about 3 times the average annual natural background radiation dose 
in the UK.  This is slightly less than a single CT chest which is 8 mSv. The lifetime risk 
of fatal cancer is between 1 in 3 [233] and 1 in 4 [236].  The estimated lifetime 
additional risk of fatal cancer associated with this exposure is 1 in 2,500. This increases 
the estimated risk of fatal cancer by 0.12-0.16% of the existing risk.  This information 
was included in the Participant Information Sheets and explicitly discussed with each 
potential participant as part of obtaining informed consent.  
 
2.5.6.4 Ad libitum meal 
After each PET scan, participants underwent a one hour ad libitum meal [81]. 100 kcal 
of ice-cream was presented every 5 min and the subject was instructed to ‘continue to 
eat the ice-cream when offered until you cannot eat any more, until you are completely 
full’. The amount of ice-cream consumed was recorded.  Participants were offered a 
choice of flavours (all Haagen Dazs: ‘Vanilla’, ‘Strawberries and Cream’, or ‘Belgian 
Chocolate’) and their choice was used for the ad libitum meal at all study visits. 
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2.5.6.5 Visual Analogue Scales (VAS) 
VAS were used to measure appetitive sensations and several parameters of wellbeing.   
The nine questions assessed by VAS are listed in Table 2.2.  The original set consisted 
of six questions [81], and assessed hunger, sickness, pleasantness, anticipated 
consumption, sleepiness and fullness.  This set was used for NOS01 and NOS02.  After 
presenting my protocol at the Rank Prize Funds mini-symposium on Regulation of 
Appetite 2009 I added three questions to assess wellbeing. The complete set of nine 
questions was used for all remaining participants. 
 
The VAS question panel was undertaken at: 
• -105 min (RYGB only), before the start of the infusions 
• -20 min, 15 min before the start of the meal 
• -7 min, 2 min before the start of the meal 
• +10 min, 10 min after the end of the meal, before FDG injection 
• +80 min, after completion of FDG-PET scanning 
   
For the first visit of the first subject (NOS01) the VAS panel was done during the ad 
libitum meal only.  I considered it would be useful to apply the VAS immediately pre-
meal (-7 min) and +10 min aswell as +80 min after meal completion to allow 
assessment of the effect of consuming the 400 kcal meal.  I elected not to apply the 
VAS question panel during FDG uptake or scanning because answering the questions 
involve the participants thinking about their hunger and fullness which might impact on 
the imaging.   After one subject did not complete the -7 min VAS, I added a second pre-
meal timepoint (-20 min, 15 min before start of the meal) to be used as a baseline in the 
event of missing data from the -7 min VAS.  This was added after the first six 
participants. 
 
The VAS questions were presented, in the order shown in Table 2.2, on a laptop 
computer.  An example of a VAS (for fullness) is shown in Figure 2.3.  Each panel of 
nine questions took 90 seconds to complete. This was programmed, for this study and to 
my specifications, by Chris Andrew, Neuroimaging Research Group, Institute of 
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Table 2.2:  Visual analogue scale (VAS) questions 
Question Left of scale Right of scale 
How hungry do you feel right now? 
How relaxed do you feel right now? 
How sick do you feel right now? 
How anxious do you feel right now? 
How pleasant would it be to eat right 
now? 
How much do you think you could eat 
right now? 
How sleepy do you feel right now? 
How contented do you feel right now? 
How full do you feel right now? 
Not at all 
Tense 
Not at all 
Calm 
 
Not at all 
 
Nothing 
Not at all 
Discontented 













Table 2.2:  Visual analogue scale (VAS) questions  
The questions were presented, in the order shown, on a laptop computer.  Each screen 
presented one question above a plain visual analogue scale with the extreme left and 
right of the scale labelled as shown.  The cursor appeared at the left of the scale and was 
moved using left and right keyboard arrows.  A new question screen was presented 




HOW FULL DO YOU FEEL RIGHT NOW? 
 
          
 NOT AT ALL       EXTREMELY 
 
Figure 2.3:  Sample visual analogue scale (VAS) (for fullness)  
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Participants practiced using the VAS programme at the OGTT visit (NW and Ob) or 
test meal visit (RYGB) and again at the beginning of each scanning visit. Participants 
were advised to inform the researcher if they missed a question, ran out of time or 
answered a question inaccurately.  If this occurred it was recorded and the VAS panel 
was repeated if time allowed. 
 
I produced a paper version of the VAS question panel as backup.  A new sheet was used 
for each timepoint, and participants could not see their previous responses.  The paper 
version was used in 3 participants: RYGB03 (all visits) due to subject preference, and 
NOS10 (both scanning visits) and NOS11 (FASTED only) due to computer availability.  
 
2.5.6.6 Venous glucose, pancreatic peptides, gut peptides and adipokines  
Venous blood was taken at the following time points, with time 0 being the end of the 
meal: 
• for glucose every 5-20 min throughout 
• for leptin, adiponectin, insulin, glucagon, GLP-1, PYY, GIP and ghrelin.   
 -100 min (RYGB only), prior to commencing infusions,  
 -10 min.  Baseline for NW and Ob, after 85 min infusion for RYGB.  
 +30 min, +80 min (end of FDG-PET scanning) (not for adiponectin or leptin)  
The aims of the gut hormone measurements were to demonstrate: a response to the 400 
kcal meal; that the 3 groups showed the expected responses to the meal; and that 
somatostatin successfully suppressed gut peptide secretion. There was no intention to 
obtain detailed gut peptide profiles.  The original protocol included one postprandial 
time point: +80 min at the end of FDG-PET scanning.  This is approximately within the 
peak for normal weight and obese subjects (PYY 90-120 min (section 1.3.3.1); GLP-1 
60-90 min (section 1.3.3.2); GIP 30-90 min (section 1.3.3.3); ghrelin nadir 60-90 min 
(section 1.3.3.5); insulin for obese (60-90 min) although not normal weight (30-45 min) 
(section 1.3.3.6)).  However, on review of the literature it was clear that post-RYGB the 
peak responses were earlier around +30 min post-meal (PYY 30-60 min, GLP-1 by 30 
min, GIP by 30 min, insulin by 30 min, and concentrations may return to baseline by 
+80 min (GIP, insulin).   I therefore added the +30 min sample which was taken in 6/12 
NW participants, 11/21 Ob participants, and all 9 RYGB participants.  I decided to 
measure at three time points only (baseline, 30 min and 80 min), in order to minimise 
the risk of disturbing the subjects during FDG uptake and scanning that the larger 
(relative to glucose sampling) sample draw would pose and to focus resources on the 
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neuroimaging (the primary aim of the project).  These post-meal time points would be 
expected to capture the gut peptide rise, recognising that this sampling schedule may 
miss peak responses.  For the purposes outlined above, total (rather than active) gut 
peptide measurement was deemed sufficient. These were standard assays in use in the 
laboratory at the time and much of the literature reports total gut peptides (section 
1.3.3).  There was no intention to perform the correlations with brain activity, which 
were done as post hoc analyses (Chapter 8).  Measuring active gut peptide 
concentrations and more frequent sampling would have been useful for this purpose.   
 
All assays (except glucose) were performed by research laboratory staff at Viapath, 
King’s College Hospital using commercially available assays. Table 2.3 gives details of 
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Table 2.3: Sample handling and assays 
Plasma glucose 
• 0.5ml blood was collected and transferred into Microvette tubes containing 
lithium heparin (an anticoagulant, Sarstedt). 
• Samples were centrifuged at 13,000 rpm for 30 sec in a microcentrifuge.  
• Plasma glucose samples were analysed immediately using a YSI 2300 stat 
glucose analyser.  
Serum insulin 
• 5ml blood was collected into red top tubes (BD Vacutainer Blood Collection 
Tubes) which contain a clot activator. 
• Samples were inverted 5 times, placed in a rack and allowed to stand for a 
minimum of 20 min at room temperature. 
• Samples were centrifuged at 3000 rpm for 10 min at 4 ˚C. Serum was collected 
into cryotubes and frozen at -20 or -80 ºC. 
• Serum insulin was measured using a chemiluminometric sandwich 
immunoassay (Advia Centaur, Seimens).   
• For mean insulin concentrations 14.7, 45.7 & 124.5 mIU/l: intra-assay 
coefficient of variation (CV) 4.6, 3.2 & 3.3%; for inter-assay CV 5.9, 2.6 & 
4.8%. 
Serum leptin and adiponectin 
• 5ml blood was collected into Gold Top (Serum Separator Tube, SST, BD 
Vacutainer Blood Collection Tubes).   
• Samples were inverted 5 times, placed in a rack and allowed to stand for a 
minimum of 20 min at room temperature. 
• Samples were centrifuged at 3000 rpm for 10 min at 4 ˚C. Serum was collected 
into cryotubes and frozen at -80 ºC. 
• Adiponectin and leptin were measured using sandwich ELISAs (R&D systems). 
• For mean adiponectin concentrations 1.98, 6.99 & 14.3 mg/l: intra-assay CV 2.5, 
3.4 & 4.7%: inter-assay CV 6.8, 5.8 & 6.9%. 
• For mean leptin concentrations at 64.5, 146 and 621 ng/l, intra-assay CV 3.3, 3.0 
& 3.2%; for mean leptin concentrations at 65.7, 146 & 581 ng/l, inter-assay CV 
5.4, 4.2 & 3.5%. 
Plasma total GLP-1 and GIP 
• 4ml venous blood was collected into EDTA tubes (BD Vacutainer Blood 
Collection Tubes) with added DPP-IV (dipeptidyl peptidase-IV) inhibitor. GLP-
1 and GIP are  subject to enzymatic degradation by endogenous DPP-IV which 
is present in a soluble form in plasma [99].   
• Samples were inverted 8-10 times and kept on ice (to limit peptide breakdown) 
until centrifuged.  
• Samples were centrifuged at 3000 rpm for 10 minutes at 4 ˚C.   Plasma was 
collected into cryotubes and frozen at -80C. 
• GLP-1 and GIP were measured using sandwich ELISA (Millipore Corporation).  
The GLP-1 kit measures total GLP-1 (active (7-36) and inactive (9-36) forms).  
• For GLP-1 concentrations 32 & 216 pmol/l: intra-assay CV 1 & 2%; inter-assay 
CV <12 & <10%. 
• For GIP concentrations 15, 185 & 279 ng/l: intra-assay CV 6.7, 8.8 & 3.0%; 
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continued Table 2.3: Sample handling and assays 
Plasma total PYY, glucagon and total ghrelin 
• 4ml venous blood was collected into EDTA tubes (BD Vacutainer Blood 
Collection Tubes) with added aprotinin (Trasylol). Aprotinin is a protease 
inhibitor added to limit breakdown of peptides. 
• Samples were inverted 8-10 times and kept on ice until centrifuged.  
• Samples were centrifuged at 3000 rpm for 10 min at 4˚C. Plasma was collected 
into two cryotubes.  10% HCl was added to the ghrelin sample to further retard 
ghrelin breakdown.  Samples were frozen at -80 ºC  
• PYY and glucagon were measured by radioimmunoassays (RIA) (Millipore 
Corporation).   This assay measures total PYY (1-36 and 3-36).   
• For mean PYY concentrations 82.7, 111.1 & 542.6 ng/L: intra-assay CV 9.4, 2.9 
and 3.6%; inter-assay CV 8.5, 7.1 & 5.5%.  
• For mean glucagon concentrations 60, 90 and 220 ng/l: intra-assay CV 6.8, 4.6 
& 4.0%; inter-assay CV 13.5, 13.4 & 7.3%. 
• Ghrelin was measured by sandwich ELISA (Millipore Corporation) which 
measures total ghrelin (active and non-octanoylated forms). 
• For mean ghrelin concentrations 1000, 1500, 2000 & 3000 ng/l: intra-assay CV 
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2.6 ANALYSIS: AD LIBITUM MEAL, VAS, AND GUT PEPTIDES  
2.6.1 Data processing and missing data: ad libitum meal, VAS, and gut peptides  
2.6.1.1 Ad libitum meal data processing 
The amount consumed at the ad libitum meal (in kcal) was calculated from the weight 
in grams and the nutritional information listed for the ice cream and entered into an 
SPSS spreadsheet.  All data entry was checked.  
 
2.6.1.2 VAS data processing  
The VAS data were entered into an SPSS spreadsheet.  If the subject had commented 
they had made a mistake this was removed from the analysis. All other data were kept 
in the analysis as per protocol.  All data entry was checked and inspected for outliers, 
Outliers were identified by inspection of boxplots and defined as values more than 1.5 x 
interquartile range above the upper or below the lower quartile [237].   Outliers were 
checked against source data.   
 
In some cases the VAS were not applied, either due to omission or because the 
questions or time points were not part of the protocol at the time (section 2.5.6.5).  On 
the basis that VAS scores were unlikely to change in the course of 20 min without 
intervention, in participants where -7 min VAS data were missing -20 min data 
wassubstituted if present (and performed within 20 min). In participants where +10 min 
data were missing in FASTED state, I substituted -7 min data.  
 
2.6.1.3 Glucose, pancreatic peptides, gut peptides and adipokines: data processing 
Glucose, peptide and adipokine data were entered into SPSS spreadsheets. All data 
entry was checked and inspected for outliers (section 2.6.1.2). When outliers were 
identified the data was checked against the original laboratory assay spreadsheet by 
Viapath laboratory staff.  There were no errors in transcribing data.  For insulin only, 
unusual results were re-assayed and corrected if necessary.  All other data was kept in 
the analysis as per protocol. 
 
Time with VPG between 3-3.8mmol/l and below 3 mmol/l was calculated as the time 
from the first reading in the specified range to the time of the first reading outside the 
specified range between -95 to +80 min.  Repeated episodes were summed. I included 
the pre-meal phase because antecedent hypoglycaemia, and glucose infusion, might 
impact on responses.  For the post-meal phase (between 0 and +80 min inclusive) mean, 
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range (difference between highest and lowest), lowest and highest VPG were calculated 
for each visit. 
 
For peptide and adipokine samples above range the exact number was obtained by 
dilution.  For samples below the assay range, the exact number was used if available 
(e.g. for insulin) accepting the result may not be completely accurate.  If this was not 
available the lower limit of the assay was entered. The manufacturers of the insulin 
assay state the limit of the assay as 0.5 mU/L.  When Viapath evaluated the assay they 
found the functional sensitivity to be 2 mU/L.  There were no undetectable results and 
eight samples between 0.5-0.99 mU/L and the absolute number was entered for these.  
The manufacturers of the GLP-1 assay state the lower limit of the assay as 1.5 pmol/L.  
Fourteen were below the lower limit of the assay (all RYGB with somatostatin) and 
these were entered as 1.4pmol/l.  There were no results below the lower limit of the 
assay for PYY, GIP, glucagon, total ghrelin, leptin or adiponectin. 
 
2.6.2 Statistical analysis for demographics, ad libitum meal, VAS, and gut peptides  
Statistical analyses were performed using SPSS version 22 (IBM).  Significance was 
taken as p≤0.05.  Uncorrected p values are reported throughout. 
 
2.6.2.1 Demographic data statistical analysis   
Continuous data were compared between three groups using one-way ANOVA 
(analysis of variance), provided the data met the required assumptions tested as follows:  
• Outliers: the presence of outliers was assessed by inspection of boxplots and 
defined as values more than 1.5 x interquartile range above the upper, or below 
the lower, quartile [237]. 
• Normality was assessed using Shapiro-Wilk’s test and considered to be normally 
distributed if p>0.05. 
• Homogenicity of variances was assessed by Levene’s Test and considered to 
hold if p>0.05. 
If the one-way ANOVA was significant, the location of the difference was determined 
using post hoc Fisher’s least significant difference (LSD) test, which is essentially 
multiple independent samples t tests without correction for multiple comparisons, but 
with different degree of freedom.  If only 3 groups are compared, Fisher’s LSD 
procedure (significant ANOVA followed by Fisher’s post hoc test) guarantees that the 
family wise type 1 error (FWE) rate is not more than the pre-specified level of 
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significance (ie α=0.05) (advice from Dr Daniel Stahl (Reader in Biostatistics, King’s 
College London), [238, 239]).  Therefore if, as here, only 3 groups are compared it is 
appropriate to use Fisher’s LSD procedure, and Tukey’s or other procedures used to 
adjust for multiple testing are not needed.   
 
For categorical data, Fisher’s exact test was used (Chi-squared test was not appropriate 
due to small sample size (cell numbers <5)). 
 
2.6.2.2  VAS and glucose statistical analysis for test meal visit (RYGB only) 
Repeated measures ANOVA (rmANOVA) was used to test the impact of test meal 
ingestion, provided the data met the required assumptions.  The assumptions were tested 
as follows:  
• Outliers and normality were assessed as for one-way ANOVA (section 2.6.2.1), 
• Sphericity was assessed using Mauchly’s test, and data considered to have 
sphericity if p>0.05.  If the assumption of sphericity was violated, the 
Greenhouse-Geisser method was used to adjust the reported p value [237]. 
Where rmANOVA was significant, paired t tests were used to compare post-meal time 
points versus baseline.   The Bonferroni method was used to adjust α. 
 
For data which did not fulfil the assumptions for rmANOVA, the non-parametric 
Friedman test was used to test the impact of the test meal.  If significant, Wilcoxon 
signed-rank tests were used to compare post-meal time points versus baseline. The 
Bonferroni method was used to adjust α. 
 
2.6.2.3 Ad libitum meal, VAS, glucose, peptides and adipokines statistical analysis for 
FDG-PET visits 
Comparisons were performed at each time point. Participants with the required data at 
the time point (including substituted data for VAS) were included in each analysis.  I 
choose to compare the original data, and not to normalise the VAS or peptide data to 
baseline, because this aligns to the neuroimaging analysis.  I considered calculating area 
under the curve, but as there were only three time points for both VAS and peptides this 
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Three-group statistical analyses 
Mixed ANOVA was used for the three group analysis of ad libitum consumption, VAS, 
glucose, peptides and adipokines, provided the data met the required assumptions.  The 
assumptions were tested as follows:  
• Outliers, normality and homogenicity of variances were assessed as for one-way 
ANOVA (section 2.6.2.1). 
• Homogeneity of covariance was assessed by Box’s test of equality of covariance 
matrices and considered to hold if p>0.001. 
With small numbers, and real data, it is unlikely that all assumptions will be perfectly 
fulfilled.   Because ANOVA is robust to at least some deviations [237], and the ad 
libitum meal, VAS and gut peptides are supporting rather than primary endpoint data, a 
lenient approach towards fulfilment of assumptions is reasonable  For significant 
interactions between fed state and group, post hoc comparisons in FED effect were 
performed using Fisher’s LSD (section 2.6.2.1).  For significant interactions, main 
effects of fed state and group are reported (although it should be noted that these can be 
misleading if there is a significant interaction) and in addition within group (paired t 
tests) and within condition (ANOVA) contrasts reported.  If there was no significant 
interaction, main effect of fed state and of group (with post hoc Fisher’s LSD test if 
appropriate) were reported. 
 
For data which did not fulfil the assumptions for the parametric tests above, I tried using 
appropriate transformations.   If this was not successful non-parametric tests were used.  
There is no single non-parametric equivalent of the mixed ANOVA in SPSS and 
therefore separate non-parametric tests were used to test each comparison.  Interaction 
between fed state and group was tested using a Kruskal-Wallis H test to compare mean 
rank FED effect between groups. If the Kruskal-Wallis test was significant, post hoc 
tests were performed using Dunn’s procedure.   Main effect of fed state was tested using 
a Wilcoxon signed-rank test and main effect of group using a Kruskal-Wallis H test as 
above.  Data were reported as described for the mixed ANOVA. 
 
Within RYGB statistical analyses 
Within-within-subject ANOVA tests were used to analyse effects of 
somatostatin+insulin in RYGB.  The assumption of normality was checked by Shapiro-
Wilks test and outliers identified using boxplots.  Interaction between fed state and 
somatostatin, and main effects of fed state and somatostatin, were reported.  
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If the data did not meet the required assumptions (VAS sickness and relaxedness) non-
parametric tests were used.  There is no single non-parametric equivalent of the within-
within participants ANOVA.  Wilcoxon signed-rank tests were used to test the effect of 
somatostatin+insulin on FED effect (interaction); main effect of fed state; and main 
effect of somatostatin+insulin.  
 
2.6.3 Ad libitum meal, VAS, glucose, peptides and adipokines results reporting 
For graphs and tables the means or medians use all available data for the condition at 
the time point (unless otherwise stated) (i.e. data points on a graph may include 
different participants).  Where the numbers included at consecutive time points are very 
different (e.g. with the gut peptides) this is indicted on the graphs.   
 
 
2.7 FDG-PET NEUROIMAGING ANALYSIS 
2.7.1 FDG-PET data preparation for Statistical Parametric Mapping (SPM) 
2.7.1.1 Checking for FDG-PET data completeness 
Images were reconstructed using the filtered back-projection algorithm on the scanner, 
producing 15 x 1 min frames of 47 slices for each scan.  Reconstructed FDG-PET 
images were loaded into HERMES (a program for viewing medical images) [130].  
Reconstructed images were checked for missing data, and inspected visually to ensure 
the whole image was included in the field of view, for alignment with the CT brain 
scan, and movement during the 15 min scanning period. In two scans (NOS01 FASTED 
and NOS07 FASTED) part of the image was out of the field of view on the first 
reconstruction.  The reconstruction was repeated on the scanner using an adjusted field 
of view.  There were no instances where the FDG-PET images were not aligned with 
the CT brain image.  
 
2.7.1.2 Converting images to SPM format and dealing with movement 
Images were converted from DICOM format into SPM format using a program written 
by Dr Joel Dunn (‘Loaddicom’ in a SPM toolbox called BrainPIC).  In cases where 
visual inspection showed no evidence of movement during the scanning period (96/102 
scans), the 15 x 1 min frames were summed to provide a single image dataset per 
subject per visit (using the ‘sum frames’ option in Loaddicom).  If the subject had 
moved during the 15 min scan period (6/102 scans), the images were converted into 
SPM format without summing the frames (using the ‘as is’ option in Loaddicom).  
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Frames were realigned to the first frame (using the ‘frame by frame realignment’ in 
BrainPIC). Visual inspection in HERMES and inspection of the realignment graphic 
were used to determine whether movement had occurred gradually throughout the 15 
min (drift) or had occurred in, or between, specific frames.  More than 2 mm translation 
or 2 degree rotation was considered significant movement.   Where there was drift, all 
realigned frames were summed to produce a single image (using BrainPIC).  Where 
there was movement in specific frames these were excluded and the remaining frames 
were summed to produce a single image (using BrainPIC).  
  
Movement was identified in the following scans: 
• NOS09 FED (Ob) 4mm z drift, images realigned but no frames excluded. 
• RYGB07 somatostatin-FED, 3 degree pitch drift, images realigned but no 
frames excluded. 
• RYGB09 placebo-FASTED, 3.5mm drift, images realigned but no frames 
excluded 
• RYGB09 placebo-FED, minor drift, realigned but no frames excluded.  
• RYGB10 placebo-FASTED, >2mm translation and 5.5 degree yaw between 
frames 11 and 12,  realigned and frames 11 and 12 excluded from the summed 
image. 
• RYGB11 placebo-FED, movement in frames 3, 4, 5.  Realigned and frames 3-5 
excluded from summed image. 
 
Voxel dimensions were checked and resized if required.  For each summed FDG-PET 
image the origins were set at anterior commissure identified visually (using the ‘Set 
Origins’ function in SPM).  This gives the SPM procedures described below a ‘fixed 
point’ in the scans. 
 
2.7.1.3 Structural MRI brain data preparation for SPM 
MRI images were converted from DICOM into SPM format using the DICOM import 
function in SPM.  For each MRI image the origins were set at anterior commissure 
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2.7.2 FDG-PET image pre-processing in SPM 
Differences in FDG uptake between scans were analysed using Statistical Parametric 
Mapping (SPM), a software package designed by the Wellcome Trust Centre for 
Neuroimaging to test hypotheses using functional neuroimaging data (SPM8, 
www.fil.ion.ucl.ac.uk on the MATLAB (R2011a) platform).  The aim of image pre-
processing is to generate images in standard anatomical space (meaning a given voxel 
should correspond to the same brain location in all images in all participants) that are 
prepared for statistical comparison of voxel activity between images.  Image pre-
processing involves realignment, spatial normalisation to standard space (warping), and 
smoothing.  Intensity normalisation and masking are also part of image pre-processing 
but are performed during the SPM analysis.  
  
2.7.2.1 Realignment 
Realignment is performed within subject and imaging modality and is a rigid body 
process.  It corrects for difference in head position between each subject’s two or four 
FDG-PET scans (or for movement during scans as above).  Realignment was performed 
in SPM (using the Realign (Estimate) function).  For each subject, each summed image 
was realigned to the mean of the two (or four for RYGB participants) images.   
 
2.7.2.2 Spatial normalisation 
Spatial normalisation to standard anatomical space was performed using each subject’s 
structural MRI scan (because MRI scans provide more anatomical detail which aids 
spatial normalisation). For each subject the mean PET image was co-registered to the 
MRI image (using the Coregister (Estimate) function in SPM.  The MRI images for 
each subject were then warped to standard space (Montreal Neurological Institute, MNI, 
space) using the ‘Segment’ function in SPM.  Finally each summed PET image was 
normalised to MNI space by applying the saved ‘instructions’ required to realign each 
image to the mean PET image, to co-register the mean PET image to the MRI image 
and to warp the MRI image to MNI space (using the Normalise (Estimate) function in 
SPM).  In 2 participants (NOS07 and NOS19) there was no MRI image available. In 
these participants the mean PET image was warped directly to standard space. 
 
2.7.2.3 Smoothing 
Images were then smoothed to reduce the impact of artefact.  The warped image files 
were smoothed using a Gaussian kernel of 8mm (using the Smooth function in SPM). 
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2.7.3 FDG-PET image analysis in SPM 
Images were compared in SPM to identify clusters where there were significant 
differences, using appropriate statistical models to address each research question. 
Models were set up using the Basic Models function in SPM. 
 
2.7.3.1 Intensity normalisation 
Overall FDG availability to the brain may be different between scans and participants, 
and therefore in SPM analyses voxel values are intensity-normalised to a global value 
calculated for each scan.  For all analyses presented in this thesis voxel values were 
intensity-normalised to mean grey matter (excluding cerebellum) values for each scan.   
The rationale for this is discussed in section 4.2.  The global value is scaled to 100 (so 




The images were masked to specify voxels to be included in the analyses.  For all 
analyses presented in this thesis, white matter was masked-out by including voxels with 
a grey-matter probability >30% (based on the spm8 a priori grey mask) and values 
>60% mean grey matter (excluding cerebellum).  Cerebellum was masked out (defined 
by the Tziortzi atlas [128]).  Hypothalamus (Baroncini et al [240]) and pituitary (defined 
by MRI template) were masked-in (mask-2014Oct01-Ob21-pit-hypothal).  As discussed 
in section 4.3, this mask was chosen as providing the best exclusion of white matter 
while minimising exclusion of subcortical structures. It should be noted that this mask 
excludes parts of the caudate, thalamus, hippocampus, amygdala, pons and medulla.  
 
2.7.3.3 Contrasts 
Contrasts were set up using the Results function in SPM.  For paired tests (paired t tests 
or main effect of fed state) clusters of voxels were considered to show a significant 
effect at a voxel level p<0.001 and cluster level pfwe-corr<0.05 (p value corrected for 
family-wise error).  For interactions (e.g. between fed state and group) cluster level pfwe-
corr is not available in SPM.  Clusters were considered to show significant interaction 
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2.7.4 Localisation of clusters 
Cluster maps, showing significant clusters mapped onto a standard MRI brain, were 
generated in SPM.  Clusters were formally localised using the Tziortzi atlas [128], 
modified to include hypothalamus (based on coordinates from Baroncini et al [240]) 
and pituitary (defined by MRI template).  For each cluster an image was made of  
intersects between the cluster and the modified Tziortzi atlas (using the ImCalc function 
in SPM).  The Extract TACS program (in the BrainPIC SPM toolbox, written by Dr Joel 
Dunn) was then used to extract data for the combined image, giving the atlas regions 
included in each cluster and the number of voxels in each cluster-atlas region intersect.   
Tziortzi atlas regions are of varying sizes meaning that a given number of voxels could 
cover a whole region or a small proportion of a region.  It is therefore useful to know 
the proportion of the atlas region included in the cluster.  The total number of available 
(i.e. masked-in) voxels in each Tziortzi atlas region was calculated by creating an image 
of intersects between the mask used in the analysis and the atlas (using ImCalc) and 
then extracting the voxel numbers (using Extract TACS).  From this, the percentage of 
available (masked-in) voxels in each atlas region included in a given cluster was 
calculated.  
 
2.7.5 Post hoc analysis of SPM cluster data 
For clusters identified in SPM where there was a significant interaction between fed 
state and group, post hoc analyses were performed to determine the nature of the 
difference by extracting mean normalised voxel values for each scan for each cluster 
and performing statistical comparisons in SPSS.  To extract voxel values each cluster 
was saved as an image file and the Extract TACs program (in BrainPIC) was used to 
extract mean voxel values from warped, intensity normalised, but unsmoothed images.  
For larger clusters (>500 voxels), which may extend across brain regions, mean voxel 
values were also extracted for intersects between the cluster and modified Tziortzi atlas. 
 
For each cluster (or intersect) food-evoked signal change (FESC, mean normalised 
voxel value in FED minus mean normalised voxel value in FASTED) was calculated for 
each subject (separately for placebo and somatostatin+insulin in RYGB).    Differences 
in FESC between groups were analysed using Fisher’s LSD test in SPSS.  Differences 
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CHAPTER 3: PARTICIPANT CHARACTERISTICS 
 
3.1 INTRODUCTION 
In this short chapter I describe participant recruitment, flow through the study and 
characteristics of the participants who completed the study.  
 
 
3.2 PARTICIPANT RECRUITMENT 
I recruited 14 normal weight and 38 obese people and 10 people post-RYGB (9 from 
bariatric clinics at KCH and 1 from another centre self-referred) (Figure 3.1) who 
fulfilled the initial inclusion and exclusion criteria (section 2.3, Table 2.1).  Of the 14 
normal weight people, 1 was excluded after OGTT because HOMA2-IR>1.47.  
Although this was not one of the listed exclusion criteria for the NW group, the 
participant would be a clear outlier for HOMA2-IR in the NW group.  Another 
withdrew after 1 FDG-PET scanning visit.  Of 39 obese participants 1 withdrew after 
the screening visit and 38 underwent OGTT, of which 17 were excluded because 
HOMA2-IR 0.77-1.46 or HOMA2-IR≥1.47 after recruitment to the ObIR group was 
complete.  Nine ObIS and 12 ObIR completed the study.   However, when mean 
HOMA2-IR was calculated for ObIS and ObIR using fasting data from the 3 visits 
(OGTT visit, 2xFDG-PET visits), although the groups were significantly different 
(p=0.002), there was considerable overlap (ObIS 1.36±0.51 (0.62-2.13); ObIR 
2.64±0.98 (1.47-4.12) (mean±SD (range)).  I therefore decided to consider ObIS and 
ObIR as a single group (Ob).  It proved challenging to recruit people post-RYGB, in 
part because of the prevalence of diabetes, use of antidepressant medications and desire 
for pregnancy which were exclusion criteria. Of the 10 post-RYGB participants 
recruited, 1 withdrew after 2 FDG-PET scans (with somatostatin+insulin).   
 
 
3.3 PARTICIPANT CHARACTERISTICS 
The study was completed in 12 NW, 21 Ob, and 9 RYGB subjects. Data from these 
subjects are used for all analyses presented in this thesis unless otherwise specified. 
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RYGB subjects were 18±12.6 months post RYGB and had lost 30.9±8.5% of their pre-
operative weight.   By design, BMI was higher in Ob and RYGB compared to NW with 
no difference between Ob and RYGB.  A similar pattern was seen in waist and hip 
circumference. There was no significant difference in waist:hip ratio between the 
groups, even when only data for female participants were considered.  Neck 
circumference was larger in Ob than NW with no significant difference between NW 
and RYGB or Ob and RYGB.  HOMA2-IR was higher in Ob compared to NW and Ob 
with no difference between NW and Ob.  RYGB subjects were older than NW and Ob 
subjects.  Diastolic blood pressure was higher in Ob than NW.  There was no significant 
difference between groups in gender, menopausal status, use of hormonal contraception, 
ethnicity or systolic blood pressure.  
 
All NW and Ob subjects underwent 75g OGTT: two Ob subjects had impaired glucose 
tolerance.  One Ob subject was taking metformin.  In the RYGB group, 3 subjects had 
type 2 diabetes prior to RYGB and one continued to take metformin only.  Two Ob 
subjects had treated hypothyroidism. Other medications were: orlistat: 2 Ob and 1 
RYGB; topiramate for migraine: 1 RYGB; antihypertensives: 4 RYGB: statins: 2 
RYGB.  Subjects taking orlistat and metformin were asked not to take these 













Figure 3.1 Participant flow diagram 
NW=normal weight group; ObIS=obese insulin sensitive group; ObIR=obese insulin 
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p value Post hoc tests 
(uncorrected) 
Months since RYGB 
(mean±SD) 
- - 18 ±12.6 - - 
Weight loss, % 
(mean±SD)  
- - -30.9±8.5 - - 
Age, years 
(mean±SD) 








F 9 (75%) 19 (90.5%) 8 (88.9%) 
0.522 - 
M 3 (25%) 2 (9.5% 1 (11.1%) 
Menopause 
status  
(n (% of 
females) 
Pre 8 (88.9%) 17 (89.5%) 4 (50%) 
0.061 
- 
Post 1 (11.1%) 2 (10.5%) 4 (50%) - 
OCP  
(n (% of 
premenopausal 
females)  
Yes 4 (50%) 7 (41.2%) 0 
0.285 - 
No 4 (50%) 10 (58.8%) 4 (100%) 
Ethnicity             White 
(n (%))                Black 
                            Other 
11 (91.7%) 14 (66.7%) 5 (55.6% 
0.395 - 0 3 (14.3%) 2 (22.2%) 
1 (8.3%) 4 (19.0%) 2 (22.2%) 
BMI, kg/m2 
(mean±SD) 






























Hip circumference cm 
(mean±SD) 
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Systolic BP  mmHg 
(mean±SD) 
114±10 124±15 121±10 0.123 - 
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This is a new neuroimaging protocol and there were unexpected challenges in the 
neuroimaging analysis specifically with intensity normalisation, masking and 
localisation of clusters and I deal with each of these here. 
 
 
4.2 INTENSITY NORMALISATION 
Overall FDG availability to the brain may be different between scans and participants.  
To address this voxel values for each scan are intensity-normalised to a global value 
calculated for each scan, a standard step in SPM analysis (section 2.7.3.1).  A common 
approach is to use mean voxel value for the whole brain (which includes grey and white 
matter) and I used this in a preliminary ROI analysis. Mean voxel values were extracted 
for anatomically-defined ROIs for each scan. The between group patterns were very 
similar across all ROIs which raised a suspicion of a global rather than a regional effect.    
Comparing mean voxel values for grey and white matter showed a differential impact of 
400 kcal meal ingestion on grey matter : white matter ratios suggesting a global impact 
of fed state on grey matter FDG uptake.  This is consistent with the findings of Wang et 
al who, in 2 separate studies, found multisensory food stimulation (which did not 
include food ingestion) resulted in increased in whole brain metabolism (although they 
did not report grey : white matter ratios) [127, 144].   
 
An alternative approach to intensity normalisation is to normalise to a brain area not 
involved in the process under investigation.  However, as relatively little is known about 
the brain responses to food ingestion it is difficult to select an appropriate brain area.  I 
therefore decided to normalise to mean grey matter values defined using the grey-matter 
mask available in SPM (spm8 a priori grey mask). Inspection of the data in the above 
analysis suggested the cerebellum behaves differently to cortical grey matter and 
therefore the cerebellum, as defined by the Tziortzi atlas [128] was excluded from the 
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For all analyses presented in this thesis voxel values were intensity-normalised to mean 




Masking specifies which voxels within the image volume are included in the analysis.  
Reducing the number of voxels increases the power of the analysis.  In this analysis, it 
was also particularly important to mask-out white matter because normalising to mean 
grey matter (excluding cerebellum) would create white matter artefact in analyses given 
the differential effect on grey:white matter ratios discussed above. The ideal mask 
would include all grey matter (including subcortical structures such as the basal ganglia) 
and exclude voxels outside the brain, in white matter and in cerebral ventricles with a 
high degree of accuracy and exclude the cerebellum as discussed above. 
 
SPM PET utilises three methods of masking.  Voxels included in all the masks applied 
are included in the analysis. 
• Implicit masking excludes voxels with a value of zero or NaN (Not a Number) 
• Explicit masking includes voxels specified by the user e.g. grey matter mask. 
• Threshold masking includes a given voxel in the analysis if it has a value above 
a defined threshold in all images included in the analysis.  It can be used to 
mask out voxels outside the brain, in white matter or in the cerebral ventricles as 
these will have lower activity.  An absolute threshold value does not take 
account of differences between scans in FDG availability to the brain, one of the 
determinants of voxel values.  A relative threshold is set as a proportion of the 
global value for each image (section 4.2). 
 
Two explicit masks were created which included voxels with >30% and >50% 
probability of being in grey matter based on the spm8 a priori grey mask (grey matter 
probabilistic masks) and both explicitly excluding the cerebellum (defined in the 
Tziortzi atlas [128]).  In a series of iterations for each explicit mask, I varied the 
threshold masking from 0 to 80% mean grey matter (excluding cerebellum) and visually 
compared each with a standard MRI brain and the Tziortzi atlas [128].  The 
combination of an explicit grey-matter probability >30% and a threshold of >60% mean 
grey matter (excluding cerebellum) provided the best exclusion of white matter while 
minimising exclusion of subcortical structures. This mask completely excluded 
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hypothalamus and pituitary and, given their potential roles in energy balance, these were 
explicitly masked in: hypothalamus based on co-ordinates given by Baroncini et al 
[240] and pituitary a volume of interest based on MRI templates.  The final mask was 
labelled mask-2014Oct01-Ob21-pit-hypothal and was used for all analyses presented in 
this thesis.   It should be noted that this mask excludes parts of caudate, thalamus, 
hippocampus, amygdala, pons and medulla.  This could be because these regions may 
have inherently lower voxel values. However they may also share a long border with 
white matter or cerebral ventricles which, due to the resolution of PET imaging and 
smoothing, reduces the voxel value at the edge of the region. This effect may have a 
particular impact on small regions.   
 
 
4.3 LOCALISATION OF CLUSTERS 
The SPM analyses, particularly the FED versus FASTED contrast, generated large 
clusters covering multiple regions (chapter 6).  Conventionally, localisation is based on 
location of voxels showing the greatest significance for the contrast (local maxima).  
However, SPM reports a maximum of 3 local maxima per cluster, which creates 
problems for formal localisation of clusters covering multiple regions. I therefore 
developed a method in which intersects between a given cluster and atlas regions are 
reported.  This provides information on all atlas regions included in the cluster, the 
number of voxels in the cluster in each atlas region, and the proportion of an atlas 
region included in the cluster.  This gives a fuller picture and aids data interpretation.   




There were challenges in the analysis of this new neuroimaging protocol which are 
addressed here.  This highlights the importance of considering global effects when ROI 
analyses report similar findings across all ROIs.  The approach to localisation developed 
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CHAPTER 5: IMPACT OF MEAL INGESTION ON APPETITIVE 
SENSATIONS, PANCREATIC AND GUT PEPTIDE 
CONCENTRATIONS AND SUBSEQUENT AD LIBITUM 




In this chapter I address the following questions: 
- Is the 400 kcal mixed meal stimulus sufficient to have measureable impact on 
appetitive sensations, pancreatic and gut peptides and subsequent ad libitum 
consumption? 
- Are there differences between the three groups (NW, Ob and RYGB) in the 
effect of consuming a 400 kcal mixed meal on appetitive sensations, pancreatic 
and gut peptides and subsequent ad libitum consumption and are these consistent 
with the literature? 
I analysed data for 4 appetitive sensations: fullness, hunger, anticipated pleasantness of 
eating and sickness and also relaxedness.  The first three represent contrasting aspects of 
food experience and are commonly presented in the literature (section 1.1.3).   Nausea is 
an unpleasant post-ingestive response to eating that may influence other responses and 
is a recognised effect of somatostatin relevant for later analyses (chapter 8). I chose 
relaxedness as the measure of wellbeing during the study because study subjects said 
that they found ‘How contented do you feel right now?’ difficult to answer. Previous 




The methods are described in chapter 2.  To recap, RYGB subjects underwent a 400 
kcal test meal visit prior to the first FDG-PET scanning visit. RYGB subjects unable to 
consume the full 400 kcal were given the amount tolerated for the pre-scan meal at FED 
FDG-PET scanning visits, thus ensuring that participants consumed the same amount 
before the PET scan at placebo-FED and somatostatin-FED visits (Chapter 8). At the 
test meal visit, RYGB subjects completed VAS for appetitive sensations and 
relaxedness and venous blood was sampled for glucose (and insulin, although this was 
not assayed) at baseline and +10, +30, +60, +90, +120, +150 and +180 min.  
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All subjects underwent 2 FDG-PET scanning visits in random order after overnight 
fasting. At the FED FDG-PET visit subjects consumed a 400 kcal fixed meal (reduced 
in RYGB participants unable to consume 400 kcal at the test meal visit); FDG-PET 
scanning was performed  between +15 and +70 min;  subjects completed VAS for 
appetitive sensations and relaxedness at -7 min, +10 min, +80 min and an ad libitum 
meal starting at +80 min; venous blood was taken for glucose every 5-15 min and for 
insulin, glucagon, PYY, GLP-1, GIP and ghrelin at -100 min (RYGB only), -10 min, 
+30 min (timepoint added halfway to study completion) and +80 min.   At the FASTED 
FDG-PET visit procedures were the same except subjects did not consume the 400 kcal 
mixed meal.  (RYGB subjects also underwent FED and FASTED visits with 
somatostatin plus insulin, but these data are not used in this chapter).  
 
5.2.1 Participants 
Results are reported for 12 NW, 21 Ob and 9 RYGB subjects (chapter 3).    
 
5.2.2 Data processing 
5.2.2.1 Test meal visit data processing (RYGB only) 
Data were unavailable for 30/360 (8.3%) VAS data points. Eighteen of these were in 1 
subject (RYGB11).  Data were unavailable for 6/72 (8.3%) venous plasma glucose data 
points, all from 1 subject (RYGB06).  
 
5.2.2.2 VAS data processing for FDG-PET visits 
Data were unavailable for 31/1350 (2.3%) VAS data points, 22 per protocol (section 
2.5.6.5).  Missing data were handled as described in section 2.6.1.2.  At -105 min 1/90 
were missing, not substituted.  At -7 min 13 (8 per protocol)/420 were missing.  No 
substitutions were made because either it occurred before the -20 min time point was 
added (and was the reason for it) or because there was >20 min delay (due to tracer 
delay).  At +10 min 10 (6 per protocol)/210 FASTED were missing, substituted with -7 
min data in 4 instances (NOS08: pleasantness & relaxedness; NOS31: fullness; 
RYGB07: sickness). For subjects with data at both time points, there was no difference 
between -7 min and +10 min in FASTED state for fullness (p=0.340), sickness 
(p=0.577) or relaxed (2 points, p=0.094).  There was a small 5 point increase in hunger 
scores (p=0.035) (paired t tests).  At +10 min 2 (both per protocol)/210 FED were 
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5.2.2.3 Ad libitum intake data processing 
All 84 ad libitum meals were performed with no missing data.  
 
5.2.2.4 Glucose, peptides and adipokines data processing for FDG-PET visits 
There were no missing leptin or adiponectin samples.  For peptide data 203/1620 
(12.5%) were unavailable, 192 per protocol (section 2.5.6.6).   Per protocol, there were 
a very small number of missing results (0.8 %), because the sample was not taken or 
insufficient.  Results were available: insulin 238/238, glucagon 237/238, PYY 237/238, 
GLP-1 231/238, GIP 237/238, and ghrelin 237/238.   
 
5.2.3 Statistical analysis 
5.2.3.1 VAS and venous plasma glucose (VPG) statistical analysis for test meal visit 
(RYGB only) 
For fullness, hunger and anticipated pleasantness of eating scores and venous plasma 
glucose, impact of meal ingestion was tested using repeated measures ANOVA 
(rmANOVA).  In all cases the assumption of sphericity was violated and the 
Greenhouse-Geisser method in SPSS was used to adjust the reported p value (section 
2.6.2.2).  Where significant, paired t tests for post-meal time points versus baseline were 
performed.  The Bonferroni method was used to adjust α.  VAS scores for sickness and 
relaxedness had outliers and non-normal distributions (respectively positively and 
negatively skewed), therefore impact of meal ingestion was tested using Friedman tests. 
Where significant, Wilcoxon signed-rank tests for post-meal time points versus baseline 
were performed.  The Bonferroni method was used to adjust α. 
 
5.2.3.2 VAS statistical analysis (FDG-PET scanning visits) 
I analysed VAS scores at four time points: -7 min, +10 min and +80 min.  For fullness, 
hunger and anticipated pleasantness of eating mixed ANOVA was used (section 
2.6.2.3).  
 
VAS sickness and relaxedness scores had many outliers and non-normal distributions 
(respectively positively and negatively skewed).  Transforming the sickness data using a 
square root transformation, logarithmic transformation (log10) (of sickness score +1 in 
view of zero values), and inverse transformation (of sickness score +1) did not eliminate 
outliers or normalize distributions and therefore parametric approaches could not be 
used. To limit the number of approaches, transformation of relaxedness data was not 
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attempted and non-parametric tests were used for all comparisons for sickness and 
relaxedness.  There is no single non-parametric equivalent of the mixed ANOVA in 
SPSS and therefore separate non-parametric tests (Kruskal-Wallis test and Wilcoxon 
signed-rank test, section 2.6.2.3) were used to test each comparison for sickness and 
relaxedness.  
 
5.2.3.3 Ad libitum meal statistical analysis 
Mixed ANOVA was used to test for differences between NW, Ob and RYGBpl in the 
impact of 400 kcal mixed meal ingestion on subsequent ad libitum consumption 
(section 2.6.2.3).   
 
5.2.3.4 Glucose, peptides and adipokines statistical analysis (FDG-PET scanning visits) 
Comparisons of FASTED and FED between the three groups was performed using 
mixed ANOVA.  For each parameter the data fulfilled the required assumptions in most 




5.3.1 Responses to the 400 kcal meal at the test meal visit (RYGB only) (Figure 5.1, 
Table 5.1) 
Three RYGB participants were unable to consume the full 400 kcal at the test meal 
visit: RYGB03 256 kcal, RYGB07 220 kcal, RYGB11 234 kcal.  These 3 subjects were 
not otherwise unusual: gender (all female); age (2nd, 5th and 9th oldest); time post-
surgery (2nd, 4th and 7th longest); or percentage weight loss (4th, 5th and 6th highest).  
These 3 subjects were given 256 kcal, 220 kcal and 234 kcal respectively at the FDG-
PET FED visits. 
 
After the test meal, fullness scores increased (p=0.001) with a peak at 10 min (p=0.001 
versus baseline, remains significant at Bonferroni-adjusted α=0.007), remaining 
numerically above baseline until at least 120 min; anticipated pleasantness of eating 
score decreased (p=0.023) with a nadir at 10 min (p=0.005, remains significant at 
Bonferroni-adjusted α=0.007), remaining numerically below baseline until at least 60 
min; and sickness scores increased (p=0.004) with a peak at 10 min (p=0.028, which  
127 
 




KF Hunt.   Chapter 5: Impact of meal ingestion on VAS, ad libitum consumption and gut peptides 
Table 5.1: VAS scores and venous plasma glucose response to 400 kcal meal in 




































rmANOVA p=0.001** (Greenhouse-Geisser adjustment applied) 














































rmANOVA p=0.023* (Greenhouse-Geisser adjustment applied) 
































































































rmANOVA p<0.001*** (Greenhouse-Geisser adjustment applied) 





0.370 0.343 0.238 0.437 0.328 0.490 
 
Table 5.1:  For fullness scores, hunger scores, anticipated pleasantness of eating scores 
and venous plasma glucose, impact of meal ingestion was tested using repeated 
measures ANOVA (rmANOVA).  Where significant, paired t tests for post-meal time 
points versus baseline were performed.  For sickness and relaxedness scores, impact of 
meal ingestion was tested using Friedman tests. Where significant, Wilcoxon signed-
rank tests for post-meal time points versus baseline were performed. For the post hoc 
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does not survive Bonferroni-adjusted α=0.007) returning to baseline by 60 min.   There 
was no significant impact of the test meal on hunger (p=0.187) or relaxedness (p=0.299) 
scores.  The 3 subjects unable to consume the full 400 kcal meal were not unusual in 
their absolute VAS scores at 10 min for fullness (3rd, 4th and 7th highest) or sickness 
(2nd, 4th and 5th highest) or relaxedness (1st, 5th and 8th highest).  The spread of hunger 
and anticipated pleasantness of eating scores at +10 min was too small for rank to be 
meaningful.  
 
After the test meal venous plasma glucose (VPG) increased (p<0.001) with a peak at 10 
min (p=0.001, remains significant at Bonferroni-adjusted α=0.007) returning to baseline 
by 60 min.  VPG fell to 3-3.8 mmol/l in 3 subjects: RYGB03 (at baseline and between 
60-180 min (except at 120 min VPG 3.9 mmol/l); RYGB04 (at 60 and 90 min); RYGB 
11 (baseline and 30-180 min except at 150 min VPG 3.9 mmol/l).  There were no VPG 
readings below 3 mmol/l.  Subjects were asymptomatic. 
 
5.3.2 Appetitive and relaxedness VAS scores at FDG-PET visits  
5.3.2.1 Fullness scores (Figure 5.2a, Table 5.2) 
Fullness scores were numerically highest in RYGBpl at all time points in both FED and 
FASTED.  At baseline (-7 min), fullness scores were significantly higher in RYGBpl 
than in NW (p=0.008) or Ob (p=0.041) with no difference between NW and Ob 
(p=0.263). There was no significant difference between the groups on the effect of fed 
state on fullness scores at +10 min or +80 min (respectively p=0.142 and p=0.350), 
although the FED effect was numerically greatest at +10 min in RYGBpl.   Fullness 
scores were significantly higher in FED versus FASTED irrespective of group at +10 
min (p<0.001) and the difference was maintained, although smaller in magnitude, at 
+80 min (p<0.001). At +10 min fullness scores were significantly higher, irrespective of 
fed state, in RYGBpl versus both NW (p=0.003) and Ob (p=0.013), with no difference 
between NW and Ob (p=0.275). 
 
For the 3 RYGBpl subjects given less than 400 kcal at the FED visit, FED effect on 
fullness scores at +10 min were 4th, 5th and 6th and at +80 min 2nd, 4th and 5th of the 9 
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Three group comparisons 












Main effect of 
group 
-105 
Fasted - - 17.2±14.3 
- - - 
Fed - - 20.1±21.6 
-7 









Fed 6. 0±9.1 10.2±12.4 21.4±17.2 
+10 











Fed 35.8±24.9 45.1±28.8 71.8±18.2 
+80 





Fed 28.7±22.4 35.9±24.1 37.9±27.3 
 
Tables 5.2:  There were no significant interactions between fed state and group.  Main 
effect of fed state and main effect of group (with post hoc Fisher’s LSD test if 
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Three group comparisons 
(Mixed ANOVA, p values uncorrected) 











Main effect of 
group 
-105 
Fasted - - 36.4±34.8 
- - - 
Fed - - 43.1±37.3 
-7 
Fasted 56.9±25.0 66.0±25.2 47.0±28.9 
p=0.823 p=0.060 p=0.185 
Fed 62.0±31.0 70.6±22.4 56.4±22.8 
+10 











Fed 25.6±21.4 38.6±28.4 19.9±27.0 
+80 





Fed 41.4±21.9 42.4±26.1 24.9±24.5 
 
 







Three group comparisons 












Main effect of 
group 
-105 
Fasted - - 45.1±29.1 
- - - 
Fed - - 54.1±33.1 
-7 
Fasted 66.2±22.5 74.8±19.2 62.2±29.2 
p=0.699 p=0.602 p=0.124 
Fed 70.9±23.5 79.0±20.2 59.7±23.6 
+10 











Fed 35.3±25.9 50.2±27.4 20.1±27.4 
+80 











Fed 45.8±24.7 60.0±26.3 24.2±23.8 
 
Tables 5.3 & 5.4:  There were no significant interactions between fed state and group.  
Main effect of fed state and main effect of group (with post hoc Fisher’s LSD test if 
significant) are reported.    
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5.3.2.2 Hunger scores (Figure 5.2b, Table 5.3)   
Hunger scores were numerically lowest in RYGBpl at all time points in both FED and 
FASTED.  At baseline (-7 min) there were no significant differences in hunger scores 
between groups (p=0.185).  There was no significant difference between the groups on 
the effect of fed state on hunger scores at +10 min (p=0.676) or +80 min (p=0.587). 
Hunger scores were significantly lower in FED versus FASTED, irrespective of group, 
at +10 min (p<0.001) and the difference was maintained at +80 min (p<0.001).  At +10 
min hunger scores were lower in RYGBpl versus Ob, irrespective of fed state 
(p=0.019).  
 
For the 3 RYGBpl subjects given less than 400 kcal at the FED visit, FED effect on 
hunger scores at +10 min were 2nd, 3rd and 5th and at +80 min 2nd, 6th and 8th of the 9 
RYGBpl subjects ranked from largest positive to largest negative for consistency.   
 
5.3.2.3 Anticipated pleasantness of eating scores (Figure 5.2c, Table 5.4)   
Anticipated pleasantness of eating scores were numerically lowest in RYGBpl at all 
time points in both FED and FASTED.  At baseline (-7 min) there were no significant 
differences in hunger scores between groups (p=0.124).  There was no significant 
difference between the groups on the effect of fed state on hunger scores at +10 min 
(p=0.293) or +80 min (p=0.261). Scores were significantly lower in FED versus 
FASTED, irrespective of group, at +10 min (p<0.001) and +80 min (p<0.001).  At +10 
min and +80 min scores were lower in RYGBpl versus Ob, irrespective of fed state.  
 
For the 3 RYGBpl subjects given less than 400 kcal at the FED visit, FED effect on 
anticipated pleasantness of eating scores at 10 min were 2nd, 4th and 8th and at +80 min 
2nd, 4th and 6th of the 9  RYGBpl subjects ranked from largest positive to largest 
negative.    
 
5.3.2.4 Sickness scores (Figure 5.3a, Table 5.5)   
At baseline (-7 min) sickness scores were higher in NW versus RYGBpl (p=0.005) with 
a trend towards being higher in Ob versus RYGBpl (p=0.067).  There was a significant 
difference between groups in the effect of fed state on sickness scores at +10 min 
(p=0.013).  In RYGBpl sickness scores were higher in the fed state (p=0.018) but there 
was no impact of fed state on sickness scores in NW (p=0.933) or Ob (p=0.888).  There 
were no differences in sickness scores at +80 min. 
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Fasted - - 
0.0 (0.0, 
0.0) 
- - - 



















































































Table 5.5:  Interaction between fed state and group was tested using a Kruskal-Wallis H 
test to compare mean rank FED effect (FED-FASTED) between groups.  For significant 
interactions between fed state and group the following are reported:  post hoc 
comparisons (using Dunn’s procedure) for difference between groups in ‘FED effect’ 
(FED minus FASTED): main effect of fed state across all subjects and within-group 
comparisons (Wilcoxon signed-rank tests); and main effect of group and within-
condition comparisons with, if significant, post hoc Dunn’s procedure.    If there was no 
significant interaction between fed state and group, main effect of fed state (Wilcoxon 
signed-rank test) and main effect of group (Kruskal-Wallis H test, with post hoc tests 
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Three group comparisons (p values 
uncorrected) 

























Fasted - - 
95.0 (87.0, 
100.0) 
- - - 



































































Table 5.6:  Interaction between fed state and group was tested using a Kruskal-Wallis H 
test to compare mean rank FED effect (FED-FASTED) between groups.  There were no 
significant interaction between fed state and group.  Main effect of fed state (Wilcoxon 
signed-rank test) and main effect of group (Kruskal-Wallis H test, with post hoc tests 
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For the 3 RYGBpl subjects given less than 400 kcal at the FED visit, FED effect on 
sickness scores at +10 min were 2nd, 3rd and 5th and at +80 min tied 3rd (with 3 others), 
tied 7th (with 1 other) and 9th  of the 9 RYGBpl subjects ranked from largest positive to 
largest negative.   
 
5.3.2.5 Relaxedness scores (Figure 5.3b, Table 5.6) 
There was no interaction between fed state and group, and no impact of fed state, on 
relaxedness scores.  However, relaxedness scores were higher at baseline (-7 min) in 
RYGBpl versus NW (p=0.050) and Ob (p=0.019) and at +10 min (versus NW p=0.030; 
versus Ob p=0.012) with no difference between groups at +80 min (p=0.211). 
 
 5.3.3  Ad libitum consumption (Figure 5.4, Table 5.7) 
There was no significant difference between groups in the impact of fed state on amount 
consumed at the ad libitum meal (p=0.201), although this was numerically smallest in 
RYGBpl. Irrespective of group, subjects consumed less at the ad libitum meal in FED 
versus FASTED (p<0.001) and there was a significant difference between groups in ad 
libitum consumption regardless of fed state (p=0.007), with RYGBpl consuming less 
than both NW (p=0.004) and Ob (p=0.005) with no difference between NW and Ob 
(p=0.696). 
  
At the FASTED visit, the 3 RYGBpl subjects who were unable to consume 400 kcal at 
the test meal visit, consumed 132 kcal (RYGB03), 200 kcal (RYGB07) and 211 kcal 
(RYGB11) at the ad libitum meal; 6th, 8th and 9th of the 9 RYGBpl subjects ranked from 
highest to lowest consumption. Only 1 subject (RYGB05) consumed more than 400 
kcal (553 kcal).    
 
5.3.4 Glucose, pancreatic and gut peptides and adipokines 
5.3.4.1 Venous plasma glucose (VPG) (Figure 5.5, Table 5.8) 
Fasting (-10 min) VPG was higher in Ob than NW (p=0.033) and RYGBpl (p=0.002) 
with no difference between NW and RYGBpl (p=0.261). 
 
There were 6 visits where VPG fell to 3-3.8 mmol/l between -95 and +80 min: placebo-
FASTED one RYGB subject; placebo-FED one NW, one Ob, three RYGB subjects. 
There was one visit where VPG was below 3 mmol/l: in RYGB-placebo-FED (for 7 
min, lowest VPG 2.9 mmol/l). Subjects were asymptomatic. Intravenous 20% glucose  
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Table 5.7: Amount consumed at ad libitum meal 
Fed 
State 
Amount consumed, kcal  
(mean ±SD) 
Three group comparisons 
(Mixed ANOVA, p values uncorrected) 
NW Ob RYGBpl Interaction Main effect fed 
state 
Main effect group 









Fed 569±426 516±300 251±129 
 
Tables 5.7:  There were no significant interactions between fed state and group.  Main 
effect of fed state and main effect of group (with post hoc Fisher’s LSD test if 
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Table 5.8: Glucose mmol/l 
  
Concentration (mean ±SD) 
Three group comparisons 


















Fasted - - 4.8±0.5 
- - - 
Fed - - 4.9±0.6 
-10 
min 























































Fasted 4.7±0.4 4.9±0.4 4.5±0.5 
p=0.684 p=0.095 p=0.057 































Fed 5.7±0.7 6.1±0.7 6.6±0.9 
 
Table 5.8:  For significant interactions between fed state and group the following are 
reported:  post hoc comparisons (Fisher’s LSD test) for difference between groups in 
‘FED effect’ (FED minus FASTED): main effect of fed state across all subjects and 
within-group paired t tests; and main effect of group and within-condition ANOVA 
with, if significant, post hoc Fisher’s LSD test.  If there was no significant interaction 
between fed state and group, main effect of fed state and main effect of group (with post 
hoc Fisher’s LSD test if significant) are reported.    
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was administered (per protocol, section 2.5.6.1) in two RYGBpl-FED visits (-95-0 min 
nil, 0-80 min 23 & 63 ml) and no RYGBpl-FASTED visits.  The highest VPG in any 
subject in any study was 7.9 mmol/l (RYGBpl-FED in the post-meal phase).    
 
Mean VPG in the post-meal phase (0-80 min) was higher in FED than FASTED 
(p<0.001) with no difference between groups in fed effect (p=0.214) or VPG 
irrespective of fed state (p=0.166). There was a difference between groups in the effect 
of fed state on VPG range (difference between peak and nadir VPG) (interaction 
p=0.005), with a greater increase in range in FED versus FASTED in RYGBpl versus 
both NW (p=0.003) and Ob (p=0.004) with no difference between NW and Ob 
(p=0.635).  Neither fed state or group impacted significantly on nadir VPG in the post-
meal phase. There was a difference between groups in the effect of fed state on peak 
VBG (interaction p=0.001) with a greater increase in peak VPG in FED versus 
FASTED in RYGBpl versus both NW (p<0.001) and Ob (p=0.002) with no difference 
between NW and Ob (p=0.168). 
   
5.3.4.2 Insulin  (Figure 5.6a, Table 5.9) 
Fasting (-10 min) insulin was higher in Ob than NW (p<0.001) or RYGBpl (p<0.001), 
with no difference between NW and RYGBpl (p=0.898).  At +30 min, insulin was 
higher in FED versus FASTED irrespective of group (p<0.001) and the impact of fed 
state was not significantly different between groups (p=0.200), although the FED effect 
was numerically greatest in RYGBpl with FASTED insulin similar to NW and FED 
insulin similar to Ob.  At +80 min there was a significant interaction between fed state 
and group (p=0.010), with a greater FED effect in Ob versus NW (p=0.011) or RYGBpl 
(p=0.014), with no difference between NW and RYGBpl (p=0.894).  Insulin remained 
higher in FED versus FASTED at +80 min and this was significant in NW (p<0.001) 
and Ob (p<0.001) with a trend in RYGBpl (p=0.074).  At +80 min in both FED and 
FASTED, insulin was higher in Ob versus NW (FED p=0.001, FASTED p<0.001) and 
RYGBpl (p=0.001, p<0.001) with no difference between NW and RYGBpl (p=0.880, 
p=0.894).   
 
For the 3 RYGBpl subjects given less than 400 kcal at the FED visit, FED effect on 
insulin at +30 min were 3rd, 6th and 7th and at +80 min 7th, 8th and 9th of the 9 RYGBpl 
subjects ranked from largest positive to largest negative.    
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Table 5.9: Insulin mIU/L 
  
Concentration (mean ±SD) 
Three group comparisons 
















Fasted - - 5.6±2.6 
- - - 
Fed - - 6.0±2.9 
-10 









Fed 5.1±1.6 15.7±9.1 5.2±1.4 
+30 





Fed 20.0±12.8 62.4±52.0 61.7±50.3 
+80 



































Fed 9.0±3.6 27.2±17.9 8.1±6.6 
Table 5.10: Glucagon pg/ml 
  Concentration (mean ±SD) 
Three group comparisons  
















Fasted - - 53.2±13.9 
- - - 
Fed - - 52.0±11.3 
-10 
Fasted 59.4±11.5 62.2±19.9 54.6±10.1 
p=0.697 p=0.551 p=0.291 
Fed 60.7±13.3 61.2±25.7 48.5±17.5 
+30 





Fed 64.8±19.0 57.0±16.5 65.5±17.9 
+80 
Fasted 55.6±12.5 57.2±16.8 50.1±12.6 
p=0.673 p=0.515 p=0.374 
Fed 60.9±15.0 56.5±17.9 51.7±11.4 
 Tables 5.9 and 5.10:  For significant interactions between fed state and group the 
following are reported:  post hoc comparisons (Fisher’s LSD test) for difference 
between groups in ‘FED effect’ (FED minus FASTED): main effect of fed state across 
all subjects and within-group paired t tests; and main effect of group and within-
condition ANOVA with, if significant, post hoc Fisher’s LSD test.  If there was no 
significant interaction between fed state and group, main effect of fed state and main 
effect of group (with post hoc Fisher’s LSD test if significant) are reported.    
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Table 5.11: PYY pg/ml 
  
Concentration (mean ±SD) 
Three group comparisons  
















Fasted - - 86.7±27.1 
- - - 
Fed - - 88.8±21.5 
-10 
Fasted 94.8±26.4 98.7±40.2 89.8±34.0 
p=0.836 p=0.340 p=0.712 
Fed 94.1±34.1 95.0±37.6 82.5±21.9 
+30 



























Fed 106.3±24.3 110.4±40.8 177.5±53.2 
+80 



























Fed 98.1±15.6 99.6±23.4 144.3±27.6 
 
Table 5.11:  For significant interactions between fed state and group the following are 
reported:  post hoc comparisons (Fisher’s LSD test) for difference between groups in 
‘FED effect’ (FED minus FASTED): main effect of fed state across all subjects and 
within-group paired t tests; and main effect of group and within-condition ANOVA 
with, if significant, post hoc Fisher’s LSD test.  For no significant interaction between 
fed state and group, main effect of fed state and main effect of group (with post hoc 
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Table 5.12: GLP-1 EIA pmol/L 
  
Concentration (mean ±SD) 
Three group comparisons 
















Fasted - - 16.4±7.5 
- - - 
Fed - - 20.3±10.3 
-10 
Fasted 30.1±13.8 34.6±26.6 16.8±9.8 
p=0.623 p=0.805 p=0.065 
Fed 26.3±15.6 33.9±16.7 19.5±11.3 
+30 




























Fed 33.0±12.3 31.5±5.6 66.0±33.6 
+80 

























Fed 31.1±13.1 37.6±15.0 42.8±20.2 
 
Table 5.12:  For significant interactions between fed state and group the following are 
reported:  post hoc comparisons (Fisher’s LSD test) for difference between groups in 
‘FED effect’ (FED minus FASTED): main effect of fed state across all subjects and 
within-group paired t tests; and main effect of group and within-condition ANOVA 
with, if significant, post hoc Fisher’s LSD test.  For no significant interaction between 
fed state and group, main effect of fed state and main effect of group (with post hoc 
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5.3.4.3 Glucagon (Figure 5.6b, Table 5.10) 
There was no significant difference in fasting glucagon between the three groups 
(p=0.291). At +30 min glucagon was higher in FED versus FASTED irrespective of 
group (p=0.002) with no interaction between fed state and group (p=0.862) and no 
impact of group irrespective of fed state (p=0.372).  At +80 min there were no 
significant differences. 
 
For the 3 RYGBpl subjects given less than 400 kcal at the FED visit, FED effect on 
glucagon at +30 min were 4th, 8th and 9th and at +80 min 4th, 6th and 8th of the 9 RYGBpl 
subjects ranked from largest positive to largest negative.   
 
5.3.4.4 PYY (Figure 5.6c, Table 5.11) 
There were no significant differences in PYY between the three groups at baseline 
(p=0.712), or in FASTED at +30 min (p=0.793) or +80 min (p=0.634).  There was a 
significant interaction between fed state and group at +30 min (p=0.003) and +80 min 
(p<0.001) with a larger FED effect in RYGBpl than NW (+30 min p=0.002; +80 min 
p<0.001) or Ob (p=0.004; p<0.001) and no difference between NW and Ob (p=0.458; 
p=0.896).  In RYGBpl PYY was significantly higher in FED versus FASTED at both 
+30 min (p=0.004) and +80 min (p<0.001).  In NW and Ob, the effect of fed state on 
PYY was small and only significant in NW at +80 min (p=0.048). 
 
For the 3 RYGBpl subjects given less than 400 kcal at the FED visit, FED effect on 
PYY at +30 min were 6th, 8th and 9th and at +80 min 6th, 7th and 8th of the 9 RYGBpl 
subjects ranked from largest positive to largest negative.  Although these were at the 
lower end of the range for the group, these were not outliers.   
 
5.3.4.5 GLP-1 (Figure 5.6d, Table 5.12) 
There were no significant differences in GLP-1 between the three groups at baseline (-
10 min, p=0.065) or in FASTED at +30 min (p=0.093) or +80 min (p=0.495).   There 
was a significant interaction between fed state and group at +30 min (p=0.001) and +80 
min (p<0.001) with a larger FED effect in RYGBpl than NW (+30 min p=0.001, +80 
min p<0.001) or Ob (p=0.001, p<0.001) and no difference between NW and Ob 
(p>0.999, p=0.841). In all three groups GLP-1 was higher in FED versus FASTED at 
+30 min and +80 min, although this was not statistically significant at +30 min in NW 
(NW: p=0.106, p=0.005; Ob: p=0.046, p=0.006; RYGBpl: p=0.002, p<0.001). 
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For the 3 RYGBpl subjects given less than 400 kcal at the FED visit, FED effect on 
GLP-1 at +30 min were 5th, 8th and 9th and at +80 min were 2nd, 5th and 6th of the 9 
RYGBpl subjects ranked from largest positive to largest negative.   
 
5.3.4.6 GIP (Figure 5.7a, Table 5.13) 
There was no difference in GIP between the three groups at baseline (p=0.822).  At +30 
min GIP was higher in FED versus FASTED irrespective of group (p<0.001) with no 
interaction between fed state and group (p=0.172) or difference between groups 
irrespective of fed state (p=0.393).  At +80 min GIP was higher in FED versus FASTED 
in all three groups (all p<0.001) with a significant interaction between fed state and 
group (p=0.002) with a larger FED effect in both NW and Ob versus RYGBpl (p=0.008 
& p<0.001 respectively), with no difference between NW and Ob (p=0.375). The 
pattern of higher GIP at +80 min than +30 min in FED in NW and Ob persisted on 
reanalysing using only subjects with data for both time points in FED (NW n=6, +30 
min 171.0±140 pg/ml, +80 mins 292.0±115.8 pg/ml and Ob n=11, +30 min 
277.3±150.5 pg/ml and +80 min 324.5±171.6 pg/ml, all mean±SD). 
 
For the 3 RYGBpl subjects given less than 400 kcal at the FED visit, FED effect on GIP 
at +30 min were 4th, 5th and 9th and at +80 min 3rd, 7th and 9th of the 9 RYGBpl subjects 
ranked from largest positive to largest negative. 
 
5.3.4.7 Total ghrelin (Figure 5.7b, Table 5.14) 
Baseline (-10 min) total ghrelin was higher in NW than Ob (p=0.006) and RYGBpl 
(p=0.003), with no difference between Ob and RYGBpl (p=0.364).  At +30 min and 
+80 min there was no interaction between fed state and group on total ghrelin and no 
difference between FED and FASTED or between groups.  
 
For the 3 RYGBpl subjects given less than 400 kcal at the FED visit, FED effect on 
total ghrelin at +30 min were 3rd, 4th and 6th and at +80 min were 1st, 5th and 6th of the 9 
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Table 5.13: GIP pg/ml 
  
Concentration (mean ±SD) 
Three group comparisons  














Fasted - - 31.4±17.3 
- - - 
Fed - - 29.1±19.2 
-10 
Fasted 42.2±38.0 34.7±17.8 31.4±16.1 
p=0.780 p=0.822 p=0.822 
Fed 33.0±28.3 38.3±53.7 31.4±19.2 
+30 















































Table 5.14: Total ghrelin (pg/ml) 
  
Concentration (mean±SD) 
Three group comparisons 

















Fasted - - 887±335 
- - - 
Fed - - 883±305 
-10 









Fed 1235±536 855±307 785±248 
+30 
Fasted 1122±575 870±334 791±338 
p=0.755 p=0.938 p=0.263 
Fed 1018±433 930±333 741±218 
+80 
Fasted 1151±517 989±439 888±414 
p=0.976 p=0.220 p=0.129 
Fed 1079±389 883±242 797±224 
Tables 5.13 and 5.14:  For significant interactions between fed state and group the 
following are reported:  post hoc comparisons (Fisher’s LSD test) for difference 
between groups in ‘FED effect’ (FED minus FASTED): main effect of fed state across 
all subjects and within-group paired t tests; and main effect of group and within-
condition ANOVA with, if significant, post hoc Fisher’s LSD test. For no significant 
interaction between fed state and group, main effect of fed state and main effect of 
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5.3.4.8 Adiponectin (Figure 5.8a, Table 5.15) 
Adiponectin (at -10 min) was higher in NW than Ob (p<0.001) and in RYGBpl was in 
between NW and Ob with a trend towards significant difference with both NW 
(p=0.090) and Ob (p=0.069).  
 
5.3.4.9 Leptin (Figure 5.8b, Table 5.16) 
Leptin (at -10 min) was higher in Ob than both NW (p<0.001) and RYGBpl (p=0.001).  
Leptin was numerically higher in RYGBpl than NW but this was not significant  




5.4.1 Impact of the 400kcal meal on appetitive VAS scores, subsequent ad libitum 
consumption and pancreatic and gut peptides 
The 400 kcal meal was chosen for this work to be tolerable for the RYGB subjects and 
might be regarded as a small meal.   The data presented here show it was a sufficient 
stimulus in all three experimental groups to impact on appetitive sensations, behaviour 
and physiological parameters and these effects were maintained for at least 80 min i.e. 
until completion of FDG-PET scanning.  Across the three groups in FED, versus 
FASTED, state, fullness scores were higher and hunger and anticipated pleasantness of 
eating scores lower at both +10 min and +80 min, with a larger effect at +10 mins, and 
subjects consumed less at the ad libitum meal which commenced at +80 min. There 
were pancreatic and gut peptide responses in all three groups with higher insulin, 
glucagon, GLP-1 (not significant in NW) and GIP at +30 min, maintained at +80 min 
for insulin (not significant in RYGBpl), GLP-1 and GIP.   
 
The more detailed profiling of appetitive VAS responses to the test meal in RYGB 
subjects showed maximum impact at 10 min post-meal (not significant for hunger).  
This is consistent with the literature which shows peak fullness (and nadir hunger) at 
10-30 min post-meal after RYGB [83, 85].  This supports assessing appetitive VAS 
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Table 5.15:  Adiponectin ng/ml 
  Concentration (mean±SD) 
Three group comparisons 
















Fasted - - 
11855± 
4812 
- - - 
























Table 5.16:  Leptin pg/ml 
  Concentration (mean±SD) 
Three group comparisons 
















Fasted - - 
24576 
±21726 
- - - 























Tables 5.15 and 5.16:  There were no significant interactions between fed state and 
group.  Main effect of fed state and main effect of group (with post hoc Fisher’s LSD 
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Three of the RYGB subjects were unable to consume the full 400 kcal at the test meal 
visit.  This appears to be a characteristic of these 3 subjects as they had amongst the  
lowest consumption at the ad libitum meal in the fasted state (at the FASTED FDG-PET 
visit).  However the 3 participants were not otherwise unusual in terms of gender, age, 
time since surgery or post-surgical weight loss. These 3 subjects were included in the 
research but were given smaller pre-scan meals than other subjects at the FED FDG-
PET visits. This is a potential limitation as the meal stimulus is smaller for these 3 
participants, and also that these 3 were fed to satiation which may or may not be the 
case for other participants.  However, the smaller meal in these 3 subjects appeared to 
have similar impact as the 400 kcal meal did in the remaining RYGBpl subjects on 
appetitive VAS scores and pancreatic and gut peptides suggesting the decision to 
include these subjects was reasonable.  
 
5.4.2 Differences between groups in appetitive sensations 
The VAS data were included to provide an indication of whether the three groups were 
typical, and the study was not powered to detect differences in VAS scores between 
groups.  According to Flint et al [18] to detect a 10 mm difference (on a 100 mm scale) 
in fasting fullness between two unrelated groups with a power of 0.8, 16 subjects per 
group would be required, and for peak fullness 68 subjects per group, with similar 
sample sizes for hunger.  Such numbers are not required for a neuroimaging study.  
 
5.4.2.1 VAS for fullness, hunger and anticipated pleasantness of eating 
RYBGpl had higher fasting fullness scores than NW or Ob, with no difference between 
NW and Ob.  There was no significant difference in fasting hunger or anticipated 
pleasantness of eating scores between groups, although scores were numerically lowest 
in RYGBpl.   Consistent with my data, four studies comparing obese and normal weight 
subjects (8-20 subjects per group) found no difference in appetitive VAS scores 
including hunger and/or fullness [19-22].  My finding of lower fasting hunger post-
RYGB (albeit not significant) is also consistent, with longitudinal studies reporting 
reduced fasting hunger post-RYGB versus pre-RYGB (5-16 subjects) [80-83] and 
cross-sectional studies showing significantly (20-21 subjects per group) [84] or non-
significantly (12 subjects per group) [21] lower fasting hunger scores in post-RYGB 
versus obese.  My finding of significantly higher fasting fullness scores post-RYGB has 
not been previously reported with studies finding no significant difference between 
post-RYGB and pre-RYGB [82, 83] or obese subjects [21, 84].  However, in two 
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studies fasting fullness was non-significantly higher [82, 83] and it is interesting that 
Scholtz et al reported lower VAS scores for ‘volume of food you could eat’, which 
might be considered a reciprocal of fullness, but no difference in fullness.   I suspect 
this discrepancy with my data is due to the limitations of VAS scales or reflect type 2 
error in the other studies rather than my subjects being atypical.  
 
Consistent with my finding no difference in postprandial fullness, hunger or anticipated 
pleasantness scores (interaction or main effect of group, analogous with incremental and 
absolute) between NW and Ob, four studies found no difference in postprandial 
appetitive VAS scores (including fullness, satiety, hunger, desire to eat, malaise and 
prospective consumption) between obese and normal weight subjects for meal sizes 
approximating to that used in my study (up to 600 kcal; 11-20 subjects per group) [19, 
20, 22, 23].  Post-RYGB studies have consistently found increased absolute (score or 
AUC) fullness or satiety and/or reduced absolute hunger after fixed mixed meal (246-
500 kcal) after RYGB versus before RYGB [80, 81, 83, 85], although this was not 
significant in a smaller study [82], or versus obese unoperated [23].  These data are 
consistent with my finding numerically higher fullness and lower hunger and 
anticipated pleasantness scores at both postprandial time points in RYGBpl.   Where 
reported in previous studies, maximum impact of RYGB on fullness and hunger is at 
10-30 min post-meal consistent with my finding a greater, albeit not significant, 
increase in fullness scores in RYGBpl at +10 min. Post-RYGB studies have generally 
not reported incremental data.  However studying the graphs gives the impression that 
the impact of RYGB on postprandial increment in fullness is greater than on decrement 
in hunger [83, 85] consistent with my data. The +10 min time point would approximate 
to meal termination and might help explain the lower ad libitum consumption.  
 
5.4.2.2 VAS for sickness 
The lower fasting sickness scores in RYGBpl versus NW and Ob (trend) is consistent 
with previous studies. Korner at al found fasting nausea/abdominal discomfort was 
lower in post-RYGB versus normal weight and obese subjects [21] and Scholtz et al 
found fasting nausea (AUC during fMRI) was non-significantly lower in post-RYGB 
than obese controls [84].  While nausea or sickness is conventionally associated with 
over-consumption, anecdotally some people feel nauseous when they are hungry, 
relieved by eating.  It is interesting to speculate that post-RYGB subjects may tolerate 
fasting better and this fits with the early studies showed reduced meal frequency after 
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RYGB [89, 90].   RYGBpl subjects had increased nausea at +10 min post-meal which 
was not seen in NW or Ob.  Increased post-meal nausea has been previously reported in 
post-RYGB subjects, versus decreased nausea in post-gastric-banding subjects [84]. 
This unpleasant post-ingestive sensation after RYGB may act to reduce meal size.    
 
5.4.2.3 VAS relaxedness 
RYGBpl had higher relaxedness scores before scanning than both NW and Ob, with no 
difference between NW and Ob and no difference in groups after scanning.  Previous 
studies have not reported relaxedness scores or other measures of wellbeing during the 
study visit.  This might reflect that RYGB subjects were likely to be more familiar with 
scanning and other hospital procedures as they had all, by definition, undergone 
surgery. 
 
5.4.2.4 Limitations of visual analogue scales 
VAS are used widely in an attempt to quantify sensations but do have limitations.  Flint 
et al assessed validity by correlating scores with subsequent ad libitum intake and found 
moderate correlations with a single score (at first visit; fullness r=-0.34, p<0.05; hunger 
r=0.26, p=<0.1) and stronger correlations for the 4.5 hour mean (fullness r=-0.44, 
p<0.001; hunger r=0.38 p<0.01 [18].  However, they also found large inter-individual 
(and to a lesser extent intra-individual) variability in appetitive VAS scores, reflected in 
the study size calculations discussed above [18].   The terms used both in the question 
and to label the scale may mean different things to different people impacting on 
between-subject differences.  Erroneous results may be due to the subject reading the 
scale the wrong way round, missing a question, having insufficient time to answer 
correctly or losing concentration if given too much time, or getting bored with 
answering the same questions repeatedly.  The sensation being assessed should have a 
linear relationship with the intervention being studied.  For example, while nausea or 
sickness is conventionally associated with over-consumption and an avoidance of eating 
more, anecdotally some people feel nauseous when they are hungry and the impact of 
food ingestion thus depends on the subject’s position on the curve before food 
ingestion.  The reproducibility of appetitive VAS is improved by repeated testing and 
using averages [18]  or presumably AUC.  However I deliberately chose not to assess 
VAS during the scanning period (in order to avoid any impact of the subject thinking 
about the questions on the imaging) and therefore only have single time points which 
are vulnerable to erroneous data.   For future studies I would use fewer questions, would 
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format the question so that ‘more’ is always at the same end of the scale and would 
modify the programme so subjects could self-pace.  
  
5.4.3 Differences between groups in ad libitum meal consumption 
RYGBpl consumed less at the ad libitum meal than NW and Ob, with no difference 
between NW and Ob, and these results are consistent with the literature.   Laurenius et 
al found lower ad libitum consumption of homogenous food 4 hours after breakfast after 
RYGB versus before RYGB  [65] reporting ad libitum meal size 42-66% of pre-RYGB 
consistent with my finding ad libitum consumption at the FED visit in RYGBpl subjects 
49% that of Ob subjects.  Consistent with my data showing no difference between Ob 
and NW, three studies found no difference between obese and normal weight subjects in 
ad libitum consumption of homogenous food 3-4 hours after the previous meal [22, 33, 
65].  In contrast Batterham et al showed obese consumed more than normal weight 
subjects at an ad libitum buffet meal [68].  This difference may be due to protocol 
differences: using a buffet meal, rather than homogenous food, and a prolonged fast of 
at least 16 hours, versus a meal 3-4 hours previously.  However, I found no significant 
difference between groups in the impact of fed state (i.e. of having consumed 400 kcal 
80 min previously versus continued fasting of at least 11 hours) on the amount 
consumed at the ad libitum meal and there was not even a suggestion of a difference 
between NW and Ob which would go against the prolonged fast, albeit >16 hours 
versus >11 hours, being the explanation of the difference found by Batterham et al [68].  
 
5.4.4 Differences between groups in glucose, pancreatic and gut peptides and 
adipokines  
The pancreatic and gut peptide and adipokines were included to provide an indication of 
whether the three groups were typical, and the study was not powered to detect 
differences in gut peptides between groups.  This is particularly important at +30 min.    
 
5.4.4.1 Venous plasma glucose 
It was important to avoid hypoglycaemia, to avoid impact on insulin, glucagon, fullness, 
hunger and brain responses, and this was achieved.  There was only one visit where 
VPG fell below 3mmol/l, and this was for 7 min, lowest VPG 2.9mmol/l (and note this 
is lower than arterial).  Two of the nine RYGB subjects required IV glucose at FED 
visits in the post-meal phase.  The maximum amount infused was 63 ml 20% glucose 
which contains 12.6 g glucose (42 kcal). It is therefore unlikely that either 
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hypoglycaemia or the infused glucose would account for differences between groups in 
other parameters. 
 
Fasting glucose was higher in Ob than NW and RYGBpl with no difference between 
NW and RYGBpl consistent with the literature  [10, 21, 22, 85, 86, 96, 97, 101, 104, 
115, 116] (section 1.3.3.9). 
 
The literature on postprandial glucose profiles is varied, likely due to protocol factors 
(section 1.3.3.9).  My finding of peak postprandial glucose being higher in RYGBpl 
than both NW and Ob with no difference between NW and Ob is consistent with the 
literature given the particular features of my study.  I measured glucose frequently in 
RYGBpl (every 5-10 min, in order to avoid hypoglycaemia) so would have been likely 
to catch the early peak [21, 85, 86, 96, 97, 101, 103, 104], whereas I measured glucose 
less frequently (every 10-20 min) in NW and Ob and particularly tried to avoid 
sampling in all groups during the 15 min scanning period (55-70 min) to avoid 
disturbing the subjects and potentially causing movement artefact and thus might have 
missed the delayed peak in Ob subjects [21, 22, 86].  Three RYGBpl subjects had 
T2DM pre-operatively and therefore my RYGBpl group would be expected to have a 
higher peak glucose [103].  Conversely most of my Ob subjects had NGT (19 had NGT 
and 2 IGT) and therefore might be expected to have a lower peak glucose than the obese 
groups in cross-sectional studies ([21, 22, 86, 101] which, although they excluded 
subjects with known diabetes, did not perform an OGTT and therefore might have 
included subjects with undiagnosed diabetes or IGT in their obese groups.  My finding 
of no difference in nadir glucose might be due to the use of IV glucose to avoid 
hypoglycaemia in RYGB subjects and my analysis looking at lowest glucose over the 
whole 80 min postprandial period rather than at specific time-points.   
   
5.4.4.2 Insulin 
I found fasting insulin was higher in Ob than NW and RYGBpl, with no difference 
between NW and RYGBpl, with the same pattern seen for HOMA2-IR (Chapter 3) and 
this is consistent with the literature (section 1.3.3.6) [10, 21, 22, 68, 84-86, 96-98, 101, 
103, 104, 115, 116].   
 
Studies on postprandial insulin profiles, (section 1.3.3.6), report insulin peaks at 30-45 
min after a mixed meal in normal weight subjects [22] with obese subjects having 
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higher insulin at all times with a delayed, higher peak and slower fall [21, 22, 86] and 
post-RYGB subjects an earlier (before +30 min) and higher insulin peak with a rapid 
post-peak fall versus obese [21, 86, 98, 101] or pre-RYGB [85, 96, 97, 103, 104]. 
Consistent with this, I found the greatest impact of food ingestion on +30 min insulin 
was in RYGBpl, followed by Ob then NW (although not statistically significant).  
However, my finding no difference in insulin between Ob and RYGBpl at +30 min is in 
contrast to many of these studies (which reported higher insulin in post-RYGB) and 
there are several possible explanations for this. The +30 min post-end-of-meal time 
point in my study may have been after the peak insulin in RYGB and coincided with 
falling insulin in RYGB and rising insulin in Ob, supported by the above studies 
showing the obese and post-RYGB insulin graph lines cross at about 40-50 min from 
beginning of meal (meal consumption took up to 10 min in some of my subjects). A 
second possibility is differences in the test meal.  A third is time post-surgery as peak 
insulin declines over the first year post RYGB [97, 103] and my subjects were 18±12.6 
months after RYGB.  A fourth is that three of my RYGBpl subjects had T2DM pre-
operatively and would thus be expected to have a lower peak insulin post-RYGB  [103].   
My finding that the impact of food ingestion was more prolonged in Ob than in 
RYGBpl or NW is consistent with studies showing that from +60 min (or earlier) 
insulin is lower post-RYGB versus obese [21, 86, 98, 101] or pre-RYGB [85, 96, 97, 
103, 104]  and similar to normal weight [21, 86, 98].    
 
5.4.4.3 Glucagon 
There were no differences in fasting glucagon between groups.  This is consistant with 
the (relatively limited) literature (section 1.3.3.7).   In my study all NW and the majority 
of Ob had NGT, and 1 previous study showed no difference in fasting glucagon 
between obese and non-obese subjects with NGT [117]. Most post-RYGB studies show 
either no difference, consistent with my data, [85, 101] or a small reduction in fasting 
glucagon [103, 116] with both no change [104] and reduction [103] being found in 
people with T2DM.  Consistent with my data, most studies on postprandial glucagon 
responses after RYGB have shown no significant differences (although there is a 
suggestion of a slightly earlier or higher peak) [85, 101-104] with a greater postprandial 
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5.4.4.4 PYY 
There was no difference in fasting total PYY between groups. Previous studies (section 
1.3.3.1) have not found consistent differences between obese and normal weight 
subjects, with two studies finding lower total PYY [20, 68] and two finding no 
difference in total and/or PYY3-36 [21, 86].  Post-RYGB studies have also not shown 
consistent differences with cross-sectional studies showing higher total PYY [84] or no 
difference in total and/or PYY3-36 [21, 86] versus obese and longitudinal studies 
showing increase in total PYY [96], decrease in total PYY  [97] and no significant 
difference in PYY3-36 [83].   
 
There was an exaggerated postprandial increase in total PYY in RYGBpl versus both 
Ob and NW and this is as anticipated based on previous studies [21, 80, 83, 86, 96-98].   
 
My study showed a minimal impact of fed state on total PYY in NW and Ob (only 
reached significance in NW at +80 min). This is consistent with the literature as the 
PYY peak is at 90-120 (i.e after my +80 min timepoint), is quite small (about 1.5-2x 
fasting) [20, 21, 86, 98] and would be expected to be proportionately smaller given my 
400 kcal meal size [20].  Studies comparing postprandial PYY (total and PYY3-36)  
responses in obese and normal weight either show no significant difference [21, 86],  or 
a small attenuation in the obese most evident at around 90 min (i.e. after my +80 min 
sample) [20, 68, 98].   My finding of no difference in postprandial PYY responses 
between Ob and NW is not surprising given the small reported difference, if any, in 
obesity and my infrequent sampling and small sample size.  
 
5.4.4.5 GLP-1 
There was no difference in fasting GLP-1 between NW, Ob and RYGBpl and this is 
consistent with the literature comparing normal weight and obese subjects [22, 68, 100] 
or post-RYGB versus obese unoperated [98, 101, 102] or pre-RYGB [80, 83, 85, 96, 97, 
102-104]. 
 
There was an exaggerated postprandial GLP-1 response (approximately 4xFASTED at 
+30 min) in RYGBpl versus NW and Ob, as anticipated based on previous studies of 
post-RYGB versus obese [98, 101, 102] or pre-RYGB [80, 83, 85, 96, 97, 102-104].  
My finding of no difference in postprandial GLP-1 responses between Ob and NW is 
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not surprising given previous studies findings of only small, and not always significant, 
attenuation in obesity [22, 98, 100] and my infrequent sampling and small sample size.  
 
5.4.4.6 GIP 
There was no difference in fasting GIP between the three groups.  Consistent with my 
data, two studies have reported similar fasting GIP in obese and normal weight subjects 
[22, 100] and most studies have found no significant difference in fasting GIP between 
post-RYGB and obese [101, 102] or pre-RYGB [85, 102, 103] although some  have 
found reduced fasting GIP at specific time points particularly in the first week [85, 103, 
104].   
 
Previous studies show that the postprandial GIP response is similar in normal weight 
and obese subjects peaking at 30-90 min [22, 100].   After RYGB, the postprandial GIP 
response shows an earlier (before 30 min), and possibly higher, peak and a sharp fall, 
being lower than in obese unoperated subjects before +60 min [101, 102] [85, 102, 104, 
105].  My data is consistent with these studies showing similar response in the three 
groups at +30 min (when presumably GIP was falling in RYGBpl and rising in NW and 
Ob) whereas at +80 min GIP was higher in NW and Ob versus RYGBpl.  
 
5.4.4.7 Total ghrelin 
Fasting total ghrelin was higher in NW than Ob and RYGBpl which were similar.  The 
higher ghrelin in NW is consistent with the literature [21, 68, 86, 98, 106, 107]. The 
data after RYGB is less clear (discussed in section 1.3.3.5) and my finding of no 
significant difference is not unexpected.  I found no significant impact of meal on total 
ghrelin and no difference between groups which again, given the variability in the 
literature, is not surprising and may relate to the small impact of food ingestion on 
ghrelin in the face of large standard deviations, the infrequent sampling, measuring total 
(rather than acylated) ghrelin, the nature of the meal, or the time post-RYGB.   
 
5.4.4.8 Adiponectin 
I found adiponectin was highest in NW, then RYGBpl and lowest in Ob with a 
significant difference between NW and Ob consistent with the literature   (discussed in 
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5.4.4.9 Leptin 
Leptin was higher in Ob than both NW and RYGBpl (despite BMI being no different to 
Ob), with no significant difference between NW and RYGBpl.  This is consistent with 
previous three group cross-sectional studies which reported higher leptin in obese than 
normal weight and RYGB, which were either similar [21, 86] or showed lower leptin in 
normal weight versus post-RYGB [98] and longitudinal studies reporting reduced 




These data show that the 400kcal meal, chosen to be tolerable for RYGB subjects and 
which might be considered a small meal, was a sufficient stimulus to impact on 
appetitive and physiological parameters and subsequent ad libitum consumption and 
these effects were maintained for at least 80 min i.e. until completion of FDG-PET 
scanning. Three RYGBpl subjects were given less than 400 kcal at the pre-scan meal 
because they were unable to consume the full 400 kcal at the test meal visit. This is a 
potential limitation.  However, the reduced amount appeared to have a similar impact on 
appetitive VAS scores and pancreatic and gut peptides as the full 400 kcal meal in the 
remaining RYGBpl subjects.  The appetitive VAS scores, ad libitum consumption, 
pancreatic and gut peptide responses and adipokine data for NW, Ob and RYGB 
subjects are largely consistent with the literature.  RYGB subjects show the expected 
higher postprandial fullness and lower hunger and anticipated pleasantness of eating, 
lower ad libitum intake and exaggerated postprandial GLP-1 and PYY responses and 
rapid post-peak fall in insulin and GIP.  The subjects also show typical differences in 
HOMA2-IR, adiponectin and leptin.  Where there are discrepancies with the literature 
these are readily explained by sample timing or relatively small reported differences 
unlikely to be detected with my sample size.  This suggests the NW, Ob and RYGB 
groups are typical.   
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CHAPTER 6: REGIONAL BRAIN RESPONSES TO FOOD 
INGESTION AND DIFFERENCES BETWEEN NORMAL WEIGHT, 
OBESE AND AFTER RYGB 
 
6.1 INTRODUCTION  
In this chapter I address the following questions: 
- What are the regional brain responses to food ingestion across all subjects using 
FDG-PET functional neuroimaging? 
- What are the differences in regional brain responses to food ingestion between 
normal weight, obese and post-RYGB subjects? 
 
6.2 METHODS 
The methods are described in chapter 2.  To recap, each subject underwent 2 FDG-PET 
scanning visits in random order after overnight fasting. At the FED visit subjects 
consumed a 400 kcal fixed meal (reduced amount given in 3 RYGB subjects) and FDG-
PET scanning was performed between +15 and +70 min. At the FASTED visit 
procedures were the same except subjects did not consume the 400 kcal mixed meal.  
(RYGB subjects also underwent FED and FASTED visits with somatostatin plus 
insulin, but these data are not used in this chapter).  
 
6.2.1 Participants 
Results are reported for 12 NW, 21 Ob and 9 RYGB subjects.  Participant 
characteristics are given in chapter 3.  
 
6.2.2 Visit order 
FDG-PET scanning visits were performed in random order as described in section 2.5.1. 
The actual visit order is shown in table 6.1.  
  
Table 6.1 Order of (placebo) FDG-PET scanning visits 











FED then   
FASTED 
Visit 1 Visit 2 6 (50%) 10 (48%) 4 (44%) 
Visit 3 Visit 4 - - 1 (11%) 
FASTED 
then FED  
Visit 2 Visit 1 6 (50%) 11 (52%) 3 (33%) 
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6.2.3 Neuroimaging analysis 
6.2.3.1 Neuroimaging data preparation and image pre-processing 
Images were prepared and pre-processed as described in Materials and Methods 
(sections 2.7.1 and 2.7.2).   Images in which movement was identified are listed in 
section 2.7.1.2 with the associated management. In 2 subjects (NOS07 and NOS19) 
there was no MRI image available and the mean PET image was warped directly to 
standard space (section 2.7.2.2). 
 
6.2.3.2 SPM analysis 
Images were intensity-normalised to mean grey matter (excluding cerebellum) values 
scaled to 100 (section 2.7.3.1 & 4.2).  Images were masked using the ‘mask-2014Oct01-
Ob21-pit-hypothal’ mask (section 2.7.3.2 & 4.3).   
 
A mixed ANOVA model was used in SPM to test main effect of fed state 
(FED>FASTED and FED<FASTED) across the three groups (NW, Ob, and RYGBpl) 
and to test interaction between fed state and group (section 2.7.3.3).  For 
FED>FASTED and FED<FASTED, clusters of voxels were considered to show a 
significant effect at a voxel level p<0.001 and cluster level pfwe-corr<0.05.  For 
interactions between fed state and group, clusters were considered to show significant 
interaction with a cluster size >100 voxels and 2 voxel level thresholds: p<0.001 
(stringent) and p<0.01 (lenient). 
 
The SPM analysis testing interaction between fed state and group was repeated 
including subject age as a covariate and again using a mask with the hippocampus and 
amygdala (defined by the Tziortzi atlas [128]) masked-in (mask2014Oct01Ob21-pit-
hypo-amyg-hippo). 
 
Clusters were localised using the Tziortzi atlas [128] modified to include hypothalamus 
and pituitary (section 2.7.4).  Brodmann areas were identified using the online 
application ‘MNI to Talairach Coordinate Converter with Brodmann Areas’ from the 
Yale BioImage Suite Package [241]. 
 
6.2.3.3 Post hoc analysis of SPM cluster data 
For clusters identified in SPM with a significant interaction between fed state and 
group, mean normalised voxel values (intensity normalised to mean grey matter 
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(excluding cerebellum)) were extracted for each cluster for all scans and food-evoked 
signal change (FESC, mean normalised voxel value in FED minus mean normalised 
voxel value in FASTED) calculated (section 2.7.5).  For each cluster, the nature of 





6.3.1 Regional brain responses to eating across all subjects 
SPM analysis for main effect of fed state across the three groups showed a single very 
large cluster (cluster K, 17,485 voxels) where FDG uptake was higher in FED compared 
to FASTED (FED>FASTED, voxel level p<0.001, cluster level pfwe-corr<0.05) and five 
clusters (clusters L-P) where FDG uptake was lower in FED compared to FASTED 
(FED<FASTED, voxel level p<0.001, cluster level pfwe-corr<0.05).  The cluster map is 
shown in Figure 6.1.  
 
Cluster K (FED>FASTED) (Table 6.2) includes hypothalamus, bilateral accumbens 
(ventral striatum), bilateral globus pallidus, bilateral temporal thalamus, bilateral insular 
cortex, bilateral medial and lateral OC, ventral cingulate subcallosal gyrus, ACC, dorsal 
ACC, extensive regions in the temporal lobes including bilateral amygdala and bilateral 
hippocampal formation, and midbrain, pons and medulla. 
 
Two of the FED<FASTED clusters (clusters L and M) (Table 6.3) mainly include 
bilateral anterior and posterior dorsolateral frontal cortex (DLFC) extending into 
bilateral frontal operculum, right lateral OC and bilateral precentral gyrus.  Cluster N 
includes ACC and dorsal ACC.  Clusters O and P include posterior cingulate gyrus, 
bilateral precuneus and cuneus, extending posteriorly to include bilateral calcarine 
cortex, lingual gyrus, occipital pole and occipital fusiform gyrus and laterally to include 
bilateral parietal lobule, angular gyrus, supramarginal gyrus, parietal operculum, central 








KF Hunt.   Chapter 6: Regional brain responses to food ingestion and difference between groups 
Table 6.2: FED>FASTED 
Cluster K: 17,485 voxels,   
2 0 -18 (hypothalamus), -30 -2 -32 (parahippocampal ambiens gyrus ant L), -36 -2 -12 (white matter) 
Cluster or 
Intersect between cluster and modified Tziortzi 




% of region 
(masked-in voxels) 
in intersect 
FESC across  
all subjects  
% (mean±SD) 
Whole Cluster K - - 2.39±1.33 
Hypothalamus_Baroncini  307 97.5% 4.13±2.73 
Accumbens (ventral striatum) R (82) 54 33.3% 1.80±3.31 
Accumbens (ventral striatum) L (74) 55 30.9% 1.58±2.65 
Post caudate L (70) 33 91.7% 1.42±3.50 
Globus pallidus R (79) 67 41.9% 2.78±3.53 
Globus pallidus L (71) 44 26.8% 1.96±3.26 
Thalamus temporal R (96) 76 39.8% 2.16±2.61 
Thalamus temporal L (89) 69 41.6% 1.89±2.95 
Thalamus occipital L (85) 11 36.7% 1.26±4.79 
Insular cortex R (32) 337 25.8% 2.49±2.21 
Insular cortex L (1) 295 22.6% 2.71±1.80 
Amygdala R (81) 167 100% 2.82±3.06 
Amygdala L (73) 227 100% 2.73±3.42 
Hippocampus R (80) 391 99.2% 2.04±2.13 
Hippocampus L (72) 453 85.5% 1.95±2.16 
Anterior temporal pole R (35) 1148 88.3% 2.34±1.95 
Anterior temporal pole L (4) 1407 97.0% 2.66±1.91 
Parahippocampal ambiens gyrus ant R (53) 294 97.7% 2.67±2.17 
Parahippocampal ambiens gyrus ant L (22) 306 98.7% 2.63±2.18 
Parahippocampal subiculum gyrus post R (54) 231 89.5% 2.26±2.30 
Parahippocampal subiculum gyrus post L (23) 274 82.3% 2.36±2.47 
Temporal fusiform cortex ant R (56) 189 96.4% 2.83±2.74 
Temporal fusiform cortex ant L (25) 176 100% 2.62±3.04 
Temporal fusiform cortex post R (57) 281 45.9% 1.70±2.13 
Temporal fusiform cortex post L (26) 317 46.8% 2.01±2.38 
Inferior temporal gyrus ant R (40) 113 43.6% 1.84±3.20 
Inferior temporal gyrus ant L (9) 154 51.9% 2.34±2.59 
Inferior temporal gyrus post R (41) 136 7.5% 2.03±2.16 
Inferior temporal gyrus post L (10) 197 11.1% 2.08±2.01 
Middle temporal gyrus ant L (7) 103 23.5% 1.99±2.40 
Superior temporal gyrus ant R (36) 339 30.1% 2.72±2.07 
Superior temporal gyrus ant L (5) 342 30.4% 2.68±2.26 
Ventral cingulate subcallosal gyrus (63) 904 54.0% 2.56±1.73 
Anterior cingulate gyrus (64) 501 16.8% 1.86±1.82 
Dorsal anterior cingulate (66) 771 29.3% 2.09±1.60 
Medial orbital cortex R (48) 113 9.3% 1.69±2.80 
Medial orbital cortex L (17) 156 11.8% 1.65±2.64 
Lateral orbital cortex R (52) 199 8.8% 2.14±1.84 
Lateral orbital cortex L (21) 272 11.7% 2.09±1.57 
Precentral gyrus R (34) 324 7.8% 1.88±1.79 
Postcentral gyrus R (42) 102 3.7% 1.81±2.43 
Lingual gyrus R (55) 118 7.6% 2.16±2.47 
Midbrain (103) 699 77.0% 2.36±2.40 
Pons (104) 271 51.7% 1.99±2.37 
Medulla (105) 63 100% 3.73±3.92 
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Table 6.2: Localisation and FESC for FED > FASTED (voxel level p<0.001, 
cluster level pfwe-corr<0.05 
Data are reported for whole Cluster K (shown in bold) and for intersects between 
Cluster K and the modified Tziortzi atlas.  Intersects are reported if  ≥100 voxels 
AND/OR ≥25% of masked-in region in intersect (provided ≥10 voxels).  Co-ordinates 
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Table 6.3: FED<FASTED 
Cluster or 
Intersect between cluster and modified Tziortzi 




% of region 
(masked-in voxels) 
in intersect  
FESC all 
subjects  % 
(mean±SD) 
Cluster L: 5,079 voxels,  pfwe-corr<0.001,  
34 36 38mm (ant DLFC R), 46 10 36mm (post DLFC R), 26 60 -2mm (ant DLFC R) 
Whole Cluster L - - - -2.62±2.38 
Anterior DLFC R (33) - 2127 46.7% -2.77±2.65 
Posterior DLFC R (111) - 2298 41.5% -2.55±2.41 
Precentral gyrus R (34) - 273 6.6% -2.40±2.31 
Lateral orbital cortex R (52) - 202 8.9% -2.36±2.48 
Frontal operculum cortex R (60) - 126 41.7% -2.41±3.63 
Cluster M: 4,571 voxels,  pfwe-corr<0.001,  
-36 32 32mm (ant DLFC L), -44 6 34mm (post DLFC L), -26 28 50mm (post DLFC L), 
Whole Cluster M - - - -2.78±1.89 
Anterior DLFC L (2) - 1651 40.0% -2.76±2.27 
Posterior DLFC L (110) - 2323 42.2% -2.80±1.97 
Precentral gyrus L (3) - 310 7.2% -2.93±2.10 
Frontal operculum cortex L (29) - 157 45.4% -2.42±2.97 
Cluster N: 388 voxels,  pfwe-corr=0.001,  
4 30 36mm (dorsal ant cingulate), 2 16 46mm (dorsal ant cingulate), -4 38 26mm (anterior cingulate) 










Cluster P: 200 voxels,  pfwe-corr=0.022,  
52 -16 12mm (central operculum R) 
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continued Table 6.3: FED<FASTED 
Cluster or 
Intersect between cluster and modified Tziortzi 




% of region 
(masked-in voxels) 
in intersect  
FESC all 
subjects  % 
(mean±SD) 
Cluster O: 19,248 voxels,  pfwe-corr<0.001,  
44 -58 46mm (angular gyrus R), -2 -66 20mm (precuneus L), -10 -68 38mm (precuneus R) 
Whole Cluster O - - - -2.99±1.88 
Posterior cingulate gyrus (65) - 1297 53.6% -3.05±2.42 
Precuneus cortex R (50) - 1733 58.8% -3.39±2.46 
Precuneus cortex L (19) - 1955 63.0% -3.06±2.15 
Cuneus R (51) - 326 51.7% -3.03±3.52 
Cuneus L (20) - 254 45.2% -2.70±3.66 
Calcarine cortex R (47) - 478 45.9% -3.89±5.53 
Calcarine cortex L (16) - 385 43.1% -4.29±5.32 
Lingual gyrus R (55) - 350 22.7% -4.32±5.87 
Lingual gyrus L (24) - 528 36.6% -4.64±5.14 
Occipital pole R (46) - 1912 34.5% -2.99±3.22 
Occipital pole L (15) - 2221 41.1% -3.32±3.11 
Occipital fusiform gyrus R (59) - 103 12.3% -3.30±5.76 
Occipital fusiform gyrus L (28) - 188 21.5% -3.60±5.41 
Parietal lobule R (43) - 565 26.8% -2.89±2.49 
Parietal lobule L (12) - 792 39.2% -2.69±2.02 
Angular gyrus R (45) - 1456 59.6% -2.65±2.19 
Angular gyrus L (14) - 1261 62.4% -2.57±1.99 
Supramarginal gyrus R (44) - 669 31.5% -2.36±2.16 
Supramarginal gyrus L (13) - 453 21.5% -2.24±2.18 
Parietal operculum cortex L (31) - 121 22.0% -2.01±3.48 
Middle temporal gyrus post R (39) - 534 19.6% -1.89±2.17 
Middle temporal gyrus post L (8) - 627 25.0% -2.01±1.76 
Inferior temporal gyrus post R (41) - 268 14.8% -2.51±2.06 
Inferior temporal gyrus post L (10) - 335 18.8% -2.12±2.71 
Table 6.3: Localisation and FESC for FED<FASTED clusters (voxel level 
p<0.001, cluster level pfwe-corr<0.05). 
For clusters of  ≥500 voxels, data are reported for the whole cluster (shown in bold) 
and for intersects between the cluster and the modified Tziortzi atlas.  Intersects are 
reported if  ≥100 voxels AND/OR ≥25% of masked-in region in intersect (provided 
≥10 voxels).   
For clusters < 500 voxels, data are reported for the whole cluster (shown in bold).  
Intersects with the modified Tziortzi atlas are shown for localisation. (Intersects of 
<10 voxels are not reported.)   
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6.3.2 Regional differences in brain responses to food ingestion between NW, Ob 
and RYGBpl 
SPM analysis for interaction between fed state and group showed 10 clusters (clusters 
A-J, voxel level p<0.01, cluster size threshold 100 voxels).  The cluster map is shown in 
Figure 6.2 and localisation in Table 6.4.   The more stringent statistical threshold (voxel 
level p<0.001, cluster size threshold 100 voxels) showed three clusters corresponding to 
clusters C, F and G (cluster map shown in Figure 6.3).   
 
FESC for NW, Ob and RYGBpl for the ten clusters A-J identified in SPM as showing a 
difference between groups are shown in Figures 6.4, 6.5, and 6.6 and Table 6.4.  There 
were five difference patterns.  In clusters A (right anterior DLFC, anterior MFC, and 
medial OC), C (right anterior and posterior DLFC) and D (right frontal operculum, 
lateral OC, insula, anterior and posterior DLFC) there was a similar negative FESC in 
NW and RYGBpl, which was not seen in Ob (Figure 6.4).  In cluster B (left medial OC) 
there was a small negative FESC in NW, with small positive FESC in Ob and a larger 
positive FESC in RYGBpl (Figure 6.4).  In clusters E (hypothalamus) and F (pituitary) 
the positive FESC was larger in RYGBpl than NW or Ob with no difference between 
NW and Ob (Figure 6.5).    In clusters G, H and I (posterior cingulate gyrus, bilateral 
precuneus, cuneus (right), bilateral angular gyrus, bilateral occipital pole, right posterior 
superior temporal gyrus and right posterior middle temporal gyrus and left parietal 
lobule) there was a larger negative FESC in RYGBpl than both NW and Ob with either 
no difference between NW and Ob (clusters G and I) or larger negative FESC in NW 
than in Ob (cluster H) (Figure 6.6).  In cluster J (lingual gyrus) FESC was positive in 
NW and negative in Ob and RYGBpl with no difference between Ob and RYGBpl 
(Figure 6.6). 
 
6.3.3 Regional differences in brain responses to food ingestion between NW, Ob 
and RYGBpl adjusting for age 
When the SPM analysis for interaction between fed state and group was repeated with 
age at first scan included as a covariate, 13 clusters were identified (voxel level p<0.01, 
cluster size threshold 100 voxels).  The 13 clusters correspond to 9 of the 10 clusters 
identified in the analysis without age as covariate (Table 6.5). The only region not 
identified is cluster E (hypothalamus), and this was identified when the cluster size 
threshold was dropped to 90 voxels.  
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Table 6.4: Interaction fed state and group for NW, Ob, RYGBpl 
Cluster OR intersect between cluster and modified 
Tziortzi atlas region (Region name (region number))  
No of voxels 
in intersect 
% region (masked-
in) in intersect 
FESC (mean±SD) 
p values for post-hoc tests 
NW Ob RYGBpl 
Cluster A: 686 voxels, 10 68 -8mm (MOC R); 20 66 -10mm (MOC R); 26 60 -4mm (Ant DLFC R) 




Anterior dorsolateral frontal 
cortex (Ant DLFC) R (33) 




Anterior medial frontal 












Cluster B: 119 voxels, -20 30 -26mm (outside atlas); -12 44 -28mm (MOC L) 
Whole Cluster B 
Medial orbital cortex 
L (17) 




Cluster C: 1036 voxels, 46 30 32mm (PostDLFC R); 40 30 26mm (PostDLFC R); 44 20 38mm (PostDLFC R) 
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continued Table 6.4: Interaction fed state and group for NW, Ob, RYGBpl 
Cluster OR intersect between cluster and modified 
Tziortzi atlas region (Region name (region number))  
No of voxels 
in intersect 
% region (masked-
in) in intersect 
FESC (mean±SD) 
p values for post-hoc tests 
NW Ob RYGBpl 
Cluster D: 310 voxels, 36 34 -2mm (white matter); 36 26 -4mm (LOC R); 50 32 2mm (AntDLFC R) 
Whole Cluster D 
Lateral OC R (52) 72 3.2% 




Ant DLFC R (33) 71 1.6% 
Post DLFC R (111) 68 1.2% 
Frontal operculum R 
(60) 
64 21.2% 
Insular cortex R (32) 25 1.9% 
Cluster E: 154 voxels,  -2 -4 -18mm (hypothalamus); -14 2 -16mm (outside atlas) 









subcallosal gyrus (63) 
10 0.6% 
Cluster F: 130 voxels, -2 -2 -28mm (pituitary) 
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continued Table 6.4: Interaction fed state and group for NW, Ob, RYGBpl 
Cluster OR intersect between cluster and modified 
Tziortzi atlas region (Region name (region number))  
No of voxels 
in intersect 
% region (masked-
in) in intersect 
FESC (mean±SD) 
p values for post-hoc tests 
NW Ob RYGBpl 
Cluster G: 1692 voxels, (10 -72 36mm (precuneus R); 10 -36 38mm (posterior cingulate); 0 -42 42mm (posterior cingulate) 




Posterior cingulate gyrus 
(65) 
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continued Table 6.4: Interaction fed state and group for NW, Ob, RYGBpl 
Cluster H: 1103 voxels, (40 -64 42mm (angular gyrus R; 58 -52 0mm (middle temporal gyrus post R; 42 -70 24mm (occipital pole R) 








Superior temporal gyrus 
posterior R (37) 




Middle temporal gyrus 
posterior R (39) 








Cluster I: 813 voxels, -42 -70 42mm (angular gyrus L); -46 -54 42mm (angular gyrus L; -44 -72 18mm (occipital pole L) 
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continued Table 6.4: Interaction fed state and group for NW, Ob, RYGBpl 
Cluster OR intersect between cluster and modified 
Tziortzi atlas region (Region name (region number))  
No of voxels 
in intersect 
% region (masked-
in) in intersect 
FESC (mean±SD) 
p values for post-hoc tests 
NW Ob RYGBpl 
Cluster J: 163 voxels, -20 -64 -4mm (lingual gyrus L) 




Table 6.4: Localisation and FESC in clusters identified in SPM where the response to food ingestion is different between NW, Ob and 
RYGBpl (mixed ANOVA, voxel level p<0.01, cluster size threshold > 100 voxels).   
For clusters of  ≥500 voxels, data are reported for the whole cluster (shown in bold) and for intersects between the cluster and the modified Tziortzi 
atlas.  Intersects are reported if  ≥100 voxels AND/OR ≥25% of masked-in region in intersect (provided ≥10 voxels).   
For clusters < 500 voxels, data are reported for the whole cluster (shown and bold) and intersects with the modified Tziortzi atlas are shown (in 
column 2) for localisation. (Intersects of <10 voxels are not reported).  
Co-ordinates for clusters are 3 local maxima more than 8.0 mm apart.  
Post hoc comparisons (Fischers’s LSD) of FESC between the three groups are shown. 
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Table 6.5: Impact of including age as a covariate.  Interaction fed state and 
group for NW, Ob, RYGBpl without and with age as a covariate 
Without age as a covariate With age as a covariate 
Cluster Voxels Coordinates Voxels Coordinates 
Cluster A 686 10 68 -8 (MOC R) 
20 66 -10 (MOC R) 
26 60 -4 (AntDLFC R) 
262 10 66 -12 (MOC R) 
20 66 -10 (MOC R) 
6 58  4 (Ant MFC R) 
192 28 58 -4 (Ant DLFC R) 
38 52 -2 (Ant DLFC R) 
22 66 12 (Ant DLFC R) 
Cluster B 119 -20 30 -26 (outside atlas) 
-12 44 -28 (MOC L) 
123 -20 30 -26 (outside atlas) 
-12 46 -28 (MOC L) 
-16 42 -20 (MOC L) 
Cluster C 1036 46 30 32 (Post DLFC R) 
40 30 26 (Post DLFC R) 
44 20 38 (Post DLFC R) 
855 46 30 32 (Post DLFC R) 
40 30 26 (Post DLFC R) 
44 20 38 (Post DLFC R) 
Cluster D 310 36 34 -2 (white matter) 
36 26 -4 (LOC R) 
50 32 2 (Ant DLFC R) 
179 36 34 0 (white matter) 
36 26 -4 (LOC R) 
50 32 2 (Ant DLFC R) 
Cluster E 154 -2 -4 -18 (hypothalamus) 
-14 2 -16 (outside atlas) 
93 -2 -4 -18 (hypothalamus) 
Cluster F 130 -2 -2 -28 (pituitary) 130 -2 -2 -28 (pituitary) 
Cluster G 1692 10 -72 36 (precuneus R) 
10 -36 38 (posterior cingulate) 
0 -42 42 (posterior cingulate) 
1482 10 -72 34 (precuneus R) 
10 -50 36 (precuneus R) 
10 -36 38 (posterior cingulate) 
 
Cluster H 1103 40 -64 42 (angular gyrus R) 
42 -70 24 (occipital pole R) 
58 -52 0 (middle temporal 
gyrus post R) 
 
469 40 -64 43 (angular gyrus R) 
36 -64 50 (angular gyrus R) 
42 -70 24 (occipital pole R) 
429 54 -60 22 (angular gyrus R) 
58 -52 0 (middle temp gyrus post 
R) 
50 -46 14 (middle temp gyrus post 
R)  
106 62 -28 -6 (middle temp gyrus post 
R) 
58 -18 -12 (middle temp gyrus post 
R) 
Cluster I 813 -42 -70 42 (angular gyrus L) 
-46 -54 42 (angular gyrus L) 
-44 -72 18 (occipital pole L) 
563 -42 -70 42 (angular gyrus L) 
-46 -52 44 (angular gyrus L)  
-30 -70 42 (occipital pole L) 
108 -44 -74 18 (occipital pole L) 
-40 -66 4 (occipital pole L) 
-40 -74 30 (occipital pole L) 
Cluster J 163 -20 -64 -4 (lingual gyrus L) 141 -20 -62 -6 (lingual gyrus L) 
Table 6.5: Impact of including age at first scan as a covariate.   
Clusters identified in SPM where the response to food ingestion is different between 
NW, Ob and RYGBpl without and with age as a covariate (mixed ANOVA, voxel 
level p<0.01, cluster size threshold > 90 voxels).  Co-ordinates for clusters are 3 local 
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Table 6.6: Impact of using a mask with amygdala and hippocampus masked-in.  
Interaction fed state and group for NW, Ob, RYGBpl 
Mask with pituitary & hypothalamus 
masked in 
Mask with pituitary, hypothalamus, 
amygdala & hippocampus masked-
in 
Cluster Voxels Coordinates Voxels Coordinates 
Cluster A 686 
10 68 -8 (MOC R) 
20 66 -10 (MOC R) 
26 60 -4 (AntDLFC R) 
687 
10 68 -8 (MOC R) 
20 66 -10 (MOC R) 
26 60 -4 (AntDLFC R) 
Cluster B 119 
-20 30 -26 (outside atlas) 
-12 44 -28 (MOC L) 
119 
-20 30 -26 (outside atlas) 
-12 44 -28 (MOC L) 
Cluster C 1036 
46 30 32 (Post DLFC R) 
40 30 26 (Post DLFC R) 
44 20 38 (Post DLFC R) 
1036 
46 30 32 (Post DLFC R) 
40 30 26 (Post DLFC R) 
44 20 38 (Post DLFC R) 
Cluster D 310 
36 34 -2 (white matter) 
36 26 -4 (LOC R) 
50 32 2 (Ant DLFC R) 
308 
36 34 -2 (white matter) 
36 26 -4 (LOC R) 
50 32 2 (Ant DLFC R) 
Cluster E 154 
-2 -4 -18 (hypothalamus) 
-14 2 -16 (outside atlas) 
190 
-2 -4 -18 (hypothalamus) 
6 0 -22 (amygdala R) 
-14 2 -16 (outside atlas) 
Cluster F 130 -2 -2 -28 (pituitary) 130 -2 -2 -28 (pituitary) 
Cluster G 1692 
10 -72 36 (precuneus R) 
10 -36 38 (posterior cingulate) 
0 -42 42 (posterior cingulate) 
1685 
10 -72 36 (precuneus R) 
10 -36 38 (posterior cingulate) 
0 -42 42 (posterior cingulate) 
Cluster H 1103 
40 -64 42 (angular gyrus R) 
42 -70 24 (occipital pole R) 
58 -52 0 (middle temporal 
gyrus post R) 
550 
40 -64 42 (angular gyrus R) 
42 -70 24 (occipital pole R) 
50 -68 4 (occipital pole R) 
551 
58 -52 0 (middle temp gyrus post 
R) 
60 -26 -40 (superior temp gyrus 
post R) 
54 -60 20 (angular gyrus R) 
Cluster I 813 
-42 -70 42 (angular gyrus L) 
-46 -54 42 (angular gyrus L) 
-44 -72 18 (occipital pole L) 
816 
-42 -70 42 (angular gyrus L) 
-46 -54 42 (angular gyrus L) 
-44 -72 18 (occipital pole L) 
Cluster J 163 -20 -64 -4 (lingual gyrus L) 162 -20 -64 -4 (lingual gyrus L) 
Table 6.6: Impact of using a mask with amygdala and hippocampus masked-in  
Clusters identified in SPM where the response to food ingestion is different between 
NW, Ob and RYGBpl using a mask without and with amygdala and hippocampus 
masked-in (mixed ANOVA, voxel level p<0.01, cluster size threshold > 100 voxels).  
Co-ordinates for clusters are 3 local maxima more than 8.0 mm apart and are 
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6.3.4 Regional differences in brain responses to food ingestion between NW, Ob 
and RYGBpl masking-in amygdala and hippocampus 
When the SPM analysis for interaction between fed state and group was repeated using 
a mask with the amygdala and hippocampus masked-in, 11 clusters were identified 
(voxel level p<0.01, cluster size threshold 100 voxels).  The 11 clusters correspond to 
the 10 clusters identified in the analysis without amygdala and hippocampus masked-in 
(Table 6.6). A small part of cluster E (hypothalamus) appears to extend into the right 




6.4.1 Regional brain responses to food ingestion across all subjects 
6.4.1.1 Responses in brain regions known to be involved in appetite control 
Across all subjects, food ingestion was associated with extensive changes in brain 
regions known to be involved in regulation of food intake and identified in previous 
functional neuroimaging studies investigating response to food ingestion in normal 
weight individuals (section 1.6.2).  The direction of signal change often contrasts with 
previous studies and this is discussed further below. 
 
FDG uptake increased in hypothalamus and the medulla which receive and process 
signals relating to food ingestion and circulating nutrients (sections 1.1.3.1, 1.1.8.1 and 
1.4.1; region location shown in Figure 1.3).  Previous functional neuroimaging studies 
have fairly consistently (although not universally) shown evidence of reduced blood 
flow in hypothalamus after food ingestion both using [15O]-H2O-PET to image response 
to a mixed meal (section 1.6.2.1) [150-152] or  BOLD-fMRI, focussed on hypothalamus 
or midsagittal sections, to image response to glucose ingestion (section 1.6.2.3) [133, 
134, 158, 159]. Only one previous study reported increased BOLD-fMRI signal in 
hypothalamus after enteral nutrient [162], and this looked at response to delivery of fat 
via oro-gastric tube in non-obese subjects and generated findings inconsistent with all 
other studies and thus should be viewed with some caution (section 1.6.2.4).  Most 
studies have not reported differences in the brainstem, although many may not include 
the brainstem either explicitly in ROI studies or by virtue of not including it in the brain 
mask. However, one study reported reduced [15O]-H2O-PET signal after mixed meal 
ingestion across normal weight and obese subjects [153] and another, which as noted 
185 
 
KF Hunt.   Chapter 6: Regional brain responses to food ingestion and difference between groups 
above should be viewed with caution, reported increased BOLD-fMRI signal after 
delivery of fat via oro-gastric tube [162]. 
 
FDG uptake increased in the bilateral temporal thalamus.  The thalamus relays sensory 
signals to cortical areas and also relays information between cortical areas [242].  
Previous studies on response to nutrient ingestion have found decreased [15O]-H2O-PET 
signal [152-154] and BOLD-fMRI signal [160] in the thalamus.  It should be noted that 
the latter study found similar patterns in all identified clusters, and did not include 
control ROIs, raising the possibility that this may be a global effect of calorie ingestion 
and thus should be viewed with caution (section 1.6.2.4).  One study found increased 
BOLD-fMRI signal in the thalamus, and as discussed above this should be viewed with 
caution [162].  
 
FDG uptake increased in regions involved in reward (section 1.4.2; region location 
shown in Figures 1.3 and 1.4) including midbrain, nucleus accumbens (ventral 
striatum), globus pallidus, insula, amygdala, hippocampal formation, medial and lateral 
OC, ACC and ventral cingulate subcallosal gyrus. Most of these regions have 
previously been shown to respond to food ingestion in human neuroimaging studies, 
usually decreased signal (section 1.6.2): midbrain, decreased signal [153, 154] and 
increased signal [162]; nucleus accumbens/ventral striatum decreased signal [150]; 
insula/operculum, decreased signal [150-154, 160] and increased signal [150]; 
amygdala, decreased signal, both used ROI analysis [151, 160]; hippocampal formation, 
decreased signal [152-154, 160] and increased signal [154];  OC, decreased signal [152, 
154, 160] and increased signal [151-154]; ACC, decreased signal [152] and increased 
signal [154]; and ventral cingulate subcallosal gyrus, decreased signal (of note this was 
the largest cluster in this study in extent and magnitude) [154].  I also found increased 
FDG uptake in bilateral globus pallidus which has not been previously identified in 
response to food ingestion studies.  There is some evidence that the globus pallidus may 
have a role in food reward especially in relation to odour/taste: it has been shown to 
respond to food odour heralding taste [141]; to have an increased response in men to 
taste of chocolate milk versus nothing when satiated with chocolate versus fasted [148] : 
and, as part of  the lentiform nucleus, to respond to taste of sucrose versus water in the 
fasted state [149].  There is also some evidence of a different response in the globus 
pallidus to food cues between obese and normal weight people [37, 170, 186].  I did not 
find convincing differences in dorsal striatum (only in left posterior caudate).  This is in 
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contrast to previous studies, many of which found differences in dorsal striatum after 
food ingestion [152-154, 157, 160, 162].  One possible explanation for this discrepancy 
is that the caudate was poorly included in the mask used in my study (chapter 4). 
 
FDG uptake decreased in frontal operculum, right lateral OC and ACC.  Note that there 
were also areas of increased FDG uptake in insula, lateral OC and ACC as discussed 
above.  This finding of responses in different directions within a region in a single study 
have been observed previously in insula/operculum [150]; OC [152, 154] and also in 
hippocampal formation [154] suggesting the responses to food ingestion in these 
regions may be complex. 
 
FDG uptake decreased in bilateral anterior and posterior DLFC, involved in inhibitory 
control (section 1.4.3; region location shown in Figure 1.5).  Only five studies looking 
at response to food ingestion used approaches that could identify differences in DLFC, 
two finding increased [15O]-H2O-PET signal [152, 154] and three not finding 
differences [150, 153, 162].   
 
It is noticeable that the direction of signal change after food ingestion in my study was 
almost always opposite to that in other studies.  The most obvious difference in my 
study is the use of a different surrogate of brain activity: glucose metabolism for FDG-
PET versus blood flow for [15O]-H2O-PET [150-154] and BOLD-fMRI [133, 134, 158-
160, 162] (section 1.5.1).  There are no other protocol issues that are consistently 
different between my study and the majority of other studies such as timing of imaging 
after food ingestion, duration of fast, nature of the meal, size of meal, or gender of 
participants.   It noteworthy that direction of change of a signal may be different even 
between neuroimaging modalities purportedly representing the same surrogate (section 
1.6.1.3).  The direction of change in a neuroimaging signal does not necessarily 
translate simply into direction of functional change.  For example reduced FDG uptake 
in response to food ingestion in DLFC described above does not necessarily mean less 
inhibition and could, for example, reflect less activity in stimulatory neurons.  This 
emphasises the difficulty in interpreting direction of change between neuroimaging 
modalities and paradigms, the importance of including a normal control group and, if 
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The consistency of these regions with those identified in previous functional 
neuroimaging studies in normal weight individuals investigating response to food 
ingestion demonstrates the utility of FDG-PET in imaging responses to food ingestion.   
 
6.4.1.2 Responses in brain regions not conventionally associated with appetite control   
There was increased FDG uptake across the temporal lobes which was unexpected.  
However, differences in the temporal lobes, often bilateral, after food ingestion have 
been reported in a number of studies: anterior temporal cortex [152]; middle temporal 
gyrus [153, 154, 162]; and inferior temporal gyrus [154].  All showed reduced signal 
after food ingestion except Lassman et al [162], and as noted before this study should be 
viewed with some caution.  Anterior temporal lobe, which includes superior, middle and 
inferior temporal gyri, the temporal pole, rhinal cortex, fusiform gyrus and 
parahippocampal gyrus, is involved in semantic or conceptual memory [243].   
 
There was decreased FDG uptake in a large posterior cluster which was unexpected.  
This cluster is centred on posterior cingulate gyrus and precuneus, extending bilaterally 
to parietal lobule, angular gyrus, supramarginal gyrus, posterior temporal gyri and 
posterior operculum and posteriorly to calcarine cortex, lingual gyrus, occipital pole and 
occipital fusiform gyri (location of some of these regions shown in Figure 6.7).  On 
reviewing the literature, several other studies have reported differences in response to 
food ingestion (usually decreased signal) in normal weight and/or obese people in 
precuneus and/or posterior cingulate cortex and sometimes lateral parietal cortex and 
other posterior regions, although these responses  are usually not discussed further in 
the papers  [152, 153, 162, 191] and Batterham et al reported decreased BOLD signal in 
angular gyrus with PYY [206]. Posterior cingulate cortex, precuneus and lateral parietal 
cortex show functional connectivity with the hippocampal formation and are associated 
with recollection of prior experience  [244] and one interpretation is that this response to 
food ingestion is related to recollection of past food experience. However, these regions 
also correspond to one of the subdivisions of the ‘default mode network’ (DMN) [245].  
This network was first identified in PET neuroimaging studies as showing reduced 
activity when performing a variety of attention demanding, goal-directed tasks 
compared to the resting state [246, 247] and subsequent resting state functional 
connectivity analyses have shown coherent fluctuations in BOLD-fMRI signal across 








Figure 6.7:  Diagram showing location of posterior cingulate cortex (PCC), 
precuneus, cuneus and angular gyri.  
Verticofrontal, sagittal, and axial sections are shown with cross-hairs at x=-5mm, y=-
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unclear.  Hypotheses have included spontaneous cognition (or daydreaming/mind 
wandering); constructing and maintaining an operational model of the world; 
unconscious attention; impulsivity; and functional integration, with evidence of a 
structural core or hub of cortico-cortical axonal pathways centred on posterior elements 
of DMN [245].  The DMN is considered to have three major subdivisions:   posterior 
cingulate cortex, precuneus and lateral parietal cortex (approximately Brodmann area 39 
in angular gyrus); ventral medial prefrontal cortex; and dorsal medial prefrontal cortex 
[245].  Although in my study there was clear evidence of reduced FDG uptake in 
regions corresponding to the posterior subdivision of DMN, there were no differences 
identified in MFC.  However, other studies have also shown variable dissociation of 
suppression of activity in different subdivisions of DMN depending on the nature of the 
task. For example decreased activity in ventromedial prefrontal cortex during a task is 
influenced by emotional state (summarised in [245].  Considering these regions as part 
of DMN, a simple interpretation of the decreased signal is that food ingestion is a ‘task’ 
for the brain.   
 
6.4.2 Differences in regional brain responses to food ingestion between normal 
weight, obese and post-RYGB 
There were differences between NW, Ob and RYGBpl in the brain’s response to 400 
kcal meal ingestion in hypothalamus, pituitary, right DLFC, right anterior MFC, right 
frontal operculum/lateral OC, bilateral medial OC and regions corresponding to the 
posterior subdivision of DMN.  Location of these regions is shown in Figures 1.3, 1.4, 
1.5, and 6.7). No differences were identified in other parts of the reward network 
including ventral and dorsal striatum, globus pallidus, amygdala and hippocampus, even 
when amygdala and hippocampus were masked-in.   
 
6.4.2.1 Hypothalamus and pituitary 
In hypothalamus and pituitary there was exaggerated activation in RYGBpl compared to 
both NW and Ob, with no difference between NW and Ob.  As discussed above (section 
6.4.1.1) hypothalamus receives and processes signals relating to food ingestion and 
circulating nutrients and has been shown to respond to nutrient ingestion. The 
exaggerated response in RYGBpl is consistent with ingestion of the same 400 kcal meal 
resulting in a greater physiological signal to hypothalamus, and thus the brain, after 
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The only previous study looking at brain responses to nutrient (glucose) ingestion after 
RYGB, a BOLD-fMRI study analysed using temporal clustering analysis, also found a 
difference in hypothalamic response between pre-RYGB and post-RYGB [204] (section 
1.8.3).  However, in contrast to my data they found the post-RYGB and normal weight 
responses to be similar and the pre-RYGB (i.e. obese) and normal weight responses to 
be different.  An fMRI study including only hypothalamus also found differences in 
response to glucose ingestion between obese and normal weight subjects, with the 
BOLD response being attenuated and delayed in the obese in one quadrant of 
hypothalamus [133].   However, consistent with my data, two [15O]-H2O-PET studies 
from the same group did not find differences (using whole brain analysis) in 
hypothalamus in response to consumption of a liquid meal after a 36 h fast [192, 193].  
There are a number of differences between studies that might account for these 
discrepancies.  In both fMRI studies [133, 204], analysis focussed on the time course of 
the response, whereas FDG-PET imaging and analysis integrates FDG uptake and is 
therefore insensitive to time course.  The study by Matsuda et al focussed on 
hypothalamus and found differences in one quadrant.  It is unlikely that PET imaging, 
given its lower resolution (section 1.5.1), would detect differences in such a small area 
particularly using whole brain analysis.  There were also differences in the duration of 
the fast, the stimulus used (oral glucose versus mixed meal) and the time after RYGB 
(subjects were re-scanned at about 6 months post-RYGB in van de Sande-Lee [204] 
whereas in my study subjects were 18±13 months post RYGB). 
 
In studies looking at brain responses to external food cues, although hypothalamus does 
respond to external food cues [135] (section 1.6.1.1), generally no differences have been 
identified after RYGB (section 1.8.2) or between obese and normal weight subjects 
(section 1.7.2).  My finding a difference after RYGB may relate to the difference in the 
stimulus – i.e. response to food ingestion rather than response to external food cue. 
 
The findings of differences in pituitary, which survive stringent statistical thresholds, 
are initially unexpected.  To my knowledge no other neuroimaging studies have 
reported differences in pituitary either in response to food ingestion per se (or to 
external food cues) or between groups.  However, most whole brain masks do not 
include pituitary whereas in this study pituitary was masked-in (chapter 4). Pituitary and 
hypothalamus are closely linked: hypothalamic hormones are released into the 
hypophyseal portal system and control the release of anterior pituitary hormones [248].  
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The arcuate nucleus of hypothalamus (which contains the orexigenic NPY/AgRP and 
the anorexigenic POMC/CART neurons) also contain growth hormone releasing 
hormone (GHRH) and luteinizing hormone-releasing hormone (LHRH) neurons.   
NPY/AgRP and POMC/CART neurons project to the paraventricular nucleus (PVN) of 
hypothalamus which contains corticotrophin-releasing hormone (CRH) and thyrotropin-
releasing hormone (TRH) neurons.  Post meal increases in anterior pituitary hormone 
concentrations have been described.  It therefore seems reasonable for pituitary activity 
to reflect hypothalamic activity.  
 
6.4.2.2 Right DLFC 
In right anterior and posterior DLFC there was similar deactivation in NW and RYGBpl 
that was not seen in Ob. This is seen in the large cluster C, which survives stringent 
statistical thresholds, and also in DLFC component of Cluster A and in cluster D which 
includes voxels localised to right DLFC.  As discussed above (section 6.4.1.1), DLFC is 
associated with inhibitory control (‘stop’) and has been shown to respond to nutrient 
ingestion.  This pattern is consistent with loss of the normal ‘stop eating’ signal in 
obesity being restored to normal after RYGB.   
 
Consistent with my findings in NW and Ob, 2 [15O]-H2O-PET studies from the same 
group found an attenuated post-meal (versus pre-meal) response in the obese versus 
normal weight in DLFC [156, 192, 193].  Note they found an increase in [15O]-H2O-
PET signal post-meal (compared to pre-meal) in normal weight whereas I found a 
decrease in FDG-PET uptake in FED versus FASTED and this is addressed above 
(section 6.4.1.1).  Interestingly Le et al found that in women with sustained non-surgical 
volitional weight loss, the [15O]-H2O-PET signal response post-meal in the inferior 
frontal gyrus was similar to normal weight (whereas it was attenuated in the obese) 
[193] suggesting restoration of the normal response in DLFC is a feature of weight loss. 
The only previous study looking at brain responses to nutrient (glucose) ingestion after 
RYGB did not find differences in DLFC between normal weight, pre-RYGB and post-
RYGB subjects [204] (section 1.8.3).  However, there are data suggesting restoration of 
DLFC response to external food cues (rather than food ingestion) after successful 
RYGB: DLFC does respond to external food cues in normal weight subjects (section 
1.6.1), the response is different (usually increased) in obesity (section 1.7.2.1) and there 
is evidence of reduced responses post-RYGB, versus pre-RYGB, to high ED food cues 
(section 1.8.2.1) [82, 200].  However, unlike my study, none of those that showed 
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differences in DLFC after RYGB included a normal weight control group which would 
help confirm this hypothesis of restoration of normal response after RYGB,   The 
reduced response after RYGB has been explained as post-RYGB reduction in food 
motivation necessitating a lower requirement for inhibitory control (section 1.8.2.3).    
Goldman et al found that in post-RYGB subjects instructed to resist craving, those with 
more successful weight loss (versus those with less successful weight loss) had greater 
activation in response to high ED food pictures versus non-food pictures in left DLFC 
[203].  This has been interpreted as greater ability to mobilise inhibitory control when 
needed.   
 
Whether these differences in DLFC are a feature of people with an ability to lose weight 
successfully (whether inherent or a consequence of RYGB) or are secondary to weight 
loss cannot be concluded from these studies.   
 
6.4.2.3 Right anterior medial frontal cortex (MFC)  
Cluster A includes anterior MFC along with anterior DLFC and medial OC.  Anterior 
MFC shows a DLFC-like response pattern with deactivation in NW and RYGBpl that 
was not seen in Ob. Anterior MFC receives information from the external and internal 
environment via OC and conveys this information to hypothalamus, amygdala and 
midbrain and is thought to have a role in external and internal sensations influencing 
social behaviour, mood and motivation [245].  My data would be consistent with 
restoration of normal function after RYGB. However, anterior MFC is also one of the 
components of the default mode network [245] discussed further in section 6.4.2.6.  
 
Previous studies have shown increased 2 [15O]-H2O-PET signal in MFC post-meal in 
normal weight people [153, 154] but the few studies investigating response to food 
ingestion in obesity or after RYGB have not shown a difference in MFC.   However, 
response to food cue (rather than food ingestion) studies are consistent with altered 
function in MFC in obesity and restoration of function after RYGB, although, unlike my 
study, none of those showing a difference contained all three groups. Several studies in 
normal weight subjects have shown increased BOLD signal to high ED food cues   [37, 
137, 138, 149].  A meta-analysis [170] and several other studies [25, 37, 174, 190] have 
shown increased response to food cues in MFC in the obese,  who also do not show the 
post-meal attenuation seen in normal weight subjects [148, 189].  Finally Ochner et al 
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[82] found reduced BOLD signal to high versus low ED food cues after versus before 
RYGB in the fasted state.  
 
6.4.2.4 Frontal operculum/lateral OC 
Cluster D includes right frontal operculum and lateral OC as well as anterior and 
posterior DLFC (section 6.4.2.2).  Frontal operculum contains the primary gustatory 
cortex [125] and, along with anterior insula, has been shown to respond to aliquots of 
liquid food in the mouth (section 1.6.1.2) [125, 140-142].  Consistent with my findings, 
several studies found clusters spanning anterior operculum/insula and posterior lateral 
OC [125, 140, 142] which some authors suggest might represent an anterior extension 
of the primary gustatory cortex.  
 
The response pattern in frontal operculum/lateral OC was similar deactivation in NW 
and RYGBpl that was not seen in Ob (similar to DLFC).  These data could be 
interpreted as taste being attenuated in obesity and restored after RYGB and would be 
consistent with data from clinical studies suggesting that taste processing is altered after 
RYGB (reviewed in [71, 72]).    
 
Although several studies have found response to food ingestion in the operculum/insula 
in normal weight subjects (section 1.6.2), previous studies have not identified 
differences in response to food ingestion either between obese and normal weight 
subjects [192, 193, 204] or after RYGB [204].  However, several studies have shown 
positive differences in the response to aliquots of food in the mouth in the 
operculum/insula in obese versus normal weight subjects (section 1.7.2.3) [176, 180, 
182, 185, 186]. To my knowledge, no studies have looked at responses to aliquots of 
food in the mouth after RYGB.  Consistent with restoration of function in the 
operculum/insula after RYGB, several studies have shown positive difference in 
response to high ED food versus non-food or low ED food pictures in the obese versus 
normal weight in the operculum/insula [37, 178, 181] (although a metaanalysis found a 
negative difference [170]) and Ochner et al found reduced BOLD responses after 
RYGB, versus before RYGB, in insula (low ED>non-food, fed state [200]; high>low 
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6.4.2.5 Medial orbital cortex (OC) 
In left medial OC there was decreased FDG uptake in the fed state in NW, minimal 
response in Ob and increased FDG uptake in RYGBpl.  The right medial OC 
component of Cluster A shows decreased FDG uptake in NW and minimal response in 
Ob and RYGB which is a different pattern to the anterior DLFC and MFC components 
(Table 6.4).  As FESC is calculated from average voxel values, such a pattern could be 
produced by some voxels in right medial OC component of cluster A having a response 
pattern similar to left medial OC and others similar to DLFC, perhaps reflecting that the 
process used to divide the cluster is based on an anatomical atlas and this may not 
necessarily correspond to function.   
 
OC is thought to encode reward value or salience [125].  The pattern seen in left medial 
OC could be consistent with a pleasant sensation after eating in NW, minimal impact in 
Ob and an unpleasant sensation in RYGBpl.   
  
Studies in normal weight subjects have shown a response to food ingestion in OC, both 
increased [15O]-H2O-PET signal (section 1.6.2.1) [151-154] and decreased [
15O]-H2O-
PET signal [152, 154] and BOLD signal [160] with some evidence that the direction of 
response may be different in different parts of OC [152, 154].  The only previous study 
looking at brain responses to nutrient (glucose) ingestion after RYGB also found 
differences in OC [204] (section 1.8.3).  Although the exact nature of OC response is 
not reported, it is interesting that they found the response in post-RYGB was different 
from both pre-RYGB and NW which were also different and that this pattern was 
different from other regions where a difference was found, both similar to my findings.   
Two other studies comparing response to food ingestion between normal weight and 
obese subjects did not find differences in [15O]-H2O-PET signal in OC in response to 
consumption of a liquid meal after a 36 h fast [192, 193].  However, the meal size was 
50% resting energy expenditure (REE), and therefore meals were larger for obese 
versus normal weight subjects (females 885 versus 641 kcal; males 954 versus 725 
kcal). When they compared the impact of 50% REE versus a 600 kcal fixed meal they 
found differences in OC in obese, but no differences in normal weight subjects [192].  It 
could be inferred from this that the response to a fixed meal would be different between 
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Studies looking at response to food cues have generally not identified differences in OC 
in obese versus normal weight subjects (section 1.7.2).  However, three studies have 
shown a difference in obese or obesity prone people in the impact of fed state on the 
response to food cues in OC [174, 189, 190]. In one study this difference was visualised 
as no impact of fed state on response to high ED food cues in the obese whereas in 
normal weight subjects the response to high ED food cues was attenuated post-meal 
[174] which would be consistent with my data showing no impact of fed state on OC 
function in the obese. Only one of the post-RYGB response to food cue studies found a 
significant difference in OC: using a ROI analysis, the response in post-RYGB was less 
positive than post-band and obese for all food, high ED, and low ED versus non-food 
cues (although not all significant) [84] supporting my findings that OC function is 
different after RYGB, and additionally suggesting this difference is not secondary to 
weight loss.  However, as this study did not include a normal weight control group it is 
not possible to conclude whether the response is more or less like the normal response.  
 
Further support for difference in OC function after RYGB comes from a study showing 
differences in a resting state connectivity between OC, superior frontal gyrus and ACC, 
with stronger connectivity in obese than normal weight and post-RYGB which were 
similar [23]. 
 
6.4.2.6 Regions mapping to posterior default mode network (DMN) 
Clusters G, H and I map to the posterior subsection of DMN described above (section 
6.4.1.2).  Cluster G, which survives very stringent statistical thresholds, includes 
posterior cingulate and precuneus, the defining components of posterior DMN [245].  
Clusters H and I include right and left angular gyrus respectively with SPM-generated 
local maxima mapping to Brodmann Area 39, also considered key components of 
posterior DMN [245].  Note there were also differences in right anterior MFC 
(discussed in section 6.4.2.3) one of the anterior components of DMN [245].  
 
In clusters corresponding to posterior DMN, there was exaggerated deactivation in 
response to food ingestion in RYGBpl compared to NW and Ob.  The deactivation in 
NW and Ob was either similar, or was attenuated in Ob versus NW.   This could be 
interpreted as more intense recollection of past food experience in response to food 
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One previous study fMRI specifically looked for differences in posterior DMN in the 
obese in the resting state, finding greater activity in posterior aspects of DMN in obese 
compared to lean with activity correlated with appetite in left lateral parietal cortex but 
not posterior cingulate [167] 
 
Previous studies have not identified differences in response to food ingestion between 
obese and normal weight subjects in regions mapping to posterior DMN [192, 193, 204] 
and this is consistent with my data given that any differences are subtle.  However, in 
contrast to my data, van de Sande-Lee did not find differences in DMN regions in post-
RYGB subjects, although this study was very different in terms of stimulus (pure 
glucose versus ice-cream), neuroimaging (fMRI versus FDG-PET), analysis (based on 
time course of response versus magnitude of integrated response) and time post-surgery 
(8 months versus 18±13 months) [204].  However interestingly Ochner et al identified 
reduced responses in precuneus to high versus low ED food cues in post-RYGB, 
compared to pre-RYGB, in 2 separate cohorts [82, 200] and Frank et al found lower 
BOLD-fMRI signal (irrespective of food cue) in precuneus in post-RYGB versus obese 
[202]. 
 
6.4.2.7 Lingual gyrus 
There was a cluster in left lingual gyrus where the response to food ingestion was 
different between groups, with increased FDG uptake in normal weight, and similar 
decrease in Ob and RYGBpl.  Lingual gyrus is involved in visual processing, especially 
of complex images.  Lingual gyrus is not conventionally associated with appetite 
control and has not been specifically identified in response to food ingestion in normal 
weight or obese subjects (although several have identified regions in occipital cortex 
[153, 154, 191]) or in studies comparing response to nutrient ingestion between normal 
weight and obese or after RYGB, although again occipital cortex has been identified in 
both comparisons [191, 204].   The cluster is unilateral, relatively small and did not 
survive the more stringent statistical threshold.  It is important to avoid over interpreting 
unexpected findings in neuroimaging studies, unless very convincing, due to the risk of 
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6.4.3 Potential confounders in the three group analysis 
Other than the intended differences in BMI and RYGB status, there were differences 
between the three groups and it is possible that these differences impacted on the 
results.  
 
6.4.3.1 Impact of differences in age of participants between groups  
Mean age was higher in RYGB compared to NW and Ob, although there was 
considerable overlap between groups (Chapter 3).  There is some evidence that age may 
impact on appetite regulation and/or functional neuroimaging per se [249] and therefore 
the neuroimaging analysis of difference in response to food ingestion between NW, Ob 
and RYGBpl was repeated including age at first PET scan as a covariate with no 
important impact on the results.  The smaller cluster sizes, the splitting of clusters (such 
that several clusters in the analysis including age as a covariate correspond to 1 larger 
cluster without age as a covariate)  and 1 cluster (E) dropping below the 100 voxel 
cluster size threshold are all consistent with loss of power from including an additional 
variable in the analysis.  It therefore appears that age is not an important confounder in 
this study.   
 
6.4.3.2 Impact of differences in glucose  
Postprandial hypoglycaemia is a recognised complication of RYGB [101].  It was 
important to avoid hypoglycaemia to avoid the associated brain responses and this was 
achieved (section 5.3.4.1).  There was only one visit where VPG fell below 3 mmol/l, 
and this was for 7 min, lowest VPG 2.9 mmol/l (note this is venous which is lower than 
arterial).  The participant was asymptomatic for hypoglycaemia.  Two of the 9 RYGB 
subjects required IV glucose to avoid hypoglycaemia at FED visits. The maximum 
amount infused was 63 ml 20% glucose which contains 12.6 g glucose (42 kcal). It is 
therefore unlikely that either hypoglycaemia, or the glucose infused to avoid 
hypoglycaemia, would account for differences between groups in neuroimaging data. 
 
Endogenous glucose competes with FDG for uptake, and therefore with higher glucose 
concentrations FDG uptake will be reduced.  Global differences in FDG 
uptake/availability between conditions and subjects are factored out by intensity 
normalisation within SPM neuroimaging analysis (section 2.7.3.1).  However, it is 
possible this may not be reliable at extremes of blood glucose or might have varying 
impact across brain regions.  There was no difference between groups in impact of 400 
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kcal meal on mean VPG or on mean VPG irrespective of fed state (section 5.3.4.1). 
However, there was a greater increase in VPG range in FED compared to FASTED in 
RYGBpl compared to both NW and Ob, largely due to a greater increase in highest 
VPG in RYGBpl (section 5.3.4.1).  However, the highest VPG was 7.9 mmol/l, which 
would not be regarded as extreme.  The theoretical impact of blood glucose levels 
across brain regions has been shown by my colleague Dr Joel Dunn [250].  However, 
that study did not investigate the impact on uptake per se. Dr Dunn performed a similar 
simulation of the effect of rising glucose levels from 4 to 7.9 mmol/l (the highest VPG 
recorded in my subjects) and found that the effect on FDG uptake would be expected to 
be very similar across the brain.  For example, regions with a 25% difference in 
metabolic rate for glucose would show the same effect on FDG uptake to within 0.1%.  
The largest food-evoked signal change was 15% and therefore differences in glucose 
excursion are unlikely to account for the differences in normalised regional FDG uptake 
between conditions and groups. 
 
6.4.3.3 Impact of differences in relaxedness scores between groups 
Relaxedness scores were higher before scanning in RYGBpl versus NW and Ob 
(sections 5.3.2.5 and 5.4.2.3).  However, there was no interaction between fed state and 
group, and no impact of fed state, on relaxedness scores and therefore it seems unlikely 
that this would impact on the brain responses to food ingestion findings or the 
difference in brain responses to food ingestion between groups. 
  
6.4.3.4 Impact of scan order  
Scan order can impact on neuroimaging results [221]; and therefore subjects underwent 
a dummy scan before their first real scan and visits were performed in random order as 
described in section 2.5.1. The actual visit order was well balanced (section 6.2.2) 
therefore the difference between FED and FASTED and the difference between groups 




Across all subjects, food ingestion was associated with extensive changes in FDG 
uptake in brain regions known to be involved in regulation of food intake.  FDG uptake 
increased in: hypothalamus and medulla; temporal thalamus; and regions involved in 
reward including midbrain, nucleus accumbens (ventral striatum), globus pallidus, 
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insula, amygdala, hippocampal formation, medial and lateral OC, ACC and ventral 
cingulate subcallosal gyrus.  FDG uptake decreased in bilateral anterior and posterior 
DLFC.  There was both increased and decreased FDG uptake in insula/frontal 
operculum, lateral OC and ACC.  The consistency of these regions with those identified 
in previous functional neuroimaging studies investigating response to food ingestion in 
normal weight individuals demonstrates the utility of FDG-PET in imaging responses to 
food ingestion.  The direction of signal change was often different to previous studies 
emphasising the difficulty in interpreting direction of change between neuroimaging 
modalities and paradigms, the importance of including a normal control group and 
correlating changes with sensations or behaviours (Chapter 7).  There was decreased 
FDG uptake in regions mapping to posterior DMN which, although previously reported 
as responding to food ingestion, are not discussed further in the papers.   
 
There were differences between NW, Ob and RYGBpl in the regional brain responses to 
food ingestion.  The findings of several different response patterns, and of the same 
response pattern in regions known to be functionally associated, lends weight to these 
data.  In hypothalamus and pituitary there was an exaggerated activation post-RYGB, 
consistent with ingestion of the same 400 kcal meal resulting in a greater physiological 
signal to the brain after RYGB.  In right frontal operculum (gustatory cortex) there was 
similar deactivation in NW and RYGBpl that was attenuated in Ob, consistent with 
enhanced taste after RYGB. In left medial OC there was decreased FDG uptake in NW, 
minimal response in Ob and increased FDG uptake in RYGBpl which could be 
interpreted as differences in reward salience in the post-ingestive phase, perhaps a 
pleasant sensation in NW, minimal impact in Ob and an unpleasant sensation in 
RYGBpl.  In regions corresponding to posterior DMN there was exaggerated 
deactivation in RYGB consistent with either more intense recollection of past food 
experience or with the response to food ingestion being a greater task for the brain after 
RYGB.  Finally, and perhaps most importantly, in right DLFC there was similar 
deactivation in NW and RYGBpl that was not seen in Ob, consistent with restoration of 
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CHAPTER 7: CORRELATIONS BETWEEN BRAIN RESPONSES 
AND APPETITIVE SENSATION RESPONSES TO FIXED MEAL 
INGESTION AND AD LIBITUM INTAKE.  
 
7.1 INTRODUCTION 
In chapter 6 functional interpretation of differences in regional brain responses to food 
ingestion between NW, Ob and RYGBpl were based on the literature.  However, 
understanding of the function of brain regions is far from complete and anatomical/atlas 
regions may have several ascribed functions.  Furthermore, as discussed in section 
6.4.1.1, the direction of change in neuroimaging signal can be difficult to translate into 
direction of functional change and difficult to interpret across neuroimaging modalities.  
It is therefore important to seek within-study correlations between signal change and 
appetitive sensations or, more importantly, behaviours (such as ad libitum 
consumption).  The VAS used to assess appetitive sensations have limitations (section 
5.4.2.4) and correlations between VAS scores and with behaviour may give an 
indication of internal consistency. Correlations in food-evoked FDG signal change 
(FESC) between clusters may suggest functional relationships between brain regions.  
 
In this chapter I address the questions:  
- Are there correlations between food-evoked difference (FED effect) in 
appetitive (fullness, hunger, nausea, anticipated pleasantness of eating) or 
relaxedness VAS scores at +10 min after 400 kcal fixed meal? 
- Are there correlations between food-evoked difference (FED effect) in 
appetitive or relaxedness VAS scores at +10 min after 400 kcal fixed meal and 
ad libitum intake in the fasted state?  
- In each of the 10 clusters where there was a difference in response to food 
ingestion between NW, Ob and RYGBpl (chapter 6), is FESC correlated with 
food-evoked difference in appetitive or relaxedness VAS scores (FED effect) at 
+10 min or ad libitum intake in the fasted state? 
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7.2 METHODS 
The methods are described in chapter 2.  To recap, each subject underwent 2 FDG-PET 
scanning visits in random order after overnight fasting. At the FED visit subjects 
consumed a 400 kcal fixed meal (reduced amount given in 3 RYGB subjects), FDG-
PET scanning was performed  between +15 and +70 min,  subjects completed VAS for 
appetitive sensations and relaxedness at -7 min, +10 min, +80 min and an ad libitum 
meal starting at +80 min.  At the FASTED visit procedures were the same except 
subjects did not consume the 400 kcal mixed meal.  (RYGB subjects also underwent 
FED and FASTED visits with somatostatin plus insulin, but these data are not used in 
this chapter).  
 
7.2.1 Participants 
Results are reported for 12 NW, 21 Ob and 9 RYGB subjects (chapter 3).   
 
7.2.2 Data used in analyses 
7.2.2.1 FED effect VAS scores 
The effect of 400 kcal fixed meal ingestion on VAS scores (the food-evoked difference 
or FED effect) was calculated as FED minus FASTED.   In the analyses presented in 
this chapter +10 min data were used because the impact of the 400 kcal meal, where 
present, was greater at +10 min than +80 min (Chapter 5) and because FDG signal is 
weighted towards brain activity earlier in the uptake period (section 1.5.1.1). 
 
7.2.2.2 FESC  
As presented in chapter 6, 10 clusters (A-J) were identified where there were differences 
between NW, Ob and RYGBpl in the brain response to 400 kcal fixed meal ingestion.  
For each subject, FESC was calculated for each cluster (mean normalised voxel value in 
FED minus mean normalised voxel value in FASTED (section 2.7.5). 
 
7.2.2.3 Ad libitum consumption (fasted) 
The ad libitum meal performed after the scan at the FASTED visit assesses ad libitum 
consumption in the fasted state.   
 
7.2.3 Data processing  
Missing +10 min VAS data were handled as described in sections 2.6.1.2 and 5.2.2.2.  
There were no missing FESC or ad libitum meal data.   
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7.2.4 Statistical analysis  
Spearman’s rank order correlational analyses were performed between:  
- FED effect VAS fullness, hunger, sickness, anticipated pleasantness of eating 
and relaxedness at +10 min; 
- ad libitum consumption at the FASTED visit; 
- FESC in each of the 10 clusters (A-J). 
For each correlation, analyses were performed across all subjects and within each group.   
 
The study was not designed to perform such correlational analyses and was 
underpowered for them. A sample size of at least 82 would be required to give an 80% 
power to detect a medium strength correlation (r=0.3) at a significance level of 5% 
(G*Power 3.1 [227]).  Analyses were performed including all 42 subjects to maximise 
power.  As subjects were from 3 separate groups it was not appropriate to use 
parametric tests, particularly for analyses involving FESC as clusters were identified 
because responses were different between groups.  Therefore the non-parametric 
Spearman’s correlational analysis was used as it does not require normal distribution, 
and is also robust to outliers and is sensitive to any monotonic relationship (linear or 
non-linear). There was possibility that correlations may be different in the 3 groups and 
therefore within-group correlational analyses were also performed.    
 
Given the multiple comparisons there is a risk of false positive results (type 1 error).  
Each analysis (the all-subjects analysis and each within-group analysis) includes 120 
correlations: Bonferroni-corrected α=0.0004 (<0.001).  In order to have a possibility of 
detecting relationships in this small study, correlations were considered significant if 
p≤0.05 (uncorrected), therefore these analyses should be considered highly exploratory.      
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7.3 RESULTS 
Results of the correlational analyses are shown in Tables 7.1 (all subjects), 7.2 (NW), 
7.3 (Ob) and 7.4 (RYGBpl). 
 
7.3.1 Correlations between +10 min FED effect appetitive and relaxedness VAS 
scores (Figure 7.1) 
There was a strong negative correlation between FED effect fullness and hunger scores 
across all subjects (rs=-0.654, p<0.001) also seen in NW (n=11) (rs=-0.765, p=0.006) 
and Ob (n=21) (rs=-0.784, p<0.001), but was not significant in RYGBpl (n=9) (rs=-
0.517, p=0.154) (Figure 7.1a).  There was a strong negative correlation between FED 
effect fullness and anticipated pleasantness of eating scores across all subjects (rs=-
0.652, p<0.001) also seen Ob (rs=-0.719, p<0.001), but was not significant in NW (rs=-
0.445, p=0.170) or RYGBpl (rs=-0.417, p=0.265) (Figure 7.1b).  There was a strong 
positive correlation between FED effect hunger and anticipated pleasantness of eating 
scores across all subjects (rs=0.504, p=0.001) also seen in Ob (rs=0.663, p=0.001) but 
was not significant in NW (rs=0.415, p=0.205) and not seen in RYGBpl (rs=-0.117, 
p=0.765) (Figure 7.1c).  There were no significant correlations between FED effect 
sickness and fullness, hunger or anticipated pleasantness of eating across all subjects. 
However, in RYGBpl there was a strong positive correlation between FED effect 
fullness and sickness scores (rs=0.728, p=0.028) not seen in NW (rs=0.089, p=0.796) or 
Ob (rs=-0.099, p=0.670) (Figure 7.1d). There were no significant correlations between 
FED effect relaxedness and FED effect on any appetitive VAS scores across all subjects 
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7.3.2 Correlations between +10 min FED effect appetitive and relaxedness VAS 
scores and ad libitum consumption (fasted) (Figure 7.2) 
There was a moderate negative correlation between FED effect fullness scores and ad 
libitum consumption (fasted) across all subjects (rs=-0.456, p=0.003), not significant in 
NW (rs=-0.476, p=0.139) or Ob (rs=-0.395, p=0.076), and not seen in RYGBpl 
(rs=0.176, p=0.651) (Figure 7.2a). RYGBpl subjects cluster at one end of the 
distribution with 8 of the 9 RYGBpl subjects showing FED effect fullness at or above 
the median for all subjects and 7 being both above median FED effect fullness and in 
the lowest 30% for ad libitum consumption (RYGB09 shows low FED effect fullness 
and RYGB05 high ad libitum consumption relative to other RYGBpl subjects) whereas 
only 2 of 11 NW (NOS11 & NOS23) and 1 of 21 Ob (NOS09) subjects fulfil these 
criteria.  There is no evidence that the finite nature of the VAS impacts on FED effect 
fullness in RYGBpl: only 2 RYGBpl subjects had fullness scores above 90 at +10 min 
at the FED visit and in RYGBpl smaller FED effect fullness was associated with lower 
absolute fullness scores at the FED visit at +10 min (rs=0.711, p=0.032).   
 
There was no significant correlation between FED effect sickness and ad libitum 
consumption (fasted) across all subjects (rs=-0.157, p=0.327).  However, for NW 
subjects, there was a positive correlation (rs=0.608, p=0.047) which was not seen in Ob 
(rs=-0.009, p=0.969) or RYGBpl (rs=-0.227, p=0.557) (Figure 7.2b).  
 
There was no significant correlation between FED effect hunger scores and ad libitum 
consumption across all subjects (rs=0.100, p=0.534), in NW (rs=0.525, p=0.097) or Ob 
(rs=0.256, p=0.263). In RYGBpl there was a negative correlation (rs=-0.695, p=0.038) 
(Figure 7.2c). It is possible that the finite nature of the VAS may limit the FED effect 
hunger score in RYGBpl: 5 of 9 had hunger scores at +10 min at the FASTED visit of 
40 or below of which 4 had hunger scores at +10 min in the FED visit of 0-2. 
Furthermore, for RYGBpl higher baseline hunger scores (+10 min FASTED visit) 
showed non-significant associations with greater negative +10 min FED effect hunger 
(rs=-0.653, p=0.057) and with greater ad libitum consumption (fasted) (rs=0.639, 
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There was a moderate strength positive correlation between FED effect anticipated 
pleasantness of eating scores and ad libitum consumption for all subjects (rs=0.335, 
p=0.032), but this was not seen in individual groups (NW rs=0.055, p=0.873;  Ob 
rs=0.258, p=0.259; RYGBpl rs=0.176, p=0.651) (Figure 7.2d). 
 
There were no significant correlations between FED effect relaxedness and ad libitum 
consumption (fasted) across all subjects or within groups. 
 
7.3.3 Correlations between FESC and ad libitum consumption (fasted) and +10 min 
FED effect appetitive and relaxedness VAS scores  
For clusters E (hypothalamus) (Figure 7.3a) and F (pituitary) there were negative 
correlations between FESC and ad libitum consumption (fasted) across all subjects (E 
rs=-0.596,  p<0.001; F rs=-0.539, p<0.001) and within NW for cluster E (rs=-0.699,  
p=0.011) (not significant for  F, rs=-0.541, p=0.069) but not Ob (E rs=-0.239,  p=0.298; 
F rs=-0.080, p=0.729) or RYGBpl (E rs=-0.176,  p=0.651; F rs=-0.025, p=0.949), 
although RYGBpl data clusters at one end of the distribution around the NW best fit 
line. There were no significant correlations between FESC and any FED effect VAS 
score for all subjects or within NW or Ob. For RYGBpl there was a negative correlation 
with FED effect fullness (E rs=-0.750, p=0.020; F rs=-0.867, p=0.002) (Figure 7.3b). 
 
For cluster C (DLFC (R)) (Figure 7.4a), within NW there was a significant strongly 
positive correlation between FESC and ad libitum consumption (fasted) (rs=0.910, 
p<0.001).  However, there was no significant correlation across all subjects (rs=0.293, 
p=0.060) or within Ob (rs=-0.078,   p=0.737) or RYGBpl (rs=0.126, p=0.748).  RYGBpl 
data clusters at one end of the NW distribution: 7 of 9 RYGBpl subjects show greater 
negative FESC in cluster C than all Ob subjects with 3 RYGBpl on the NW best fit line 
(RYGB05, RYGB09, RYGB11) and 4 showing lower ad libitum consumption than 
would be predicted from NW best fit line (RYGB03, RYGB04, RYGB06, RYGB10).  
Two subjects (RYGB02 and RYGB07) showed no deactivation.   These 2 subjects were 
not unusual in terms of gender (both female), age (1st & 9th oldest), time post-surgery 
(3rd & 7th longest), weight loss (6th and 9th greatest), FED effect fullness (3rd and 6th 
greatest) or FED effect sickness (5th and 7th greatest) although 1 subject (RYGB07) 
was given less than 400 kcal at the pre-scan meal (220 kcal, see chapter 5). For cluster 
C there were no significant correlations between FESC and any FED effect VAS score 
for all subjects, NW, Ob or RYGBpl.   
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For cluster A (anterior MFC/medial OC (R)) (Figure 7.4b) there was a positive 
correlation between FESC and ad libitum consumption (fasted) across all subjects 
(rs=0.378, p=0.014) but no significant correlations within individual groups (NW 
rs=0.548, p=0.065;Ob rs=0.213, p=0.354; or RYGBpl rs=-0.335, p=0.379).  There were 
no significant correlations between FESC and any FED effect VAS score for all 
subjects, NW or RYGBpl.  For Ob there was a  positive correlation between FESC and 
FED effect relaxedness (rs=0.615, p=0.003) (Figure 7.4d). 
 
For cluster D (frontal operculum (R) etc) (Figure 7.4c) there were no significant 
correlations between FESC and ad libitum consumption (fasted)(all subjects rs=0.280, 
p=0.073;NW rs=0.137, p=0.671; Ob rs=0.182, p=0.429; RYGBpl rs=0.059, p=0.881).  
There were no significant  correlations between FESC and any FED effect VAS score 
for all subjects, NW or RYGBpl.  For Ob there was a positive correlation between 
FESC and FED effect relaxedness (rs=0.448, p=0.042) (Figure 7.4c).   
 
For clusters G, H and I (posterior DMN) there were positive correlations between FESC 
and ad libitum consumption (fasted) (Figure 7.5) across all subjects (G rs=0.461, 
p=0.002; H rs=0.640, p<0.001; I rs=0.662, p<0.001), and within Ob for clusters H 
(rs=0.530, p=0.014) and I (rs=0.544, p=0.011). There were no correlations within 
RYGBpl, but RYGBpl subjects cluster at one end of the distribution around the Ob best 
fit line (for clusters H&I).  Across all subjects, there were significant negative 
correlations between FESC and FED effect sickness for cluster G (rs=-0.321, p=0.041, 
Figure 7.6a) and FED effect fullness for cluster I (rs=-0.331, p=0.034, Figure 7.6c).  
There were no significant correlations between FESC and any FED effect VAS score 
for NW or Ob.  For RYGBpl there was a negative correlation between FESC and FED 
effect relaxedness for cluster G (rs=-0.734, p=0.024, Figure 7.6b). 
 
For cluster B (medial OC (L)) there were no significant correlations between FESC and 
ad libitum consumption (fasted) or any FED effect VAS scores for all subjects or within 
individual groups.   
 
For cluster J (lingual gyrus (L)) there were no significant correlations between FESC 
and ad libitum consumption or FED effect VAS scores for all subjects, NW or Ob.  For 
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7.3.4 Correlations in FESC between clusters 
Correlations in FESC between clusters for NW, Ob and RYGBpl are shown 
schematically in Figure 7.7 and representative correlations shown as graphs in Figures 
7.8 and 7.9.   
 
Across all subjects there were highly significant, strong positive correlations in FESC 
between clusters showing the same between-group response patterns (chapter 6) (Figure 
7.8).  Positive correlations were also seen within subject groups.   
 
Between clusters E (hypothalamus) and F (pituitary) (Figure 7.8a), there was a positive 
correlation across all subjects (rs=0.617, p<0.001), also seen in RYGBpl (rs=0.817, 
p=0.007).   
 
For frontal clusters A (anterior MFC/medial OC (R) etc), C (DLFC (R)) and D (frontal 
operculum (R) etc) across all subjects there were positive correlations between all 3 
clusters (A&D rs=0.826, p<0.001, Figure 7.8b; A&C rs=0.795, p<0.001, Figure 7.8c; 
C&D rs=0.722, p<0.001, Figure 7.8d).  In NW and Ob there were significant positive 
correlations between clusters A and D only (NW rs=0.650, p=0.022; Ob rs=0.560, 
p=0.008) whereas in RYGBpl there were significant positive correlations between all 3 
clusters (A&D rs=0.683, p=0.042; A&C rs=0.817, p=0.007; C&D rs=0.917, p=0.001).   
 
For posterior DMN clusters G (posterior cingulate/precuneus etc), H (angular gyrus (R) 
etc) and I (angular gyrus (L) etc), across all subjects there were positive correlations 
between all 3 clusters (G&H rs=0.627, p<0.001, Figure 7.8e; G&I rs=0.635, p<0.001, 
Figure 7.8f; H&I rs=0.657, p<0.001). NW showed no significant correlations, in Ob 
there was a positive correlation between G and H (rs=0.561, p=0.008), whereas in 
RYGBpl there were positive correlations between all 3 clusters (G&H rs=0.667, 
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There were also correlations in FESC between clusters showing different response 
patterns (Figure 7.9).  FESC in clusters E (hypothalamus) and F (pituitary) was 
negatively correlated with FESC in frontal clusters (A, C & D) across all subjects (E&C 
rs=-0.540, p<0.001,Figure 7.9a; F&C rs=-0.320, p<0.039; E&A rs=-0.442, p=0.003; 
F&A rs=-0.335, p=0.030; E&D rs=-0.362, p=0.018,Figure 7.9b).  In NW FESC in 
clusters E and F was negatively correlated with FESC in cluster C (E&C rs=-0.678, 
p=0.015; F&C rs=-0.741, p=0.006) but not A or D.  In Ob and RYGBpl there were no 
significant correlations between FESC in clusters E or F and frontal clusters.  
 
FESC in clusters E and F was significantly negatively correlated with FESC in posterior 
DMN clusters (G, H & I) across all subjects for all 6 correlations (E&G rs=-0.699, 
p<0.001, Figure 7.9d; E&H rs=-0.753, p<0.001, Figure 7.9c; E&I rs=-0.764, p<0.001; 
F&G rs=-0.647, p<0.001; F&H rs=-0.467, p=0.002; F&I rs=-0.534, p<0.001).   For NW 
there were 3 significant negative correlations (E & I rs=-0.727, p=0.007; F & G rs=-
0.720, p=0.008; F&I (rs=-0.734, p=0.007).  For Ob there was 1 significant negative 
correlation (E&H rs=-0.535, p=0.012).  For RYGBpl there were 5 significant negative 
correlations (E&G rs=-0.767, p=0.016; E&H rs=-0.667, p=0.050; E&I rs=-0.717, 
p=0.030; F&H rs=-0.700, p=0.036; F&I rs=-0.667, p=0.050).      
  
FESC in frontal clusters (A, C & D) was significantly positively correlated with FESC 
in posterior DMN clusters (G, H & I) across all subjects for all 9 correlations (C&G 
rs=0.486, p=0.001; C&H rs=0.503, p=0.001, Figure 7.9e; C&I rs=0.417, p=0.006; A&G 
rs=0.461, p=0.002; A&H rs=0.515, p<0.001; A&I rs=0.420, p=0.006; D&G rs=0.465, 
p=0.002; D&H rs=0.439, p=0.004; D&I rs=0.350, p=0.023).  In NW and Ob there were 
no significant correlations in FESC between frontal clusters and posterior DMN 
clusters.  In RYGBpl there were 3 positive correlations (C&H rs=0.667, p=0.050, Figure 
7.9e; A&H rs=0.783, p=0.013; D&H rs=0.733, p=0.025). 
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For cluster B (medial OC (L)) across all subjects FESC was positively correlated with 
FESC in clusters E and F (E&B rs=0.364, p=0.018; F&B rs=0.515, p<0.001) and 
negatively correlated with FESC in posterior DMN clusters (B&G rs=-0.539, p<0.001, 
Figure 7.9f; B&H rs=-0.334, p=0.031; B&I rs=-0.322, p=0.037) and cluster J (lingual 
gyrus (L)) (rs=-0.321, p=0.038).  In Ob FESC in cluster B was negatively correlated 
with FESC in cluster G (posterior DMN)(rs=-0.635, p=0.002, Figure 7.9f)). For NW and 
RYGBpl there were no significant correlations between FESC in cluster B and any 
other clusters.  
 
For cluster J (lingual gyrus (L)) across all subjects FESC was negatively correlated with 
FESC in cluster F (F&J rs=-0.319, p=0.039), frontal clusters (C&J rs=-0.381, p=0.013; 
A&J rs=-0.335, p=0.030; D&J rs=-0.452, p=0.003) and cluster B (as above).  In NW 
FESC in cluster J was negatively correlated with FESC in frontal clusters ((A&J rs=-
0.594, p=0.042;D&J rs=-0.636,  p=0.026). In Ob FESC in cluster J was negatively 
correlated with FESC in frontal cluster D (rs=-0.470, p=0.032).  In RYGBpl there were 




7.4.1 Correlations between food-evoked difference in appetitive sensations  
The correlations between food-evoked difference at +10 min in hunger, fullness and 
anticipated pleasantness of eating are as expected with larger increases in fullness 
associated with larger decreases in both hunger and anticipated pleasantness of eating 
and larger decreases in hunger associated with larger decreases in anticipated 
pleasantness of eating.  This demonstrates a reasonable degree of internal consistency 
between scores.  However, correlations are not perfect, possibly related to 
reproducibility of VAS scores [18]  or suggest fullness, hunger and anticipated 
pleasantness of eating, while related, reflect different aspects of appetite.  Generally the 
within-group correlations are consistent with those including all subjects. The finding of 
significant correlations within Ob, but not within NW (only seen between FED effect 
fullness and hunger) or RYGBpl, may be due to the larger size (and therefore greater 
power) for the Ob group.  The exception is the lack of correlation between FED effect 
hunger and anticipated pleasantness of eating for RYGBpl, which may be due to FED 
effect hunger being limited by the finite nature of the VAS in RYGBpl (see section 
7.3.2). The greater increase in sickness being associated with greater increase in fullness 
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in RYGBpl is again as expected.  The majority of NW and Ob subjects did not exhibit 
change in sickness scores, which may explain the lack of correlation in these groups. 
 
7.4.2 Correlations between food-evoked difference in appetitive sensations and ad 
libitum consumption (fasted)  
A strength of this protocol is FED effect on appetitive VAS scores (and FESC) in 
response to 400 kcal fixed meal ingestion were measured separately to ad libitum 
consumption (fasted).  It is therefore reasonable to assume that ad libitum consumption 
is the dependent variable, as it is difficult to see how ad libitum consumption could 
impact on FED effect VAS scores (or FESC), and to conclude that where correlations 
are significant the change in appetitive VAS score (or FESC) might have a role in 
controlling meal size and/or meal termination.  There may, of course, be confounding 
factors.  Furthermore FED effect VAS scores (and FESC) were measured in response to 
a fixed meal (i.e. subjects were not given a choice about stopping eating) and therefore 
assess subconscious factors controlling meal size and/or meal termination.   Finally any 
factor identified is likely to be intrinsic to subjects, rather than a variable external factor 
which might be acting if responses and ad libitum intake were assessed simultaneously.   
 
My data across all subjects suggest increased sensation of fullness and decreased 
pleasantness of eating may contribute to determination of meal size . The strength of the 
correlations suggest these are not the only factors.  Although expected, to my 
knowledge this has not been previously reported as Flint et al reported correlations 
between mean (rather than incremental) VAS scores over 4.5 h after a fixed meal and 
subsequent ad libitum consumption [18].   
 
For fullness, while in NW and Ob the data (although not significant) are consistent with 
the all-subjects analysis, there is no association in RYGBpl despite a range of FED 
effect fullness values.  The RYGBpl distribution is consistent with restoration of a 
fullness response to eating after RYGB in at least some subjects and/or restoration of a 
link between increased fullness and meal termination.  This is consistent with the 
literature which reports increased postprandial fullness after RYGB (section 1.3.1.1) 
and, in a separate study, lower ad libitum consumption [65].  
 
For hunger, the negative correlation in RYGBpl subjects is unexpected with those with 
the greatest decrease in hunger at +10 min post-fixed meal showing the highest ad 
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libitum consumption.  This may be a type 1 error.  However, it could also be due to FED 
effect hunger being limited by the finite nature of the VAS in RYGBpl and/or due to 
confounding by baseline hunger scores (see section 7.3.2).  
 
The finding of a positive correlation between FED effect sickness at +10 min and ad 
libitum consumption in NW is unexpected.  However, as the majority of NW subjects 
showed minimal change in sickness and the correlation appears to be driven by 3 
subjects this result should be viewed with caution.   
 
7.4.3 Correlations between FESC and ad libitum consumption (fasted) and food-
evoked difference in appetitive sensations  
7.4.3.1 Hypothalamus and pituitary 
In NW greater activation in hypothalamus was associated with lower ad libitum 
consumption, with variance in hypothalamic activation accounting for 49% of the 
variance in ad libitum consumption. This is a novel finding, although not unexpected 
given the known hypothalamic functions (sections 1.1.3.1 and 1.4.1), and suggests that 
in normal weight people physiological signalling through hypothalamus may have a 
major role in determining meal size.  Animal studies suggest centres in brainstem are 
key in controlling meal size (section 1.1.8.1).  NTS (brainstem) neurons project to 
hypothalamus [14] and hypothalamic neurons project to brainstem centres [5, 14, 60]. 
My data could be consistent with a pathway from brainstem centres to hypothalamus 
with onward pathways from hypothalamus influencing meal size; or hypothalamus 
receiving information from other sources (section 1.1.3.1) and influencing meal size 
either via brainstem centres or independently; or possibly there could be no causative 
relationship, with the correlation being confounded, perhaps by brainstem centres 
causing both hypothalamic activation and limiting meal size.   
 
Ob showed ranges of hypothalamic (and pituitary) activation and of ad libitum 
consumption similar to NW but no correlation between the two, despite the larger size 
of the group.  This is consistent with either a much smaller (or even absent) contribution 
of hypothalamic activation to determining meal size, or a higher threshold at which 
hypothalamic activation impacts on meal size, and suggests non-hypothalamic factors 
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RYGBpl responses were consistent with the same fixed meal resulting in hypothalamic 
activation at or above the top end of the normal/obese range and the ad libitum 
consumption that would be expected from the normal weight data, which might be due 
to restoration of a connection, weaker or absent in obesity, or the hypothalamic response 
being above any higher obese threshold. 
 
There are no convincing correlations with food-evoked appetitive sensations which 
might mediate the lower ad libitum intake. The apparent correlation between increased 
activation and decreased fullness in RYGBpl may be due to clustering of RYGBpl 
subjects, but is otherwise difficult to rationalise.  
 
7.4.3.2 Right DLFC 
In NW there was a highly significant strong association between greater deactivation in 
DLFC (R) in response to 400 kcal fixed meal and lower ad libitum consumption in the 
fasted state: the extent of deactivation in DLFC (R) accounts for 83% of the variance in 
ad libitum consumption.  Given the known role of DLFC in inhibitory control [126], 
this suggests deactivation in DLFC may have a major role in meal termination in NW.  
Although previous studies have shown a DLFC response (increased [15O]-H2O-PET 
signal) to food ingestion [152, 154] (section 1.6.2), and a role in meal termination has 
been hypothesised, this is the first time that change in DLFC activation has been shown 
to be correlated with ad libitum intake.  As discussed in section 6.4.1.1, the direction of 
change in neuroimaging signal can be difficult to translate into direction of functional 
change and difficult to interpret across neuroimaging modalities.  These data provide 
evidence that, at least in this FDG-PET neuroimaging paradigm, decreased signal can be 
associated with increased function.    
 
The correlation between deactivation in DLFC and lower ad libitum consumption was 
not seen in Ob or RYGBpl.   Ob subjects show minimal DLFC response to ingestion of 
400 kcal fixed meal suggesting DLFC deactivation is defective in obesity.  However, 
Ob subjects showed a wide range of ad libitum consumption.  Therefore, in contrast to 
NW, extent of deactivation in response to 400 kcal meal ingestion in this part of DLFC 
accounts for little, if any, of the variance in ad libitum consumption seen in Ob 
suggesting other factors are major determinants of meal size  in the obese.  Whether or 
not a larger meal would result in DLFC deactivation in obese subjects, and if so whether 
this correlates with ad libitum consumption, requires further investigation.  The 
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RYGBpl distribution is consistent with restoration of a high-normal DLFC response to 
eating after RYGB in the majority of subjects with the associated low ad libitum intake.  
In 4 RYGBpl subjects ad libitum intake was even lower than would be expected for 
DLFC deactivation and 2 otherwise unremarkable subjects show no DLFC response but 
have low ad libitum consumption suggesting this is not the only mechanism involved in 
limiting meal size after RYGB.  
 
The mechanism by which deactivation in DLFC might result in reduced ad libitum 
consumption is not clear, as there are no significant correlations between FESC and 
food-evoked change in fullness, hunger,anticipated pleasantness of eating or sickness 
across all subjects or within groups.   
 
7.4.3.3 Anterior MFC/medial OC and frontal operculum 
Associations between greater difference in relaxedness scores and greater activation in 
both anterior MFC/medial OC and frontal operculum were seen in Ob only.  Anterior 
MFC is thought to have a role linking external and internal stimuli with behaviour, 
mood and motivation, and decreased anterior MFC activity during a task is influenced 
by emotional state (summarised in [245]).     These regions might mediate a wellbeing 
or mood response to food ingestion.  However, there was no impact of FED state on 
relaxedness scores (section 5.3.2.5).  Alternatively they might represent sites where 
difference in wellbeing or mood (perhaps related to scan order or other factors) interacts 
with response to food ingestion. Either way, it is interesting that this was only seen in 
Ob (although might be due to greater power) which might speak to the greater 
emotional eating reported in obesity [25, 26].  To my knowledge, other neuroimaging 
studies in relation to food have not assessed wellbeing.    
 
7.4.3.4 Posterior DMN clusters 
In bilateral angular gyri (components of posterior DMN, see section 6.4.1.2) greater 
deactivation in response to food ingestion was associated with lower ad libitum 
consumption across all subjects and within Ob (the largest group), with variance in 
deactivation accounting for 41% (right) and 44% (left) of the variance in ad libitum 
consumption across all subjects (in Ob 28% and 30%).  Although there is no correlation 
within RYGBpl, the data are consistent with exaggerated angular gyri deactivation after 
RYGB with the expected associated lower ad libitum consumption.   These data suggest 
the novel hypothesis that angular gyri deactivation might have a role in controlling meal 
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size.  These regions are associated with recollection of prior experience (section 6.4.1.2 
[244]) and perhaps mediate the impact of past food experience on determining meal 
size. Alternatively the association could relate to the postulated DMN role as a cortico-
cortical pathway hub [245] or perhaps to non-specific DMN deactivation in relation to 
the meal as a task.  The pattern in posterior cingulate/precuneus is similar to angular 
gyri, but the correlations are weaker and within Ob correlations absent, consistent with 
angular gyri being directly involved in determining meal size and posterior 
cingulate/precuneus a step removed. Interestingly, an fMRI study focussed on DMN 
found fasting resting activity in the left lateral parietal cortex, but not in posterior 
cingulate, was correlated with appetite [167].  
 
The mechanisms by which angular gyri and posterior cingulate/precuneus deactivation 
might contribute to determination of meal size are not clear.  Across all subjects 
deactivation in left angular gyrus was associated with greater increase in fullness and 
greater increase in fullness was associated with lower ad libitum consumption (section 
7.3.2).  However, this was not significant for right angular gyrus or within individual 
groups.  Across all subjects there was a correlation between posterior 
cingulate/precuneus deactivation and increased sickness. It is possible that increased 
sickness might mediate the link between posterior cingulate/precuneus deactivation and 
lower ad libitum consumption, at least for some subjects, although it should be noted 
there was no evidence of correlation between increased sickness and reduced ad libitum 
consumption (section 7.32).  Alternatively, perhaps increased sickness impacts on 
posterior cingulate/precuneus  deactivation.  The correlation between change in 
relaxedness scores for posterior cingulate/precuneus in RYGBpl only is noted and is 
difficult to rationalise. 
 
7.4.3.5 Left medial OC 
I suggested in section 6.4.2.5 that deactivation in the left medial OC in NW might be 
associated with a pleasant sensation after eating and activation in left medial OC in 
RYGBpl might be associated with an unpleasant sensation after eating. I did not find 
significant correlations between left medial OC activation and food-evoked change in 
sickness, anticipated pleasantness of eating or relaxedness. However, the protocol was 
not  designed to capture the experience of pleasantness of eating the ice-cream at the 
moment of finishing the fixed meal as the VAS were conducted 10 min after meal 
completion and the question was not specific to ice-cream.  Furthermore the anticipated 
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pleasantness of eating VAS scale ranged from ‘Not at all’ to ‘Extremely’ and was 
therefore not well-designed to detect an unpleasant sensation.   
 
7.4.4 Correlations in FESC between clusters 
Positive correlations across all subjects in FESC between clusters showing the same 
between-group response patterns (Chapter 6) support the suggestion that these 3 groups 
of clusters (hypothalamus and pituitary; frontal operculum, anterior MFC/medial OC 
and DLFC (frontal network); and posterior cingulate/precuneus and bilateral angular 
gyri (DMN)) operate as networks in relation to food ingestion.  The literature provides 
evidence of structural and/or functional links consistent with this. Hypothalamus and 
pituitary are closely linked (section 6.4.2.1).  The orbitomedial cortex (including OC 
and MFC) is recognised as the major prefrontal target of gustatory afferents (page 660 
[251], chapter 2, section VI [252]) and there are cortico-cortical connections within the 
prefrontal cortex (chapter 2, section VI [252]).  This suggests any link between frontal 
operculum and prefrontal cortex would be via OC/MFC consistent with my findings of 
positive correlations in FESC between frontal operculum and anterior MFC/medial OC 
in all 3 groups aswell as across all subjects.  Positive correlations between anterior 
MFC/medial OC and DLFC are only significant in RYGBpl and across all subjects.  
Posterior cingulate/precuneus and bilateral angular gyri are key components of posterior 
DMN and there is extensive evidence of structural and functional links between these 
areas, although as discussed previously not in relation to food ingestion (sections 6.4.1.2 
and 6.4.2.6).   
 
My data also provide evidence of functional links between these 3 networks. Greater 
activation in the hypothalamic-pituitary network was associated with greater 
deactivation in the frontal network (DLFC across all subjects and in NW; anterior 
MFC/medial OC across all subjects).  There are known to be bidirectional links between 
hypothalamus and the prefrontal cortex which might mediate this ((chapter 2, section VI 
[252]).  Greater activation in the hypothalamic-pituitary network was associated with 
greater deactivation in posterior DMN clusters across all subjects and, to varying 
extents, within all 3 groups.  Greater deactivation in posterior DMN clusters was 
associated with greater deactivation in the frontal network across all subjects and within 
RYGBpl.  Links with DMN network may be through the thalamus (chapter 2, section 
VI [252]).  It seems likely that pituitary correlations with other regions (and by 
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extension ad libitum consumption (section 7.4.3.1)) are due to the link with 
hypothalamus.  
 
The pattern of significant correlations between clusters appears to be different between 
the 3 groups (Figure 7.7). Ob shows fewer significant correlations between clusters than 
NW, despite being the larger group. The correlations in FESC between hypothalamic-
pituitary network and DLFC seen in NW are absent in Ob, and correlations between 
hypothalamic-pituitary network and posterior DMN are less extensive.   The 
connectivity literature is complex.  However, in obese compared to normal weight 
subjects, one study has shown decreased functional connectivity of right DLFC with the 
whole brain network at rest and additionally of lateral occipital cortex during a task 
(viewing pictures) [166] and others focussed on DMN in the fasting resting state have 
found greater activity/connectivity in posterior aspects of DMN [167, 168], at least 
partly consistent with my findings.   
 
RYGBpl shows a larger number of significant correlations than NW and Ob, despite 
being the smallest group. However, this does not appear to be simply a restoration of a 
normal pattern.  The correlation between hypothalamic-pituitary network and DLFC 
seen in NW is absent in RYGBpl (and Ob).   In RYGBpl there are more correlations 
both between hypothalmic-pituitary network and DMN and within DMN than in NW 
and Ob.   Furthermore, there are positive correlations between DMN and frontal 
network not seen in NW and Ob and more correlations within the frontal network.   At 
least partially consistent with my findings, two studies including normal weight, obese 
and post-RYGB subjects have shown similar connectivity in normal weight and post-
RYGB and different connectivity in the obese, one looking at hypothalamic 
connectivity in response to glucose ingestion  [204] and the other analysing in the fed 
state [23] although in contrast to my data the latter found stronger connectivity in the 
obese.  
 
Correlations with left medial OC and left lingual gyrus are different between NW, Ob 
and RYGBpl but the implications of this are not clear.  
 
The lack of correlations in Ob does not appear to be due to a reduced FESC range 
(difference between highest and lowest) as most clusters (except cluster C in Ob) show 
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comparable FESC range between NW, Ob, and RYGBpl.   It is possible that the 
connections are absent/weaker or have a higher threshold/show resistance.  
 
7.4.5 Limitations 
As discussed in section 7.2.4, the study was not designed to perform such correlational 
analyses and was underpowered for them.   It is likely that some correlations, 
particularly weaker ones, would be missed.  Conversely, a large number of correlations 
were performed with the risk of false positive results (type 1 error).  Therefore these 
analyses should be considered exploratory.  In the parallel group analyses it is important 
to take into account the different group sizes, and thus power.  
 
These analyses considered FESC only in clusters identified as showing a different 
response to food ingestion between groups and therefore does not give information 
about regions outside these clusters.   
 
Appetitive sensations were assessed at +10min and FDG-PET scanning was between 
+15 and +70 min. It is possible that these timings might miss some of the factors 
controlling meal size and/or meal termination occurring before 10-15 min.   Assessing 
appetitive sensations during the FDG-PET uptake and scanning might be better for 
correlations with FESC, however would risk influencing the neuroimaging results and 
were deliberately avoided for this reason.   The VAS are finite, and this may impact on 
extent of difference. Finally the wording of the VAS for anticipated pleasantness of 
eating would have been better made specific to ice-cream (‘How pleasant would it be to 
eat ice-cream right now?’) and the lower end labelled ‘extremely unpleasant’ (rather 
than ‘not at all’) to capture unpleasant sensations.  
 
 
7.5 SUMMARY AND CONCLUSIONS 
These are correlations and thus do not demonstrate causation.   However, my data 
suggest that in normal weight people control of meal size is highly dependent on 
hypothalamic activation and is mediated by DLFC.  The data are consistent with the 
primary pathway in normal weight people being food ingestion causing (perhaps 
indirectly via the brainstem) hypothalamic activation causing DLFC deactivation with 
consequent meal termination.  The data across all subjects are also consistent with a 
second pathway, in which hypothalamic activation results in deactivation in bilateral 
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angular gyri and posterior cingulate/precuneus which influence meal size, either via 
onward links to DLFC or via other pathways.  Perhaps this pathway engages memory of 
previous food experience in meal termination.      
 
In obese people, the same 400 kcal fixed meal results in a similar range of hypothalamic 
activation as in normal weight but, in contrast to normal weight, there is no evidence the 
hypothalamic activation influences meal size.   Hypothalamic activation does not result 
in DLFC deactivation, consequently there is no deactivation in this part of DLFC and 
thus no impact on meal size. However, there was no difference between normal weight 
and obese subjects in ad libitum consumption in the fasted state suggesting other non-
hypothalamic, non-DLFC mechanisms influence meal size in the obese.  Perhaps these 
are related to conscious limitation based on memory of previous experience: in obese 
subjects greater deactivation in bilateral angular gyri was associated with lower ad 
libitum consumption.  The correlation between change in relaxedness scores and 
activation in anterior MFC seen in obese only might represent a site of interaction 
between mood or wellbeing and food intake. 
 
After RYGB the same 400 kcal fixed meal results in hypothalamic activation at the top 
end of the normal/obese range with the impact on meal size that would be expected 
from the normal weight data.  In the majority of RYGBpl subjects DLFC deactivation, 
absent in the obese, is restored, with meal size consistent with that expected from 
normal weight data at least in some subjects.   However, this is not simply a restoration 
of normal pathways, as there is no correlation between hypothalamic activation and 
DLFC deactivation in RYGBpl subjects.  The data are consistent with an enhanced 
pathway via DMN regions to frontal regions including DLFC.  In a minority of 
RYGBpl subjects DLFC deactivation is not restored but there is low ad libitum intake, 
suggesting other pathways are involved in determining meal size after RYGB.  My data 
are consistent with enhanced angular gyri deactivation in RYGBpl subjects contributing 
to lower ad libitum consumption.        
 
My data show a reasonable degree of internal consistency between appetitive VAS 
scores and suggest food-evoked increase in fullness and decrease in  pleasantness of 
eating may mediate meal termination.  The data are consistent with restoration of a 
fullness response to eating after RYGB with associated reduced meal size.  However, 
generally it proved difficult to ascribe sensations to individual brain regions and thus 
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explain how change in activation might contribute to determination of meal size or meal 
termination.  This may be due to the reproducibility of VAS scores, the timing, or the 
wording.  However, it is also possible that there are inter-individual differences in the 
experience or naming of these sensations, or that they are co-located, at least at the 
resolution of FDG-PET neuroimaging.  
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Table 7.1:  Across all subjects, Spearman’s rank correlations between ad libitum consumption in the fasted state, food evoked change (FED 
effect) in appetitive VAS scores at +10 min and FESC in clusters A-J. 
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Table 7.2:  In normal weight (NW), Spearman’s rank correlations between ad libitum consumption in the fasted state, food evoked change 
(FED effect) in appetitive VAS scores at +10 min and FESC in clusters A-J. 
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Table 7.3:  In obese (Ob), Spearman’s rank correlations between ad libitum consumption in the fasted state, food evoked change (FED effect) 
in appetitive VAS scores at +10 min and FESC in clusters A-J.  
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Table 7.4:  In RYGB, Spearman’s rank correlations between ad libitum consumption in the fasted state, food evoked change (FED effect) in 
appetitive VAS scores at +10 min and FESC in clusters A-J
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CHAPTER 8: THE ROLE OF GUT PEPTIDES IN THE ALTERED 
BRAIN RESPONSES TO FOOD INGESTION AFTER RYGB. 
 
8.1 INTRODUCTION 
In chapter 6 I showed the regional brain responses to 400 kcal meal ingestion were 
different after RYGB and in chapter 7 that the responses seen after RYGB in several of 
these regions were associated with lower ad libitum consumption. However, the 
mechanisms by which the altered gut structure of RYGB signals to the brain to alter 
responses and thus eating behaviour are not understood (section 1.3.2).  One extensively 
researched potential mechanism is the exaggerated gut peptide, particularly PYY and 
GLP-1, responses to eating post-RYGB (section 1.3.3) and in chapter 5 I showed that 
the RYGB subjects exhibited the expected exaggerated postprandial GLP-1 and PYY 
responses and lower ad libitum intake.  Somatostatin inhibits gut and pancreatic peptide 
secretion (section 1.3.3.8) and Le Roux et al found that the somatostatin analogue 
octreotide reduced fullness at 15 min into an ad libitum meal and increased ad libitum 
consumption after RYGB [81].  In this chapter I investigate the role of exaggerated 
postprandial gut peptide responses after RYGB by addressing the questions:  
- In RYGB, does inhibition of pancreatic and gut peptide responses using 
somatostatin (with basal insulin replacement): 
o impact on the appetitive or relaxedness sensations response to 400 kcal 
meal ingestion or on ad libitum consumption? 
o impact on food-evoked FDG signal change (FESC) in the 10 clusters 
where there was a difference in response to 400 kcal meal ingestion 
between NW, Ob and RYGBpl (Chapter 6)? 
- Across all subjects are there correlations between food-evoked difference (FED 
effect) in pancreatic and gut peptides at +30 min and FESC in the 10 clusters? 
This is an exploratory analysis.  The +30 min sample was part of the protocol 
(section 2.5.6.6) for 26 participants (6/12 NW, 11/21 Ob and all 9 RYGB 
subjects) and as discussed in chapter 7, a sample size of at least 82 would be 
required to give an 80% power to detect a medium strength correlation (r=0.3) at 
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8.2 METHODS 
The methods are described in chapter 2.  Briefly, RYGB underwent 4 PET scanning 
visits in paired random order (placebo-FASTED, placebo-FED, somatostatin-FASTED, 
somatostatin-FED).   NW and Ob underwent 2 PET scanning visits (FASTED and FED) 
in random order.  RYGB received intravenous infusions from -95 min until visit end: 
0.9% saline at placebo visits and somatostatin plus basal insulin replacement at 
somatostatin visits.  At the FED visit subjects consumed a 400 kcal mixed meal 
(reduced in 3 RYGB participants unable to consume 400 kcal at the test meal visit: 
RYGB03 256 kcal, RYGB07 220 kcal, RYGB11 234 kcal (section 5.3.1)); FDG-PET 
scanning was performed  between +15 and +70 min; subjects completed VAS for 
appetitive sensations and relaxedness at -105 min (RYGB only, before start of 
infusions), -20 min, -7 min, +10 min, +80 min;  venous blood was taken for glucose 
every 5-15 min and for insulin, glucagon, PYY, GLP-1, GIP and ghrelin at -100 min 
(RYGB only), -10 min, +30 min (timepoint added halfway to study completion) and 
+80 min.  At the FASTED visit procedures were the same except subjects did not 
consume the 400 kcal mixed meal.   
 
Two subjects (RYGB07 and RYGB09) developed nausea during the -95 to -10 min 
phase at their first somatostatin visit, and somatostatin infusion rate was reduced to 70% 
and continued at 70% for the remainder of the visit (section 2.5.6.1).  At the second visit 
the infusion rate was mimicked.  
 
In RYGB if VPG fell, or was projected to fall, below 3.8 mmol/l, 20% glucose was 
infused intravenously at a variable rate to maintain VPG 4-4.5 mmol/l and avoid 
hypoglycaemia which might influence brain responses (section  2.5.6.1).   
 
8.2.1 Participants 
Within RYGB analyses include all 9 RYGB participants (chapter 3).   The exploratory 
analyses across all subjects include a subset of participants for whom the +30 min 
sample was part of the protocol (section 2.5.6.6):    6/12 NW, 11/21 Ob and all 9 RYGB 
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8.2.2 Derived data used in analyses 
8.2.2.1 FESC  
As presented in chapter 6, 10 clusters (A-J) were identified where there were differences 
between NW, Ob and RYGBpl in the brain response to 400 kcal fixed meal ingestion 
(note 12 NW, 21 Ob, and 9 RYGBpl contributed to this data).  FESC was calculated for 
each cluster (mean normalised voxel value in FED minus mean normalised voxel value 
in FASTED) for each subject and for RYGB separately for placebo (RYGBpl) and 
somatostatin+insulin (RYGBss) (section 2.7.5).  
 
8.2.2.2 FED effect PYY, GLP-1, GIP and insulin at +30 min 
Food-evoked difference (FED effect) at +30 min (rather than +80 min) was used in the 
correlations with FESC because FDG signal is weighted towards brain activity earlier in 
the uptake period (section 1.5.1.1). Data on PYY, GLP-1, GIP and insulin were 
analysed because they showed a response at +30 min across all subjects and the overall 
response was different between groups (although at +30 min only significant for PYY 
and GLP-1) (section 5.3.4).  FED effect was calculated as FED minus FASTED.   
 
8.2.3 Data processing  
One ad libitum meal was not performed (RYGB11 somatostatin-FASTED) because the 
subject declined at the final PET scanning visit due to abdominal discomfort after the ad 
libitum meal at the preceding visit.   
 
Missing VAS data were handled as described in section 2.6.1.2, with details for NW, 
Ob and RYGBpl in section 5.2.2.2.  For RYGBss 24/360 (7%) data points were 
missing, of which 17 were substituted.  At -105 min: 4/90 (5 VAS scales x 2 conditions 
x 9 subjects) were missing, not substituted.  At -7 min 13/90 were missing, 12 
substituted with -20 min data (RYGB07 somatostatin-FASTED: all 5 VAS; RYGB11 
somatostatin-FASTED: hunger & pleasantness; RYGB05 somatostatin-FED: all 5 
VAS).  At +10 min 5/45 FASTED missing, substituted with -7 min data in 5 (RYGB03 
all 5 VAS) and no FED were missing.  At +80 min 2/90 missing, not substituted.  
 
A small number of peptide data were missing.  For NW, Ob and RYGBpl this is 
described in section 5.2.2.4.  For RYGBss data were available as follows: insulin 72/72, 
glucagon 69/72, PYY 70/72, GLP-1 71/72, GIP 70/72, and ghrelin 69/72.  There were 
no missing leptin or adiponectin samples.  There were no missing FESC data.   
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8.2.4 Statistical analysis  
8.2.4.1 Effect of somatostatin+insulin on peptide concentrations, appetitive and 
relaxedness VAS scores and ad libitum consumption in RYGB  
Within-within-subjects ANOVA was used to analyse effects of somatostatin in RYGB 
(section 2.6.2.3) for peptides; glucose; ad libitum consumption; and VAS fullness, 
hunger and anticipated pleasantness of eating.  Interaction between fed state and 
somatostatin, and main effects of fed state and somatostatin, are reported. 
 
VAS sickness and relaxedness did not meet the required assumptions for within-within-
subjects ANOVA. There is no single non-parametric equivalent, and therefore 
Wilcoxon signed-rank tests were used to test the effect of somatostatin on FED effect 
(interaction); main effect of fed state; and main effect of somatostatin.  
 
8.2.4.2 Effect of somatostatin+insulin on FESC in RYGB  
Differences in FESC between placebo and somatostatin+insulin in RYGB were 
analysed using paired t tests (section 2.7.5).  
 
8.2.4.3 Correlational analyses 
Exploratory Spearman’s rank correlational analyses were performed between +30 min 
FED effect PYY, GLP-1, GIP and insulin and FESC.  For each correlation, analyses 
were performed across all subjects and within each group. 
 
There was no original intention to perform such correlational analyses and the study is 
underpowered for them.  As discussed in section 7.2.4, a sample size of at least 82 
would be required to give an 80% power to detect a medium strength correlation (r=0.3) 
at a significance level of 5%. The +30 min sample was part of the protocol (section 
2.5.6.6) for only 26/42 participants (6/12 NW, 11/21 Ob and all 9 RYGB subjects). 
 
Each analysis (the all-subjects analysis and each within-group analysis) includes 40 
correlations: Bonferroni-adjusted α=0.00125.  In order to have a possibility of detecting 
relationships in this small sample, correlations were considered significant if p≤0.05 
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8.3 RESULTS 
8.3.1 Effect of somatostatin+insulin on pancreatic and gut peptide responses in 
RYGB 
Somatostatin plus insulin in RYGB achieved no significant difference in insulin 
between placebo and somatostatin at -10 min (85 min into infusions) and this was 
sustained in FASTED at +30 and +80 min (Figure 8.1a, Table 8.1).  Glucagon, PYY, 
GLP-1, GIP and total ghrelin were lower with somatostatin+insulin at -10 min and this 
was sustained in FASTED at +30 min (not significant for PYY, p=0.069) and at +80 
min for GLP-1 and  GIP (Figure 8.1 and Tables 8.1 and 8.2).   
 
Somatostatin+insulin abolished the insulin, PYY, GLP-1 and GIP responses to 400 kcal 
meal ingestion.  Somatostatin+insulin reversed the glucagon response to food ingestion 
at +30 min with a FED effect of +14.9±4.8 pg/ml (mean±SE) with placebo and -
12.1±3.8 pg/ml with somatostatin plus insulin.  There was no significant total ghrelin 
response to food ingestion with placebo or somatostatin+insulin.  The reduced 
somatostatin infusion rate in RYGB07 and RYGB09 did not have any impact on the 
effect of somatostatin on insulin, glucagon, PYY, GLP-1, GIP or total ghrelin. 
 
Somatostatin+insulin had no impact on adiponectin or leptin.  
 
8.3.2 Effect of somatostatin+insulin on VPG in RYGB 
Intravenous 20% glucose was used in: placebo-FASTED, no subjects; placebo-FED, 2 
subjects (23 & 63 ml between -95 min to +80 min); somatostatin-FASTED, 8 subjects 
(12-95 ml) and somatostatin-FED 7 subjects (21-49 ml).    VPG fell to 3-3.8 mmol/l 
between -95 and +80 min in: placebo-FASTED, 1 subject; placebo-FED, 3 subjects; 
somatostatin-FASTED, 3 subjects; and somatostatin-FED 2 subjects.  VPG fell below 3 
mmol/l at 2 visits: RYGB11 in the placebo-FED post-meal phase for 7 min, lowest VPG 
2.9 mmol/l; and RYGB10 in the somatostatin-FASTED post-meal phase for 16 min, 
lowest VPG 2.9 mmol/l. Subjects were asymptomatic. 
 
Somatostatin plus insulin with intravenous glucose as required had no significant impact 
on VPG at -10 min (after 85 min infusions) or on effect of 400 kcal meal ingestion to 
increase post-meal phase (0-80 min) VPG mean, peak or range or on VPG nadir (Figure 
8.2, Table 8.3).  The highest VPG was 7.9 mmol/l (RYGB09: placebo-FED post-meal 
phase (+30 min); RYGB10: somatostatin-FED post-meal phase (+80 min).  
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Table 8.1: Effect of somatostatin and 400 kcal meal ingestion on insulin, 







Within RYGB comparisons 













Fasted 5.6±2.6 5.4±1.5 
- - - 
Fed 6.0±2.9 6.1±2.6 
-10 
Fasted 5.2±2.9 6.3±3.2 
p=0.314 p=0.345 p=0.105 
Fed 5.2±1.4 7.5±4.2 
+30 









Fed 61.7±50.3 5.8±3.7 
+80 
Fasted 3.5±1.6 5.1±2.6 
p=0.085 p=0.094 p=0.817 
Fed 8.1±6.6 5.9±2.2 
Glucagon pg/ml 
-100 
Fasted 53.2±13.9 50.7±13.6 
- - - 
Fed 52.0±11.3 51.7±15.1 
-10 
Fasted 54.6±10.1 43.7±9.3 
p=0.558 p=0.567 p<0.001*** 
Fed 48.5±17.5 40.6±20.8 
+30 








Fed 65.5±17.9 32.8±12.5 
+80 








Fed 51.7±11.4 30.4±10.5 
PYY pg/ml 
-100 
Fasted 86.7±27.1 91.4±24.7 
- - - 
Fed 88.8±21.5 86.9±29.1 
-10 
Fasted 89.8±34.0 74.6±18.9 
p=0.954 p=0.300 p=0.005** 
Fed 82.5±21.9 67.9±19.2 
+30 









Fed 177.5±53.2 67.9±20.1 
+80 








Fed 144.3±27.6 63.0±23.1 
GLP-1 EIA pmol/L 
-100 
Fasted 16.4±7.5 14.8±9.5 
- - - 
Fed 20.3±10.3 17.8±8.7 
-10 
Fasted 16.8±9.8 6.0±5.1 
p=0.633 p=0.281 p<0.001*** 
Fed 19.5±11.3 7.4±4.5 
+30 








Fed 66.0±33.6 5.0±3.2 
+80 













KF Hunt.   Chapter 8: The role of gut peptides in altered regional brain responses after RYGB 
Table 8.2: Effect of somatostatin and 400 kcal meal ingestion on GIP, total 







Within RYGB comparisons 













Fasted 31.4±17.3 33.9±28.6 
- - - 
Fed 29.1±19.2 38.6±18.8 
-10 
Fasted 31.4±16.1 9.5±4.5 
p=0.575 p=0.621 p=0.005** 
Fed 31.4±19.2 14.4±11.8 
+30 








Fed 219.6±90.7 8.6±5.0 
+80 








Fed 105.1±37.9 9.9±6.6 
Total ghrelin (pg/ml) 
-100 
Fasted 887±335 800±352 
   
Fed 883±305 716±362 
-10 
Fasted 833±354 589±171 
p=0.399 p=0.695 p=0.012* 
Fed 785±248 595±155 
+30 
Fasted 791±338 531±126 
p=0.974 p=0.970 p=0.023* 
Fed 741±218 514±134 
+80 
Fasted 888±414 530±261 
p=0.860 p=0.396 p=0.054 
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Within RYGB comparisons 











VPG at -10 min  
-10 min 
Fasted 4.9±0.5 4.4±0.2 
0.087 0.431 0.097 
Fed 4.8±0.5 4.6±0.2 
VPG between 0 and +80 min 
Mean 
Fasted 4.7±0.5 4.3±0.3 
p=0.152 p<0.001*** p=0.675 
Fed 5.2±0.9 5.4±0.7 
Nadir 
Fasted 4.5±0.5 4.0±0.5 
p=0.247 p=0.893 p=0.230 
Fed 4.3±0.9 4.2±0.5 
Peak 
Fasted 4.9±0.5 4.6±0.3 
p=0.612 p<0.001*** p=0.061 
Fed 6.6±0.9 6.2±1.0 
Range 
Fasted 0.3±0.2 0.6±0.4 
p=0.132 p=0.001** p=0.843 
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8.3.3 Effect of somatostatin+insulin on appetitive and relaxedness VAS scores and 
ad libitum consumption in RYGB 
Somatostatin+insulin had no impact on -7 min fullness (p=0.252), hunger (p=0.442), 
anticipated pleasantness of eating (p=0.819) or relaxedness (p=0.131) scores (Figure 
8.3, Tables 8.4 and 8.5).  Somatostatin+insulin had no significant effect on the impact of 
400 kcal meal to increase fullness scores at +10 min (p=0.314) or +80 min (p=0.377) 
(Figure 8.3a) or to decrease anticipated pleasantness of eating scores at +10 min 
(p=0.902) (Figure 8.3d).  However, somatostatin+insulin did result in an attenuated +80 
min decrease in anticipated pleasantness of eating scores, due to non-significantly lower 
FASTED and non-significantly higher FED scores.   For hunger scores (Figure 8.3c) at 
+10 min there was an unexpected greater decrease in FED versus FASTED with 
somatostatin+insulin (-44±8 points, mean±SE) versus placebo (-29±11 points) 
(p=0.036) with no impact at +80 min.  
 
Sickness scores were higher with somatostatin at -7 min (p=0.017) (Figure 8.3b, Table 
8.5).  However, somatostatin attenuated the increase in sickness scores seen in RYGBpl 
at +10 min (median FED effect +26 points with placebo and +5 points with 
somatostatin, p=0.05).   
  
For relaxedness scores, at +10 min there was a small difference in FED effect between 
placebo (median FED effect -6 points) and somatostatin (median FED effect +1 point).   
 
The apparent increase in consumption at the ad libitum meal with somatostatin+insulin 
was not significant (Figure 8.3f, Table 8.4) even when considering the impact on ad 
libitum consumption in the fasted state only (paired t test p=0.233, n=8). 
 
8.3.4 Effect of somatostatin+insulin on FESC in RYGB 
In cluster B (left medial OC), somatostatin+insulin abolished the positive FESC seen in 
RYGBpl (p<0.001) (Figure 8.4, Table 8.6).  Somatostatin+insulin had no significant 
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Table 8.4 Effect of somatostatin and 400 kcal meal ingestion on ad libitum 







Within RYGB comparisons  












Ad libitum consumption 
- 
Fasted 294±127 444±321 
p=0.413 p=0.014* p=0.266 
Fed 251±129 322±292 
Fullness scores 
-105 
Fasted 17.2±14.3 19.8±19.5 
- - - 
Fed 20.1±21.6 16.0±20.4 
-7 
Fasted 26.2±24.4 24.4±27.3 
p=0.579 p=0.088 p=0.252 
Fed 21.4±17.2 14.6±15.7 
+10 
Fasted 19.2±15.2 21.1±20.5 
p=0.314 p<0.001*** p=0.354 
Fed 71.8±18.2 59.6±23.9 
+80 
Fasted 27.7±18.6 20.2±22.8 
p=0.377 p=0.051 p=0.714 
Fed 37.9±27.3 40.4±29.8 
Hunger scores 
-105 
Fasted 36.4±34.8 23.0±31.7 
- - - 
Fed 43.1±37.3 21.8±24.6 
-7 
Fasted 47.0±28.9 58.6±27.3 
p=0.403 p=0.152 p=0.442 
Fed 56.4±22.8 60.6±29.7 
+10 












Fed 19.9±27.0 12.7±21.5 
+80 
Fasted 59.3±25.4 50.3±31.4 
p=0.682 p=0.003** 
p=0.905 
 Fed 24.9±24.5 28.9±20.3 
Anticipated pleasantness of eating scores 
-105 
Fasted 45.1±29.1 43.0±36.3 
- - - 
Fed 54.1±33.1 44.3±37.3 
-7 
Fasted 62.2±29.2 52.3±30.9 p=0.162 p=0.327 p=0.819 
Fed 59.7±23.6 65.9±31.0 
+10 
Fasted 60.2±28.5 55.4±32.2 p=0.902 p=0.001** p=0.688 
Fed 20.1±27.4 17.0±32.0 
+80 
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(median (lower quartile, 
upper quartile)) 
Within RYGB comparisons (Wilcoxon signed 













Fasted 0.0 (0.0, 0.0) 
0.0 (0.0, 
2.0) 
- - - 




Fasted 0.0 (0.0, 0.0) 
7.0 (0.5, 
36.5) 
p=0.345 p=0.889 p=0.017* 
























Fasted 0.0 (0.0, 3.0) 
0.0 (0.0, 
3.5) 
p>0.999 p=0.258 p=0.674 





































































KF Hunt.   Chapter 8: The role of gut peptides in altered regional brain responses after RYGB 
Table 8.6: Effect of somatostatin and 400 kcal meal ingestion on FESC in RYGB 
Cluster OR 
Intersect between cluster and modified Tziortzi atlas region 
(Region name (region number))  
FESC (mean±SD)  paired t 
test RYGBpl RYGBss  
Whole cluster A - -3.07±2.18 -3.83±1.98 0.374 
Anterior DLFC R (33) - -4.09±2.89 -4.68±3.30 0.664 
Anterior MFC R (106) - -3.02±3.51 -3.40±2.48 0.725 
Medial orbital cortex R (48) - -0.41±2.71 -2.03±2.88 0.239 
Whole Cluster B Medial orbital cortex L (17) 4.83±2.50 -0.27±2.06 <0.001*** 
Whole Cluster C - -4.18±3.07 -4.47±4.06 0.859 
Anterior DLFC R (33) - -3.42±4.74 -3.11±2.78 0.883 
Posterior DLFC R (111) - -4.47±2.96 -5.02±4.71 0.721 
Whole Cluster D 
Lateral orbital cortex R (52) 
-3.65±2.87 -3.15±2.41 0.762 
Ant DLFC R (33) 
Post DLFC R (111) 
Frontal operculum cortex R 
(60) 
Insular cortex R (32) 
Whole Cluster E 
Hypothalamus (Baroncini) 
9.37±2.37 6.83±5.57 0.277 Ventral cingulate subcallosal 
gyrus (63) 
Whole Cluster F Pituitary VOI 14.47±4.76 9.52±8.83 0.169 
Whole Cluster G - -7.59±2.69 -8.09±5.31 0.742 
Posterior cingulate (65) - -7.26±2.51 -6.72±4.24 0.648 
Precuneus cortex R (50) - -8.90±3.36 -9.66±5.91 0.666 
Precuneus cortex L (19) - -7.52±2.62 -8.88±6.29 0.444 
Cuneus R (51) - -6.93±4.43 -6.80±6.34 0.955 
Whole Cluster H - -5.38±1.97 -4.76±4.62 0.717 
Angular gyrus R (45)  -5.06±1.91 -5.61±5.97 0.788 
Superior temporal gyrus 
posterior R (37) 
- 
-4.09±3.82 -4.16±3.02 0.971 
Middle temporal gyrus 
posterior R (39) 
- 
-5.28±2.33 -4.34±4.08 0.570 
Occipital pole R (46) - -6.21±2.46 -4.22±5.21 0.326 
Whole Cluster I - -6.00±1.76 -4.91±3.90 0.366 
Angular gyrus L (14) - -5.91±2.43 -5.82±4.02 0.908 
Occipital pole L (15) - -5.84±1.58 -4.02±4.51 0.252 
Parietal lobule L (12) - -6.82±3.28 -5.64±4.29 0.502 
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8.3.5 Correlations between time post-RYGB and +30 min FED effect insulin and 
gut peptides, +10 min appetitive and relaxedness VAS scores, ad libitum 
consumption and FESC  
The lack of impact of somatostatin+insulin in RYGB was unexpected.  Exploratory 
Spearman’s correlational analyses were performed to investigate if time post-surgery 
impacted on the pancreatic and gut peptide responses, appetitive and relaxedness 
responses, ad libitum consumption, or FESC in the 10 clusters (Table 8.7).  Analyses 
were performed within placebo and within somatostatin+insulin.  There were 21 
correlations within each analysis: Bonferroni adjusted α=0.0024.  In order to have a 
possibility of detecting relationships in this small sample, correlations were considered 
significant if p≤0.05 (uncorrected), therefore these analyses should be considered highly 
exploratory. 
 
There were no significant (p≤0.05) correlations between time post-RYGB and +30 min 
FED effect insulin, PYY, GLP-1 or GIP with placebo and, as would be expected, no 
evidence that the effectiveness of somatostatin to suppress responses changed with time 
post-RYGB (Figure 8.5).    
 
There was a positive correlation between time post-RYGB and +10 min FED effect 
fullness with placebo (rs=0.767, p=0.016) but not somatostatin (rs=-0.250, p=0.516) 
(Figure 8.6a).  For +10 min FED effect sickness there was no correlation with time post-
RYGB with placebo (Figure 8.6b). Somatostatin attenuated food-evoked sickness in all 
subjects in whom this was present (whether early or late after RYGB). There was a 
positive correlation between time post-RYGB and +10 min FED effect sickness with 
somatostatin (rs=0.790, p=0.011), apparently driven by 3 subjects >20 months post 
RYGB: 2 in whom high food-evoked sickness was not completely suppressed by 
somatostatin and 1 with food-evoked sickness with somatostatin but not placebo (Figure 
8.6b).  There were no correlations between time post-RYGB and FED effect hunger, 
anticipated pleasantness of eating (Figure 8.6c) or relaxedness with placebo or 
somatostatin.  
 
There were no significant correlations between time post-RYGB and ad libitum 
consumption in the fasted (Figure 8.6d) or fed state.  However, 3/5 subjects <12 months 
post-surgery showed marked increase in ad libitum consumption in the fasted state with 
somatostatin+insulin not seen in 3/3 subjects >20 months post-RYGB.   
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Figure 8.7: Correlations between time post RYGB and FESC in clusters E 
(hypothalamus), F (pituitary), H (angular gyrus (R) etc) and I (angular gyrus (L) 
etc) with placebo and somatostatin 
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Table 8.7: Correlations between time post RYGB and: +30 min FED effect insulin 
and gut peptides; ad libitum consumption; +10 min FED effect appetitive and 
relaxedness VAS scores; and FESC 
 
RYGBpl RYGBss 
rs p rs p 
+30 min FED effect insulin (mIU/L) -0.217 0.576 -0.017 0.966 
+30 min FED effect PYY (pg/ml) 0.017 0.966 0.571 0.139 
+30 min FED effect GLP-1 (pmol/L) -0.317 0.406 -0.467 0.205 
+30 min FED effect GIP (pg/ml) 0.400 0.286 -0.024 0.955 
Ad libitum consumption (FASTED) (kcal) 0.059 0.881 -0.167 0.693 
Ad libitum consumption (FED) (kcal) 0.276 0.472 -0.435 0.242 
+10 min FED effect fullness 0.767 0.016* -0.250 0.516 
+10 min FED effect sickness 0.494 0.177 0.790 0.011* 
+10 min FED effect hunger -0.283 0.460 0.200 0.606 
+10 min FED effect anticipated 
pleasantness of eating 
-0.167 0.668 -0.333 0.381 
+10 min FED effect relaxedness 0.059 0.880 -0.170 0.663 
Cluster A FESC (%) 0.283 0.460 0.100 0.798 
Cluster B FESC (%) 0.200 0.606 0.033 0.932 
Cluster C FESC (%) 0.217 0.576 0.177 0.765 
Cluster D FESC (%) 0.333 0.381 -0.100 0.798 
Cluster E FESC (%) -0.617 0.077 0.333 0.381 
Cluster F FESC (%) -0.867 0.002** 0.050 0.898 
Cluster G FESC (%) 0.217 0.576 0.00 >0.999 
Cluster H FESC (%) 0.583 0.099 -0.017 0.966 
Cluster I FESC (%) 0.667 0.050* -0.083 0.831 
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With placebo, but not somatostatin, there was a significant negative correlation between 
time post-RYGB and FESC in cluster F (pituitary; rs=-0.867, p=0.002 (survives 
Bonferroni correction); Figure 8.7b) (not significant for cluster E (hypothalamus) rs=-
0.617, p=0.077; Figure 8.7a) and a positive correlation between time post-RYGB and 
FESC in cluster I  (angular gyrus (L); rs=0.667, p=0.050; Figure 8.7d) (not significant 
for cluster H (angular gyrus (R)) rs=0.583, p=0.099; Figure 8.7c).   In clusters E 
(hypothalamus), F (pituitary), H (angular gyrus (R)) and I (angular gyrus (L)) there was 
a suggestion that somatostatin+insulin had a greater impact in subjects <12 months 
post-surgery to reduce activation in clusters E and F and reduce deactivation in clusters 
H and I.  There were no significant correlations between time post-RYGB and FESC in 
any other cluster (Figure 8.8, Table 8.7).  In cluster B (Figure 8.8b) 
somatostatin+insulin reduced activation in all subjects.   In clusters A (Figure 8.8a), C 
(Figure 8.8c) and D (Figure 8.8d) the impact was variable and did not appear to vary 
with time.  
 
There were no significant correlations between +10 min appetitive or relaxedness VAS 
scores, ad libitum consumption in the fasted state, or FESC in any cluster and post-
RYGB weight loss (data not shown).  
 
8.3.6 Correlations between +30 min FED effect insulin and gut peptides and FESC  
Results are presented for insulin (Table 8.8), PYY (Table 8.9), GLP-1 (Table 8.10) and 
GIP (Table 8.11).  For this exploratory analysis I have focussed on: hypothalamus, 
which might be expected to show responses to gut peptides; clusters which showed 
significant correlations (p≤0.05) across all subjects for more than one peptide; and 
clusters where correlations across all subjects remained significant at Bonferroni-
corrected α=0.00125.  
 
For cluster E (hypothalamus) there was a positive correlation between +30 min FED 
effect GLP-1 and FESC across all subjects but no significant correlations for FED effect 
insulin, PYY or GIP (Figure 8.9). For cluster F (pituitary) there was a positive 
correlation between +30 min PYY and GLP-1 and FESC across all subjects.   
 
For cluster B (medial OC (L)) there were positive correlations between +30 min FED 
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Table 8.8: Correlations between +30 min FED effect insulin and FESC 
Cluster 
All (n=26) NW (n=6) Ob (n=11) RYGBpl (n=9) 
rs p rs p rs p rs p 
Cluster A 0.100 0.626 0.029 0.957 -0.364 0.272 0.167 0.668 
Cluster B 0.472 0.015* 0.200 0.704 0.373 0.259 0.050 0.898 
Cluster C 0.019 0.925 -0.486 0.329 -0.155 0.650 0.167 0.668 
Cluster D 0.193 0.344 0.886 0.019* 0.091 0.790 -0.083 0.831 
Cluster E 0.165 0.420 0.086 0.872 0.345 0.298 -0.300 0.433 
Cluster F 0.111 0.589 0.200 0.704 -0.227 0.502 -0.117 0.765 
Cluster G 0.052 0.802 0.143 0.787 -0.164 0.631 0.617 0.077 
Cluster H -0.186 0.362 -0.371 0.468 -0.427 0.190 -0.067 0.865 
Cluster I -0.043 0.836 -0.029 0.957 0.055 0.873 0.200 0.606 
Cluster J -0.187 0.360 -0.371 0.468 -0.273 0.417 0.217 0.576 
 
Table 8.9: Correlations between +30 min FED effect PYY and FESC 
Cluster 
All (n=25) NW (n=6) Ob (n=10) RYGB (n=9) 
rs p rs p rs p rs p 
Cluster A -0.206 0.323 -0.543 0.266 -0.406 0.244 0.017 0.966 
Cluster B 0.468 0.018* -0.029 0.957 -0.127 0.726 0.250 0.516 
Cluster C -0.120 0.568 -0.371 0.468 -0.212 0.556 0.400 0.286 
Cluster D -0.201 0.336 -0.371 0.468 -0.539 0.108 0.417 0.265 
Cluster E 0.294 0.154 0.086 0.872 -0.212 0.556 -0.200 0.606 
Cluster F 0.562 0.003** 0.314 0.544 0.624 0.054 -0.317 0.406 
Cluster G -0.375 0.064 0.371 0.468 0.079 0.829 0.000 >0.999 
Cluster H -0.366 0.072 0.200 0.704 0.236 0.511 -0.033 0.932 
Cluster I -0.279 0.176 0.200 0.704 0.600 0.067 0.017 0.966 
Cluster J -0.227 0.275 0.886 0.019* -0.018 0.960 -0.400 0.286 
 
Table 8.10: Correlations between +30 min FED effect GLP-1 and FESC 
Cluster 
All (n=24) NW (n=6) Ob (n=9) RYGB (n=9) 
rs p rs p rs p rs p 
Cluster A -0.398 0.054 -0.429 0.397 -0.183 0.637 0.267 0.488 
Cluster B 0.708 <0.001*** 0.771 0.072 0.500 0.170 0.117 0.765 
Cluster C -0.294 0.163 -0.486 0.329 -0.367 0.332 0.633 0.067 
Cluster D -0.397 0.078 0.429 0.397 -0.533 0.139 0.533 0.139 
Cluster E 0.632 0.001** 0.771 0.072 -0.050 0.898 -0.333 0.381 
Cluster F 0.709 <0.001*** 0.657 0.156 0.067 0.865 -0.133 0.732 
Cluster G -0.725 <0.001*** -0.543 0.266 -0.517 0.154 0.400 0.286 
Cluster H -0.729 <0.001*** -0.371 0.468 -0.267 0.488 0.067 0.865 
Cluster I -0.662 <0.001*** -0.829 0.042* 0.250 0.516 -0.033 0.932 
Cluster J -0.263 0.215 -0.371 0.468 -0.050 0.898 -0.133 0.732 
 
Table 8.11: Correlations between +30 min FED effect GIP and FESC  
Cluster 
All (n=25) NW (n=6) Ob (n=10) RYGB (n=9) 
rs p rs p rs p rs p 
Cluster A 0.237 0.254 -0.543 0.266 -0.467 0.174 0.583 0.099 
Cluster B 0.154 0.463 -0.429 0.397 0.273 0.446 0.200 0.606 
Cluster C 0.307 0.136 -0.600 0.208 0.236 0.511 0.733 0.025* 
Cluster D 0.455 0.022* 0.371 0.468 -0.188 0.603 0.900 0.001** 
Cluster E -0.133 0.526 0.543 0.266 -0.200 0.580 -0.517 0.154 
Cluster F 0.042 0.844 0.600 0.208 0.273 0.446 -0.683 0.042* 
Cluster G 0.122 0.563 -0.429 0.397 -0.079 0.829 0.267 0.488 
Cluster H 0.182 0.385 -0.257 0.623 0.091 0.803 0.667 0.050* 
Cluster I 0.210 0.314 -0.371 0.468 0.430 0.214 0.267 0.488 
Cluster J -0.218 0.296 -0.257 0.623 0.091 0.803 -0.267 0.488 
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For clusters G (posterior cingulate/precuneus), H and I (bilateral angular gyri) there 
were negative correlations between FED effect GLP-1 and FESC across all subjects 




8.4.1 Effect of somatostatin+insulin on pancreatic and gut peptide and glucose 
responses   
As expected (section 1.3.3.8), somatostatin+insulin suppressed basal (fasting) glucagon, 
PYY, GLP-1, GIP and ghrelin.  The concomitant insulin infusion resulted in successful 
replacement of basal insulin.  As expected, somatostatin abolished the food-evoked 
increase in insulin, glucagon, PYY, GLP-1 and GIP.  The further suppression of 
glucagon in somatostatin-FED compared to somatostatin-FASTED was unexpected 
suggesting suppression of glucagon secretion is not complete at this dose of 
somatostatin. Both somatostatin and insulin inhibit glucagon production (sections 
1.3.3.7 and 1.3.3.8), however infusion rates were the same in somatostatin-FASTED 
and FED and the insulin levels achieved were not different. This might be a 
consequence of higher plasma glucose in FED compared to FASTED further 
suppressing glucagon secretion.  Somatostatin+insulin with intravenous glucose as 
needed achieved no significant differences in VPG responses compared to placebo.  
  
8.4.2 The role of insulin and gut peptides in appetitive and relaxedness sensations 
and determining meal size after RYGB 
Based on the work of le Roux et al [81], somatostatin was expected to reduce the impact 
of ingesting 400 kcal fixed meal on fullness and hunger scores and increase ad libitum 
consumption but I did not find this.  Somatostatin+insulin had no significant effect on 
increase in fullness scores or decrease in anticipated pleasantness of eating scores at +10 
min and actually increased the impact on hunger scores at +10 min, although as 
discussed in section 7.3.2 FED effect hunger scores are limited by the finite nature of 
the VAS in RYGB subjects.   Somatostatin+insulin did, however, attenuate the increase 
in sickness scores seen in RYGBpl at +10 min across the 9 subjects, and individually in 
all 5 subjects who showed postprandial sickness (irrespective of time post-surgery), 
suggesting that postprandial sickness after RYGB is mediated by gut peptides.   The 
attenuation of the small postprandial decrease in relaxedness scores with 
somatostatin+insulin might be due to the impact on postprandial sickness, although the 
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negative correlation between FED effect relaxedness and sickness was not significant 
(rs=-0.487, p=0.183, Table 7.4).  The apparent increase in the amount consumed at the 
ad libitum meal with somatostatin+insulin was not statistically significant.   
 
It is not clear why somatostatin infusion, which did abolish the gut peptide response to 
food ingestion as expected, did not have the anticipated effects on fullness, hunger, 
anticipated pleasantness of eating and food consumption. Interestingly, consistent with 
my study, Goldstone et al reported octreotide plus insulin (versus saline) in post-RYGB 
did suppress PYY and GLP-1, but had no effect on postprandial hunger or fullness 
[201].    The protocol used here versus in le Roux et al [81] were similar in VAS timing 
(respectively 10 min after end of meal versus 15 min after start of meal), and in the use 
of ice-cream as the meal and although I assessed VAS after a 400 kcal fixed meal and 
ad libitum consumption separately and they assessed VAS 15 min (=400 kcal) into an 
ad libitum meal it is difficult to see how this would have such an impact. However, a 
potentially important difference is that I used intravenous somatostatin infusion and 
replaced basal insulin whereas le Roux et al [81] used a single subcutaneous dose of 
octreotide without basal insulin replacement.  It is possible that absence of basal insulin 
was responsible for the lower fullness scores and increased ad libitum consumption seen 
in le Roux et al.  Studies in animals and humans demonstrate insulin, albeit at higher 
than basal concentrations, can act on the brain to reduce food intake [253-255] and 
regional differences in brain FDG uptake were found in reward regions with 
somatostatin with, versus without, low-dose insulin infusion [215] suggesting absence 
of basal insulin may be important. Alternatively there may be a difference in the effects 
of octreotide and somatostatin.  It is possible that somatostatin causes more nausea, or 
other unpleasant effects, than octreotide and thus attenuates any effect to increase food 
intake.  However the increase in nausea seen with somatostatin at -7 min in my study 
was small.  It is possible that somatostatin and octreotide have different effects on 
different gut peptides. Both studies showed abolition of post-meal response in all 
peptides measured (in this study insulin, glucagon, PYY, GLP-1 and GIP and le Roux et 
al PYY and GLP-1).   However, differences in impact on un-measured, or undiscovered, 
gut peptides is possible. Another possibility is that octreotide exerts its effect to increase 
food intake and reduce fullness post-RYGB by a direct action on neuropeptide secretion 
in the brain, rather than by its effect on peripheral gut peptide responses.  It is possible 
that somatostatin, while having a similar impact on peripheral gut peptide responses, 
does not reach, or has a different effect in, the brain.  However, evidence from animal 
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studies suggests that neither somatostatin or octreotide cross the blood brain barrier in 
appreciable amounts [256] making this less likely.   Whatever the explanation for the 
difference between studies, my subjects had responded to RYGB and had low ad 
libitum intake and the finding that successful acute inhibition of the gut peptide 
response did not impact significantly on ad libitum consumption suggest exaggerated 
insulin, GLP-1, PYY or GIP responses to the acute meal were not the major mechanism 
limiting meal size at least in my subjects considered as a group at the time studied.    
 
The RYGB subjects in my study were similar to the 7 post-RYGB subjects studied by le 
Roux et al [81] in age (respectively 45.1±10.7 (mean±SD) versus 43±4.5 (mean±SE) 
years) and BMI (34±3.3 versus 33.2±1.9 kg/m2).  However the time post-RYGB was 
longer at 18±13 versus 9.5±1.5 months and therefore the effect of time post-RYGB was 
investigated.  There was no evidence that insulin or gut peptide responses to 400 kcal 
meal ingestion, or the ability of somatostatin to inhibit these, changed with time after 
surgery and this is consistent with the literature suggesting that the responses are 
maintained in the longer term post-surgery (section 1.3.3).  There was no evidence that 
food-evoked sickness, hunger or anticipated pleasantness of eating changed with time 
after RYGB and food-evoked fullness actually increased.  Individual subject data 
showed a consistent effect of somatostatin to reduce postprandial nausea, as mentioned 
above.  However the effect of somatostatin+insulin on food-induced fullness and 
anticipated pleasantness of eating was variable, with some subjects showing an 
attenuated effect, some no effect and others an increased effect, and did not seem to 
change with time post-surgery.  It is not possible to determine from these data whether 
this is due to inter-individual difference in the mechanisms producing these appetitive 
sensations after RYGB or whether the variance is due to chance and the limitations of 
VAS scales [18]. There was no evidence that ad libitum consumption changed with time 
after RYGB.  However, the impact of somatostatin to increase ad libitum consumption 
varied between subjects with a suggestion of a more marked effect in some, but not all, 
subjects less than 12 months post-RYGB, although the numbers are too small to test this 
statistically.  Given that both this study and others [65] suggest reduced ad libitum 
consumption is maintained in the longer term after RYGB, these findings would be 
consistent with inter-individual differences in mechanisms leading to reduced meal size 
after RYGB, with exaggerated gut peptide responses to a meal being one mechanism, 
and/or that, although exaggerated gut peptide responses persist in the longer term after 
RYGB, the acute impact to reduce ad libitum consumption is attenuated with time.  It 
263 
 
KF Hunt.   Chapter 8: The role of gut peptides in altered regional brain responses after RYGB 
has been suggested that repeated exposure to exaggerated gut peptide responses might 
be important [7], which would be consistent with the lack of impact of acute 
suppression seen in my study, and of course there are other candidates for gut-to-brain 
signalling after RYGB (section 1.3.2). 
 
8.4.3 The role of insulin and gut peptides in altered regional brain responses to 
eating after RYGB 
Somatostatin+insulin only impacted significantly on FESC in left medial OC (cluster B) 
where it abolished the positive FESC seen in RYGBpl, converting it to response similar 
to the minimal responses seen in both NW and Ob.  This effect of somatostatin was 
seen, to varying extents, in all 9 individual subjects.  Furthermore, for cluster B there 
were positive correlations across all subjects between +30 min food-evoked difference 
in insulin, PYY and GLP-1 and FESC.  Taken together, these suggest the exaggerated 
insulin and/or gut peptides responses mediate left medial OC activation seen after 
RYGB.  These findings are consistent with previous neuroimaging studies investigating 
responses to gut peptides and insulin (section 1.9). Batterham et al [206] performed 
resting BOLD-fMRI scans in normal weight men with and without PYY infusion and 
found, on a whole brain analysis, the greatest effect of PYY to be in left OC (albeit 
lateral OC) where BOLD signal co-varied positively with PYY concentrations.  De 
Silva et al [207] found, in a ROI analysis, non-significant attenuation in the BOLD-
fMRI response to food versus non-food pictures in OC with PYY and GLP-1 infusions.  
Van Bloemendaal et al [208] found, in a ROI analysis, the GLP-1 receptor agonist 
exenatide attenuated the positive BOLD-fMRI response in OC to food versus non-food 
pictures (obese subjects with T2DM) and to high ED food versus non-food pictures 
(obese subjects with NGT and T2DM).  Kullmann et al found intranasal insulin, versus 
placebo, decreased intrinsic BOLD activity in OC (whole brain analysis) [218].  
Goldstone et al did not include OC as a ROI (for technical reasons) in their study 
looking at the impact of octreotide (plus insulin) on the BOLD-fMRI response to food 
versus non-food pictures after RYGB [201].   
 
My data showed that in post-RYGB subjects both FED effect sickness (section 8.3.3) 
and FESC in cluster B were attenuated by somatostatin+insulin, raising the possibility 
that medial OC activation might mediate, or be influenced by, postprandial nausea.  
However, as presented in chapter 7, there was no significant correlation between FED 
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effect sickness and FESC in cluster B across all subjects (rs=0.285, p=0.071, Table 7.1) 
or within RYGBpl (rs=0.410, p=0.273, Table 7.4).  
 
There was no significant impact of somatostatin+insulin in any other cluster considering 
RYGB subjects as a group. However, there is a suggestion that somatostatin+insulin 
may have a greater impact in subjects less than 12 months post-RYGB to reduce 
activation in hypothalamus and pituitary, and reduce deactivation in bilateral angular 
gyri etc..  This suggests acute postprandial insulin and/or gut peptide responses may 
have a role in activation in hypothalamus and pituitary and deactivation in angular gyri 
earlier after RYGB.  This potential role for gut peptides in these regions is supported by 
the finding that, across all subjects, +30 min food-evoked difference in GLP-1  is 
positively correlated with FESC in hypothalamus and pituitary and negatively 
correlated with FESC in bilateral angular gyri.  
 
It is worth noting that for right DLFC (cluster C) (for which my data was consistent 
with deactivation in NW, absent in Ob and restored after RYGB (section 6.3.2) and 
suggested a major role in meal termination (section 7.4.3.2)) there was no consistent 
evidence for a role for exaggerated gut peptide responses mediating restoration of 
response after RYGB.   
 
8.4.4 Limitations  
8.4.4.1 Impact of differences in glucose  
As discussed in section 6.4.3.2 it was important to avoid hypoglycaemia to avoid the 
associated brain responses. The lowest VPG (which is higher than arterial) of 2.9 
mmol/l was seen in 2 subjects for maximum of 16 min and occurred after 60 min, after 
the majority of FDG is trapped (section 1.5.1.1). More subjects required intravenous 
glucose with somatostatin+insulin than with placebo, maximum 95 ml 20% glucose 
(=19g glucose = 63 kcal).  It is possible this may have influenced results, although as 
similar numbers of subjects required comparable amounts of glucose in somatostatin-
FASTED and somatostatin-FED this would not be expected to impact on the effect of 
somatostatin on the response to meal ingestion.   
 
The possible impact of differences in glucose excursion on FDG uptake is discussed in 
section 6.4.3.2.   To note here somatostatin+insulin with intravenous glucose as needed 
achieved no significant differences in VPG responses compared to placebo.  
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8.4.4.2 Analysis within clusters 
These analyses considered whether exaggerated gut peptide responses were responsible 
for the differences seen in brain responses to food ingestion between RYGB and NW or 
Ob.  Therefore they do not give information about regions outside these identified 
clusters which might respond to gut peptides.  To address this, my colleague Dr Joel 
Dunn performed a within-within subjects ANOVA of the effect of somatostatin and 
FED state within RYGB (this analysis is not available in SPM) finding differences in 
medial OC only, consistent with my analysis. 
 
8.4.4.3 Power and multiple testing in correlational analyses  
As discussed in sections 8.2.4.3 and 7.2.4, the study was not designed to perform such 
correlational analyses and was underpowered for them.   It is likely that some 
correlations, particularly weaker ones, would be missed.  Conversely, a large number of 
correlations were performed with the risk of false positive results (type 1 error).  
Therefore these analyses should be considered exploratory.   
 
8.4.4.4 Assessment of postprandial pancreatic and gut peptide responses  
Only 2 postprandial phase blood samples (+30 and +80 min) were performed and total, 
rather than active, GLP-1, PYY and ghrelin were measured (section 2.5.6.6).  These 
measures were sufficient to demonstrate that, in RYGB subjects, somatostatin (+insulin) 
had the expected effect to suppress pancreatic and gut peptide secretion, one of the key 
reasons for measuring these peptides in this protocol (section 2.5.6.6).   
 
There was no original intention to perform the correlations between food-evoked 
difference in insulin and gut peptide concentrations and food-evoked signal change 
presented in this chapter (section 8.3.6).  Measuring at only 2 time points will not have 
captured the peaks, which occur at different times for the different peptides and in the 
different subject groups (section 1.3.3).  More frequent sampling would have allowed 
calculation of AUC data which would have been better for these correlational analyses.  
The +30 min time point was part of the protocol for only 6/12 NW, 11/21 Ob subjects 
(section 2.5.6.6) which limited the number of subjects that could be included in these 
correlational analyses.  Measurement of biologically active (rather than total) gut 
peptide concentrations would have been more suitable for correlational analyses with 
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8.4.4.5 Timing of assessment of appetitive sensations 
Only 2 postprandial phase VAS (+10 and +80 min) were performed.   These may well 
have missed the peak or nadir (section 1.3.1.1)  More frequent measurement would have 
allowed use of AUC data which would have been better for correlational analyses and 
also reduce the impact of error or poor reproducibility (section 5.4.2.4).  However, 
assessing appetitive sensations during the FDG-PET uptake and scanning would risk 
influencing the neuroimaging results and were deliberately avoided for this reason.   
 
8.4.4.6 RYGB subjects given less than 400 kcal at the pre-scan meal 
As presented in section 5.3.1, 3 RYGB subjects were unable to consume the full 400 
kcal at the test meal visit and were given reduced amounts at both FED visits 
(somatostatin and placebo) (RYGB03 256 kcal, RYGB07 220 kcal, RYGB11 234 kcal).  
The main focus of this chapter is the impact of somatostatin (+insulin) on the responses 
to food ingestion in RYGB subjects.   As subjects act as their own controls for these 
analyses, it was important that each RYGB participant consumed the same amount 
before PET scanning at both somatostatin-FED and placebo-FED visits (section 2.5.4) 
which was achieved using this approach.   
 
As discussed in section 5.4.1, the 3 RYGB subjects consuming less is a potential 
limitation for between-subject comparisons, both as the meal stimulus is smaller for 
these 3 participants, and also that these 3 participants were fed to satiety (at the placebo-
FED visit) which may or may not be the case for other participants.  However, as 
discussed in section 5.4.1, the smaller meal in these 3 subjects appeared to have similar 
impact as the 400 kcal meal did in the remaining RYGB subjects at placebo visits on 




Exaggerated postprandial insulin and/or gut peptide responses mediate postprandial 
nausea and increased activation in left medial OC after RYGB.  However in this group 
of post-RYGB subjects, which are otherwise typical (chapter 5), the acute postprandial 
insulin and/or gut peptide responses are not the major mediators of high postprandial 
fullness, low postprandial hunger/anticipated pleasantness of eating or low ad libitum 
consumption after RYGB and do not mediate the other differences in brain responses 
after RYGB compared to NW and Ob.   However, the data suggest that acute gut 
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peptide responses may have a role in some subjects, particularly within the first year 
after RYGB, in the greater activation in hypothalamus and pituitary and greater 
deactivation in bilateral angular gyri, and in reducing ad libitum consumption.    
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CHAPTER 9: DISCUSSION 
 
9.1 INTRODUCTION 
In this study I developed and used a new FDG-PET functional neuroimaging protocol to 
investigate differences in the brain responses to 400 kcal fixed meal ingestion between 
NW, Ob and post-RYGB subjects and the role of exaggerated postprandial gut peptide 
responses after RYGB.  Mechanisms operating during (or shortly after) food ingestion, 
which may contribute to satiation, meal termination and control of meal size (section 
1.1.8.1), are of particular interest because the most consistent differences found after 
RYGB are increased postprandial fullness or satiety [23, 80, 81, 83, 85] (section 
1.3.1.1) and reduced ad libitum meal size which is correlated with post-RYGB weight 
loss [65] (section 1.3.1.6). However, functional neuroimaging protocols looking at 
responses to food ingestion are not well established. To date only two groups have 
studied differences in response to nutrient ingestion in obesity, one using [15O]-H2O-
PET to image response to a mixed meal after a prolonged fast [153, 156, 191-193] and 
the other BOLD-fMRI focussed on hypothalamus to image response to glucose 
ingestion [133] (section 1.7.3).    The only previous study looking at brain responses to 
nutrient (glucose) ingestion after RYGB used BOLD-fMRI analysed using temporal 
clustering and functional connectivity analyses [204] (section 1.8.3).   
 
The methods are described in chapter 2.  Briefly, 12 NW, 21 Ob and 9 RYGB subjects 
underwent 2 FDG-PET scanning visits in random order after overnight fasting. At the 
FED visit subjects consumed a 400 kcal fixed meal (reduced amount given in 3 RYGB 
subjects), FDG-PET scanning was performed  between +15 and +70 min,  appetitive 
sensations and relaxedness were assessed using VAS, venous blood was assayed for 
glucose, pancreatic and gut peptides and ad libitum consumption was assessed starting 
at +80 min (after FDG-PET scanning).  At the FASTED visit procedures were the same 
except subjects did not consume the 400 kcal meal.  RYGB subjects also underwent 
FED and FASTED visits with somatostatin (plus basal insulin replacement) to inhibit 
pancreatic and gut peptide responses. 
  
I have discussed the results throughout.  Here I highlight key findings and discuss 
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9.2 RESEARCH FINDINGS 
9.2.1 A new FDG-PET functional neuroimaging protocol for imaging brain 
responses to food ingestion 
There are now well established BOLD-fMRI protocols for investigating brain responses 
to food anticipation and pre-ingestive food receipt (sections 1.5.2.1; 1.6.1; 1.7.2; 1.8.2).  
However, imaging brain responses to food ingestion has proved more challenging and 
there are no widely-used protocols (sections 1.5.1, 1.6.2, 1.7.3, 1.8.3).  With the support 
of my supervisors and PET centre colleagues, I have developed a new functional 
neuroimaging protocol using FDG-PET to image the regional brain responses to food 
ingestion (chapter 2). Brain FDG uptake is a surrogate marker for brain activity and the 
kinetics and half-life of [18F]-FDG make it well suited to imaging the response to a 
slowly changing stimulus such as food ingestion (section 1.5.1.1). In chapter 4 I 
describe approaches to adapting neuroimaging analysis techniques to deal with 
particular challenges.   
  
Across all subjects, 400 kcal meal ingestion was associated with extensive changes in 
FDG uptake in brain regions known to be involved in regulation of food intake (chapter 
6).  The consistency of these regions with those identified in previous functional 
neuroimaging studies investigating response to food ingestion in normal weight 
individuals [133, 134, 150-154, 158-160, 162] (sections 1.6.2 and 6.4.1.1)  demonstrates 
the utility of this FDG-PET paradigm in imaging responses to food ingestion.   The 
direction of signal change in my study was usually opposite to that found in previous 
studies (section 6.4.1.1) likely to be due to use of different surrogates of neuronal 
activation.    For example I found decreased FDG uptake in bilateral DLFC whereas two 
previous studies found increased [15O]-H2O-PET signal in DLFC in response to food 
ingestion [152, 154]. This underlines the importance of including normal weight 
controls and of correlating neuroimaging changes with sensations or behaviours.  
Indeed I was able to show that right DLFC deactivation in NW was correlated with 
lower ad libitum consumption (chapter 7) providing evidence of deactivation being 
associated with greater (inhibitory) function, which might relate to deactivation of 
stimulatory pathways. 
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9.2.2 Differences in regional brain responses to 400 kcal meal ingestion between 
NW, Ob and RYGB  
The differences between NW, Ob and RYGBpl in the regional brain responses to food 
ingestion were the main focus of my studies.   
 
I found exaggerated activation in hypothalamus and pituitary in response to 400 kcal 
meal ingestion after RYGB compared to NW and Ob consistent with the meal being a 
greater physiological signal to the brain (section 6.4.2.1).   My data showed a positive 
correlation between activation in hypothalamus and pituitary across all subjects (and 
within RYGB) (section 7.3.4). It seems likely that pituitary activation is secondary to 
hypothalamic activation.  My data show that in normal weight people meal size is 
highly correlated with hypothalamic activation, with variance in hypothalamic 
activation accounting for 49% of the variance in ad libitum consumption (section 
7.4.3.1).  Animal studies suggest centres in brainstem are key in controlling meal size 
and there are reciprocal connections between brainstem and hypothalamus [14][5, 14, 
60] (section 1.1.8.1). My data could be consistent with a pathway from brainstem 
centres to hypothalamus with onward pathways influencing meal size; or hypothalamus 
receiving information from other sources (section 1.1.3.1) and influencing meal size 
either via brainstem centres or independently; or possibly there could be no causative 
relationship, with the correlation being confounded, perhaps by brainstem centres 
causing both hypothalamic activation and limiting meal size (7.4.3.1)..  In Ob, despite  a 
similar range of hypothalamic activation as NW, there was no association with ad 
libitum consumption suggesting this potential mechanism of determining meal size may 
be defective in obesity.  After RYGB the greater hypothalamic activation was 
associated with the meal size that would be expected from the normal weight data, 
consistent with restoration of hypothalamus-mediated influence on meal size after 
RYGB.  Perhaps the greater hypothalamic activation after RYGB is sufficient to 
overcome any higher threshold/resistance present prior to surgery.  Consistent with my 
data, two [15O]-H2O-PET studies did not find differences in hypothalamus in response 
to mixed meal between normal weight and obese [192, 193].  However, two fMRI 
studies did find differences between normal weight and obese in the response to glucose 
ingestion in hypothalamus [133, 204].  Van de Sande-Lee et al also found a difference 
between pre-RYGB and post-RYGB, but in contrast to my data found the post-RYGB 
and normal weight responses to be similar [204].  As discussed in section 6.4.2.1 there 
are between-study differences that might account for these discrepancies.  In addition 
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the temporal clustering analytic approach used by van de Sande-Lee et al [204] depends 
on temporal coherence of activation across multiple brain regions and therefore might 
be influenced by the reduced correlations between brain regions I found in Ob (section 
7.4.4).   
 
In right DLFC there was deactivation in response to 400 kcal meal in NW which was 
absent in Ob and restored in RYGB (section 6.4.2.2).  In NW there was a highly 
significant strong association between greater deactivation in right DLFC and lower ad 
libitum consumption: the extent of deactivation in right DLFC accounting for 83% of 
the variance in ad libitum consumption (section 7.4.3.2).  Given the known role of 
DLFC in inhibitory control [126], this suggests deactivation in DLFC may have a major 
role in meal termination in normal weight people.  Although previous studies have 
shown a DLFC response (increased [15O]-H2O-PET signal) to food ingestion [152, 154] 
(section 1.6.2), and a role in meal termination has been hypothesised, this is the first 
time that change in DLFC activation has been shown to be correlated with ad libitum 
intake.  In Ob there was no evidence of DLFC deactivation in response to 400 kcal meal 
suggesting this potential mechanism of meal termination is defective in obesity. 
Whether a larger meal would result in DLFC deactivation in obese subjects, and if so 
whether this correlates with ad libitum consumption, requires further investigation.  My 
data are consistent with two [15O]-H2O-PET studies which found an attenuated post-
meal response in the obese versus normal weight in DLFC [156, 192, 193].   In the 
majority of RYGB subjects DLFC deactivation was restored and, in 3 subjects, was 
associated with ad libitum consumption that would be expected from the normal weight 
data, suggesting restoration of this potential mechanism of meal termination. However, 
in 4 subjects ad libitum intake was even lower than would be predicted and in 2 subjects 
DLFC deactivation was not restored but there was low ad libitum intake, suggesting 
other pathways are involved in determining meal size after RYGB.    Van de Sande-Lee 
et al did not find differences in response to glucose ingestion in DLFC between normal 
weight, pre-RYGB and post-RYGB subjects [204] (section 1.8.3).  However, there are 
data suggesting restoration of DLFC response to external food cues (rather than food 
ingestion) after successful RYGB [82, 200] (sections 1.8.2.1 and 6.4.2.2).  
 
Right frontal operculum (section 6.4.2.4) and anterior MFC (section 6.4.2.3) showed 
deactivation in NW which was absent in Ob and restored in RYGB, similar to right 
DLFC.  Previous studies have not identified differences in response to food ingestion in 
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these regions in obesity or after RYGB. However, the frontal operculum contains the 
gustatory cortex and my findings are consistent with studies suggesting altered central 
(and/or peripheral) taste processing after RYGB (reviewed in [71, 72]). My data show 
positive correlations in activation between frontal operculum and anterior MFC/medial 
OC in all 3 groups aswell as across all subjects (section 7.4.4) consistent with the 
recognised role of orbitomedial cortex (including MFC and OC) as the major prefrontal 
target of gustatory afferents (page 660 [251], chapter 2, section VI [252]).  For right 
frontal operculum and anterior MFC/medial OC there was an association between 
activation and change in relaxedness scores in Ob only (section 7.4.3.3).  Anterior MFC 
is thought to have a role linking external and internal stimuli with behaviour, mood and 
motivation [245].    Perhaps these are sites where wellbeing or mood interacts with 
response to food ingestion. These findings in Ob only might relate to larger group 
ormight speak to the greater emotional eating reported in obesity [25, 26].  
 
In left medial OC there was activation in RYGB, in contrast to a small deactivation in 
NW and small activation in Ob (section 6.4.2.5).  Consistent with my data, Van de 
Sande-Lee found differences in OC in response to glucose ingestion reporting the 
response in post-RYGB was different from both pre-RYGB and NW which were also 
different [204].   OC encodes reward value or salience [125] and this could provide a 
neural correlate of altered reward responses after RYGB (although there is little data on 
consummatory food reward after RYGB in humans) (section 1.3.1.2).  I did not find any 
significant associations between left medial OC activation and food-evoked change in 
sickness, anticipated pleasantness of eating or relaxedness (section 7.4.3.5). However, 
the protocol was not designed to capture the experience of pleasantness/unpleasantness 
of eating ice-cream at the moment of finishing the fixed meal: the VAS were conducted 
10 min after meal completion,  the question was not specific to ice-cream and the lower 
end of the scale was anchored with ‘not at all’ (section 9.3.2).   
 
In regions corresponding to posterior DMN there was exaggerated deactivation in 
RYGB compared to both NW and Ob (section 6.4.2.6).  These regions are not 
conventionally associated with appetite although other studies have reported differences 
(usually decreased signal) in response to food ingestion [152, 153, 162, 191] or gut 
peptide infusion [68] and there is interest in DMN in relation to appetite and obesity 
[167].   My data showed greater deactivation in bilateral angular gyri was associated 
with lower ad libitum consumption across all subjects, with variance in deactivation 
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accounting for 41-44% of the variance in ad libitum consumption, and within Ob (the 
largest group) (section 7.4.3.4), suggesting the novel hypothesis that angular gyri 
deactivation has a role in determining meal size (and is not just an abnormal response 
seen after RYGB).  These regions are associated with recollection of prior experience 
[244] (section 6.4.1.2) and perhaps mediate the impact of past food experience on 
determining meal size.  The pattern in posterior cingulate/precuneus was similar to 
angular gyri, but the correlations were weaker and the within Ob correlations were 
absent, perhaps relating to the postulated DMN role as a cortico-cortical pathway hub 
[245].  The enhanced angular gyri deactivation after RYGB was associated with the 
lower ad libitum consumption that would be expected from the all subjects and Ob data, 
consistent with enhancement of this potential mechanism of controlling meal size after 
RYGB. 
 
Studies looking at responses to external food cues after RYGB (compared to before 
RYGB, or post-band) have found reduced responses to external food cues, especially 
high ED food cues, in regions involved in reward and executive control [82, 84, 87, 
200] (section 1.8.2).  None of these studies included a normal weight group, but given 
the studies showing increased responses to external food cues in obese versus normal 
weight subjects in similar regions (section 1.7.2.1) it is tempting to conclude that RYGB 
reverses the abnormal responses seen in obesity.   This is similar to the restoration of 
responses I found in at least some brain regions.   Unlike the food cue studies I did not 
find differences in reward regions such as the nucleus accumbens/ventral striatum or 
putamen/globus pallidus.  It is possible that this is because these are small regions and 
therefore less likely to be identified on whole brain analyses used here.   However, it is 
also possible that these regions are more involved with anticipatory and pre-ingestive 
phases rather than the post-ingestive phase studied here.  
 
9.2.3 Correlations between regional brain activation in response to 400 kcal meal 
ingestion, potential pathways controlling meal size and differences between NW, 
Ob and RYGB  
In the brain regions where there were differences between the three groups, I found 
evidence of 3 networks operating in response to food ingestion (hypothalamus and 
pituitary; frontal operculum, anterior MFC/medial OC and DLFC (frontal network); and 
posterior cingulate/precuneus and bilateral angular gyri (DMN)) and evidence of links 
between these networks (section 7.4.4).   
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My data are consistent with the primary pathway determining meal size in normal 
weight people being food ingestion causing (perhaps indirectly via the brainstem 
(section 9.2.2)) hypothalamic activation causing DLFC deactivation with consequent 
meal termination (section 7.5).  However my data across all subjects are also consistent 
with a second pathway, in which hypothalamic activation results in deactivation in 
bilateral angular gyri (components of DMN) which also influences meal size.  As 
suggested above, perhaps this pathway engages memory of previous food experience in 
determining meal size.   
 
The Ob group showed fewer significant correlations in FESC between clusters than NW 
with evidence that both proposed pathways may be impaired in obesity (section 7.4.4 
and 7.5).  As discussed above, obese subjects show a similar range of hypothalamic 
activation to 400 kcal meal as normal weight but, in contrast to normal weight, there is 
no evidence hypothalamic activation influences meal size.   Hypothalamic activation 
does not result in DLFC deactivation, consequently there is no deactivation in this part 
of DLFC and thus no impact on meal size.  Correlations between hypothalmic-pituitary 
network and DMN are less extensive, (however, as discussed above, angular gyri 
deactivation was associated with lower ad libitum consumption in obese subjects).  Ad 
libitum consumption was no different between NW and Ob (section 5.4.3) suggesting 
other mechanisms of determining meal size  may operate in obesity.  Given that my 
protocol detects particularly sub-conscious mechanisms, perhaps conscious efforts 
determine meal termination in obesity.  
  
After RYGB there were a greater number of significant correlations in FESC between 
clusters than in NW or Ob, despite being the smallest group.   However this is not 
simply a restoration of normal: the hypothalamus-DLFC pathway proposed to operate in 
NW appears to be absent; whereas the proposed DMN pathway is more extensive with 
the additional finding of correlations in activation between DMN and the frontal 
network including DLFC.   
   
The connectivity literature is complex.  However, at least partially consistent with my 
findings, two studies including normal weight, obese and post-RYGB subjects have 
shown similar connectivity in normal weight and post-RYGB and different connectivity 
in the obese, one looking at hypothalamic connectivity in response to glucose ingestion  
275 
 
KF Hunt.   Chapter 9: Discussion 
[204] and the other analysing in the fed state [23] although in contrast to my data the 
latter found stronger connectivity in the obese.  Furthermore, in obese compared to 
normal weight subjects, one study has shown decreased functional connectivity of right 
DLFC with the whole brain network at rest [166] and others focussed on DMN in the 
fasting resting state have found greater activity/connectivity in posterior aspects of 
DMN [167, 168], at least partly consistent with my findings.   
 
9.2.4 The role of exaggerated postprandial pancreatic and gut peptide responses 
after RYGB 
The somatostatin+insulin data demonstrate that exaggerated postprandial insulin and/or 
gut peptide responses to food ingestion mediate postprandial nausea (section 8.4.2) and 
increased activation in left medial OC (section 8.4.3) after RYGB and that these effects 
persist in the longer term after RYGB.  The data also suggest that acute postprandial gut 
peptide responses may have a role in the greater activation in hypothalamus and 
pituitary and greater deactivation in bilateral angular gyri (section 8.4.3), and in 
reducing ad libitum consumption (section 8.4.2), in some subjects, particularly within 
the first year after RYGB.  The gut peptides might be acting directly on brain centres as 
hormones or influencing brain function by activating vagal neurons in the 
gastrointestinal tract in a paracrine fashion (section 1.1.8.1).  However in this group of 
post-RYGB subjects, who seem typical of other RYGB patients (chapter 5), the acute 
postprandial insulin and/or gut peptide responses were not the major mediators of high 
postprandial fullness, low postprandial hunger/anticipated pleasantness of eating or of 
persistent low ad libitum consumption after RYGB (section 8.4.2) and did not mediate 
the differences seen after RYGB, compared to Ob, in frontal operculum, anterior MFC 
or, perhaps most importantly given its potential role in meal termination described 
above, DLFC (section 8.4.3).  
 
As discussed in section 1.3.1 there is already extensive research into other potential 
mechanisms of action of RYGB and my data support the importance of this and also of 
considering that different mechanisms may predominate at different stages after RYGB 
[7, 71, 72].  Importantly my data show that differences in these regions persist in the 
longer term (although attenuated in hypothalamus, pituitary, and bilateral angular gyri) 
suggesting that physiological / subconscious mechanisms of limiting meal size remain 
important in the longer term after RYGB rather than being largely related to education 
and behavioural change.   
276 
 
KF Hunt.   Chapter 9: Discussion 
9.3 STRENGTHS AND LIMITATIONS  
9.3.1 Strengths  
My studies included both a normal weight and an obese control group which I found to 
be essential in the interpretation of differences found after RYGB. The protocol 
included an ad libitum meal which is an assessment of actual eating behaviour, albeit 
one the might be influenced by being observed, which proved more reliable at detecting 
differences than appetitive VAS and supports the inclusion of assessment of ad libitum 
intake in such studies.  Furthermore, the regional brain responses and appetitive VAS 
responses to 400 kcal fixed meal ingestion were measured separately from ad libitum 
consumption in the fasted state.   It is therefore reasonable to assume that ad libitum 
consumption is the dependent variable, as it is difficult to see how it could impact on 
FESC or FED-effect VAS scores derived from measurements made earlier in the day or 
on a separate day. As food-evoked FDG signal change was measured in response to a 
fixed meal (i.e. subjects were not given a choice about stopping eating), they assess only 
subconscious factors in determining meal size.    
  
Due to the kinetics of FDG, regional brain FDG signal essentially integrates FDG 
uptake over the period from FDG injection to the end of scanning weighted towards the 
earlier phase (section 1.5.1.1).  This means the subject is not in the scanner during FDG 
uptake and regional brain uptake can be assessed in a relatively normal, albeit clinical, 
environment and position.  
 
Finally the main analysis in this study was a non-hypothesis driven whole brain analysis 
which allowed identification of new regions which, by definition, would not have been 
identified on a ROI analysis. 
 
9.3.2 Limitations  
FDG-PET scanning does involve exposure to radiation (section 2.5.6.3) and this must 
be taken into consideration when used for research that is not for participants’ benefit: 
full informed consent must be obtained.  This also limits the use of repeated scans.   As 
FDG signal integrates FDG uptake over time, subtle differences in time course of a 
response may not be detected.  FDG-PET scanning was between +15 and +70 min. It is 
possible that these timings might miss some of the factors controlling meal size and/or 
meal termination.  As discussed in section 6.4.3.2 limited variations in blood glucose 
excursion are unlikely to impact significantly on FESC.  However, more extreme 
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glucose excursions may impact which limits the use of my protocol in investigating 
responses to food ingestion in some people with diabetes.  
 
This protocol was cross-sectional and therefore while inferences can made, it cannot be 
certain that the obese group are equivalent to the RYGB participants before surgery.  
 
Three RYGB subjects, who were unable to consume the full 400 kcal at the test meal 
visit, were given smaller pre-scan meals than other subjects at the FED FDG-PET visits. 
This is a potential limitation as the meal stimulus is smaller for these 3 participants, and 
also these 3 participants were fed to satiation which may or may not be the case for 
other participants.  However, these 3 participants were not otherwise unusual and the 
smaller meal appeared to have similar impact as the 400 kcal meal did in the remaining 
RYGBpl subjects on appetitive VAS scores and pancreatic and gut peptides (section 
5.4.1).   This suggests the decision to include these subjects was reasonable. 
 
Insulin and gut peptides were measured at only 2 postprandial phase time points (+30 
min and +80 min) (sections 2.5.6.6 and 8.4.4.4).  Furthermore +30 min data are 
available for only half the NW and Ob subjects, as the time point was added about half-
way through the study.  Assays measuring total (rather than only active) GLP-1, PYY 
and ghrelin were used (Table 2.3).  This approach does not provide detailed profiles of 
the gut peptide response: peak responses may have been missed; meaningful ‘area under 
the curve’ (AUC) data cannot be calculated; and total gut peptide concentration may not 
reflect biological activity.  More frequent sampling and measuring active gut peptide 
concentrations would have given more information which would have been particularly 
useful for the correlations with brain activation (chapter 8).  However, it should be 
noted that there was no original intention to perform such analyses.  Measuring total gut 
peptides at 2 postprandial phase time points was sufficient to achieve the original aims 
of measuring gut peptides in this study, which were to confirm that: the 400 kcal meal 
caused a gut peptide response (section 5.4.1); the 3 groups showed the expected meal 
responses (section 5.4.4); and somatostatin successfully suppressed gut peptide 
secretion (section 8.4.1).  
 
Appetitive sensations were assessed at only 2 postprandial phase timepoints (+10 and 
+80 min) (sections 2.5.6.5 and 8.4.4.5), and therefore did not capture appetitive 
sensations at the moment of finishing the fixed meal, may well have missed the peak or 
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nadir (section 1.3.1.1) and meaningful AUC data cannot be calculated.  In future studies 
I would assess appetitive sensations using VAS at the moment of finishing the fixed 
meal.  Additional measurements between +10 and +80 min would allow use of AUC 
data which would be better for correlational analyses and also reduce the impact of error 
or poor reproducibility (section 5.4.2.4).    However, assessing appetitive sensations 
during the FDG-PET uptake and scanning would risk influencing the neuroimaging 
results and were deliberately avoided for this reason.  
 
 The VAS was not designed to capture the experience of pleasantness, or 
unpleasantness, of eating ice-cream as the question was not specific to ice-cream and 
the lower end of the scale was anchored with ‘not at all’.  In future studies using a 
similar protocol I would make the VAS for anticipated pleasantness of eating specific to 
ice-cream and anchor the lower end with ‘extremely unpleasant’ (rather than ‘not at all’) 
to capture unpleasant sensations.  
 
A single flavour of ice-cream was used for the ad libitum meal and this therefore 
assessed sensory specific satiation [34] (section 1.1.4.1).  It is possible that different 
results may have been obtained using a buffet ad libitum meal (section 1.1.8.2). 
 
 
9.4 FUTURE RESEARCH  
These data would be amenable to an analysis to investigate whether differences between 
normal weight and obese subjects are related to obesity-related insulin resistance. My  
FDG-PET neuroimaging protocol could be used to investigate a number of research 
questions including, but not limited to: what are the brain responses to food ingestion in 
obesity prone versus obesity resistant individuals; in obese individuals does increasing 
meal size restore the correlations between brain regions; what brain responses determine 
meal size and meal termination in obesity (by imaging during ad libitum consumption); 
and what are the brain responses to food ingestion after other types of bariatric surgery 
or, potentially, other newer interventions? 
 
For wider appetite-related neuroimaging research it is important to recognise the 
importance of determination of meal size and meal termination, as well as meal 
initiation; to widen the scope of appetite related functional neuroimaging analysis to 
include the whole brain rather than only classical reward-related regions; and to 
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consider including an ad libitum meal. And for bariatric surgery research it is important 
to bear in mind that several different mechanisms may operate, perhaps with different 
mechanisms predominating in different people and at different times post-surgery [7, 
71, 72]. 
 
9.5 CONCLUSIONS  
This new FDG-PET functional neuroimaging protocol identifies responses to 400 kcal 
meal ingestion in regions consistent with those identified in previous studies, thus 
demonstrating its utility.  The NW, Ob and RYGB subjects studied were typical in their 
appetitive and pancreatic and gut peptide responses to 400 kcal meal ingestion and 
RYGB subjects showed the expected lower ad libitum consumption.  
 
Differences in regional brain responses to 400 kcal meal ingestion between NW, Ob and 
RYGB were as follows.  There was exaggeration of hypothalamic activation after 
RYGB, compared to NW and Ob, consistent with the same 400 kcal meal being a 
greater physiological stimulus after RYGB.  In NW, ad libitum consumption was highly 
correlated with  hypothalamic activation.  The data are consistent with absence of 
hypothalamus-mediated limitation of meal size in obesity (despite similar hypothalamic 
activation), and exaggerated hypothalamic activation after RYGB resulting in 
restoration of hypothalamus-mediated limitation of meal size.   There was deactivation 
in right DLFC in NW, with greater deactivation being associated with lower ad libitum 
consumption consistent with DLFC having a role in meal termination in normal weight 
people.  This DLFC deactivation was absent in Ob, suggesting this potential mechanism 
of meal termination is defective in obesity, and restored after RYGB with the associated 
lower ad libitum consumption.  Right frontal operculum and anterior MFC/medial OC 
showed deactivation in NW, which was absent in Ob and restored in RYGB.  Frontal 
operculum contains the gustatory cortex and these findings may provide a neurological 
correlate of altered taste processing after RYGB.  The positive correlations in activation 
between frontal operculum and anterior MFC/medial OC are consistent with the 
recognised role of orbitomedial cortex as the major prefrontal target of gustatory 
afferents.  The association between activation and relaxedness scores in these regions, 
seen in Ob only, raise the possibility that these are sites where wellbeing or mood 
interacts with response to food ingestion.  In left medial OC there was abnormal 
activation after RYGB which, given the role of OC, might be consistent with alteration 
of food salience after RYGB, although I did not find specific evidence to support this.  
280 
 
KF Hunt.   Chapter 9: Discussion 
There was exaggerated deactivation in RYGB, compared to NW and Ob, in posterior 
cingulate/precuneus and bilateral angular gyri, regions corresponding to posterior DMN.  
Greater deactivation in bilateral angular gyri was associated with lower ad libitum 
consumption suggesting the novel hypothesis that angular gyri deactivation may have a 
role in determining meal size, perhaps encoding the impact of past food experience.  
The data are consistent with enhancement of this potential mechanism of determining 
meal size  after RYGB.  These changes in brain responses to food ingestion after 
RYGB, some associated with reduced ad libitum consumption, would be expected to 
contribute to weight loss. 
 
Correlational analyses suggest that in normal weight people the primary pathway 
determining meal size  is food ingestion causing hypothalamic activation (perhaps 
indirectly via the brainstem) causing DLFC deactivation with consequent meal 
termination and a second pathway in which hypothalamic activation results in 
deactivation in bilateral angular gyri which also influences meal size.  The Ob group 
showed fewer significant correlations between clusters with evidence that both proposed 
pathways may be impaired in obesity.  After RYGB correlations are more extensive, 
although this is not simply a restoration of normal: the hypothalamus-DLFC pathway 
proposed to operate in NW appears to be absent, whereas the proposed DMN pathway 
is more extensive with the additional finding of correlations in activition between DMN 
and frontal network including DLFC.   
  
The use of somatostatin+insulin in RYGB demonstrated that exaggerated postprandial 
insulin and/or gut peptide responses mediate postprandial nausea and increased 
activation in left medial OC after RYGB and may have a role in the greater activation in 
hypothalamus and greater deactivation in bilateral angular gyri, and in reducing ad 
libitum consumption, in some subjects, particularly within the first year after RYGB.  
However, in this group of post-RYGB subjects, the acute postprandial insulin and/or gut 
peptide responses were not the major mediators of high postprandial fullness and low 
postprandial hunger/anticipated pleasantness of eating or of persistent low ad libitum 
consumption after RYGB and did not mediate the differences seen after RYGB in other 
brain regions.  
 
Taken together, these data explain the importance of the brain responses to food 
ingestion in the bariatric effects of RYGB. 
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